FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Santos, GR
   Pinto, CAL
   Prudente, RCS
   Bevilacqua, EMAF
   Witkin, SS
   Passos, SD
   Moron, AF
   Ventura, DF
   Massad, E
   Zanotto, PMA
   Rodrigues, LC
   Bertozzi, APAP
   Grion, AP
   Mingotti, AC
   Silva, ACB
   Martins, CMG
   Barreira, ER
   Fujiwara, DT
   Souza, FMS
   Velasco, FG
   Cangerana, F
   Arita, FN
   Hernandez, FDM
   Tabares, HS
   Milani, HJF
   Sampaio, MMSC
   Machado, MB
   Silva, MMA
   Rodrigues, MMD
   Almeida, MF
   Rizzo, MF
   Damico, FM
   Clemente, NS
   Cunha, MP
   Izbicki, R
   Gazeta, RE
   Dezena, RCAB
   Bonom, SHA
   Pour, SZ
   Uranjec, S
   Rosemberg, S
   Oyama, SMR
   Sarmento, SGP
   Quintella, TM
   Fajardo, TCG
   Ferrareto, TRG
   Rodrigues, WM
   Baran, L
   Soares, AP
   Costa, M
   Barboni, MTS
   Lima, D
   Franca, VCRM
   Vidal, KS
   Barbosa, AR
   Zanquetta, GU
   Silva, AB
AF Santos, Geovane R.
   Pinto, Clovis A. L.
   Prudente, Raphael C. S.
   Bevilacqua, Estela M. A. F.
   Witkin, Steven S.
   Passos, Saulo D.
   Moron, A. F.
   Ventura, D. F.
   Massad, E.
   Zanotto, P. M. A.
   Rodrigues, L. C.
   Bertozzi, A. P. A. P.
   Grion, A. P.
   Mingotti, A. C.
   Silva, A. C. B.
   Martins, C. M. G.
   Barreira, E. R.
   Fujiwara, D. T.
   Souza, F. M. S.
   Velasco, F. G.
   Cangerana, F.
   Arita, F. N.
   Hernandez, F. D. M.
   Tabares, H. S.
   Milani, H. J. F.
   Sampaio, M. M. S. C.
   Machado, M. B.
   Silva, M. M. A.
   Rodrigues, M. M. D.
   Almeida, M. F.
   Rizzo, M. F.
   Damico, F. M.
   Clemente, N. S.
   Cunha, M. P.
   Izbicki, R.
   Gazeta, R. E.
   Dezena, R. C. A. B.
   Bonom, S. H. A.
   Pour, S. Z.
   Uranjec, S.
   Rosemberg, S.
   Oyama, S. M. R.
   Sarmento, S. G. P.
   Quintella, T. M.
   Fajardo, T. C. G.
   Ferrareto, T. R. G.
   Rodrigues, W. M.
   Baran, L.
   Soares, A. P.
   Costa, M.
   Barboni, M. T. S.
   Lima, Ds
   Franca, V. C. R. M.
   Vidal, K. S.
   Barbosa, A. R.
   Zanquetta, G. U.
   Silva, A. B.
CA Zika Virus Cohort Study Grp
TI Histopathologic Changes in Placental Tissue Associated With Vertical
   Transmission of Zika Virus
SO INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
LA English
DT Article
DE Zika virus; Placenta; Congenital; pathology; Immunohistochemistry
ID BCL-2; EXPRESSION; INFECTION
AB Zika virus (ZIKV) is highly neurotropic after crossing the placenta, inducing teratogenic effects that result in delayed development and microcephaly in infants. The available evidence for vertical transmission of this infection is based on placental studies showing alterations in trophoblastic tissue. However, complete characterization of ZIKV-infected placenta and involved pathways has yet to be fully clarified. This case report of placental ZIKV infection describes morphologic and molecular changes in the placenta. Hyperplasia of placental Hofbauer cells in chorionic villi and numerous histiocyte-like cells in the decidua were observed. The decidua, fibroblasts, and chorion, as well as circulating cells in the intravascular compartment stained positive for ZIKV envelop protein. Deciduitis was present on the maternal surface of the placenta, with a prevalence of lymphocytes associated with vasculitis. A high level of uncommitted CD3(+) T lymphocytes were present, in addition to CD4(+) and CD8(+) cells. Elevated expression of the apoptosis inhibitor, Bcl-2, was observed in syncytiotrophoblasts. These parameters may promote the persistence of ZIKV in placental tissue and transmission to the fetus.
C1 [Santos, Geovane R.; Pinto, Clovis A. L.; Prudente, Raphael C. S.] Jundiai Med Sch, Dept Morphol & Pathol, Jundiai, Brazil.
   [Passos, Saulo D.] Jundiai Med Sch, Dept Pediat, Jundiai, Brazil.
   Jundiai Med Sch, Jundiai, Brazil.
   [Passos, Saulo D.] Jundiai Med Sch, Univ Teaching Hosp, Jundiai, Brazil.
   [Pinto, Clovis A. L.] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, SP, Brazil.
   [Bevilacqua, Estela M. A. F.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, SP, Brazil.
   [Witkin, Steven S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, SP, Brazil.
   [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Pinto, CAL (corresponding author), R Francisco Teles 250,Vila Arens 2, BR-13202550 Sao Paulo, SP, Brazil.
EM patologia@fmj.br
RI Clemente, Nuria Sanchez/AAL-4309-2020; Bevilacqua, Estela/H-3354-2011;
   Passos, Saulo/C-5166-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; Alexandrasmello@gmail.com,
   Alexandra/0000-0002-7996-873X; FAJARDO, THAMIRYS/0000-0003-1096-1078;
   Passos, Saulo/0000-0002-0908-2677
FU Sao Paulo Research Foundation (FAPESP) (Sao Paulo, Brazil)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/08578-0]
FX This research work was developed by the Zika Virus Cohort Study Group at
   the Jundiai Medical School and was funded by the Sao Paulo Research
   Foundation (FAPESP) (Sao Paulo, Brazil) under reference number
   2016/08578-0.
CR Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   De Falco M, 2001, HISTOCHEM J, V33, P421, DOI 10.1023/A:1013728012048
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kim CJ, 1995, PATHOL RES PRACT, V191, P1239, DOI 10.1016/S0344-0338(11)81132-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Soni S, 2010, ANAT HISTOL EMBRYOL, V39, P426, DOI 10.1111/j.1439-0264.2010.01012.x
   Straszewski-Chavez SL, 2004, MOL HUM REPROD, V10, P33, DOI 10.1093/molehr/gah001
NR 13
TC 3
Z9 3
U1 3
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-1691
EI 1538-7151
J9 INT J GYNECOL PATHOL
JI Int. J. Gynecol. Pathol.
PD MAR
PY 2020
VL 39
IS 2
BP 157
EP 162
DI 10.1097/PGP.0000000000000586
PG 6
WC Obstetrics & Gynecology; Pathology
SC Obstetrics & Gynecology; Pathology
GA KO4UP
UT WOS:000515546900011
PM 30789499
DA 2020-12-01
ER

PT J
AU da Silva, FC
   Magaldi, FM
   Sato, HK
   Bevilacqua, E
AF da Silva, Fernanda C.
   Magaldi, Fernanda M.
   Sato, Helena K.
   Bevilacqua, Estela
TI Yellow Fever Vaccination in a Mouse Model Is Associated With
   Uninterrupted Pregnancies and Viable Neonates Except When Administered
   at Implantation Period
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE yellow fever (YF) vaccine; pregnancy; congenital transmission; placenta;
   fetal losses
ID STOCHASTIC-MODEL; VIRUS; CELLS; 17D; IMMUNIZATION; PATHOGENESIS;
   INFECTION; PATHOLOGY; IMMUNITY; MONKEYS
AB The potential risk of yellow fever (YF) infection in unvaccinated pregnant women has aroused serious concerns. In this study, we evaluated the effect of the YF vaccine during gestation using a mouse model, analyzing placental structure, immunolocalization of the virus antigen, and viral activity at the maternal-fetal barrier and in the maternal liver and fetus. The YF vaccine (17DD) was administered subcutaneously at a dose of 2.0 log(10) PFU to CD-1 mice on gestational days (gd) 0.5, 5.5, and 11.5 (n = 5-10/group). The control group received sterile saline (n = 5-10/group). Maternal liver, implantation sites with fetus, and placentas were collected on gd18.5. The numbers of implantation sites, reabsorbed embryos, and stillborn fetuses were counted, and placentas and live fetuses were weighed. Tissues (placenta, fetuses, and liver) of vaccinated pregnant mice on gd5.5 (n = 15) were paraffin-embedded in 10% buffered-formalin and collected in TRIzol for immunolocalization of YF vaccine virus and PCR, respectively. PCR products were also subjected to automated sequence analysis. Fetal growth restriction (p < 0.0001) and a significant decrease in fetal viability (p < 0.0001) occurred only when the vaccine was administered on gd5.5. In stillbirths, the viral antigen was consistently immunolocalized at the maternal-fetal barrier and in fetal organs, suggesting a transplacental transfer. In stillbirths, RNA of the vaccine virus was also detected by reverse transcriptase-PCR indicating viral activity in the maternal liver and fetal tissues. In conclusion, the findings of this study in the mouse suggest that vaccination did not cause adverse outcomes with respect to fetal development except when administered during the early gestational stage, indicating the implantation period as a susceptible period in which the YF vaccine virus might interfere with pregnancy.
C1 [da Silva, Fernanda C.; Magaldi, Fernanda M.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Sato, Helena K.] Secretaria Estado Sao Paulo, Epidmiol Surveillance Ctr, Dept Hlth, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
EM bevilacq@usp.br
OI Silva, Fernanda Carini/0000-0002-9290-1812
FU Coordination of Improvement of Higher Education (CAPES)CAPES; National
   Council of Research and Technological Development (CNPq)National Council
   for Scientific and Technological Development (CNPq)
FX Fellowship for FM and FC were provided by Coordination of Improvement of
   Higher Education (CAPES), and National Council of Research and
   Technological Development (CNPq), respectively. Foundation for Research
   Support in the State of Sao Paulo (Fapesp) provided support for animal
   housing. The Department of Health of the State of Sao Paulo kindly
   provided the vaccines.
CR Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Bjornberg JE, 2014, J APPL PROBAB, V51, P599
   Blake LE, 2014, MBIO, V5, DOI 10.1128/mBio.01253-14
   Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9
   Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015
   Croy B. A., 2014, GUIDE INVESTIGATION
   D'Acremont V, 2008, J TRAVEL MED, V15, P77, DOI 10.1111/j.1708-8305.2007.00175.x
   Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797
   Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020
   Engelmann F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003295
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Hagmann SHF, 2017, OBSTET GYNECOL, V130, P1357, DOI 10.1097/AOG.0000000000002360
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh
   Khaiboullina SF, 2005, VIROLOGY, V342, P167, DOI 10.1016/j.virol.2005.07.035
   Khaiboullina SF, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060558
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   MARCHETTE NJ, 1973, J INFECT DIS, V128, P23, DOI 10.1093/infdis/128.1.23
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   Martins RD, 2015, HUM VACC IMMUNOTHER, V11, P2183, DOI 10.1080/21645515.2015.1022700
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2013, AM J TROP MED HYG, V89, P1225, DOI 10.4269/ajtmh.13-0443a
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Monath TP, 2013, VACCINES, P870
   NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K
   Nathanson N., 2007, VIRAL PATHOGENESIS I, P174
   Nishioka SD, 1998, TROP MED INT HEALTH, V3, P29, DOI 10.1046/j.1365-3156.1998.00164.x
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Quaresma JAS, 2006, MED HYPOTHESES, V67, P618, DOI 10.1016/j.mehy.2006.01.060
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Robert E, 1999, VACCINE, V17, P283, DOI 10.1016/S0264-410X(98)00051-6
   SALEWSKL E., 1964, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMEEDEBERGS], V247, P367
   Staples JE, 2011, TROPICAL INFECT DIS, P492, DOI 10.1016/B978-0-7020-3935-5.00074-4
   Suzano CES, 2006, VACCINE, V24, P1421, DOI 10.1016/j.vaccine.2005.09.033
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Tuckwell HC, 1998, J THEOR BIOL, V195, P451, DOI 10.1006/jtbi.1998.0806
   Waggoner JJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00827-18
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   Woodson SE, 2011, VIROLOGY, V412, P188, DOI 10.1016/j.virol.2011.01.012
   Yuan Y, 2011, MATH BIOSCI, V234, P84, DOI 10.1016/j.mbs.2011.08.007
NR 51
TC 1
Z9 1
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 20
PY 2020
VL 11
AR 245
DI 10.3389/fmicb.2020.00245
PG 9
WC Microbiology
SC Microbiology
GA KT6QD
UT WOS:000519138000001
PM 32153534
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Yung, HW
   Burton, GJ
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Yung, Hong Wa
   Burton, Graham J.
   Bevilacqua, Estela
TI The potential contribution of stromal cell-derived factor 2 (SDF2) in
   endoplasmic reticulum stress response in severe preeclampsia and
   labor-onset
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Review
DE SDF2; Placenta; Trophoblast; Preeclampsia; Labor; UPR
ID UNFOLDED PROTEIN RESPONSE; SIGNAL SEQUENCE TRAP; INDUCED APOPTOSIS;
   GENE-EXPRESSION; QUALITY-CONTROL; ER STRESS; INHIBITION; PREGNANCY;
   ISCHEMIA; PLACENTA
AB Endoplasmic reticulum (ER) stress occurs when the protein folding machinery in the cell is unable to cope with newly synthesized proteins, which results in an accumulation of misfolded proteins in the ER lumen. In response, the cell activates a cellular signaling pathway known as the Unfolded Protein Response (UPR), aiming to restore cellular homeostasis. Activation and exacerbation of the UPR have been described in several human pathologies, including cancer and neurological disorders, and in some gestational diseases such as preeclampsia and gestational diabetes. This review explores the participation of stromal cell-derived factor 2 (SDF2) in UPR pathways, shows new information and discusses its exacerbation regarding protein expression in severe preeclampsia and labor, both of which are associated with ER stress.
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, SP, Brazil.
   [Yung, Hong Wa; Burton, Graham J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Dept Physiol, Cambridge, England.
RP Lorenzon-Ojea, AR; Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, SP, Brazil.
EM aline.lorenzon@usp.br; bevilacq@usp.br
RI Lorenzon, Aline/G-8733-2014
OI Lorenzon, Aline/0000-0002-6052-6296
FU FAPESP -Fundacao de Amparo Pesquisa do Estado de Sao Paulo/Sao Paulo
   Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2014/13052-1, 2016/04210-8, 2017/06824-6]; CNPq, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/Brazilian Council
   for Scientific and Technological DevelopmentNational Council for
   Scientific and Technological Development (CNPq) [301387/2015-0]
FX This research was supported by FAPESP -Fundacao de Amparo Pesquisa do
   Estado de Sao Paulo/Sao Paulo Research Foundation (2014/13052-1,
   2016/04210-8 and 2017/06824-6), and in part, by the CNPq, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico/Brazilian Council
   for Scientific and Technological Development (301387/2015-0).
CR Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974
   Bastida-Ruiz D, 2017, PLACENTA, V57, P163, DOI 10.1016/j.placenta.2017.07.004
   Benedetti G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023680
   Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041
   Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043
   Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096
   Burton GJ, 2017, PLACENTA, V52, P146, DOI 10.1016/j.placenta.2016.04.001
   Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003
   Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002
   Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575
   Charnock-Jones DS, 2016, J REPROD IMMUNOL, V114, P81, DOI 10.1016/j.jri.2015.07.004
   Chen SH, 2005, PHYSIOL GENOMICS, V22, P257, DOI 10.1152/physiolgenomics.00063.2005
   Cindrova-Davies T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00119
   Curtis EM, 2018, BRIT MED BULL, V126, P57, DOI 10.1093/bmb/ldy010
   Davies EL, 2016, HYPERTENS PREGNANCY, V35, P510, DOI 10.1080/10641955.2016.1190846
   Du L, 2017, J HUM HYPERTENS, V31, P49, DOI 10.1038/jhh.2016.17
   Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042
   Fujimori T, 2017, GENES CELLS, V22, P684, DOI 10.1111/gtc.12506
   Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Ingles J, 2017, J CARDIOVASC PHARM T, V22, P337, DOI 10.1177/1074248417702482
   Jain A, 2012, AM J PATHOL, V180, P2309, DOI 10.1016/j.ajpath.2012.03.005
   Jha S, 2011, BIOTECHNOL J, V6, P623, DOI 10.1002/biot.201000327
   Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x
   Kang H, 2009, INT J ONCOL, V35, P205, DOI 10.3892/ijo_00000330
   Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008
   Kita K, 2017, CANCER SCI, V108, P1820, DOI 10.1111/cas.13318
   Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636
   Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183
   Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950
   Li HJ, 2012, PROTEIN CELL, V3, P10, DOI 10.1007/s13238-012-2004-y
   Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048
   Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005
   Liong S, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120741
   Lorenzon-Ojea AR, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.138164
   Lorenzon-Ojea AR, 2014, INT J BIOCHEM CELL B, V53, P262, DOI 10.1016/j.biocel.2014.05.024
   Madden E, 2019, BIOL CELL, V111, P1, DOI 10.1111/boc.201800050
   Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609
   Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311
   Mizuuchi M, 2016, J PATHOL, V238, P550, DOI 10.1002/path.4678
   Modell H, 2015, ADV PHYSIOL EDUC, V39, P259, DOI 10.1152/advan.00107.2015
   Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331
   Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103
   Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590
   Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262
   OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x
   Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0
   Padmini E, 2012, CELL BIOCHEM BIOPHYS, V64, P187, DOI 10.1007/s12013-012-9371-0
   Perrucci GL, 2016, INT J CARDIOL, V212, P324, DOI 10.1016/j.ijcard.2016.03.082
   Phillips Cathi, 2016, Nurs Womens Health, V20, P400, DOI 10.1016/j.nwh.2016.07.003
   Qi WW, 2018, MOL MED REP, V18, P3599, DOI 10.3892/mmr.2018.9360
   Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816
   Salsoso R, 2015, PLACENTA, V36, P287, DOI 10.1016/j.placenta.2014.12.007
   Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257
   Schott A, 2010, J BIOL CHEM, V285, P18113, DOI 10.1074/jbc.M110.117176
   Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056
   Shi ZH, 2012, CELL BIOCHEM BIOPHYS, V63, P183, DOI 10.1007/s12013-012-9350-5
   Shirozu M, 1996, GENOMICS, V37, P273, DOI 10.1006/geno.1996.0560
   Singh V.K., 1998, MOL VIS, V20, P4
   Siragusa M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2819
   STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107
   Sui CG, 2016, EUR J CANCER PREV, V25, P288, DOI 10.1097/CEJ.0000000000000185
   Takahashi K, 2016, CANCER LETT, V378, P8, DOI 10.1016/j.canlet.2016.05.002
   TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023
   Tian XY, 2016, DNA CELL BIOL, V35, P59, DOI 10.1089/dna.2015.2885
   Tongaonkar P, 2009, J BIOL CHEM, V284, P5602, DOI 10.1074/jbc.M806664200
   Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]
   Veerbeek JHW, 2015, PLACENTA, V36, P88, DOI 10.1016/j.placenta.2014.11.005
   Vendrell E, 2007, INT J ONCOL, V30, P1099
   Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394
   Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068
   Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082
   Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894
   Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193
   Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com
   Yung HW, 2016, DIABETOLOGIA, V59, P2240, DOI 10.1007/s00125-016-4040-2
NR 82
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD FEB 1
PY 2020
VL 1866
IS 2
AR 165386
DI 10.1016/j.bbadis.2019.01.012
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA KG0EP
UT WOS:000509614800009
PM 30776414
DA 2020-12-01
ER

PT J
AU Gomes, SZ
   Araujo, F
   Bandeira, CL
   Oliveira, LG
   Hoshida, MS
   Zugaib, M
   Francisco, RPV
   Bevilacqua, E
AF Gomes, Sara Z.
   Araujo, Franciele
   Bandeira, Carla L.
   Oliveira, Leandro G.
   Hoshida, Mara S.
   Zugaib, Marcelo
   Francisco, Rossana P. V.
   Bevilacqua, Estela
TI The Impact of Immunosuppressive Drugs on Human Placental Explants
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE placenta; explants; sFLT1; PlGF; cyclosporine; azathioprine
ID IN-VITRO; PREGNANCY; AZATHIOPRINE; TRANSPLANTATION; 6-MERCAPTOPURINE;
   GROWTH; WOMEN; ANGIOGENESIS; HYPERTENSION; EXPRESSION
AB The use of immunosuppressive drugs guarantees the vitality of the graft and allows gestation in spite of intercurrences such as prematurity and intrauterine growth restriction. However, little is known about the direct effects of immunosuppressive drugs on placental cells. We investigated the effects of immunosuppressive drugs in the chorionic villous explants from human term placentas of healthy gestations. Human placental explants from term gestations (37-39 week gestational age, n = 12) were exposed to cyclosporine A (CSA, 0, 62.5, 125, 1250 ng/mL) or azathioprine (AZA, 0, 5, 10, 100 ng/mL) separately or, in combination for up to 48 hours. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays showed a significant decrease in the explant metabolic activity between AZA and the control group (24 hours, 100 ng/mL, 48 hours, all concentrations, P < .005). Cyclosporin A (CsA) reduced cell activity when associated with AZA (48 hours, P < .005). Fibrinoid deposits increased in AZA-treated explants alone (5 ng/mL, 48 hours; 10 ng/mL, 24-48 hours; P < .005) or when associated with CsA (10 AZA/125 CsA, P < .05), whereas in CsA treatment alone, there was an augment in syncytial knots (24-48 hours, P < .005). The sFLT1 gene (24 hours, P < .05) and protein (P < .005) expression increased in AZA and CsA-treatments separately or in combination (P < .05). Placental growth factor increased in AZA (24 hours, 10 ng/mL) and CsA (125 ng/mL; P < .05). In conclusion, our data indicate that AZA primarily acts on the villous metabolism, perturbing placental homeostasis. Since these drugs may alter the balance of angiogenic factors in its selection for clinical application, their impact on the behavior of placental villous should be considered.
C1 [Gomes, Sara Z.; Araujo, Franciele; Bandeira, Carla L.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, Av Prof LineuPrestes 1524, BR-05508 Sao Paulo, SP, Brazil.
   [Oliveira, Leandro G.] Sao Paulo State Univ, Botucatu Med Sch, Gynecol & Obstet Dept, Sao Paulo, Brazil.
   [Hoshida, Mara S.; Zugaib, Marcelo; Francisco, Rossana P. V.] Univ Sao Paulo, Obstet & Gynecol Dept, Med Sch, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, Av Prof LineuPrestes 1524, BR-05508 Sao Paulo, SP, Brazil.
EM bevilacq@usp.br
RI Hoshida, Mara S/D-3900-2012; Bevilacqua, Estela/H-3354-2011; Francisco,
   Rossana Pulcineli Vieira/AAG-7461-2020; Francisco, Rossana
   PV/C-5648-2012; De Oliveira, Leandro/G-3476-2012
OI Hoshida, Mara S/0000-0003-2232-4631; Bevilacqua,
   Estela/0000-0003-4178-4625; Francisco, Rossana Pulcineli
   Vieira/0000-0002-9981-8069; Francisco, Rossana PV/0000-0002-9981-8069;
   Rodrigues Araujo, Franciele/0000-0002-1009-7710; De Oliveira,
   Leandro/0000-0002-8422-9907
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the Sao Paulo State Research Foundation (FAPESP) and
   the Brazilian National Council for Scientific and Technological
   Development (CNPq).
CR Alston PK, 2001, OBSTET GYNECOL SURV, V56, P289, DOI 10.1097/00006254-200105000-00024
   Armenti Vincent T, 2008, Transplant Rev (Orlando), V22, P223, DOI 10.1016/j.trre.2008.05.001
   Bar-Oz B, 2001, TRANSPLANTATION, V71, P1051, DOI 10.1097/00007890-200104270-00006
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC
   Bergan S, 1997, THER DRUG MONIT, V19, P502, DOI 10.1097/00007691-199710000-00003
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Bertolin K., 2010, Animal Reproduction, V7, P146
   Bhattacharjee P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141986
   Brogan PA, 2000, ARCH DIS CHILD, V83, P259, DOI 10.1136/adc.83.3.259
   Bukowski R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182874
   Chaabane W, 2016, ONCOTARGET, V7, P75616, DOI 10.18632/oncotarget.12313
   Colla L, 2018, J NEPHROL, V31, P361, DOI 10.1007/s40620-018-0477-3
   de Boer NKH, 2006, AM J GASTROENTEROL, V101, P1390, DOI 10.1111/j.1572-0241.2006.00538.x
   de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9
   Du MR, 2008, BIOL REPROD, V78, P1102, DOI 10.1095/biolreprod.107.063503
   Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222
   Eklund BI, 2007, BIOCHEM PHARMACOL, V73, P1829, DOI 10.1016/j.bcp.2007.02.002
   Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297
   FRANK HG, 1994, ACTA ANAT, V150, P55
   Ghanem ME, 2005, EUR J OBSTET GYN R B, V121, P178, DOI 10.1016/j.ejogrb.2004.11.035
   Hoffmann M, 2001, J AM CHEM SOC, V123, P6404, DOI 10.1021/ja010378c
   Janssen NM, 2000, ARCH INTERN MED, V160, P610, DOI 10.1001/archinte.160.5.610
   Josephson MA, 2007, ADV CHRONIC KIDNEY D, V14, P156, DOI 10.1053/j.ackd.2007.01.006
   Josephson MA, 2011, SEMIN NEPHROL, V31, P100, DOI 10.1016/j.semnephrol.2010.10.009
   Kaufmann P, 1996, ANN ANAT, V178, P485, DOI 10.1016/S0940-9602(96)80102-6
   Lee AU, 2001, J HEPATOL, V35, P756, DOI 10.1016/S0168-8278(01)00196-9
   Malhotra SS, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0046-0
   Maltzman JS, 2003, J CLIN INVEST, V111, P1122, DOI 10.1172/JCI200318384
   Matalon ST, 2005, HUM REPROD, V20, P1390, DOI 10.1093/humrep/deh721
   Mayhew TM, 2002, PLACENTA, V23, P742, DOI 10.1053/plac.2002.0865
   Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
   Narasimha A, 2011, INDIAN J PATHOL MICR, V54, P15, DOI 10.4103/0377-4929.77317
   Norgard B, 2007, AM J GASTROENTEROL, V102, P1406, DOI 10.1111/j.1572-0241.2007.01216.x
   Oliveira LG, 2007, CLIN TRANSPLANT, V21, P301, DOI 10.1111/j.1399-0012.2006.00627.x
   Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200
   Pacheco Neto M, 2008, J BRAS PATOL MED LAB, V44, P161
   Parolin Mônica Beatriz, 2009, Arq. Gastroenterol., V46, P154, DOI 10.1590/S0004-28032009000200015
   PLATZEK T, 1994, CHEM-BIOL INTERACT, V93, P59, DOI 10.1016/0009-2797(94)90086-8
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Riss TL, 2004, ASSAY DRUG DEV TECHN, V2, P51, DOI 10.1089/154065804322966315
   Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014
   Sava RI, 2018, CLIN CARDIOL, V41, P220, DOI 10.1002/clc.22892
   Shah DA, 2015, BIOCHEM PHARMACOL, V95, P211, DOI 10.1016/j.bcp.2015.04.012
   Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136
   Svetitsky S, 2018, TRANSPL P, V50, P1461, DOI 10.1016/j.transproceed.2018.02.092
   Thellin O, 2003, TOXICOLOGY, V185, P179, DOI 10.1016/S0300-483X(02)00607-8
   Townsend R, 2016, INTEGR BLOOD PRESS C, V9, P79, DOI 10.2147/IBPC.S77344
   Vause S, 2005, ANAEST INTENS CARE M, V6, P77, DOI 10.1383/anes.6.3.77.62220
   Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097
   Wang L, 2006, ONCOGENE, V25, P1629, DOI 10.1038/sj.onc.1209372
   Wang SC, 2013, PLACENTA, V34, P374, DOI 10.1016/j.placenta.2013.01.009
   Ye L, 2016, PLACENTA, V48, P110, DOI 10.1016/j.placenta.2016.10.013
   Yu NH, 2017, J CELL BIOCHEM, V118, P2208, DOI 10.1002/jcb.25867
   Zand MS, 2005, SEMIN DIALYSIS, V18, P511, DOI 10.1111/j.1525-139X.2005.00098.x
NR 54
TC 0
Z9 0
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD SEP
PY 2019
VL 26
IS 9
BP 1225
EP 1234
DI 10.1177/1933719118812739
PG 10
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA IX9HS
UT WOS:000485999400007
PM 30458698
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Alencar, AP
   Moreli, JB
   Borbely, AU
   Lima, LD
   Scavone, C
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Correa-Silva, Simone
   Alencar, Aline P.
   Moreli, Jusciele B.
   Borbely, Alexandre U.
   Lima, Larissa de S.
   Scavone, Cristoforo
   Damasceno, Debora C.
   Rudge, Marilza V. C.
   Bevilacqua, Estela
   Calderon, Iracema M. P.
TI Hyperglycemia induces inflammatory mediators in the human chorionic
   villous
SO CYTOKINE
LA English
DT Article
DE Hyperglycemia; Placenta; Inflammatory cytokines; Inflammasome
ID GESTATIONAL DIABETES-MELLITUS; NF-KAPPA-B; ACTIVATION; MECHANISMS;
   PREGNANCY; WOMEN
AB This study was based on the hypothesis that IL-1 beta and its central regulator, the inflammasome, may play a role in the inflammatory condition exhibited by placental tissues from mothers with different gestational hyperglycemia levels. Pregnant women were classified according to the glycemic reference as non-diabetic (n = 15), mild gestational hyperglycemia (n = 15), gestational diabetes mellitus (n = 15) and type 2 diabetes mellitus (n = 15). We investigated levels of pro-inflammatory factors in maternal plasma and placental tissues (by ELISA or immunohistochemistry) and, NFKB activity (by electrophoretic mobility shift assay) and inflammasome protein expression (by Western blot) in chorionic villous. Maternal plasma and placental levels of inflammatory factors (IL-1 beta, IL-6, and MCP-1) were increased during all hyperglycemic conditions. Villous stroma cells showed strong immunoreactivity to CD68. In addition, with syncytiotrophoblast, the villous stroma cells were also stained to detect iNOS, MCP-1, TLR2, and TLR4. Although the levels of protein had fluctuated in the groups, NLRP1, NLRP3, ASC, and Caspase 1 were up-regulated in all hyperglycemic groups suggesting the inflammasome may be assembled in these pregnant women. The NFKB activity also exhibited higher levels in hyperglycemic groups, which might imply in pro-inflammatory cytokines production. In summary, increased maternal glucose levels during pregnancy changed systemic and placental inflammatory patterns, which occurred in parallel with the expression of inflammasome factors and processing and secretion of the pro-inflammatory cytokine IL-1 beta. These results suggest an inflammatory condition in all gestational hyperglycemic conditions, even in hyperglycemia that is less severe than gestational or overt diabetes, likely associated with inflammasome activation and inflammatory cytokine secretion. Inflammasome activation as a possible source of inflammatory factors may be an important target to be considered while managing hyperglycemia and preventing adverse pregnancy outcomes.
C1 [Correa-Silva, Simone; Moreli, Jusciele B.; Damasceno, Debora C.; Rudge, Marilza V. C.; Calderon, Iracema M. P.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Grad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
   [Correa-Silva, Simone; Alencar, Aline P.; Borbely, Alexandre U.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, SP, Brazil.
   [Correa-Silva, Simone] Univ Paulista, Inst Hlth Sci, Sao Paulo, Brazil.
   [Moreli, Jusciele B.] Univ Fed Sao Paulo, Postgrad Struct & Funct Biol, Sao Paulo, SP, Brazil.
   [Borbely, Alexandre U.] Univ Fed Alagoas, Inst Hlth & Biol Sci, Alagoas, Brazil.
   [Lima, Larissa de S.; Scavone, Cristoforo] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.
   [Moreli, Jusciele B.] Faceres Sch Med, Sao Jose Do Rio Preto, SP, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, SP, Brazil.; Calderon, IMP (corresponding author), UNESP Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynecol, Distrito Rubino Jr S-N, BR-18618000 Botucatu, SP, Brazil.
EM bevilacq@usp.br; calderon@fmb.unesp.br
RI Borbely, Alexandre Urban/Q-2884-2019; Calderon, Iracema/W-4336-2019; da
   Saude, Programa Ciencias/ABF-1705-2020; Bevilacqua, Estela/H-3354-2011;
   Damasceno, Debora C/C-7234-2012; Vieira Cunha Rudge, Marilza/C-8338-2012
OI Borbely, Alexandre Urban/0000-0001-6737-0901; Calderon,
   Iracema/0000-0003-4761-4336; Bevilacqua, Estela/0000-0003-4178-4625;
   Damasceno, Debora C/0000-0002-7003-9643; Vieira Cunha Rudge,
   Marilza/0000-0002-9227-832X; Moreli, Jusciele/0000-0002-0945-9462
FU Fundacao para o Amparo da Ciencia do Estado de Sao Paulo - Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Fundacao Capes; Programa
   PNPD)
FX The authors thank Rosangela Oliveira for providing excellent technical
   assistance and the Research Support Group (Botucatu Medical
   School/UNESP) for their technical support in statistical analysis. This
   work was supported by the Fundacao para o Amparo da Ciencia do Estado de
   Sao Paulo - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (Fundacao Capes; Programa PNPD).
CR Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081
   Bacha F, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0750-6
   Berti C, 2016, CRIT REV FOOD SCI, V56, P82, DOI 10.1080/10408398.2012.745477
   Chiefari E, 2017, J ENDOCRINOL INVEST, V40, P899, DOI 10.1007/s40618-016-0607-5
   Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485
   Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799
   De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025
   Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86
   Devaraj S, 2011, CYTOKINE, V55, P441, DOI 10.1016/j.cyto.2011.03.023
   Feresu SA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0696-8
   Gobl CS, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0138-3
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Hayati Abdul Rahman, 2010, Malays J Pathol, V32, P13
   Khavandi M, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0818-1
   Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452
   Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Lekva T, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0715-9
   Liston A, 2017, NAT REV IMMUNOL, V17, P208, DOI 10.1038/nri.2016.151
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Manama C.A., 2017, INFECT IMMUN, V23, DOI [10.1128/IA1.00897-16, DOI 10.1128/IA1.00897-16]
   Montane J, 2014, DIABET METAB SYND OB, V7, P25, DOI 10.2147/DMSO.S37649
   Moreli JB, 2015, DIABETES RES CLIN PR, V107, P362, DOI 10.1016/j.diabres.2015.01.005
   Moreli JB, 2012, J CLIN IMMUNOL, V32, P604, DOI 10.1007/s10875-011-9634-3
   Patel S, 2009, PHARMACOL REP, V61, P595, DOI 10.1016/S1734-1140(09)70111-2
   Hara CDP, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7154524
   Place DE, 2018, CURR OPIN IMMUNOL, V50, P32, DOI 10.1016/j.coi.2017.10.011
   Rayanagoudar G, 2016, DIABETOLOGIA, V59, P1403, DOI 10.1007/s00125-016-3927-2
   Rehman K, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0303-y
   RUDGE MVC, 1990, BRAZ J MED BIOL RES, V23, P1079
   Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Schiekofer S, 2003, DIABETES, V52, P621, DOI 10.2337/diabetes.52.3.621
   Sisino G, 2013, BBA-MOL BASIS DIS, V1832, P1959, DOI 10.1016/j.bbadis.2013.07.009
   Stewart ZA, 2016, NEW ENGL J MED, V375, P644, DOI 10.1056/NEJMoa1602494
   Zand H, 2017, DIABETES METAB SYND, V11, pS307, DOI 10.1016/j.dsx.2017.03.006
NR 36
TC 11
Z9 11
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD NOV
PY 2018
VL 111
BP 41
EP 48
DI 10.1016/j.cyto.2018.07.020
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA HG1XG
UT WOS:000454753800006
PM 30114628
OA Green Published
DA 2020-12-01
ER

PT J
AU Hebeda, CB
   Machado, ID
   Reif-Silva, I
   Moreli, JB
   Oliani, SM
   Nadkarni, S
   Perretti, M
   Bevilacqua, E
   Farsky, SH
AF Hebeda, Cristina B.
   Machado, Isabel D.
   Reif-Silva, Isadora
   Moreli, Jusciele B.
   Oliani, Sonia M.
   Nadkarni, Suchita
   Perretti, Mauro
   Bevilacqua, Estela
   Farsky, Sandra H. P.
TI Endogenous annexin A1 (AnxA1) modulates early-phase gestation and
   offspring sex-ratio skewing
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
DE AnxA1 knockout mice; blastocyst; inflammation; progesteron; reproduction
ID HUMAN FETAL MEMBRANES; SEMINAL FLUID; FETOMATERNAL INTERFACE; EMBRYO
   IMPLANTATION; ANTIINFLAMMATORY MECHANISMS; ENDOMETRIAL RECEPTIVITY;
   GENE-EXPRESSION; MATERNAL DIET; HUMAN AMNION; T-CELLS
AB Annexin A1 (AnxA1) is a glucocorticoid-regulated anti-inflammatory protein secreted by phagocytes and other specialised cells. In the endocrine system, AnxA1 controls secretion of steroid hormones and it is abundantly expressed in the testis, ovaries, placenta and seminal fluid, yet its potential modulation of fertility has not been described. Here, we observed that AnxA1 knockout (KO) mice delivered a higher number of pups, with a higher percentage of female offsprings. This profile was not dependent on the male features, as sperm from KO male mice did not present functional alterations, and had an equal proportion of Y and X chromosomes, comparable to wild type (WT) male mice. Furthermore, mismatched matings of male WT mice with female KO yielded a higher percentage of female pups per litter, a phenomenon which was not observed when male KO mice mated with female WT animals. Indeed, AnxA1 KO female mice displayed several differences in parameters related to gestation including (i) an arrested estrous cycle at proestrus phase; (ii) increased sites of implantation; (iii) reduced pre- and post-implantation losses; (iv) exacerbated features of the inflammatory reaction in the uterine fluid during implantation phase; and (v) enhanced plasma progesterone in the beginning of pregnancy. In summary, herein we highlight that AnxA1 pathway as a novel determinant of fundamental non-redundant regulatory functions during early pregnancy.
C1 [Hebeda, Cristina B.; Machado, Isabel D.; Reif-Silva, Isadora; Farsky, Sandra H. P.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Ave Prof Lineu Prestes,580 Bloco 13B,Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
   [Moreli, Jusciele B.; Oliani, Sonia M.] Fed Univ Sao Paulo UNIFESP, Botucatu, SP, Brazil.
   [Oliani, Sonia M.] Univ Sao Paulo State UNESP, IBILCE, Dept Biol, Sao Paulo, Brazil.
   [Nadkarni, Suchita; Perretti, Mauro] Queen Mary Univ London, William Harvey Res Inst, London, England.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Farsky, SH (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Ave Prof Lineu Prestes,580 Bloco 13B,Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
EM sfarsky@usp.br
RI Machado, Isabel D/B-8913-2014; Bevilacqua, Estela/H-3354-2011; Farsky,
   Sandra HP/C-4044-2012; Machado, Isabel/AAE-3418-2020; Oliani, Sonia
   Maria/E-3476-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; Machado,
   Isabel/0000-0003-0724-5150; Oliani, Sonia Maria/0000-0003-0918-2130;
   Moreli, Jusciele/0000-0002-0945-9462
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/07328-4, 2016/02012-4]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo, Grant numbers:
   2014/07328-4, 2016/02012-4; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior
CR Aalberts M, 2013, BBA-PROTEINS PROTEOM, V1834, P2326, DOI 10.1016/j.bbapap.2012.08.008
   Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004
   Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006
   Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174
   Atwood CS, 2016, MOL CELL ENDOCRINOL, V430, P33, DOI 10.1016/j.mce.2016.03.039
   Behrouz GF, 2013, J REPROD IMMUNOL, V99, P10, DOI 10.1016/j.jri.2013.04.007
   BENNETT P, 1994, PROSTAG OTH LIPID M, V48, P81, DOI 10.1016/0090-6980(94)90086-8
   Bhusane K, 2016, AM J REPROD IMMUNOL, V75, P226, DOI 10.1111/aji.12472
   Blidner AG, 2013, AM J REPROD IMMUNOL, V69, P369, DOI 10.1111/aji.12090
   Bromfield JJ, 2014, J ASSIST REPROD GEN, V31, P627, DOI 10.1007/s10815-014-0243-y
   Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111
   Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538
   Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027
   Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012
   Chung TW, 2016, BIOCHEM BIOPH RES CO, V469, P936, DOI 10.1016/j.bbrc.2015.12.103
   Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110
   Cover PO, 2002, ENDOCRINE, V18, P33, DOI 10.1385/ENDO:18:1:33
   Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279
   Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089
   Damasceno DC, 2013, REPROD SCI, V20, P730, DOI 10.1177/1933719112461186
   Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410
   Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6
   Desai N, 1999, HUM REPROD, V14, P1588, DOI 10.1093/humrep/14.6.1588
   Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020
   Fan DX, 2011, CLIN IMMUNOL, V141, P284, DOI 10.1016/j.clim.2011.07.008
   Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003
   Gavins FNE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00354
   Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411
   Gibbs L, 2002, INFLAMM RES, V51, P300, DOI 10.1007/PL00000308
   Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030
   Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143
   Gopichandran N, 2006, REPRODUCTION, V131, P613, DOI 10.1530/rep.1.00959
   Goulding NJ, 1998, INFLAMM RES, V47, pS158
   Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035
   Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje
   Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014
   Heitmann RJ, 2017, REPROD SCI, V24, P1014, DOI 10.1177/1933719116675054
   HUCK UW, 1988, J REPROD FERTIL, V83, P209, DOI 10.1530/jrf.0.0830209
   Huo XF, 2005, BIOCHEM BIOPH RES CO, V331, P1346, DOI 10.1016/j.bbrc.2005.04.049
   John CD, 2004, TRENDS ENDOCRIN MET, V15, P103, DOI 10.1016/j.tem.2004.02.001
   Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860
   Kano T, 2004, REPROD BIOMED ONLINE, V9, P306, DOI 10.1016/S1472-6483(10)62146-3
   Kano T, 2009, AM J REPROD IMMUNOL, V62, P125, DOI 10.1111/j.1600-0897.2009.00721.x
   Kerr JB, 2013, REPRODUCTION, V146, pR205, DOI 10.1530/REP-13-0181
   Kim YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20242
   Kwan M, 2014, PLACENTA, V35, P1027, DOI 10.1016/j.placenta.2014.09.018
   Locatelli I, 2014, HEPATOLOGY, V60, P531, DOI 10.1002/hep.27141
   LYNCHSALAMON DI, 1992, AM J OBSTET GYNECOL, V167, P1657, DOI 10.1016/0002-9378(92)91757-2
   Machado ID, 2016, J CELL PHYSIOL, V231, P2418, DOI 10.1002/jcp.25346
   Meggyes M, 2015, PLACENTA, V36, P1153, DOI 10.1016/j.placenta.2015.07.124
   Miller WL, 1998, CLIN PERINATOL, V25, P799
   Mizugishi K, 2015, J BIOL CHEM, V290, P2053, DOI 10.1074/jbc.M114.628867
   MYATT L, 1992, J CELL BIOCHEM, V50, P363, DOI 10.1002/jcb.240500405
   Okabe M, 2013, DEVELOPMENT, V140, P4471, DOI 10.1242/dev.090613
   Oktem O, 2010, HUM REPROD, V25, P2944, DOI 10.1093/humrep/deq275
   Parker RM, 2012, DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY: A PRACTICAL APPROACH, 3RD EDITION, P184
   Perucci LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138475
   Petrunkina AM, 2007, REPRODUCTION, V134, P3, DOI 10.1530/REP-07-0046
   Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004
   Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001
   Riella LV, 2013, AM J PATHOL, V182, P2204, DOI 10.1016/j.ajpath.2013.02.014
   Robertson SA, 2000, P AUST SOC REPROD BI, V31, P97
   Rodrigues P, 2008, J CELL PHYSIOL, V216, P355, DOI 10.1002/jcp.21473
   ROMISCH J, 1992, BLOOD COAGUL FIBRIN, V3, P11
   Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890
   Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100
   Salewski E, 1964, N-S ARCH PHARMACOL, P247
   Seshagiri PB, 2016, AM J REPROD IMMUNOL, V75, P208, DOI 10.1111/aji.12464
   Sharkey DJ, 2012, J IMMUNOL, V189, P1024, DOI 10.4049/jimmunol.1200005
   Sharkey DJ, 2012, J IMMUNOL, V188, P2445, DOI 10.4049/jimmunol.1102736
   Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533
   Su RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034325
   Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258
   Sun M, 1996, PLACENTA, V17, P181, DOI 10.1016/S0143-4004(96)80012-9
   Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221
   Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x
   TSAO FHC, 1995, LIPIDS, V30, P507, DOI 10.1007/BF02537024
   Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012
   Van Sinderen M, 2013, AM J REPROD IMMUNOL, V69, P427, DOI 10.1111/aji.12038
   Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808
   Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201
NR 81
TC 3
Z9 3
U1 2
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD SEP
PY 2018
VL 233
IS 9
BP 6591
EP 6603
DI 10.1002/jcp.26258
PG 13
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA GI1JX
UT WOS:000434127700025
PM 29115663
DA 2020-12-01
ER

PT J
AU Weingrill, RB
   Hoshida, MS
   Martinhago, CD
   Correa-Silva, S
   Cardoso, E
   Palmeira, P
   Marinho, CRF
   Bevilacqua, E
AF Weingrill, Rodrigo Barbano
   Hoshida, Mara S.
   Martinhago, Ciro Dresch
   Correa-Silva, Simone
   Cardoso, Elaine
   Palmeira, Patricia
   Farias Marinho, Claudio Romero
   Bevilacqua, Estela
TI Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and
   leukocytes bearing its receptor Ccr9: An alliance during embryo
   implantation?
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE Ccl25; Ccr9; chemokine; ectoplacental cone; endometrium; fetal-maternal
   interface
ID PLASMACYTOID DENDRITIC CELLS; CUTTING EDGE; ROLES; RECRUITMENT;
   MIGRATION; CYTOKINES; INFLAMMATION; MACROPHAGES; PREGNANCY; MATRIX
AB ProblemWe hypothesized that trophoblast expression of Ccl25 attracts a specific leukocyte cell population to the implantation site for local regulation.
   Method of studyMice blastocysts, ectoplacental cones, and decidua at gestational days 3.5-7.5 were evaluated for Ccl25 and Ccr9 expressions. Peripheral availability and characterization of Ccr9+ leukocytes were determined by flow cytometry. Leukocyte chemotaxis was assessed in the presence of Ccl25 recombinant protein and embryos using antisense oligomers (ODNs) to Ccl25 and Ccr9 neutralizing antibody.
   ResultsCcl25 was expressed by embryonic cells, whereas Ccr9 expression was strong at the maternal compartment and in PBMC. Immunolocalization confirmed this expression. In vitro, chemotaxis assays showed that the embryonic Ccl25 signals to Ccr9+ PBMCs. Maternal Ccr9+47+ monocytes switch from an anti-inflammatory phenotype (F4/80+11b+Ly6C-TGF-+ cells, pre-implantation) to an inflammatory profile (F4/80+11b+Ly6C+TNF-+ cells, post-implantation).
   ConclusionOur data support the establishment of a CCL25/CCR9-axis at the maternal-fetal interface in mice, which may be involved in immune regulatory mechanisms during embryo implantation.
C1 [Weingrill, Rodrigo Barbano; Correa-Silva, Simone; Cardoso, Elaine; Bevilacqua, Estela] Univ Sao Paulo, Dept Cellular & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Hoshida, Mara S.] Univ Sao Paulo, Dept Obstet & Gynecol, Lab Med Invest, Sch Med, Sao Paulo, Brazil.
   [Martinhago, Ciro Dresch] Chromosome Genom Med, Sao Paulo, Brazil.
   [Palmeira, Patricia] Univ Sao Paulo, Dept Pediat, Lab Med Invest, Sch Med, Sao Paulo, Brazil.
   [Farias Marinho, Claudio Romero] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.
RP Weingrill, RB; Bevilacqua, E (corresponding author), Univ Sao Paulo, Dept Cellular & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
EM rodrigobarbano@gmail.com; bevilacq@usp.br
RI Marinho, Claudio Romero Farias/F-7507-2012; Hoshida, Mara S/D-3900-2012;
   Bevilacqua, Estela/H-3354-2011
OI Marinho, Claudio Romero Farias/0000-0002-1227-3845; Hoshida, Mara
   S/0000-0003-2232-4631; Bevilacqua, Estela/0000-0003-4178-4625
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX FAPESP, CAPES, and CNPq grants supported this study.
CR Aldo PB, 2014, AM J REPROD IMMUNOL, V72, P270, DOI 10.1111/aji.12288
   Baggiolini M, 2004, ADV IMMUNOL, V55, P97
   Blois SM, 2004, J IMMUNOL, V172, P5893, DOI 10.4049/jimmunol.172.10.5893
   Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782
   Briana DD, 2007, MEDIAT INFLAMM, V2007, P1, DOI DOI 10.1155/2007/65032
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Campbell DJ, 2002, J CLIN INVEST, V110, P1079, DOI 10.1172/JCI200216946
   Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012
   Chaouat G, 2009, J REPROD IMMUNOL, V82, P132, DOI 10.1016/j.jri.2009.08.004
   Chu PS, 2013, HEPATOLOGY, V58, P337, DOI 10.1002/hep.26351
   Dekel N, 2014, AM J REPROD IMMUNOL, V72, P141, DOI 10.1111/aji.12266
   Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023
   Du MR, 2014, CELL MOL IMMUNOL, V11, P438, DOI 10.1038/cmi.2014.68
   Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125
   Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467
   Grasso E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097147
   Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658
   Hannan NJ, 2008, BIOL REPROD, V79, P58, DOI 10.1095/biolreprod.107.066480
   Hannan NJ, 2006, BIOL REPROD, V74, P896, DOI 10.1095/biolreprod.105.045518
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Johnson EL, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-62
   Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341
   Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193
   Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721
   Laham N, 1999, BIOL REPROD, V61, P823, DOI 10.1095/biolreprod61.3.823
   Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445
   Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899
   Li CM, 2014, REPROD SCI, V8
   Lin Y, 2009, FERTIL STERIL, V91, P2687, DOI 10.1016/j.fertnstert.2008.01.109
   Mildner A, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0033-2016
   Nakamoto N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00221
   Nakamoto N, 2012, GASTROENTEROLOGY, V142, P366, DOI 10.1053/j.gastro.2011.10.039
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361
   Parmo-Cabanas M, 2007, J LEUKOCYTE BIOL, V82, P380, DOI 10.1189/jlb.1206726
   Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031
   Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041
   Sharma S, 2016, AM J REPROD IMMUNOL, V75, P341, DOI 10.1111/aji.12466
   Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134
   WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0
   Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993
   Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104
   White CA, 2005, MOL HUM REPROD, V11, P649, DOI 10.1093/molehr/gah235
   Zaballos A, 1999, J IMMUNOL, V162, P5671
   Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011
NR 45
TC 1
Z9 1
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD JAN
PY 2018
VL 79
IS 1
DI 10.1111/aji.12783
PG 11
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA FP5YE
UT WOS:000417698100012
PM 29154408
DA 2020-12-01
ER

PT J
AU Bevilacqua, E
AF Bevilacqua, Estela
TI INVOLVEMENT OF CASPASE-8 IN THE DIFFERENTIATION OF SYNCYTIAL LAYERS OF
   THE MOUSE PLACENTAL LABYRINTH
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY AUG 30-SEP 02, 2017
CL Manchester, ENGLAND
SP Int Federat Placenta Assoc
C1 [Bevilacqua, Estela] Univ Sao Paulo, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX FAPESP, CAPES and CNPq.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2017
VL 57
MA S9.3
BP 237
EP 237
DI 10.1016/j.placenta.2017.07.058
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FH9OL
UT WOS:000411541500069
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Rocha, CR
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Rocha, Clarissa Ribeiro
   Bevilacqua, Estela
TI THE ROLE OF SDF2 (STROMAL CELL DERIVED FACTOR 2) IN CELL SURVIVAL/DEATH
   DECISION DURING ENDOPLASMIC RETICULUM STRESS IN HUMAN TROPHOBLAST CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY AUG 30-SEP 02, 2017
CL Manchester, ENGLAND
SP Int Federat Placenta Assoc
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Deparment Cell & Dev Biol, Sao Paulo, SP, Brazil.
   [Rocha, Clarissa Ribeiro] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.
RI Lorenzon, Aline R/G-8733-2014; Bevilacqua, Estela/H-3354-2011
OI Lorenzon, Aline R/0000-0002-6052-6296; Bevilacqua,
   Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2017
VL 57
MA P1.27
BP 257
EP 257
DI 10.1016/j.placenta.2017.07.116
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FH9OL
UT WOS:000411541500127
DA 2020-12-01
ER

PT J
AU Cardoso, E
   Oliveira, L
   Zanette, N
   Daolio, G
   Sato, M
   Bevilacqua, E
AF Cardoso, Elaine
   Oliveira, Luanda
   Zanette, Natalli
   Daolio, Gabriela
   Sato, Maria
   Bevilacqua, Estela
TI CL097 AND GARDIMIQUIMOD LIGANDS OF THE TLRS EXPRESSED BY TROPHOBLAST
   CELLS MODULE CYTOKINE IN THE ANTI VIRAL RESPONSE
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY AUG 30-SEP 02, 2017
CL Manchester, ENGLAND
SP Int Federat Placenta Assoc
C1 [Cardoso, Elaine; Oliveira, Luanda; Zanette, Natalli; Daolio, Gabriela; Sato, Maria; Bevilacqua, Estela] Univ Sao Paulo, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011; da Silva Oliveira, Luanda
   Mara/E-7273-2013
OI Bevilacqua, Estela/0000-0003-4178-4625; da Silva Oliveira, Luanda
   Mara/0000-0003-0903-8219
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2017
VL 57
MA P2.126
BP 332
EP 332
DI 10.1016/j.placenta.2017.07.335
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA FH9OL
UT WOS:000411541500345
DA 2020-12-01
ER

PT J
AU Barboza, R
   Lima, FA
   Reis, AS
   Murillo, OJ
   Peixoto, EPM
   Bandeira, CL
   Fotoran, WL
   Sardinha, LR
   Wunderlich, G
   Bevilacqua, E
   Lima, MRD
   Alvarez, JM
   Costa, FTM
   Goncalves, LA
   Epiphanio, S
   Marinho, CRF
AF Barboza, Renato
   Lima, Flavia Afonso
   Reis, Aramys Silva
   Murillo, Oscar Javier
   Machado Peixoto, Erika Paula
   Bandeira, Carla Leticia
   Fotoran, Wesley Luzetti
   Sardinha, Luis Roberto
   Wunderlich, Gerhard
   Bevilacqua, Estela
   D'Imperio Lima, Maria Regina
   Alvarez, Jose Maria
   Maranhao Costa, Fabio Trindade
   Goncalves, Ligia Antunes
   Epiphanio, Sabrina
   Farias Marinho, Cludio Romerso
TI TLR4-Mediated Placental Pathology and Pregnancy Outcome in Experimental
   Malaria
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TOLL-LIKE RECEPTORS; NECROSIS-FACTOR-ALPHA; PLASMODIUM-FALCIPARUM;
   PATTERN-RECOGNITION; INNATE IMMUNITY; MICE;
   GLYCOSYLPHOSPHATIDYLINOSITOLS; INFLAMMATION; PARASITEMIA; EXPRESSION
AB Malaria-associate pregnancy has a significant impact on infant morbidity and mortality. The detrimental effects of malaria infection during pregnancy have been shown to correlate with immune activation in the placental tissue. Herein we sought to evaluate the effect of Toll-like receptors (TLRs) activation on placental malaria (PM) development by using the Plasmodium berghei NK65(GFP) infection model. We observed that activation of the innate immune system by parasites leads to PM due to local inflammation. We identified TLR4 activation as the main pathway involved in the inflammatory process in the placental tissue since the absence of functional TLR4 in mice leads to a decrease in the pro-inflammatory responses, which resulted in an improved pregnancy outcome. Additionally, a similar result was obtained when infected pregnant mice were treated with IAXO-101, a TLR4/CD14 blocker. Together, this study illustrates the importance of TLR4 signalling for the generation of the severe inflammatory response involved in PM pathogenesis. Therefore, our results implicate that TLR4 blockage could be a potential candidate for therapeutic interventions to reduce malaria-induced pathology both in the mother and the fetus.
C1 [Barboza, Renato] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, Brazil.
   [Lima, Flavia Afonso; Reis, Aramys Silva; Murillo, Oscar Javier; Machado Peixoto, Erika Paula; Bandeira, Carla Leticia; Fotoran, Wesley Luzetti; Wunderlich, Gerhard; Goncalves, Ligia Antunes; Farias Marinho, Cludio Romerso] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil.
   [Sardinha, Luis Roberto] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Sao Paulo, Brazil.
   [D'Imperio Lima, Maria Regina; Alvarez, Jose Maria] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Inst Biol, Campinas, SP, Brazil.
   [Maranhao Costa, Fabio Trindade] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil.
   [Epiphanio, Sabrina] Univ Sao Paulo, Dept Analises Clin & Toxicol, Fac Ciencias Farmaceut, Sao Paulo, Brazil.
RP Marinho, CRF (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil.
EM marinho@usp.br
RI Costa, Fabio/E-1181-2012; Alvarez, Jose M/I-6181-2012; Barboza,
   Renato/G-5833-2012; Bevilacqua, Estela/H-3354-2011; Epiphanio,
   Sabrina/C-7572-2012; Lima, Maria Regina D'Imperio/I-4747-2012; Peixoto,
   Erika Paula Machado/AAB-5441-2020; Wunderlich, Gerhard/G-8245-2012;
   Lima, Flavia Afonso/G-9713-2013; Bandeira, Carla Leticia/U-8685-2017;
   Marinho, Claudio Romero Farias/F-7507-2012; Reis, Aramys S/N-9170-2019;
   REIS, ARAMYS SILVA/G-4806-2012; Murillo, Oscar/H-5039-2017; Fotoran,
   Wesley/N-2545-2016; Goncalves, Ligia Antunes/F-6242-2014
OI Costa, Fabio/0000-0001-9969-7300; Alvarez, Jose M/0000-0002-9711-4914;
   Barboza, Renato/0000-0002-6441-7513; Bevilacqua,
   Estela/0000-0003-4178-4625; Epiphanio, Sabrina/0000-0001-6094-9750;
   Lima, Maria Regina D'Imperio/0000-0002-4683-7709; Wunderlich,
   Gerhard/0000-0003-1724-0337; Lima, Flavia Afonso/0000-0003-0742-2209;
   Bandeira, Carla Leticia/0000-0002-0796-3462; Marinho, Claudio Romero
   Farias/0000-0002-1227-3845; Reis, Aramys S/0000-0003-4999-6382; REIS,
   ARAMYS SILVA/0000-0003-4999-6382; Murillo, Oscar/0000-0003-1204-7984;
   Fotoran, Wesley/0000-0001-8203-8384; Goncalves, Ligia
   Antunes/0000-0001-9804-6899; Reis, AlessanRSS/0000-0001-8486-7469
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/53889-0,
   2014/09964-5, 2014/20451-0, 2012/16525-2]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPESCAPES [AUX-PE-PNPD
   2751/2010]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPqNational Council for Scientific and Technological
   Development (CNPq) [475771/2009-5]; FAPESPFundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [2011/17880-8, 2013/16417-8,
   2011/19048-8, 2013/00981-1, 2015/06106-0]
FX We thank Penn Vector Core (University of Pennsylvania School of
   Medicine, USA) for kindly providing the TLR9 plasmid, Prof. Igor C.
   Almeida (University of Texas, USA) for kindly providing all other
   plasmids used in this study and Bernardo Paulo Albe for his technical
   support. This work was supported by the Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo - FAPESP (Grant # 2009/53889-0; 2014/09964-5;
   2014/20451-0; 2012/16525-2); Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - CAPES (Grant # AUX-PE-PNPD 2751/2010) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Grant #
   475771/2009-5). RB, FAL, ASR, OJM and LAG were supported by the FAPESP
   fellowships # 2011/17880-8; 2013/16417-8; 2011/19048-8; 2013/00981-1 and
   2015/06106-0, respectively. GH, EB, JMA, MRIL, FTMC, SE and CRFM are
   CNPq research fellows.
CR Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599
   Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010
   Arce RM, 2012, MOL ORAL MICROBIOL, V27, P373, DOI 10.1111/j.2041-1014.2012.00651.x
   Barboza R, 2014, INFECT IMMUN, V82, P830, DOI 10.1128/IAI.01288-13
   Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699
   Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042
   Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003
   Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05
   FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4
   Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106
   Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456
   Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003
   GENDRON RL, 1990, J REPROD FERTIL, V90, P395, DOI 10.1530/jrf.0.0900395
   Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005
   Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   KERN P, 1992, J INFECT DIS, V166, P930, DOI 10.1093/infdis/166.4.930
   KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331
   Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200
   Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440
   Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106
   Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marinho CRF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005630
   Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x
   MEURIS S, 1993, AM J TROP MED HYG, V48, P603, DOI 10.4269/ajtmh.1993.48.603
   Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102
   Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608
   Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104
   Pasare C, 2005, ADV EXP MED BIOL, V560, P11
   Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014
   Piazza M, 2009, J MED CHEM, V52, P1209, DOI 10.1021/jm801333m
   Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926
   Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006
   Poovassery J, 2009, INFECT IMMUN, V77, P4998, DOI 10.1128/IAI.00617-09
   Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679
   Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1
   Rounioja S, 2005, AM J PATHOL, V166, P1585, DOI 10.1016/S0002-9440(10)62469-8
   SILEN ML, 1989, AM J PATHOL, V135, P239
   Sobota RS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1189-6
   Sylvester B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1417-0
   Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293
NR 42
TC 17
Z9 18
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 17
PY 2017
VL 7
AR 8623
DI 10.1038/s41598-017-08299-x
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FD9TG
UT WOS:000407864400004
PM 28819109
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Ridano, ME
   Racca, AC
   Flores-Martin, JB
   Fretes, R
   Bandeira, CL
   Reyna, L
   Bevilacqua, E
   Genti-Raimondi, S
   Panzetta-Dutari, GM
AF Ridano, M. E.
   Racca, A. C.
   Flores-Martin, J. B.
   Fretes, R.
   Bandeira, C. L.
   Reyna, L.
   Bevilacqua, E.
   Genti-Raimondi, S.
   Panzetta-Dutari, G. M.
TI Impact of chlorpyrifos on human villous trophoblasts and chorionic villi
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Chlorpyrifos; Placental villi; Basement membrane; Trophoblast cells;
   Xenobiotic transporters
ID ORGANOPHOSPHATE PESTICIDE EXPOSURE; ENVIRONMENTAL CHEMICALS; PRENATAL
   EXPOSURE; OXIDATIVE STRESS; HUMAN PLACENTA; EXPRESSION; CELLS;
   PREGNANCY; APOPTOSIS; GROWTH
AB Placental barrier regulates maternal-fetal interchange protecting the baby from damage caused by substances found in the uterine environment or circulating in the vascular system. Organophosphate (OP) pesticides are a paramount group of environmental pollutants used in intensive agriculture for protection against diseases and pests. While many studies have reported an increased risk of pregnancy alterations in pregnant women exposed to OPs, few have analyzed the effects caused by these pesticides in the placenta.
   Herein, we evaluated the effects of chlorpyrifos (CPF), one of the most widely used OP insecticides, on human placenta using in vitro and ex vivo exposure models. Villous cytotrophoblast cells isolated from normal human term placentas maintained their cell viability, differentiated into syncytiotrophoblast-like structures, and increased the expression of beta-hCG, ABCG2, and P-gp in the presence of CPF at concentrations of 10 to 100 mu M. The same doses of CPF induced marked changes in chorionic villi samples. Indeed, CPF exposure increased stroma cell apoptosis, altered villi matrix composition, basement membrane thickness, and trophoblastic layer integrity. Histomorphological and ultrastructural alterations are compatible with those found in placentas where maternal-placenta injury is chronic and able to impair the placental barrier function and nutrient transport from mother to the fetus.
   Our study shows that placental ex vivo exposure to CPF produces tissue alterations and suggest that human placenta is a potential target of CPF toxicity. In addition, it highlights the importance of using different models to assess the effects of a toxic on human placenta. (C) 2017 Elsevier Inc All rights reserved.
C1 [Ridano, M. E.; Racca, A. C.; Flores-Martin, J. B.; Reyna, L.; Genti-Raimondi, S.; Panzetta-Dutari, G. M.] Univ Nacl Cordoba, CONICET, Ctr Invest Bioquim Clin & Inmunol CIBICI, Dept Bioquim Clin,Fac Ciencias Quim, Cordoba, Argentina.
   [Fretes, R.] Univ Nacl Cordoba, CONICET, Inst Invest Ciencias Salud INICSA, Dept Histol Embriol,Fac Med, Cordoba, Argentina.
   [Bandeira, C. L.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Panzetta-Dutari, GM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, Dept Bioquim Clin, Ciudad Univ,X5000HUA, Cordoba, Argentina.
EM gpan@fcq.unc.edu.ar
RI Bandeira, Carla Leticia/U-8685-2017; Bevilacqua, Estela/H-3354-2011
OI Bandeira, Carla Leticia/0000-0002-0796-3462; Bevilacqua,
   Estela/0000-0003-4178-4625; Flores Martin, Jesica
   Belen/0000-0002-1619-399X; Racca, Ana Cristina/0000-0002-5909-2451
FU CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET)
FX We gratefully acknowledge Gina Mazzudulli for her technical assistance
   with histological and immunohistochemistry assays, and Alexandre Urban
   Borbely and Fernanda Carini da Silva for their advice with explant
   cultures. We also acknowledge the Hospital Privado Obstetric staff. SG-R
   and GMP-D are Career Investigators of CONICET. MER, ACR, JFM and LR
   thank CONICET for their fellowships.
CR Agarwala S, 2004, TOXICOL IN VITRO, V18, P403, DOI 10.1016/j.tiv.2003.12.006
   Amani N, 2016, CELL J, V18, P464
   Androutsopoulos VP, 2013, TOXICOLOGY, V307, P89, DOI 10.1016/j.tox.2012.09.011
   Angeletti S, 2008, PLACENTA, V29, P396, DOI 10.1016/j.placenta.2008.02.011
   Aris AK, 2007, CLIN BIOCHEM, V40, P94, DOI 10.1016/j.clinbiochem.2006.10.008
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P1083, DOI 10.1289/ehp.7617
   Bechi N, 2013, TOXICOL IN VITRO, V27, P995, DOI 10.1016/j.tiv.2013.01.013
   Benachour N, 2009, CHEM RES TOXICOL, V22, P97, DOI 10.1021/tx800218n
   Bulgaroni V, 2013, REPROD TOXICOL, V39, P23, DOI 10.1016/j.reprotox.2013.03.010
   Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016
   Calvert SJ, 2016, REPRODUCTION, V151, P657, DOI 10.1530/REP-15-0544
   Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004
   Caughlan A, 2004, TOXICOL SCI, V78, P125, DOI 10.1093/toxsci/kfh038
   Chen JG, 2004, TOXICOL SCI, V78, P166, DOI 10.1093/toxsci/kfh046
   Chiapella G, 2013, PLACENTA, V34, P792, DOI 10.1016/j.placenta.2013.06.007
   Chiapella G, 2014, ENVIRON TOXICOL PHAR, V38, P220, DOI 10.1016/j.etap.2014.06.001
   Douglas G.C., 2014, ENVIRON TOXICOL, V31, P427
   Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI [10.1080/10408440802272158, 10.1080/10408440802272158 ]
   Elersek T., 2011, IMPACTS PESTICIDES E, P244
   Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828
   Gheorman L, 2012, ROM J MORPHOL EMBRYO, V53, P329
   Giordano G, 2007, TOXICOL APPL PHARM, V219, P181, DOI 10.1016/j.taap.2006.09.016
   Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012
   Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007
   Huen K, 2012, ENVIRON RES, V117, P8, DOI 10.1016/j.envres.2012.05.005
   Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008
   Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016
   Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016
   Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008
   Jirkovska M, 2012, PLACENTA, V33, P343, DOI 10.1016/j.placenta.2012.01.014
   Karalliedde LD, 2003, FOOD CHEM TOXICOL, V41, P1, DOI 10.1016/S0278-6915(02)00232-6
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Lanning CL, 1996, J TOXICOL ENV HEALTH, V47, P395, DOI 10.1080/009841096161726
   Le Vee M, 2014, CHEM-BIOL INTERACT, V210, P1, DOI 10.1016/j.cbi.2013.12.004
   Levario-Carrillo M, 2004, EXP TOXICOL PATHOL, V55, P489, DOI 10.1078/0940-2993-00346
   Levario-Carrillo M, 2004, CHEMOSPHERE, V55, P1421, DOI 10.1016/j.chemosphere.2003.11.027
   Levario-Carrillo M, 2001, GYNECOL OBSTET INVES, V52, P269, DOI 10.1159/000052989
   Li Q, 2009, TOXICOLOGY, V255, P53, DOI 10.1016/j.tox.2008.10.003
   Mannelli C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/635364
   Mannelli C, 2015, DOSE-RESPONSE, V13, DOI 10.1177/1559325815611902
   Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z
   Meng Q, 2015, OBSTET GYNECOL INT, V2015, DOI 10.1155/2015/283124
   Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002
   Monfared AL, 2014, TOXICOL IND HEALTH, V30, P174, DOI 10.1177/0748233712452603
   Morck TJ, 2010, REPROD TOXICOL, V30, P131, DOI 10.1016/j.reprotox.2010.02.007
   Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3
   Mostafalou S, 2017, ARCH TOXICOL, V91, P549, DOI 10.1007/s00204-016-1849-x
   Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021
   Myllynen P, 2013, TOXICOL IN VITRO, V27, P507, DOI 10.1016/j.tiv.2012.08.027
   Myren M, 2007, TOXICOL IN VITRO, V21, P1332, DOI 10.1016/j.tiv.2007.05.011
   Narasimha A, 2011, INDIAN J PATHOL MICR, V54, P15, DOI 10.4103/0377-4929.77317
   Needham LL, 2005, ENVIRON HEALTH PERSP, V113, P494, DOI 10.1289/ehp.7490
   Nguyen D.H., 2013, CANC INCYTES, V2
   Oostingh GJ, 2009, J IMMUNOTOXICOL, V6, P136, DOI 10.1080/15476910902977407
   Ostrea EM, 2002, NEUROTOXICOLOGY, V23, P329, DOI 10.1016/S0161-813X(02)00077-3
   Parran DK, 2005, NEUROTOXICOLOGY, V26, P77, DOI 10.1016/j.neuro.2004.07.003
   Patnaik R, 2016, ENVIRON SCI POLLUT R, V23, P8492, DOI 10.1007/s11356-015-5963-8
   Peris-Sampedro F, 2014, FOOD CHEM TOXICOL, V72, P289, DOI 10.1016/j.fct.2014.07.036
   Pidoux G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133506
   Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160
   Reyna L, 2017, TOXICOL IN VITRO, V40, P88, DOI 10.1016/j.tiv.2016.12.008
   Ridano ME, 2012, REPROD TOXICOL, V33, P331, DOI 10.1016/j.reprotox.2012.01.003
   Osimani VLR, 2016, REPROD TOXICOL, V61, P47, DOI 10.1016/j.reprotox.2016.02.018
   Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017
   Saulsbury MD, 2008, TOXICOLOGY, V244, P98, DOI 10.1016/j.tox.2007.10.020
   Saunders M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S5
   Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252
   Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020
   Solomon KR, 2014, REV ENVIRON CONTAM T, V231, P13, DOI 10.1007/978-3-319-03865-0_2
   Souza MS, 2005, BIOMARKERS, V10, P376, DOI 10.1080/13547500500272614
   Souza MS, 2004, J BIOCHEM MOL TOXIC, V18, P30, DOI 10.1002/jbt.20003
   Tirelli V, 2007, TOXICOL IN VITRO, V21, P308, DOI 10.1016/j.tiv.2006.08.015
   Venerosi A, 2012, NEUROTOXICOLOGY, V33, P1420, DOI 10.1016/j.neuro.2012.08.009
   Wessels D, 2003, ENVIRON HEALTH PERSP, V111, P1939, DOI 10.1289/ehp.6179
   Whyatt RM, 2005, TOXICOL APPL PHARM, V206, P246, DOI 10.1016/j.taap.2004.11.027
   Wojtowicz AK, 2007, PHARMACOL REP, V59, P224
   Zarei MH, 2016, ENVIRON TOXICOL, V31, P1510, DOI 10.1002/tox.22155
   Zhang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109159
NR 79
TC 15
Z9 15
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD AUG 15
PY 2017
VL 329
BP 26
EP 39
DI 10.1016/j.taap.2017.05.026
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FC3JU
UT WOS:000406735700004
PM 28549829
DA 2020-12-01
ER

PT J
AU Cardoso, VES
   Dutra, F
   Soares, CO
   Alves, ANL
   Bevilacqua, E
   Gagioti, SM
   Penatti, CAA
   Bechara, EJH
AF Cardoso, Vanessa E. S.
   Dutra, Fernando
   Soares, Chrislaine O.
   Alves, Atecla N. L.
   Bevilacqua, Estela
   Gagioti, Sonia M.
   Penatti, Carlos A. A.
   Bechara, Etelvino J. H.
TI Liver Damage Induced by Succinylacetone: A Shared Redox Imbalance
   Mechanism between Tyrosinemia and Hepatic Porphyrias
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE 5-aminolevulinic acid; succinylacetone; intermittent acute porphyria;
   hereditary tyrosinemia type 1; redox imbalance
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; ACUTE INTERMITTENT PORPHYRIA;
   5-AMINOLEVULINIC ACID; RAT-LIVER; FREE-RADICALS; IN-VIVO; CELLS; DNA;
   GLUTATHIONE; QUANTITATION
AB To show liver failure mediated by 5-aminolevulinic acid (ALA), a heme precursor accumulated in inborn and acquired porphyrias, rats were treated with succinylacetone methyl ester (SAME). Treated rats underwent the expected ALA accumulation in plasma, liver and urine as a result from inhibition of ALA dehydratase (ALAD) activity. The enzyme activity decreased concomitantly with diminished urinary coproporphyrin levels. Additionally, liver protein carbonyls, iron and ferritin were higher in groups treated with a lower concentration of SAME whereas malondialdehyde was higher in the group treated with a higher ester dose. Consistent with these biochemical data, chronic treatment SAME was associated with induced oxidative subcellular and tissue damage revealed by cytosolic and mitochondrial changes within the liver cells. Altogether, these data expand the understanding of the direct biochemical mechanism for liver cell death in hepatic inborn disorders by generating excess ALA and may foster future therapeutic-driven strategies to preserve liver function.
C1 [Cardoso, Vanessa E. S.; Soares, Chrislaine O.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, SP, Brazil.
   [Dutra, Fernando] Univ Cruzeiro Sul, Ctr Ciencias Biol & Saude, BR-08060070 Sao Paulo, SP, Brazil.
   [Alves, Atecla N. L.] Univ Sao Paulo, Fac Med, Lab Cent Hosp Clin, BR-01246903 Sao Paulo, SP, Brazil.
   [Bevilacqua, Estela; Gagioti, Sonia M.] Univ Sao Paulo, Inst Ciencias Biol, Dept Biol Celular & Desenvolvimento, BR-05508900 Sao Paulo, SP, Brazil.
   [Penatti, Carlos A. A.] Univ Nove Julho, Dept Ciencias Med, BR-01504001 Sao Paulo, SP, Brazil.
   [Bechara, Etelvino J. H.] Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, SP, Brazil.
RP Bechara, EJH (corresponding author), Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, SP, Brazil.
EM ejhbechara@gmail.com
RI Bechara, Etelvino JH/M-6251-2013; Bevilacqua, Estela/H-3354-2011
OI Bechara, Etelvino JH/0000-0001-9526-2529; Bevilacqua,
   Estela/0000-0003-4178-4625
FU Brazilian agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2006/056530-4]; Brazilian agency Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [300777/2005-1]; Brazilian agency
   FAPESP/INCT Redoxoma [573530/2008-4]
FX This work is dedicated in memoriam to Angelo da Cunha Pinto, an
   outstanding Brazilian chemist devoted to the study of natural products
   and tireless member of the Brazilian Chemical Society. We thank the
   Brazilian agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP, Proc. 2006/056530-4), the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Proc. 300777/2005-1) and the FAPESP/INCT
   Redoxoma (Proc. 573530/2008-4) for the financial support of this work.
   We are indebted to Donna Porter (Dartmouth Medical School, NH) for
   kindly reviewing the manuscript, and to Cassius Vinicius Stevani for
   kindly performing the design of the Graphic Abstract.
CR Adhikari A, 2006, BRAIN RES, V1093, P95, DOI 10.1016/j.brainres.2006.03.103
   Astruc T, 2007, J AGR FOOD CHEM, V55, P9554, DOI 10.1021/jf0717586
   Bechara EJH, 2007, COMP BIOCHEM PHYS C, V146, P88, DOI 10.1016/j.cbpc.2006.07.004
   BIEMPICA L, 1974, ARCH PATHOL, V98, P336
   BIEMPICA L, 1971, LAB INVEST, V24, P110
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F
   Cappellini MD, 2010, INTERN EMERG MED, V5, pS73, DOI 10.1007/s11739-010-0449-7
   Cypriani MGSC, 2014, J BRAZIL CHEM SOC, V25, P1918, DOI 10.5935/0103-5053.20140230
   Dehghani Seyed Mohsen, 2013, Int J Prev Med, V4, P1380
   Dekel R, 2003, DIGEST DIS SCI, V48, P1642, DOI 10.1023/A:1024792529601
   Demasi M, 1997, FREE RADICAL RES, V26, P235, DOI 10.3109/10715769709097802
   Demasi R, 1996, FREE RADICAL BIO MED, V20, P291, DOI 10.1016/0891-5849(95)02035-7
   Douki T, 1998, CHEM RES TOXICOL, V11, P150, DOI 10.1021/tx970157d
   ESTERBAUER H, 1984, METHOD ENZYMOL, V105, P319
   Floderus Y, 2006, CLIN CHEM, V52, P701, DOI 10.1373/clinchem.2005.058198
   FRAGA CG, 1994, CARCINOGENESIS, V15, P2241, DOI 10.1093/carcin/15.10.2241
   GARRICK LM, 1993, BLOOD, V81, P3414
   GRANICK S, 1963, J BIOL CHEM, V238, P2247
   Kalinina EV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1562, DOI 10.1134/S0006297914130082
   Kang DC, 2005, CURR MED CHEM, V12, P429, DOI 10.2174/0929867053363081
   Karim Z, 2015, CLIN RES HEPATOL GAS, V39, P412, DOI 10.1016/j.clinre.2015.05.009
   Laafi J, 2014, BIOCHIMIE, V106, P157, DOI 10.1016/j.biochi.2014.08.014
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   MEDEIROS MHG, 1982, CLIN CHEM, V28, P242
   MONTEIRO HP, 1989, ARCH BIOCHEM BIOPHYS, V271, P206, DOI 10.1016/0003-9861(89)90271-3
   Morliere P, 2014, BBA-GEN SUBJECTS, V1840, P3190, DOI 10.1016/j.bbagen.2014.07.002
   Murata K, 2003, J OCCUP HEALTH, V45, P209, DOI 10.1539/joh.45.209
   ONUKI J, 1994, BBA-MOL BASIS DIS, V1225, P259, DOI 10.1016/0925-4439(94)90004-3
   OTEIZA PI, 1995, ARCH BIOCHEM BIOPHYS, V316, P607, DOI 10.1006/abbi.1995.1080
   Pantopoulos K., 2012, PRINCIPLES FREE RADI
   Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x
   PEREIRA B, 1992, J APPL PHYSIOL, V72, P226
   RAO UM, 1989, FREE RADICAL BIO MED, V7, P513
   REYNOLDS ES, 1965, J CELL BIOL, V25, P53, DOI 10.1083/jcb.25.3.53
   Rocha MEM, 2000, FREE RADICAL RES, V32, P343, DOI 10.1080/10715760000300341
   Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146
   SASSA S, 1982, ENZYME, V28, P133, DOI 10.1159/000459097
   Sassa S, 2006, BRIT J HAEMATOL, V135, P281, DOI 10.1111/j.1365-2141.2006.06289.x
   Scott CR, 2006, AM J MED GENET C, V142C, P121, DOI 10.1002/ajmg.c.30092
   SINCLAIR P, 1977, ANAL BIOCHEM, V79, P380, DOI 10.1016/0003-2697(77)90412-2
   Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1
   Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866
   SMITH NC, 1995, J CHROMATOGR B, V673, P35, DOI 10.1016/0378-4347(95)00245-E
   TSCHUDY DP, 1981, J BIOL CHEM, V256, P9915
   Vendemiale G, 2001, HEPATOLOGY, V33, P808, DOI 10.1053/jhep.2001.23060
   VENKATESWAR V, 1991, ARCH BIOCHEM BIOPHYS, V290, P167, DOI 10.1016/0003-9861(91)90603-G
   Wendel A, 1981, Methods Enzymol, V77, P325
   WYSS PA, 1993, BIOCHIM BIOPHYS ACTA, V1182, P323, DOI 10.1016/0925-4439(93)90076-D
NR 49
TC 0
Z9 0
U1 0
U2 2
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD JUL
PY 2017
VL 28
IS 7
BP 1297
EP 1307
DI 10.21577/0103-5053.20160294
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA EZ2DW
UT WOS:000404521000019
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Sanches, JC
   Favaro, RR
   Barrence, FC
   Bevilacqua, E
   Fortes, ZB
   Zorn, TMT
AF Sanches, Juliane C.
   Favaro, Rodolfo R.
   Barrence, Fernanda C.
   Bevilacqua, Estela
   Fortes, Zuleica B.
   Zorn, Telma M. T.
TI Distinct effects of short- and long-term type 1 diabetes to the
   placental extracellular matrix and fetal development in mice
SO PLACENTA
LA English
DT Article
DE Extracellular matrix; Fetal development; Mouse; Placenta; Type 1
   diabetes
ID CELL-PROLIFERATION; GENE-EXPRESSION; PREGNANCY; COMPLICATIONS;
   PROTEOGLYCANS; MYOMETRIUM; ESTRADIOL; VERSICAN; MELLITUS; OUTCOMES
AB Purpose: We have previously shown that the development of complications in the early pregnant decidua and myometrium in mice correlates with diabetes progression. In the current study, we investigated the influence of diabetes progression on the placental extracellular matrix (ECM) and on fetal development at the end of pregnancy.
   Methods: Alloxan-induced type 1 diabetic female mice were bred either 30-50 days after diabetes induction (D) or 90-110D. Fetal and placental weights were registered at the 19th day of pregnancy together with analysis of gene expression, deposition and turnover of the placental ECM.
   Results: The short-term diabetic group (30-50D) showed elevated embryonic losses and underweight fetuses (89%) with normal weight placentas. In contrast, the long-term group (90-110D) had increased malformations/fetal deaths and underweight fetuses (42%) and heavy placentas (50%). Normal-weight fetuses from the long-term group had placentas with either regular weight and fetal/placental weight ratio or increased weight and low fetal/placental weight ratio. Furthermore, the placentas of the shortterm group showed alterations in the synthesis and deposition of collagen types I and V and in the activity of MMP2 whereas placentas of the 90-110D group presented alterations in collagen type III and V and MMP9.
   Conclusions: Diabetes progression promoted distinct outcomes in pregnancy. Modifications of both synthesis and turnover of ECM occurred even before changes of placental weight were detected. Adjustment of fetal/placental weight ratio or placental enlargement restored normal growth in part of the fetuses from the long-term group. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Sanches, Juliane C.; Favaro, Rodolfo R.; Barrence, Fernanda C.; Bevilacqua, Estela; Zorn, Telma M. T.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Fortes, Zuleica B.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.
RP Favaro, RR; Zorn, TMT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Lab Reprod & Extracellular Matrix Biol, Av Prof Lineu Prestes 1524,Room 429, BR-05508000 Sao Paulo, SP, Brazil.
EM rodolfofavaro@usp.br; temtzorn@usp.br
RI Bevilacqua, Estela/H-3354-2011; Favaro, Rodolfo/AAE-9400-2020
OI Bevilacqua, Estela/0000-0003-4178-4625; Favaro,
   Rodolfo/0000-0002-2889-5921
FU Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [07/55277-6, 11/22429-3]; Coordination for
   the Improvement of Higher Education Personnel - CAPESCAPES
   [303830/2013-1, 20131525]
FX This work fulfills part of the requirements for a Ph.D. degree by
   Juliane C. Sanches (Supervisor: Telma M.T. Zorn). Grants and fellowship
   were provided by Sao Paulo Research Foundation - FAPESP (07/55277-6 and
   11/22429-3) and Coordination for the Improvement of Higher Education
   Personnel - CAPES (303830/2013-1 TMTZ; 20131525 RRF).
CR Aerts L, 2003, PLACENTA, V24, P905, DOI 10.1016/S0143-4004(03)00115-2
   Arai KY, 2007, BIOL REPROD, V77, P923, DOI 10.1095/biolreprod.107.061382
   Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894
   Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275
   Chang SC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/457971
   Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004
   Chung C S, 1975, Birth Defects Orig Artic Ser, V11, P23
   Desoye G, 2005, FRONT DIABETES, V17, P94
   Dimasuay KG, 2016, FRONT PHYSIOL, V7, DOI [10.3389/fphys.2016.00012, 10.3339/fphys.2016.00012]
   Ejdesjo A, 2011, AM J PHYSIOL-ENDOC M, V300, pE454, DOI 10.1152/ajpendo.00543.2010
   ERIKSSON UJ, 1986, DIABETES, V35, P1356, DOI 10.2337/diabetes.35.12.1356
   Favaro RR, 2013, PLACENTA, V34, P1128, DOI 10.1016/j.placenta.2013.09.012
   Favaro RR, 2015, HISTOL HISTOPATHOL, V30, P435, DOI 10.14670/HH-30.435
   Favaro RR, 2010, INT J EXP PATHOL, V91, P426, DOI 10.1111/j.1365-2613.2010.00718.x
   Forsberg H, 1998, AM J OBSTET GYNECOL, V179, P772, DOI 10.1016/S0002-9378(98)70081-X
   GEWOLB IH, 1986, DIABETES, V35, P1254, DOI 10.2337/diabetes.35.11.1254
   Giachini FRC, 2008, J ANAT, V212, P31, DOI 10.1111/j.1469-7580.2007.00839.x
   Howarth C, 2007, DIABETIC MED, V24, P1229, DOI 10.1111/j.1464-5491.2007.02254.x
   Huynh J, 2015, PLACENTA, V36, P101, DOI 10.1016/j.placenta.2014.11.021
   Jawerbaum A, 2006, CURR MED CHEM, V13, P2127, DOI 10.2174/092986706777935302
   Jawerbaum A, 2010, ENDOCR REV, V31, P680, DOI 10.1210/er.2009-0038
   Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819
   Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957
   KARLSSON K, 1972, AM J OBSTET GYNECOL, V112, P213, DOI 10.1016/0002-9378(72)90118-4
   Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7
   Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011
   Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011
   Pietro L, 2010, PLACENTA, V31, P770, DOI 10.1016/j.placenta.2010.07.003
   Pustovrh MC, 2005, PLACENTA, V26, P339, DOI 10.1016/j.placenta.2004.06.011
   Rogus JJ, 2002, DIABETES, V51, P1655, DOI 10.2337/diabetes.51.6.1655
   Salbaum JM, 2011, DIABETOLOGIA, V54, P1909, DOI 10.1007/s00125-011-2132-6
   Salgado RM, 2013, J MOL HISTOL, V44, P221, DOI 10.1007/s10735-012-9476-1
   Salgado RM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-22
   Salgado RM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-60
   Sati L, 2008, ACTA HISTOCHEM, V110, P371, DOI 10.1016/j.acthis.2007.11.006
   Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090
   Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23
   Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194
   Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258
   Torchinsky A, 1997, Early Pregnancy, V3, P27
   Wender-Ozegowska E, 2005, ACTA OBSTET GYN SCAN, V84, P17, DOI 10.1111/j.0001-6349.2005.00606.x
   Yu Yang, 2008, Archives of Physiology and Biochemistry, V114, P99, DOI [10.1080/13813450802033776, 10.1080/13813450802033776 ]
   Zorn TMT, 2011, HISTOL HISTOPATHOL, V26, P1049, DOI 10.14670/HH-26.1049
NR 43
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAY
PY 2017
VL 53
BP 1
EP 7
DI 10.1016/j.placenta.2017.03.005
PG 7
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA EV8ZA
UT WOS:000402072400001
PM 28487012
OA Bronze
DA 2020-12-01
ER

PT J
AU Neto, DFD
   Lorenzon-Ojea, A
   Gomes, SZ
   Bandeira, C
   Zanotto, P
   Palmisano, G
   Bevilacqua, E
AF Ferreira de Lima Neto, D.
   Lorenzon-Ojea, A.
   Zago Gomes, S.
   Bandeira, C.
   Zanotto, P.
   Palmisano, G.
   Bevilacqua, E.
TI ZIKA VIRUS INFECTION IN HUMAN PLACENTAL CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the
   Latin-American-Society-for-Maternal-Fetal-Interaction-and-Placenta
   (SLIMP)
CY APR 11-13, 2017
CL Puerto Varas, CHILE
SP Latin Amer Soc Maternal Fetal Interact & Placenta
C1 [Ferreira de Lima Neto, D.; Lorenzon-Ojea, A.; Zago Gomes, S.; Bandeira, C.; Zanotto, P.; Palmisano, G.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014; de A. Zanotto, Paolo M./B-9286-2019
OI Lorenzon, Aline R/0000-0002-6052-6296; de A. Zanotto, Paolo
   M./0000-0002-8167-0625
FU FapespFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX Fapesp and CNPq.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR
PY 2017
VL 51
BP 106
EP 106
DI 10.1016/j.placenta.2017.01.033
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ER2SZ
UT WOS:000398645400038
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Rocha, CR
   Bevilacqua, E
AF Lorenzon-Ojea, A. R.
   Rocha, C. R.
   Bevilacqua, E.
TI STROMAL CELL DERIVED FACTOR 2 AND ITS ROLE IN ENDOPLASMIC RETICULUM
   STRESS IN HUMAN TROPHOBLAST CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the
   Latin-American-Society-for-Maternal-Fetal-Interaction-and-Placenta
   (SLIMP)
CY APR 11-13, 2017
CL Puerto Varas, CHILE
SP Latin Amer Soc Maternal Fetal Interact & Placenta
C1 [Lorenzon-Ojea, A. R.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Rocha, C. R.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR
PY 2017
VL 51
BP 110
EP 111
DI 10.1016/j.placenta.2017.01.048
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ER2SZ
UT WOS:000398645400054
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Hebeda, CB
   Machado, ID
   -Silva, IR
   Oliani, SM
   Perretti, M
   Bevilacqua, E
   Farsky, SHP
AF Moreli, J. B.
   Hebeda, C. B.
   Machado, I. D.
   -Silva, I. Reif
   Oliani, S. M.
   Perretti, M.
   Bevilacqua, E.
   Farsky, S. H. P.
TI THE ROLE OF ENDOGENOUS ANNEXIN A1 (ANXA1) IN PREGNANCY
SO PLACENTA
LA English
DT Meeting Abstract
CT Joint Meeting of the
   Latin-American-Society-for-Maternal-Fetal-Interaction-and-Placenta
   (SLIMP) and Sociedad Chilena de Ciencias Fisiologicas (SLIMP-SCHCF)
CY APR 11-13, 2017
CL Puerto Varas, CHILE
SP Latin Amer Soc Maternal Fetal Interact & Placenta, Soc Chilena Ciencias Fisiologicas
C1 [Moreli, J. B.; Oliani, S. M.] Univ Fed Sao Paulo, UNIFESP, Postgrad Struct & Funct Biol, Sao Paulo, Brazil.
   [Hebeda, C. B.; Machado, I. D.; -Silva, I. Reif; Farsky, S. H. P.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Perretti, M.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London, England.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Oliani, S. M.] Sao Paulo State Univ, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, UNESP, Sao Jose Do Rio Preto, Brazil.
RI Machado, Isabel/AAE-3418-2020; Farsky, Sandra HP/C-4044-2012; Machado,
   Isabel D/B-8913-2014
OI Machado, Isabel/0000-0003-0724-5150; 
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [308144/2014-7]
FX Funding: CNPq (308144/2014-7).
NR 0
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAR
PY 2017
VL 51
BP 121
EP 121
DI 10.1016/j.placenta.2017.01.078
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA ER2SZ
UT WOS:000398645400084
DA 2020-12-01
ER

PT J
AU Xavier-Neto, J
   Carvalho, M
   Pascoalino, BD
   Cardoso, AC
   Costa, AMS
   Pereira, AHM
   Santos, LN
   Saito, A
   Marques, RE
   Smetana, JHC
   Consonni, SR
   Bandeira, C
   Costa, VV
   Bajgelman, MC
   de Oliveira, PSL
   Cordeiro, MT
   Gil, LHVG
   Pauletti, BA
   Granato, DC
   Leme, AFP
   Freitas, L
   de Freitas, CBMH
   Teixeira, MM
   Bevilacqua, E
   Franchini, K
AF Xavier-Neto, Jose
   Carvalho, Murilo
   Pascoalino, Bruno dos Santos
   Cardoso, Alisson Campos
   Sousa Costa, Angela Maria
   Macedo Pereira, Ana Helena
   Santos, Luana Nunes
   Saito, Angela
   Marques, Rafael Elias
   Costa Smetana, Juliana Helena
   Consonni, Silvio Roberto
   Bandeira, Carla
   Costa, Vivian Vasconcelos
   Bajgelman, Marcio Chaim
   Lopes de Oliveira, Paulo Sergio
   Cordeiro, Marli Tenorio
   Vega Gonzales Gil, Laura Helena
   Pauletti, Bianca Alves
   Granato, Daniela Campos
   Paes Leme, Adriana Franco
   Freitas-Junior, Lucio
   Moraes Holanda de Freitas, Carolina Borsoi
   Teixeira, Mauro Martins
   Bevilacqua, Estela
   Franchini, Kleber
TI Hydrocephalus and arthrogryposis in an immunocompetent mouse model of
   ZIKA teratogeny: A developmental study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   VIRUS-INFECTION; MICE; EXPRESSION; INTERFACE; PREGNANCY; PLACENTA;
   BRAZIL; DAMAGE
AB The teratogenic mechanisms triggered by ZIKV are still obscure due to the lack of a suitable animal model. Here we present a mouse model of developmental disruption induced by ZIKV hematogenic infection. The model utilizes immunocompetent animals from wild-type FVB/NJ and C57BL/6J strains, providing a better analogy to the human condition than approaches involving immunodeficient, genetically modified animals, or direct ZIKV injection into the brain. When injected via the jugular vein into the blood of pregnant females harboring conceptuses from early gastrulation to organogenesis stages, akin to the human second and fifth week of pregnancy, ZIKV infects maternal tissues, placentas and embryos/fetuses. Early exposure to ZIKV at developmental day 5 (second week in humans) produced complex manifestations of anterior and posterior dysraphia and hydrocephalus, as well as severe malformations and delayed development in 10.5 days post-coitum (dpc) embryos. Exposure to the virus at 7.5-9.5 dpc induces intra-amniotic hemorrhage, widespread edema, and vascular rarefaction, often prominent in the cephalic region. At these stages, most affected embryos/fetuses displayed gross malformations and/or intrauterine growth restriction (IUGR), rather than isolated microcephaly. Disrupted conceptuses failed to achieve normal developmental landmarks and died in utero. Importantly, this is the only model so far to display dysraphia and hydrocephalus, the harbinger of microcephaly in humans, as well as arthrogryposis, a set of abnormal joint postures observed in the human setting. Late exposure to ZIKV at 12.5 dpc failed to produce noticeable malformations. We have thus characterized a developmental window of opportunity for ZIKV-induced teratogenesis encompassing early gastrulation, neurulation and early organogenesis stages. This should not, however, be interpreted as evidence for any safe developmental windows for ZIKV exposure. Late developmental abnormalities correlated with damage to the placenta, particularly to the labyrinthine layer, suggesting that circulatory changes are integral to the altered phenotypes.
C1 [Xavier-Neto, Jose; Carvalho, Murilo; Pascoalino, Bruno dos Santos; Cardoso, Alisson Campos; Sousa Costa, Angela Maria; Macedo Pereira, Ana Helena; Santos, Luana Nunes; Saito, Angela; Marques, Rafael Elias; Costa Smetana, Juliana Helena; Consonni, Silvio Roberto; Bajgelman, Marcio Chaim; Lopes de Oliveira, Paulo Sergio; Pauletti, Bianca Alves; Granato, Daniela Campos; Paes Leme, Adriana Franco; Freitas-Junior, Lucio; Moraes Holanda de Freitas, Carolina Borsoi; Franchini, Kleber] Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
   [Santos, Luana Nunes; Bandeira, Carla; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, SP, Brazil.
   [Costa, Vivian Vasconcelos; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Lab Imunofarmacol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.
   [Cordeiro, Marli Tenorio; Vega Gonzales Gil, Laura Helena] Univ Fed Pernambuco, FIOCRUZ, CPqAM, Ave Prof Moraes Rego S-N,Cidade Univ, Recife, PE, Brazil.
RP Xavier-Neto, J; Franchini, K (corresponding author), Brazilian Biosci Natl Lab, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, Campinas, SP, Brazil.
EM xavier.neto@lnbio.cnpem.br; kleber.franchini@lnbio.cnpem.br
RI Moraes, Carolina Borsoi/I-4408-2014; Bajgelman, Marcio/A-8146-2019;
   Carvalho, Murilo/B-7950-2012; Consonni, Silvio Roberto/R-9281-2019;
   Teixeira, Mauro M/A-4587-2008; Costa, Vivian VVC/I-2499-2018; Saito,
   Angela/G-6107-2019; Saito, Angela/AAY-9404-2020; Oliveira,
   Paulo/K-5588-2013; Bandeira, Carla Leticia/U-8685-2017; Marques, Rafael
   Elias/R-4890-2016; Freitas-Junior, Lucio H/C-8677-2011; Bevilacqua,
   Estela/H-3354-2011; Smetana, Juliana/J-5354-2013
OI Moraes, Carolina Borsoi/0000-0002-0689-2770; Bajgelman,
   Marcio/0000-0003-3371-1143; Carvalho, Murilo/0000-0001-6881-5271;
   Teixeira, Mauro M/0000-0002-6944-3008; Costa, Vivian
   VVC/0000-0002-0175-642X; Saito, Angela/0000-0003-4421-9226; Bandeira,
   Carla Leticia/0000-0002-0796-3462; Marques, Rafael
   Elias/0000-0002-6949-0947; Freitas-Junior, Lucio H/0000-0002-8904-7897;
   Bevilacqua, Estela/0000-0003-4178-4625; Smetana,
   Juliana/0000-0001-9827-7013; Consonni, Silvio
   Roberto/0000-0003-3149-021X
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [CNPq
   440379/2016-4]; Fundacao de Amparo a Pesquisa do Estado de Sao
   PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [FAPESP 2013/22695-0]; individual CNPq fellowship for Productivity in
   Science [CNPq 305537/2014-8]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2016/07632-0]
FX This study was partially funded by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq 440379/2016-4), Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/22695-0) and an
   individual CNPq fellowship for Productivity in Science to JXN (CNPq
   305537/2014-8). The results in the manuscript constitute preliminary
   evidence in an application to a FAPESP grant (Project 2016/07632-0). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bevilacqua E, 2014, PLACENTA, V35, pS51, DOI 10.1016/j.placenta.2013.10.015
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Creasy RK, 2009, CREASY RESNIKS MATER, pxvii
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Davis GH, 2003, CLIN PERINATOL, V30, P531, DOI 10.1016/S0095-5108(03)00053-8
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   de Paula Freitas B, 2016, JAMA OPHTHALMOLOGY
   Doce N, 2016, BRAZIL SCI SEEK UNRA
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   DOWNS KM, 1993, DEVELOPMENT, V118, P1255
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hannon T, 2012, OBSTET GYNECOL, V120, P1345, DOI [10.1097/AOG.0b013e3182732b53, http://10.1097/AOG.0b013e3182732b53]
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Kauffman MH., 1994, ATLAS MOUSE DEV
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432
   Medina F, 2012, CURRENT PROTOCOLS MI
   Menkes JH, 2006, CHILD NEUROLOGY, pxiii
   Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1016/j.ctim.2007.01.003, 10.1002/0471142735.im1501s77]
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mouillet JF, 2014, INT J DEV BIOL, V58, P281, DOI 10.1387/ijdb.130349ys
   Nagai A, 2010, PLACENTA, V31, P126, DOI 10.1016/j.placenta.2009.11.013
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sav A, 2008, SPINA BIFIDA MANAGEM, P43
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Seaman WT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-194
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Steel CD, 2008, LAB ANIMAL, V37, P26, DOI 10.1038/laban0108-26
   Stevens DB, 1999, J IMMUNOL, V162, P7501
   Theiler K., 1989, HOUSE MOUSE ATLAS EM
   Tonra James R, 2002, Cerebellum, V1, P57, DOI 10.1080/147342202753203096
   Ueno M, 2013, DEV CELL, V27, P373, DOI 10.1016/j.devcel.2013.10.019
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   XavierNeto J, 1996, AM J PHYSIOL-HEART C, V271, pH1407
   Yadav RK, 2014, J SCI INNOVATIVE RES, V3, P258
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110620
NR 53
TC 25
Z9 25
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005363
DI 10.1371/journal.pntd.0005363
PG 29
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EN1AD
UT WOS:000395741700032
PM 28231241
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Racca, AC
   Ridano, ME
   Bandeira, CL
   Bevilacqua, E
   Portari, EA
   Genti-Raimondi, S
   Graham, CH
   Panzetta-Dutari, GM
AF Racca, A. C.
   Ridano, M. E.
   Bandeira, C. L.
   Bevilacqua, E.
   Avvad Portari, E.
   Genti-Raimondi, S.
   Graham, C. H.
   Panzetta-Dutari, G. M.
TI Low oxygen tension induces Kruppel-Like Factor 6 expression in
   trophoblast cells
SO PLACENTA
LA English
DT Article
DE Hypoxia; Kruppel-Like Factor 6; Hypoxia inducible factor-1 alpha;
   Placenta; Trophoblast
ID TRANSCRIPTION FACTOR KLF6; HYPOXIA-INDUCIBLE FACTORS; OXIDATIVE STRESS;
   PLACENTA; ENDOGLIN; PROLIFERATION; ONCOPROTEIN; ACTIVATION; REGULATOR;
   PROMOTE
AB The transcription factor Kruppel-Like Factor 6 (KLF6) has important roles in cell differentiation, angiogenesis, apoptosis, and proliferation. Furthermore, there is evidence that KLF6 is required for proper placental development. While oxygen is a critical mediator of trophoblast differentiation and function, the involvement of oxygen in the regulation of KLF6 expression remains unexplored. In the present study we examined the expression of KLF6 in placental tissue from uncomplicated and preeclamptic pregnancies, the latter often characterized by an inadequately perfused placenta. We also determined the effect of hypoxia and the involvement of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) on the expression of KLF6 in cultured trophoblast cells and placental tissues. Results revealed that villous, interstitial and endovascular extravillous cytotrophoblasts from placentas from normal and preeclamptic pregnancies express KLF6. In addition, KLF6 immunoreactivity was higher in the placental bed of preeclamptic pregnancies than in those of uncomplicated pregnancies. We demonstrated that hypoxia induced an early and transient increase in KLF6 protein levels in HTR8/SVneo extravillous cytotrophoblast cells and in placental explants. Reoxygenation returned KLF6 protein to basal levels. Moreover, hypoxia-induced up regulation of KLF6 expression was dependent on HIF-1 alpha as revealed by siRNA knockdown in HTR8/SVneo cells. These results indicate that KLF6 may mediate some of the effects of hypoxia in placental development. The regulation of KLF6 protein levels by oxygen has significant implications for understanding its putative role in diseases affected by tissue hypoxia. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Racca, A. C.; Ridano, M. E.; Genti-Raimondi, S.; Panzetta-Dutari, G. M.] Univ Nacl Cordoba, CONICET, Ctr Invest Bioquim Clin & Inmunol CIBICI, Dept Bioquim Clin,Fac Ciencias Quim, Cordoba, Argentina.
   [Bandeira, C. L.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Avvad Portari, E.] Univ Estado Rio De Janeiro, Sch Med Sci, Dept Pathol, Rio De Janeiro, Brazil.
   [Graham, C. H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.
   [Graham, C. H.] Queens Univ, Dept Urol, Kingston, ON, Canada.
RP Panzetta-Dutari, GM (corresponding author), Univ Nacl Cordoba, CONICET, CIBICI, Dept Bioquim Clin,Fac Ciencias Quim, Ciudad Univ,X5000HUA, Cordoba, Argentina.
EM gpan@fcq.unc.edu.ar
RI Bandeira, Carla Leticia/U-8685-2017; Bevilacqua, Estela/H-3354-2011
OI Bandeira, Carla Leticia/0000-0002-0796-3462; Bevilacqua,
   Estela/0000-0003-4178-4625; Racca, Ana Cristina/0000-0002-5909-2451
FU Consejo Nacional de Investigaciones Cientificas y Tecnologicas de
   Argentina (CONICET)Consejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET); Agencia Nacional de Promocion Ciencia y Tecnica
   (FONCYT) PICT [2011-0452, 2014-0806]; Secretaria de Ciencia y Tecnica de
   la Universidad Nacional de Cordoba (SECyT-UNC)Secretaria de Ciencia y
   Tecnologia (SECYT); Canadian Institutes of Health ResearchCanadian
   Institutes of Health Research (CIHR) [MOP 119496]; CONICETConsejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   International Union of Biochemistry and Molecular Biology
FX We gratefully acknowledge Drs. Gustavo Chiabrando and Jose Luis Bocco
   for reagents and helpful advice. This work was supported by the Consejo
   Nacional de Investigaciones Cientificas y Tecnologicas de Argentina
   (CONICET), the Agencia Nacional de Promocion Ciencia y Tecnica (FONCYT)
   PICT 2011-0452 and 2014-0806, and the Secretaria de Ciencia y Tecnica de
   la Universidad Nacional de Cordoba (SECyT-UNC), as well as the Canadian
   Institutes of Health Research (grant number MOP 119496, awarded to CHG).
   G.M.P-D. and S.G-R. are Career Investigators of CONICET. A.C.R and M.E.R
   thank CONICET for their fellowship. A.C.R acknowledges the Journal of
   Cell Science and the Wood-Whelan Research Fellowship from the
   International Union of Biochemistry and Molecular Biology, for her
   Travelling Fellowships.
CR Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033
   Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396
   Bandeira CL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/892856
   Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4
   Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001
   Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb
   Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102
   Chen PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071282
   Racca AC, 2015, MOL HUM REPROD, V21, P347, DOI 10.1093/molehr/gau113
   Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007
   Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001
   Dionyssiou MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-7
   ElRouby S, 1996, ONCOGENE, V13, P2623
   Erol AYG, 2012, ENDOCRINE, V42, P125, DOI 10.1007/s12020-012-9644-9
   Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074
   Gallardo-Vara E, 2016, ANGIOGENESIS, V19, P155, DOI 10.1007/s10456-016-9495-8
   Garrido-Martin EM, 2013, CIRC RES, V112, P113, DOI 10.1161/CIRCRESAHA.112.275586
   Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139
   Gregory AL, 2014, PLACENTA, V35, pS93, DOI 10.1016/j.placenta.2013.10.020
   Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189
   Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3
   Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008
   Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029
   Kim Y., J BIOL CHEM, V273
   Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019
   Koizume S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0351-z
   Koritschoner NP, 1997, J BIOL CHEM, V272, P9573
   Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012
   Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022
   Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620
   Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916
   McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009
   Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799
   Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516
   Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046
   Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438
   Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500
   Slavin D, 1999, BIOL REPROD, V61, P1586, DOI 10.1095/biolreprod61.6.1586
   Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020
   Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723
   Tarabishi R, 2005, KIDNEY INT, V68, P1511, DOI 10.1111/j.1523-1755.2005.00563.x
   Zhao XA, 2010, DEV BIOL, V344, P79, DOI 10.1016/j.ydbio.2010.04.018
NR 44
TC 2
Z9 3
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2016
VL 45
BP 50
EP 57
DI 10.1016/j.placenta.2016.07.006
PG 8
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DV9WX
UT WOS:000383294000008
PM 27577710
DA 2020-12-01
ER

PT J
AU Moreli, J
   Paula-Silva, M
   Calderon, I
   Farsky, S
   Oliani, S
   Bevilacqua, E
AF Moreli, Juscieli
   Paula-Silva, Marina
   Calderon, Iracema
   Farsky, Sandra
   Oliani, Sonia
   Bevilacqua, Estela
TI ANNEXIN A1 LOCALIZATION AND RELEVANCE IN HUMAN PLACENTA FROM PREGNANCIES
   COMPLICATED BY GESTATIONAL DIABETES MELLITUS. PRELIMINARY RESULTS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
   - Placenta-Back to the Basics
CY SEP 13-16, 2016
CL Portland, OR
SP Int Federat Placenta Assoc
C1 [Moreli, Juscieli; Paula-Silva, Marina; Oliani, Sonia] Fed Univ Sao Paulo UNIFESP, Postgrad Struct & Funct Biol, Paulista Sch Med, Sao Paulo, SP, Brazil.
   [Moreli, Juscieli; Paula-Silva, Marina; Oliani, Sonia] Sao Paulo State Univ UNESP, Dept Biol, Inst Biosci Letters & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil.
   [Calderon, Iracema] Sao Paulo State Univ UNESP, Grad Program Gynecol Obstet & Mastol, Botucatu Med Sch, Sao Paulo, SP, Brazil.
   [Farsky, Sandra] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, SP, Brazil.
RI Calderon, Iracema/W-4336-2019; Farsky, Sandra HP/C-4044-2012
OI Calderon, Iracema/0000-0003-4761-4336; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2016
VL 45
MA P2.17
BP 108
EP 109
DI 10.1016/j.placenta.2016.06.165
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DV9WX
UT WOS:000383294000162
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Guzzo, CR
   Kapidzic, M
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Guzzo, Cristiane R.
   Kapidzic, Mirhan
   Fisher, Susan J.
   Bevilacqua, Estela
TI Stromal Cell-Derived Factor 2: A Novel Protein that Interferes in
   Endoplasmic Reticulum Stress Pathway in Human Placental Cells
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE cell survival/apoptosis; ER Stress; human placenta; SDF2; UPR
ID GENE-EXPRESSION; TROPHOBLAST CELLS; PRETERM LABOR; MOUSE MODEL; CANCER;
   APOPTOSIS; PATTERNS; INVASION; SDF-2; GAMMA
AB Endoplasmic reticulum (ER) stress results from changes in ER homeostasis and folding of proteins. ER stress initiates cellular adaptive mechanisms to rescue cell homeostasis or, if that does not work, to elicit apoptosis. We have previously shown that mouse SDF2 is sublocalized in the ER, is ubiquitously expressed, and shows strong similarities with stromal cell-derived factor (SDF) 2L1 and SDF2-like from Arabidopsis, ER proteins involved in chaperone network and protein folding. Thus, we hypothesized that SDF2 plays a role in the ER stress and unfolded protein response. In this study, we investigated the possible role of SDF2 in the human placenta. Expression of SDF2 was present throughout gestation and was expressed by several cell types. Second-trimester cytotrophoblast cells (CTBs) in the differentiation process, monitored through chorionic gonadotropin production, showed upregulation of SDF2 protein. SDF2 expression, however, was significantly diminished in placentas from neonates small for gestational age and in hypoxic in vitro conditions (P <= 0.001, 2% O-2), suggesting a link with cellular stress. ER stress-induced cells-CTB and BeWo-also showed SDF2 downregulation in different time points, emphasizing this relationship. SDF2 downregulation was also followed by an increase in binding immunoglobulin protein (BiP) expression, an ER protein-associated chaperone acting as a sensor for misfolded proteins and an ER stress cell survival marker. In line with this, SDF2 siRNA resulted in significant anticipation of BiP expression. Downregulation of SDF2 also interfered with C/EBP homologous protein expression, one of the highest inducible genes during ER stress. These findings suggest that SDF2 may be an important regulatory factor by which trophoblast cells can control cell survival under ER stress. In conclusion, this study identifies a novel factor with the ability to interfere with ER stress proteins, which may contribute to the understanding of ER stress associated with placental-related diseases of pregnancy.
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Lorenzon-Ojea, Aline R.; Kapidzic, Mirhan; Fisher, Susan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [Guzzo, Cristiane R.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Guzzo, Cristiane R.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Lorenzon, Aline R/G-8733-2014; Bevilacqua, Estela/H-3354-2011; Carvalho,
   Cristiane R. G/K-2855-2016
OI Lorenzon, Aline R/0000-0002-6052-6296; Bevilacqua,
   Estela/0000-0003-4178-4625; Carvalho, Cristiane R. G/0000-0002-5664-8055
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03510-4,
   2009/11869-2]; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordernacao de Aperfeicoamento de Pessoal de Nivel Superior;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R37 HD076253];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03510-4]; EUNICE
   KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R37HD076253,
   R37HD076253, R37HD076253, R37HD076253, R37HD076253, R37HD076253,
   R37HD076253, R37HD076253] Funding Source: NIH RePORTER
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) grant 2009/03510-4 and 2009/11869-2, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Coordernacao de
   Aperfeicoamento de Pessoal de Nivel Superior, and National Institutes of
   Health grant R37 HD076253. A.R.L.-O. received a Ph.D. scholarship from
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP grant
   2009/03510-4.
CR Becher N, 2009, ACTA OBSTET GYN SCAN, V88, P502, DOI 10.1080/00016340902852898
   Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307
   Burton GJ, 2011, PREGNANCY HYPERTENS, V1, P72, DOI 10.1016/j.preghy.2010.12.002
   Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513
   Chen SH, 2005, PHYSIOL GENOMICS, V22, P257, DOI 10.1152/physiolgenomics.00063.2005
   DAMSKY CH, 1994, DEVELOPMENT, V120, P3657
   Faria MR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-95
   Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X
   Handschuh K, 2009, PLACENTA, V30, P1016, DOI 10.1016/j.placenta.2009.09.006
   Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012
   Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028
   Hoshida MS, 2008, PLACENTA, V29, P103
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Hromatka BS, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106195
   Hunkapiller NM, 2008, METHOD ENZYMOL, V445, P281, DOI 10.1016/S0076-6879(08)03012-7
   Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970
   Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106
   Kang H, 2009, INT J ONCOL, V35, P205, DOI 10.3892/ijo_00000330
   Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008
   LAVERY JP, 1982, OBSTET GYNECOL, V60, P87
   Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8
   Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361
   Liu AX, 2011, J CLIN ENDOCR METAB, V96, pE493, DOI 10.1210/jc.2010-2192
   Lorenzon-Ojea AR, 2014, INT J BIOCHEM CELL B, V53, P262, DOI 10.1016/j.biocel.2014.05.024
   Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312
   Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425
   Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819
   Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373
   Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816
   Siragusa M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2819
   Vendrell E, 2007, INT J ONCOL, V30, P1099
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wang WA, 2014, BBA-MOL CELL RES, V1843, P2143, DOI 10.1016/j.bbamcr.2014.01.012
   Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683
   Xie C, 2016, PEDIATRICS, V137, P1
   Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193
   Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
NR 41
TC 3
Z9 4
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0006-3363
EI 1529-7268
J9 BIOL REPROD
JI Biol. Reprod.
PD AUG 1
PY 2016
VL 95
IS 2
AR 41
DI 10.1095/biolreprod.115.138164
PG 11
WC Reproductive Biology
SC Reproductive Biology
GA DZ6AB
UT WOS:000385942800007
PM 27335075
OA Green Published, Bronze
DA 2020-12-01
ER

PT J
AU Costa, AF
   Gomes, SZ
   Lorenzon-Ojea, AR
   Martucci, M
   Faria, MR
   Pinto, DD
   Oliveira, SF
   Ietta, F
   Paulesu, L
   Bevilacqua, E
AF Costa, Adriana Fraga
   Gomes, Sara Zago
   Lorenzon-Ojea, Aline R.
   Martucci, Mariane
   Faria, Miriam Rubio
   Pinto, Decio dos Santos, Jr.
   Oliveira, Sergio F.
   Ietta, Francesca
   Paulesu, Luana
   Bevilacqua, Estela
TI Macrophage migration inhibitory factor induces phosphorylation of Mdm2
   mediated by phosphatidylinositol 3-kinase/Akt kinase: Role of this
   pathway in decidual cell survival
SO PLACENTA
LA English
DT Article
ID FACTOR MIF; FACTOR EXPRESSION; RECEPTOR COMPLEX; CROSS-TALK; P53; AKT;
   APOPTOSIS; ACTIVATION; IMPLANTATION; RESISTANCE
AB The phosphatidylinositol 3-kinase (PI3K)/Akt pathway has an anti-apoptotic effect through several downstream targets, which includes activation of the transformed mouse 3T3 cell double-minute 2 (Mdm2) protein, its translocation to the nucleus and degradation of the tumor suppressor p53. We show that Mif, the Macrophage Migration Inhibitory Factor, an important cytokine at the maternal fetal interface in several species, triggers phosphorylation of Mdm2 protein in a PI3K/Akt-dependent manner, thereby preventing apoptosis in cultured mouse decidual cells. Inhibition of Akt and PI3K suppresses the pathway. Mif treatment also changes the nuclear translocation of p53 and interferes with the apoptotic fate of these cells when challenged with reactive oxygen species. In conclusion, an important mechanism has been found underlying decidual cell survival through Akt signaling pathway activated by Mif, suggesting a role for this cytokine in decidual homeostasis and in the integrity of the maternal-fetal barrier that is essential for successful gestation. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Costa, Adriana Fraga; Gomes, Sara Zago; Lorenzon-Ojea, Aline R.; Martucci, Mariane; Faria, Miriam Rubio; Oliveira, Sergio F.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Costa, Adriana Fraga; Pinto, Decio dos Santos, Jr.] Univ Sao Paulo, Sch Dent, Dept Stomatol, Sao Paulo, Brazil.
   [Ietta, Francesca; Paulesu, Luana] Univ Siena, Dept Life Sci, Via Laterina 8, I-53100 Siena, Italy.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Lorenzon, Aline R/G-8733-2014; Pinto, Decio/B-6041-2011; Bevilacqua,
   Estela/H-3354-2011
OI Lorenzon, Aline R/0000-0002-6052-6296; Pinto, Decio/0000-0001-6198-5155;
   Bevilacqua, Estela/0000-0003-4178-4625; Ietta,
   Francesca/0000-0002-2160-8790
FU Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX Fundacao do Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610
   Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200
   Arcuri F, 2007, BIOL REPROD, V76, P433, DOI 10.1095/biolreprod.106.054189
   Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567
   Bevilacqua E, 2014, PLACENTA, V35, pS51, DOI 10.1016/j.placenta.2013.10.015
   Borbely AU, 2012, AM J REPROD IMMUNOL, V67, P73, DOI 10.1111/j.1600-0897.2011.01060.x
   Cecconi S, 2012, INT J DEV BIOL, V56, P809, DOI 10.1387/ijdb.120146sc
   Chaisavaneeyakorn S, 2005, INFECT IMMUN, V73, P3287, DOI 10.1128/IAI.73.6.3287-3293.2005
   Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9
   Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1
   Faria MR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-95
   Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724
   Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200
   Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj/onc/1205181
   GU Y, 1992, ENDOCRINOLOGY, V131, P1321, DOI 10.1210/en.131.3.1321
   Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327
   Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302
   Jain MV, 2015, CELL CYCLE, V14, P2109, DOI 10.1080/15384101.2015.1041692
   Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004
   Letta F, 2002, AM J REPROD IMMUNOL, V48, P404, DOI 10.1034/j.1600-0897.2002.01152.x
   Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912
   Mauro C, 2012, CURR OPIN PHARMACOL, V12, P452, DOI 10.1016/j.coph.2012.02.018
   Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198
   Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517
   Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4
   Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x
   Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001
   Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x
   O'Brate A, 2003, DRUG RESIST UPDATE, V6, P313, DOI 10.1016/j.drup.2003.10.004
   Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200
   Oliveira SF, 2000, HISTOCHEM CELL BIOL, V113, P319, DOI 10.1007/s004180000141
   Paulesu L, 2005, BIOL REPROD, V72, P949, DOI 10.1095/biolreprod.104.029058
   Peirce SK, 2011, CANCER CHEMOTH PHARM, V68, P325, DOI 10.1007/s00280-010-1486-7
   Piccinni MP, 2000, J NEUROIMMUNOL, V109, P30, DOI 10.1016/S0165-5728(00)00299-X
   Plaisier M, 2011, BEST PRACT RES CL OB, V25, P259, DOI 10.1016/j.bpobgyn.2010.10.011
   POWIS G, 1994, CANCER RES, V54, P2419
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852
   Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006
   Senturk Emir, 2012, Genes Cancer, V3, P192, DOI 10.1177/1947601912457368
   Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020
   Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004
   Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33
   Tang B, 1993, Acta Eur Fertil, V24, P221
   THOMAS T, 1993, PLACENTA, V14, P417, DOI 10.1016/S0143-4004(05)80462-X
   Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432
   VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241
   Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428
   Xu JF, 2012, INT J MOL SCI, V13, P17104, DOI 10.3390/ijms131217104
   Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200
   Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343
   Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje
NR 54
TC 9
Z9 9
U1 0
U2 9
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD MAY
PY 2016
VL 41
BP 27
EP 38
DI 10.1016/j.placenta.2016.03.001
PG 12
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DM2WF
UT WOS:000376208100004
PM 27208405
DA 2020-12-01
ER

PT J
AU Goncalves, CM
   Pires, KSN
   Silva, LC
   Santos, JC
   Ishigai, MMS
   Daher, S
   Sun, SY
   Bevilacqua, E
   Borbely, AU
AF Goncalves, Camilla M.
   Pires, Keyla S. N.
   Silva, Lais C.
   Santos, Jaqueline C.
   Ishigai, Marcia M. S.
   Daher, Silvia
   Sun, Sue Y.
   Bevilacqua, Estela
   Borbely, Alexandre U.
TI Versican: A Novel Biomarker for Placenta Accreta Invasion.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 63rd Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation
CY MAR 16-19, 2016
CL Montreal, CANADA
SP Soc Reprod Invest
C1 [Goncalves, Camilla M.; Pires, Keyla S. N.; Silva, Lais C.; Santos, Jaqueline C.; Borbely, Alexandre U.] Univ Fed Alagoas, Inst Biol & Hlth Sci, Maceio, Brazil.
   [Ishigai, Marcia M. S.; Daher, Silvia; Sun, Sue Y.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RI Sun, Sue Yazaki/N-4314-2018; DAHER, SILVIA/D-2180-2012; Pires,
   Keyla/AAL-5072-2020
OI Sun, Sue Yazaki/0000-0001-6573-7386; DAHER, SILVIA/0000-0001-5312-7804; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2016
VL 23
SU 1
MA T-175
BP 155A
EP 155A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DH6CS
UT WOS:000372879200334
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Bevilacqua, Estela
TI SDF2 (Stromal Cell Derived Factor-2) Induces Apoptosis in HTR8/Svneo
   Cells Under ER Stress.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 63rd Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation
CY MAR 16-19, 2016
CL Montreal, CANADA
SP Soc Reprod Invest
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2016
VL 23
SU 1
MA S-167
BP 320A
EP 321A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA DH6CS
UT WOS:000372879200873
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Santos, JH
   Lorenzon-Ojea, AR
   Correa-Silva, S
   Fortunato, RS
   Rocha, CR
   Rudge, MV
   Damasceno, DC
   Bevilacqua, E
   Calderon, IM
AF Moreli, Jusciele B.
   Santos, Janine H.
   Lorenzon-Ojea, Aline Rodrigues
   Correa-Silva, Simone
   Fortunato, Rodrigo S.
   Rocha, Clarissa Ribeiro
   Rudge, Marilza V.
   Damasceno, Debora C.
   Bevilacqua, Estela
   Calderon, Iracema M.
TI Hyperglycemia Differentially Affects Maternal and Fetal DNA Integrity
   and DNA Damage Response
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Diabetes; Pregnancy; DNA damage; DNA repair
ID GESTATIONAL DIABETES-MELLITUS; OXIDATIVE STRESS; BLOOD; REPAIR;
   PREGNANCY; LYMPHOCYTES; PLACENTA; BIOLOGY; MARKERS; HEALTH
AB Objective: Investigate the DNA damage and its cellular response in blood samples from both mother and the umbilical cord of pregnancies complicated by hyperglycemia. Methods: A total of 144 subjects were divided into 4 groups: normoglycemia (ND; 46 cases), mild gestational hyperglycemia (MGH; 30 cases), gestational diabetes mellitus (GDM; 45 cases) and type-2 diabetes mellitus (DM2; 23 cases). Peripheral blood mononuclear cell (PBMC) isolation and/or leukocytes from whole maternal and umbilical cord blood were obtained from all groups at delivery. Nuclear and mitochondrial DNA damage were measured by gene-specific quantitative PCR, and the expression of mRNA and proteins involved in the base excision repair (BER) pathway were assessed by real-time qPCR and Western blot, respectively. Apoptosis was measured in vitro experiments by caspase 3/7 activity and ATP levels. Results: GDM and DM2 groups were characterized by an increase in oxidative stress biomarkers, an increase in nuclear and mitochondrial DNA damage, and decreased expression of mRNA (APE1, POLa and FEN1) and proteins (hOGG1, APE1) involved in BER. The levels of hyperglycemia were associated with the in vitro apoptosis pathway. Blood levels of DNA damage in umbilical cord were similar among the groups. Newborns of diabetic mothers had increased expression of BER mRNA (APE1, POLa and FEN1) and proteins (hOGG1, APE1, POL beta and FEN1). A diabetes-like environment was unable to induce apoptosis in the umbilical cord blood cells. Conclusions: Our data show relevant asymmetry between maternal and fetal blood cell susceptibility to DNA damage and apoptosis induction. Maternal cells seem to be more predisposed to changes in an adverse glucose environment. This may be due to differential ability in upregulating multiple genes involved in the activation of DNA repair response, especially the BER mechanism. However if this study shows a more effective adaptive response by the fetal organism, it also calls for further studies to determine the limit of this response that definitely changes the fate of a fetus under these conditions of cellular stress.
C1 [Moreli, Jusciele B.; Correa-Silva, Simone; Rudge, Marilza V.; Damasceno, Debora C.; Calderon, Iracema M.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Grad Program Gynecol Obstet & Mastol, Dist Rubiao Jr S-N, BR-18618000 Botucatu, SP, Brazil.
   [Santos, Janine H.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA.
   [Lorenzon-Ojea, Aline Rodrigues; Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-09500900 Sao Paulo, Brazil.
   [Fortunato, Rodrigo S.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Biophys Inst, Lab Mol Radiobiol, Rio De Janeiro, Brazil.
   [Rocha, Clarissa Ribeiro] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, DNA Repair Lab, BR-09500900 Sao Paulo, Brazil.
RP Calderon, IM (corresponding author), UNESP Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynecol, Dist Rubiao Jr S-N, BR-18618000 Botucatu, SP, Brazil.
EM juscielemoreli@gmail.com; calderon@fmb.unesp.br
RI Calderon, Iracema/W-4336-2019; Lorenzon, Aline R/G-8733-2014; Rudge,
   Marilza V C/C-8338-2012; Rudge, Marilza/S-9057-2018; Bevilacqua,
   Estela/H-3354-2011; Rocha, Clarissa Ribeiro Reily/O-8946-2015;
   Damasceno, Debora C/C-7234-2012; Fortunato, Rodrigo/AAM-9931-2020;
   Fortunato, Rodrigo/F-2020-2014
OI Calderon, Iracema/0000-0003-4761-4336; Lorenzon, Aline
   R/0000-0002-6052-6296; Rudge, Marilza V C/0000-0002-9227-832X;
   Bevilacqua, Estela/0000-0003-4178-4625; Damasceno, Debora
   C/0000-0002-7003-9643; Moreli, Jusciele/0000-0002-0945-9462; Fortunato,
   Rodrigo/0000-0003-3497-8173
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/18240-2,
   2011/13562-1, 2012/23296-0]
FX The authors would like to thank Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo - FAPESP (grant number 2011/18240-2; 2011/13562-1 and
   2012/23296-0) for financial support and for the fellowships of JB
   Moreli. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq). Dr. Carlos Frederico Martins Menck for scientific support and
   Dr. Jose Eduardo Corrente for statistics support.
CR Ali H, 2012, STEM CELL DISCOV, V2, P15, DOI DOI 10.4236/SCD.2012.21003
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   Arya AK, 2011, DIABETES RES CLIN PR, V94, P377, DOI 10.1016/j.diabres.2011.08.004
   Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cross JA, 2010, DIABETIC MED, V27, P1264, DOI 10.1111/j.1464-5491.2010.03099.x
   Cunningham F., 2010, WILLIAMS OBSTET
   Damasceno DC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/819065
   Davi G, 1999, CIRCULATION, V99, P224
   Devaraj S, 2001, CLIN CHEM, V47, P1974
   Fraser A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0489-x
   Gelaleti RB, 2015, REPROD SCI
   Grissa O, 2007, TRANSL RES, V150, P164, DOI 10.1016/j.trsl.2007.03.007
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339
   Karacay O, 2010, DIABETES RES CLIN PR, V89, P231, DOI 10.1016/j.diabres.2010.04.015
   Kovalenko OA, 2009, CURR PROTOC HUM GENE, V19, P1
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Li P, 2014, DIABETES RES CLIN PR, V103, P310, DOI 10.1016/j.diabres.2013.12.024
   Lima PHO, 2012, EXP CLIN ENDOCR DIAB, V120, P303, DOI 10.1055/s-0031-1299766
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Matyszewski A, 2015, INT J ONCOL, V46, P1435, DOI 10.3892/ijo.2015.2865
   Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070
   Moreli JB, 2015, DIABETES RES CLIN PR, V107, P362, DOI 10.1016/j.diabres.2015.01.005
   Moreli JB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/676758
   Moreli JB, 2012, J CLIN IMMUNOL, V32, P604, DOI 10.1007/s10875-011-9634-3
   Oleszczak B, 2012, DIABETES RES CLIN PR, V96, P170, DOI 10.1016/j.diabres.2011.12.012
   Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002
   Lima PHO, 2008, MUTAT RES-GEN TOX EN, V653, P44, DOI 10.1016/j.mrgentox.2008.02.008
   Lima PHO, 2007, MUTAT RES-GEN TOX EN, V628, P117, DOI 10.1016/j.mrgentox.2006.12.004
   Paranhos Calderon Iracema Mattos, 2007, ARBS Annual Review of Biomedical Sciences, V9, P1
   PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V15, P33, DOI 10.1530/acta.0.0150033
   Qiu CF, 2011, CLIN BIOCHEM, V44, P804, DOI 10.1016/j.clinbiochem.2011.04.023
   Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001
   RUDGE MVC, 1990, BRAZ J MED BIOL RES, V23, P1079
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Sella T, 2011, CANCER CAUSE CONTROL, V22, P1513, DOI 10.1007/s10552-011-9825-5
   Spada APM, 2014, REPROD SCI, V21, P973, DOI 10.1177/1933719113519175
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   Tatsch E, 2012, MUTAT RES-FUND MOL M, V732, P16, DOI 10.1016/j.mrfmmm.2012.01.004
   West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47
   Zelenko Z, 2014, ENDOCRIN METAB CLIN, V43, P167, DOI 10.1016/j.ecl.2013.09.008
   Zhu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126490
NR 45
TC 12
Z9 13
U1 0
U2 6
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2016
VL 12
IS 4
BP 466
EP 477
DI 10.7150/ijbs.12815
PG 12
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA DF9QN
UT WOS:000371696200005
PM 27019630
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bandeira, CL
   Hoshida, MS
   Knofler, M
   Panzetta-Dutari, GM
   Genti-Raimondi, S
   Ridano, ME
   Francisco, RPV
   Bevilacqua, E
AF Bandeira, Carla L.
   Hoshida, Mara S.
   Knofler, Martin
   Panzetta-Dutari, Graciela M.
   Genti-Raimondi, Suasana
   Ridano, Magali E.
   Francisco, Rossana P. V.
   Bevilacqua, Estela
TI CRIPTO1/3 MODULATES INVASION OF TROPHOBLAST HTR8/SV-NEO CELL LINEAGE
SO PLACENTA
LA English
DT Meeting Abstract
C1 [Bandeira, Carla L.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, SP, Brazil.
   [Knofler, Martin] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, Vienna, Austria.
   [Hoshida, Mara S.; Francisco, Rossana P. V.] Univ Sao Paulo, Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Panzetta-Dutari, Graciela M.; Genti-Raimondi, Suasana; Ridano, Magali E.] Natl Univ Cordoba, Fac Chem Sci, Dept Clin Biochem, Cordoba, Argentina.
RI Francisco, Rossana Pulcineli Vieira/AAG-7461-2020; Francisco, Rossana
   PV/C-5648-2012; Bevilacqua, Estela/H-3354-2011
OI Francisco, Rossana Pulcineli Vieira/0000-0002-9981-8069; Francisco,
   Rossana PV/0000-0002-9981-8069; Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2015
VL 36
IS 9
MA P1.75
BP A36
EP A36
DI 10.1016/j.placenta.2015.07.293
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CR3UV
UT WOS:000361259500121
DA 2020-12-01
ER

PT J
AU Favaro, RR
   Sanches, JT
   Barrence, FA
   Bevilacqua, E
   Fortes, ZB
   Zorn, TMT
AF Favaro, Rodolfo R.
   Sanches, Juliane T.
   Barrence, Fernanda A.
   Bevilacqua, Estela
   Fortes, Zuleica B.
   Zorn, Telma M. T.
TI EXTRACELLULAR MATRIX REMODELING IN THE DECIDUA AND PLACENTA OF TYPE I
   DIABETIC MICE
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Favaro, Rodolfo R.; Sanches, Juliane T.; Barrence, Fernanda A.; Bevilacqua, Estela; Zorn, Telma M. T.] Univ Sao Paulo, Dept & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Fortes, Zuleica B.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA S2
BP 476
EP 477
DI 10.1016/j.placenta.2015.01.406
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500046
DA 2020-12-01
ER

PT J
AU Bevilacqua, E
   Weingrill, RB
   Hoshida, MS
   Martinhago, CD
   Correa-Silva, S
   Cardoso, E
   Paris, AF
   Oliveira, SF
   Lorenzon-Ojea, A
   Ietta, F
   Paulesu, L
AF Bevilacqua, Estela
   Weingrill, Rodrigo B.
   Hoshida, Mara S.
   Martinhago, Ciro D.
   Correa-Silva, Simone
   Cardoso, Elaine
   Paris, Adriana Fraga
   Oliveira, Sergio F.
   Lorenzon-Ojea, Aline
   Ietta, Francesca
   Paulesu, Luana
TI CCL25 AND MIF: CANDIDATE GENES ASSOCIATED WITH THE MATERNAL-FETAL
   DIALOGUE
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Bevilacqua, Estela; Weingrill, Rodrigo B.; Hoshida, Mara S.; Martinhago, Ciro D.; Correa-Silva, Simone; Cardoso, Elaine; Paris, Adriana Fraga; Oliveira, Sergio F.; Lorenzon-Ojea, Aline; Paulesu, Luana] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, SP, Brazil.
   [Ietta, Francesca; Paulesu, Luana] Univ Siena, Dept Life Sci, I-53100 Siena, Italy.
RI Bevilacqua, Estela/H-3354-2011; Lorenzon, Aline R/G-8733-2014; Dresch
   Martinhago, Ciro/M-4596-2016
OI Bevilacqua, Estela/0000-0003-4178-4625; Lorenzon, Aline
   R/0000-0002-6052-6296; Dresch Martinhago, Ciro/0000-0002-7802-8906
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA S12
BP 479
EP 479
DI 10.1016/j.placenta.2015.01.416
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500056
DA 2020-12-01
ER

PT J
AU Zheng, YY
   Correa-Silva, S
   Moreli, JB
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Zheng, Yingying
   Correa-Silva, S.
   Moreli, J. B.
   Damasceno, D. C.
   Rudge, M. V. C.
   Bevilacqua, E.
   Calderon, I. M. P.
TI INCREASED IL-1 beta PRODUCTION IN PLACENTAL VILLOUS SUBJECTED TO
   HYPERGLYCEMIC CONDITIONS
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 UNESP Sao Paulo StateUniv, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
   [Zheng, Yingying; Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Lab Cytophysiol Trophoblast, BR-05508 Sao Paulo, Brazil.
RI Rudge, Marilza V C/C-8338-2012; Rudge, Marilza/S-9057-2018; Calderon,
   Iracema/W-4336-2019
OI Rudge, Marilza V C/0000-0002-9227-832X; Calderon,
   Iracema/0000-0003-4761-4336
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PA.3
BP 489
EP 489
DI 10.1016/j.placenta.2015.01.447
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500087
DA 2020-12-01
ER

PT J
AU Paixao-Alencar, A
   Correa-Silva, S
   Moreli, JB
   De Rosa, L
   Damasceno, DC
   Rudge, MV
   Calderon, IMP
   Bevilacqua, E
AF Paixao-Alencar, A.
   Correa-Silva, S.
   Moreli, J. B.
   De Rosa, L.
   Damasceno, D. C.
   Rudge, M. V.
   Calderon, I. M. P.
   Bevilacqua, E.
TI GESTATIONAL HYPERGLYCEMIA ACTIVATES INFLAMMASOME IN THE FETAL PLACENTAL
   COMPARTMENT
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Correa-Silva, S.; Moreli, J. B.; De Rosa, L.; Damasceno, D. C.; Rudge, M. V.; Calderon, I. M. P.] UNESP Sao Paulo State Univ, Grad Program Gynecol Obstet & Mastol, Botucatu Med Sch, Sao Paulo, Brazil.
   [Paixao-Alencar, A.; Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Damasceno, D. C.; Rudge, M. V.; Calderon, I. M. P.] UNESP Sao Paulo State Univ, Dept Obstet & Gynecol, Botucatu Med Sch, Sao Paulo, Brazil.
RI Rudge, Marilza V C/C-8338-2012; Rudge, Marilza/S-9057-2018; Calderon,
   Iracema/W-4336-2019
OI Rudge, Marilza V C/0000-0002-9227-832X; Calderon,
   Iracema/0000-0003-4761-4336
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PA.39
BP 500
EP 500
DI 10.1016/j.placenta.2015.01.483
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500123
DA 2020-12-01
ER

PT J
AU Santos, JC
   Daher, S
   Mattar, R
   Sun, SY
   Knofler, M
   Oliveira, SF
   Bevilacqua, E
   Borbely, AU
AF Santos, J. C.
   Daher, S.
   Mattar, R.
   Sun, S. Y.
   Knoefler, M.
   Oliveira, S. F.
   Bevilacqua, E.
   Borbely, A. U.
TI IMMUNOLOCALIZATION OF FIBRONECTIN-1 AND VERSICAN IN HEALTHY AND ACCRETA
   PLACENTAS
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Santos, J. C.; Borbely, A. U.] Univ Fed Alagoas, Cell Biol Lab, Inst Biol & Hlth Sci, Maceio, Brazil.
   [Daher, S.; Mattar, R.; Sun, S. Y.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Knoefler, M.] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, Vienna, Austria.
   [Oliveira, S. F.; Bevilacqua, E.] Univ Sao Paulo, Dept Dev & Cell Biol, Inst Biomed Sci, Sao Paulo, Brazil.
RI Sun, Sue Yazaki/N-4314-2018; DAHER, SILVIA/D-2180-2012
OI Sun, Sue Yazaki/0000-0001-6573-7386; DAHER, SILVIA/0000-0001-5312-7804
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PA.41
BP 500
EP 501
DI 10.1016/j.placenta.2015.01.485
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500125
DA 2020-12-01
ER

PT J
AU Carvalho, A
   Bevilacqua, E
AF Carvalho, A.
   Bevilacqua, E.
TI INTERLEKIN 25 IN THE MATERNAL FETAL INTERFACE
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Carvalho, A.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PA.54
BP 504
EP 504
DI 10.1016/j.placenta.2015.01.498
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500138
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Santos, JH
   Fortunato, RS
   Correa-Silva, S
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IM
AF Moreli, J. B.
   Santos, J. H.
   Fortunato, R. S.
   Correa-Silva, S.
   Damasceno, D. C.
   Rudge, M. V. C.
   Bevilacqua, E.
   Calderon, I. M.
TI OXIDATIVE STRESS AND NUCLEAR DNA DAMAGE IN HYPERGLYCEMIC PREGNANCIES
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Moreli, J. B.; Damasceno, D. C.; Rudge, M. V. C.; Calderon, I. M.] UNESP Sao Paulo State Univ, Grad Program Gynecol Obstet & Mastol, Botucatu Med Sch, Sao Paulo, Brazil.
   [Santos, J. H.] NIEHS, Mol Carcinogenesis Lab, Durham, NC USA.
   [Fortunato, R. S.] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, BR-09500900 Sao Paulo, Brazil.
   [Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, BR-09500900 Sao Paulo, Brazil.
RI Calderon, Iracema/W-4336-2019; Rudge, Marilza/S-9057-2018; Fortunato,
   Rodrigo/AAM-9931-2020
OI Calderon, Iracema/0000-0003-4761-4336; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PA.56
BP 505
EP 505
DI 10.1016/j.placenta.2015.01.500
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500140
DA 2020-12-01
ER

PT J
AU Galdino, DAA
   Cantaruti, TA
   Souza, KS
   Azevedo, GM
   Bevilacqua, EM
   Vaz, NM
   Carvalho, CR
AF Galdino, Daniel A. A.
   Cantaruti, Thiago A.
   Souza, Kenia S.
   Azevedo-Junior, Geraldo M.
   Bevilacqua, Estela M.
   Vaz, Nelson M.
   Carvalho, Claudia R.
TI SYSTEMIC EFFECTS OF ORAL TOLERANCE DISTURB PLACENTAL DEVELOPMENT
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Galdino, Daniel A. A.; Cantaruti, Thiago A.; Souza, Kenia S.; Azevedo-Junior, Geraldo M.; Vaz, Nelson M.; Carvalho, Claudia R.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Bevilacqua, Estela M.] Univ Sao Paulo, Sao Paulo, SP, Brazil.
RI Cantaruti, Thiago/D-9189-2018
OI Cantaruti, Thiago/0000-0001-7339-1581
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PB.13
BP 510
EP 510
DI 10.1016/j.placenta.2015.01.518
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500158
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon-Ojea, A. R.
   Fisher, S. J.
   Bevilacqua, E.
TI THE ROLE OF STROMAL CELL DERIVED FACTOR 2 (SDF2) IN CELL
   SURVIVAL/APOPTOSIS DECISION IN TROPHOBLAST CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Lorenzon-Ojea, A. R.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Fisher, S. J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PB.37
BP 517
EP 517
DI 10.1016/j.placenta.2015.01.542
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500182
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Paixao-Alencar, A
   Moreli, JB
   De Rosa, L
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Correa-Silva, S.
   Paixao-Alencar, A.
   Moreli, J. B.
   De Rosa, L.
   Damasceno, D. C.
   Rudge, M. V. C.
   Bevilacqua, E.
   Calderon, I. M. P.
TI SERUM AND PLACENTAL PLGF EXPRESSION IN WOMEN WITH DIFFERENT LEVELS OF
   HYPERGLYCEMIA
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Correa-Silva, S.; Moreli, J. B.; De Rosa, L.; Damasceno, D. C.; Rudge, M. V. C.; Calderon, I. M. P.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
   [Correa-Silva, S.; Paixao-Alencar, A.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Lab Cytophysiol Trophoblast, BR-05508 Sao Paulo, Brazil.
RI Rudge, Marilza V C/C-8338-2012; Rudge, Marilza/S-9057-2018; Calderon,
   Iracema/W-4336-2019
OI Rudge, Marilza V C/0000-0002-9227-832X; Calderon,
   Iracema/0000-0003-4761-4336
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PB.41
BP 518
EP 518
DI 10.1016/j.placenta.2015.01.546
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500186
DA 2020-12-01
ER

PT J
AU Ridano, ME
   Racca, AC
   Flores-Martin, JB
   Bevilacqua, E
   Genti-Raimondi, S
   Fretes, RE
   Panzetta-Dutari, GM
AF Ridano, M. E.
   Racca, A. C.
   Flores-Martin, J. B.
   Bevilacqua, E.
   Genti-Raimondi, S.
   Fretes, R. E.
   Panzetta-Dutari, G. M.
TI CHLORPYRIFOS EXPOSURE INDUCES TROPHOBLAST BARRIER AND STROMA ALTERATIONS
   IN HUMAN CHORIONIC VILLOUS EXPLANTS
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Ridano, M. E.; Racca, A. C.; Flores-Martin, J. B.; Genti-Raimondi, S.; Panzetta-Dutari, G. M.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, CIBICI,CONICET, RA-5000 Cordoba, Argentina.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Fretes, R. E.] Univ Nacl Cordoba, Fac Med, Dept Histol & Embriol, RA-5000 Cordoba, Argentina.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PB.48
BP 520
EP 520
DI 10.1016/j.placenta.2015.01.553
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500193
DA 2020-12-01
ER

PT J
AU Bandeira, CL
   Hoshida, MS
   Francisco, RPV
   Knofler, M
   Bevilacqua, E
AF Bandeira, C. L.
   Hoshida, M. S.
   Francisco, R. P. V.
   Knoefler, M.
   Bevilacqua, E.
TI EXTRAVILLOUS CYTOTROPHOBLAST EXPRESSION OF CRIPTO ISOFORMS
SO PLACENTA
LA English
DT Meeting Abstract
CT 6th Latin American Symposium on Maternal-Fetal Interaction and Placenta
   / 5th Latin American Symposium on Reproductive Immunology
CY APR 13-16, 2015
CL Mar del Plata, ARGENTINA
C1 [Bandeira, C. L.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Hoshida, M. S.; Francisco, R. P. V.] Univ Sao Paulo, Dept Obstet, Clin Hosp, Sch Med, Sao Paulo, Brazil.
   [Knoefler, M.] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Vienna, Austria.
RI Francisco, Rossana PV/C-5648-2012; Francisco, Rossana Pulcineli
   Vieira/AAG-7461-2020
OI Francisco, Rossana PV/0000-0002-9981-8069; Francisco, Rossana Pulcineli
   Vieira/0000-0002-9981-8069
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2015
VL 36
IS 4
MA PB.52
BP 521
EP 521
DI 10.1016/j.placenta.2015.01.557
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CE4JI
UT WOS:000351796500197
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Fisher, Susan J.
   Bevilacqua, Estela
TI Stromal Cell Derived Factor-2 (SFD2) in Human Placenta: Role in
   Endoplasmic Reticulum Stress
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, SP, Brazil.
   [Fisher, Susan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2015
VL 22
SU 1
MA T-260
BP 190A
EP 190A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA CD9GW
UT WOS:000351407202022
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Correa-Silva, S
   Damasceno, DC
   Sinzato, YK
   Lorenzon-Ojea, AR
   Borbely, AU
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Moreli, Jusciele B.
   Correa-Silva, Simone
   Damasceno, Debora C.
   Sinzato, Yuri K.
   Lorenzon-Ojea, Aline R.
   Borbely, Alexandre U.
   Rudge, Marilza V. C.
   Bevilacqua, Estela
   Calderon, Iracema M. P.
TI Changes in the TNF-alpha/IL-10 ratio in hyperglycemia-associated
   pregnancies
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Cytokines; Diabetes; Mild gestational hyperglycemia; Placenta
ID NECROSIS-FACTOR-ALPHA; GESTATIONAL DIABETES-MELLITUS; TNF-ALPHA;
   INSULIN-RESISTANCE; INFLAMMATORY MEDIATORS; ADIPOSE-TISSUE; WOMEN;
   INTERLEUKIN-10; ADIPONECTIN; CYTOKINES
AB Aims: TNF-alpha is a diabetogenic cytokine associated with adverse outcomes during pregnancy that can be counterbalanced by IL-10. We have investigated IL-10 and TNF-alpha balance at maternal and placental levels in hyperglycemia-associated pregnancies.
   Methods: One hundred and ninety-two pregnant women participated, which included normoglycemic women (ND) and women with mild gestational hyperglycemia (MGH), gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2). Maternal plasma and placental tissue IL-10 and TNF-alpha levels were measured by ELISA and placental TNF-alpha was also immunolocalized.
   Results: Maternal plasma TNF-alpha levels were highest in GDM (p = 0.0190), whereas TNF-alpha levels were highest in placental tissues in DM2 (p = 0.0095). Immunohistochemistry also showed strong reactivity with anti-TNF-alpha antibody in the villous structures in the DM2 group. Conversely, IL-10 levels were lowest in maternal plasma of the DM2 group (p = 0.0228). The TNF-alpha/IL-10 ratio in maternal plasma progressively increased with the severity of hyperglycemia (p < 0.0001), being highest in placenta of the DM2 group (p = 0.0150). In both, plasma and placenta, TNF-alpha/IL-10 ratio were correlated with mean maternal glycemia and HbA1c levels.
   Conclusions: Alterations of placenta and serum TNF-alpha/IL-10 balance with predominance of TNF-alpha were correlated with the severity of hyperglycemia during gestation. This association may offer insight into the pathogenesis of gestational hyperglycemia and associated pregnancy outcomes. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Moreli, Jusciele B.; Correa-Silva, Simone; Damasceno, Debora C.; Sinzato, Yuri K.; Rudge, Marilza V. C.; Calderon, Iracema M. P.] Sao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
   [Correa-Silva, Simone; Lorenzon-Ojea, Aline R.; Borbely, Alexandre U.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Calderon, IMP (corresponding author), Sao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
EM juscielemoreli@gmail.com; calderon@fmb.unesp.br
RI Sinzato, Yuri K/E-8626-2019; Borbely, Alexandre U/A-6649-2013; Lorenzon,
   Aline R/G-8733-2014; Calderon, Iracema/W-4336-2019; Rudge,
   Marilza/S-9057-2018; Bevilacqua, Estela/H-3354-2011; Borbely, Alexandre
   Urban/Q-2884-2019; Rudge, Marilza V C/C-8338-2012; Damasceno, Debora
   Cristina/C-7234-2012
OI Sinzato, Yuri K/0000-0002-2973-1099; Lorenzon, Aline
   R/0000-0002-6052-6296; Calderon, Iracema/0000-0003-4761-4336;
   Bevilacqua, Estela/0000-0003-4178-4625; Borbely, Alexandre
   Urban/0000-0001-6737-0901; Rudge, Marilza V C/0000-0002-9227-832X;
   Moreli, Jusciele/0000-0002-0945-9462; Damasceno, Debora
   Cristina/0000-0002-7003-9643
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2007/0071-6, 2009/03253-1]
FX The authors thank the Sao Paulo Research Foundation (Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo-FAPESP, grant number 2007/0071-6 and
   2009/03253-1) for financial support.
CR Agarwal R, 2000, GYNECOL ENDOCRINOL, V14, P305, DOI 10.3109/09513590009167697
   Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x
   Altinova AE, 2007, GYNECOL ENDOCRINOL, V23, P161, DOI 10.1080/09513590701227960
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081
   Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980
   Benyo DF, 1997, J CLIN ENDOCR METAB, V82, P1582, DOI 10.1210/jc.82.5.1582
   Brogin Moreli Jusciele, 2012, ISRN Obstet Gynecol, V2012, P230742, DOI 10.5402/2012/230742
   Calderon IMP, 2007, DIABETES RES CLIN PR, V78, P65, DOI 10.1016/j.diabres.2007.01.023
   Coughlan MT, 2001, DIABETIC MED, V18, P921, DOI 10.1046/j.1464-5491.2001.00614.x
   Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203
   Gao XL, 2008, CHINESE MED J-PEKING, V121, P701, DOI 10.1097/00029330-200804020-00008
   GILLMER MDG, 1975, BRIT MED J, V3, P399, DOI 10.1136/bmj.3.5980.399
   Gomes CP, 2013, AM J REPROD IMMUNOL, V69, P545, DOI 10.1111/aji.12088
   Gueuvoghlanian-Silva BY, 2012, AM J REPROD IMMUNOL, V67, P241, DOI 10.1111/j.1600-0897.2011.01090.x
   Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012
   Hashem RM, 2008, EUR J GASTROEN HEPAT, V20, P995, DOI 10.1097/MEG.0b013e3282fdf65f
   Jiang XL, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/485082
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207
   Lappas M, 2010, J ENDOCRINOL, V204, P75, DOI 10.1677/JOE-09-0321
   Lopez-Tinoco C, 2012, CYTOKINE, V58, P14, DOI 10.1016/j.cyto.2011.12.004
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   McLachlan KA, 2006, DIABETES-METAB RES, V22, P131, DOI 10.1002/dmrr.591
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1
   Montazeri S, 2010, HEREDITAS, V147, P94, DOI 10.1111/j.1601-5223.2009.02134.x
   Moreli JB, 2012, J CLIN IMMUNOL, V32, P604, DOI 10.1007/s10875-011-9634-3
   PENNLINE KJ, 1994, CLIN IMMUNOL IMMUNOP, V71, P169, DOI 10.1006/clin.1994.1068
   Pietro L, 2010, PLACENTA, V31, P770, DOI 10.1016/j.placenta.2010.07.003
   Pimenta WP, 2004, DIABETES RES CLIN PR, V63, P87, DOI 10.1016/j.diabres.2003.09.008
   Richardson AC, 2007, OBSTET GYN CLIN N AM, V34, P213, DOI 10.1016/j.ogc.2007.04.001
   RUDGE MVC, 1990, BRAZ J MED BIOL RES, V23, P1079
   Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Sgarbosa F, 2006, DIABETES RES CLIN PR, V73, P143, DOI 10.1016/j.diabres.2005.12.014
   STEPHENS JM, 1991, J BIOL CHEM, V266, P21839
   Straczkowski M, 2005, DIABETES CARE, V28, P2036, DOI 10.2337/diacare.28.8.2036
   Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x
NR 38
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2015
VL 107
IS 3
BP 362
EP 369
DI 10.1016/j.diabres.2015.01.005
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CB9NX
UT WOS:000349959600010
PM 25648390
DA 2020-12-01
ER

PT J
AU Galdino, D
   Azevedo, G
   Souza, K
   Cantarutti, T
   Bevilacqua, E
   Vaz, N
   Carvalho, C
AF Galdino, Daniel
   Azevedo, Geraldo
   Souza, Kenia
   Cantarutti, Thiago
   Bevilacqua, Estela
   Vaz, Nelson
   Carvalho, Claudia
TI REDUCED PLACENTAL DEVELOPMENT TRIGGERED BY SUBCUTANEOUS INJECTION OF AN
   ORALLY TOLERATED PROTEIN
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting
CY SEP 09-12, 2014
CL Paris, FRANCE
SP Int Federat Placenta Assoc, EPG
DE Oral tolerance; Placenta; uNK
C1 [Galdino, Daniel; Azevedo, Geraldo; Souza, Kenia; Cantarutti, Thiago; Vaz, Nelson; Carvalho, Claudia] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011; Cantaruti, Thiago/D-9189-2018
OI Bevilacqua, Estela/0000-0003-4178-4625; Cantaruti,
   Thiago/0000-0001-7339-1581
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2014
VL 35
IS 9
MA P1.157-N
BP A59
EP A59
DI 10.1016/j.placenta.2014.06.193
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AQ6ZC
UT WOS:000342961400206
DA 2020-12-01
ER

PT J
AU Hoshida, M
   Amarante-Paffaro, A
   Bevilacqua, E
AF Hoshida, Mara
   Amarante-Paffaro, Andrea
   Bevilacqua, Estela
TI IFN CHANGES PHAGOSOMAL MARKERS IN TROPHOBLAST CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting
CY SEP 09-12, 2014
CL Paris, FRANCE
SP Int Federat Placenta Assoc, EPG
C1 [Hoshida, Mara] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Amarante-Paffaro, Andrea] Univ Fed Alfenas, Alfenas, MG, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2014
VL 35
IS 9
MA P2.146
BP A106
EP A106
DI 10.1016/j.placenta.2014.06.345
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AQ6ZC
UT WOS:000342961400358
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Fisher, Susan J.
   Bevilacqua, Estela
TI STROMAL CELL DERIVED FACTOR-2 IS INVOLVED IN THE UNFOLDED PROTEIN
   RESPONSE IN HUMAN PLACENTA
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting
CY SEP 09-12, 2014
CL Paris, FRANCE
SP Int Federat Placenta Assoc, EPG
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Sao Paulo, Brazil.
   [Lorenzon-Ojea, Aline R.; Fisher, Susan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
RI Lorenzon, Aline R/G-8733-2014; Bevilacqua, Estela/H-3354-2011
OI Lorenzon, Aline R/0000-0002-6052-6296; Bevilacqua,
   Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2014
VL 35
IS 9
MA P2.139-N
BP A104
EP A104
DI 10.1016/j.placenta.2014.06.338
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AQ6ZC
UT WOS:000342961400351
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Santos, JH
   Correa-Silva, S
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Moreli, Jusciele B.
   Santos, Janine H.
   Correa-Silva, Simone
   Damasceno, Debora C.
   Rudge, Marilza V. C.
   Bevilacqua, Estela
   Calderon, Iracema M. P.
TI MITOCHONDRIA DNA DAMAGE IN HYPERGLYCEMIC-ASSOCIATED PREGNANCIES
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting
CY SEP 09-12, 2014
CL Paris, FRANCE
SP Int Federat Placenta Assoc, EPG
C1 [Moreli, Jusciele B.; Correa-Silva, Simone; Damasceno, Debora C.; Rudge, Marilza V. C.; Calderon, Iracema M. P.] UNESP Sao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
   [Santos, Janine H.] NIEHS, Lab Mol Carcinogenesis, Durham, NC USA.
   [Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RI Calderon, Iracema/W-4336-2019; Rudge, Marilza V C/C-8338-2012;
   Bevilacqua, Estela/H-3354-2011; Rudge, Marilza/S-9057-2018
OI Calderon, Iracema/0000-0003-4761-4336; Rudge, Marilza V
   C/0000-0002-9227-832X; Bevilacqua, Estela/0000-0003-4178-4625; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2014
VL 35
IS 9
MA P1.66
BP A30
EP A31
DI 10.1016/j.placenta.2014.06.102
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AQ6ZC
UT WOS:000342961400115
DA 2020-12-01
ER

PT J
AU Sanches, J
   Favaro, R
   Bevilacqua, E
   Zorn, T
AF Sanches, Juliane
   Favaro, Rodolfo
   Bevilacqua, Estela
   Zorn, Telma
TI EFFECTS OF SHORT- AND LONG-TERM TYPE 1 DIABETES ON THE PLACENTAL
   EXTRACELLULAR MATRIX AND FETAL DEVELOPMENT IN MICE
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placenta-Associations (IFPA)/EPG Meeting
CY SEP 09-12, 2014
CL Paris, FRANCE
SP Int Federat Placenta Assoc, EPG
C1 [Sanches, Juliane; Favaro, Rodolfo; Bevilacqua, Estela; Zorn, Telma] Univ Sao Paulo, Sao Paulo, Brazil.
   [Sanches, Juliane] UniSalesiano, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2014
VL 35
IS 9
MA P1.64
BP A30
EP A30
DI 10.1016/j.placenta.2014.06.100
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AQ6ZC
UT WOS:000342961400113
DA 2020-12-01
ER

PT J
AU Lorenzon-Ojea, AR
   Caldeira, W
   Ribeiro, AF
   Fisher, SJ
   Guzzo, CR
   Bevilacqua, E
AF Lorenzon-Ojea, Aline R.
   Caldeira, Waldir
   Ribeiro, Alberto F.
   Fisher, Susan J.
   Guzzo, Cristiane R.
   Bevilacqua, Estela
TI Stromal cell derived factor-2 (Sdf2): A novel protein expressed in mouse
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Sdf2; Mouse protein; MIR; ER Stress; UPR
ID ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; LOCALIZATION; PATTERN;
   HA1
AB The stromal derived factor (SDFs) family comprises a group of molecules generated by stromal cells. SDF1 and SDF4 are chemokines; SDF2 and SDF5 are not yet functionally and structurally defined. In human and mouse, Sdfl has a paralogous gene, Sdf2l1, whose protein sequences are 78% similar and 68% identical. Human SDF2L1 is an endoplasmic reticulum-stress inducible-gene. In Arabidopsis thaliana, SDF2-like (39% and 37% amino acid sequence identity with Mus musculus Sdf2 and Sdf2l1) has also been implicated in activating the UPR in ER-stress. Here we have cloned, expressed and purified recombinant Sdf2 and raised an anti-Sdf2 antibody. We demonstrated that the protein is expressed in several tissues and is localized in the endoplasmic reticulum. We suggest that Sdf2, initially predicted as a secretory protein because it lacks the canonical ER retention signals in its C-terminal, could be ER-resident through accessory binding proteins or other amino acid sequence motifs, as suggested for the homolog protein SDF2-like. Furthermore, the crystal structure of SDF2-like from Arabidopsis thaliana is a typical beta-trefoil containing three MIR motifs; all hydrophobic residues considered important for maintaining the bottom layer of the beta-trefoil barrel seem to be conserved in the Sdf2 family. Multiple alignment using 43 sequences for SDF2 and 38 for SDF2L1 paralogous families also revealed a very similar residue conservation profile. Comparing the amino acid sequence and predicted 3D structure with other Sdf2-like proteins we suggest a role of mouse Sdf2 in the Unfolded Protein Response and ER-stress, similar to that of Sdf2l1 from human and mouse and SDF2-like from Arabidopsis thaliana. Chronic ER stress has been associated with many human diseases including cancer and diabetes. Identification of new factors associated with the ER stress pathway can help to identify and define key targets of this response. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Lorenzon-Ojea, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Caldeira, Waldir; Ribeiro, Alberto F.] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Inst Biosci, Sao Paulo, Brazil.
   [Fisher, Susan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [Guzzo, Cristiane R.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011; Carvalho, Cristiane R. G/K-2855-2016;
   Ribeiro, Alberto F./E-6839-2016; Lorenzon, Aline R/G-8733-2014
OI Bevilacqua, Estela/0000-0003-4178-4625; Carvalho, Cristiane R.
   G/0000-0002-5664-8055; Lorenzon, Aline R/0000-0002-6052-6296
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03510-4];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/11869-2]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq); Capes (Coordernagdo de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES
FX ARL-O received a PhD Scholarship from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo - FAPESP (2009/03510-4). This work was supported by
   grants from FAPESP (2009/11869-2), CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico) and Capes (Coordernagdo de
   Aperfeicoamento de Pessoal de Nivel Superior). The authors thank Chuck
   S. Farah, PhD, for helpful discussions and Rosangela Augusto de
   Oliveira, Ilda de Souza Costa and Luiz Gustavo Sparvoli for excellent
   technical assistance.
CR Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043
   Chen SH, 2005, PHYSIOL GENOMICS, V22, P257, DOI 10.1152/physiolgenomics.00063.2005
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Faria MR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-95
   Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111
   Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200
   Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X
   Hoshida M., 2007, 3 LAT AM S MAT FET I
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0
   Jordao BP, 1996, INSECT BIOCHEM MOLEC, V26, P337, DOI 10.1016/0965-1748(95)00084-4
   Kang H, 2009, INT J ONCOL, V35, P205, DOI 10.3892/ijo_00000330
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005
   Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311
   Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469
   Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031
   Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262
   Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644
   Park CJ, 2013, PLANT SCI, V210, P53, DOI 10.1016/j.plantsci.2013.05.003
   Schott A, 2010, J BIOL CHEM, V285, P18113, DOI 10.1074/jbc.M110.117176
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tongaonkar P, 2009, J BIOL CHEM, V284, P5602, DOI 10.1074/jbc.M806664200
   Vendrell E, 2007, INT J ONCOL, V30, P1099
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wang WA, 2014, BIOCH BIOPHYS ACTA
NR 29
TC 7
Z9 9
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD AUG
PY 2014
VL 53
BP 262
EP 270
DI 10.1016/j.biocel.2014.05.024
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AN1KE
UT WOS:000340340400032
PM 24878610
DA 2020-12-01
ER

PT J
AU do Prado, KM
   Correa-Silva, S
   Oliveira, LG
   Camara, NOS
   Ono, E
   Sandri, S
   Tourino, MC
   Campa, A
   Lima, LD
   Scavone, C
   Bevilacqua, E
AF do Prado, Karen Matias
   Correa-Silva, Simone
   Oliveira, Leandro Gustavo
   Saraiva Camara, Niels Olsen
   Ono, Erica
   Sandri, Silvana
   Tourino, Melissa Cavalheiro
   Campa, Ana
   Lima, Larissa de Sa
   Scavone, Cristoforo
   Bevilacqua, Estela
TI Indoleamine 2,3-dioxygenase (IDO) Activity in Placental Compartments of
   Renal-Transplanted Pregnant Women
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE IDO; IFN-; Immunosuppressive drugs; Kynurenine; NF-B; Placenta
ID NF-KAPPA-B; REGULATORY T-CELLS; TRYPTOPHAN CATABOLISM;
   ORGAN-TRANSPLANTATION; KYNURENINE PATHWAY; TOLERANCE; EXPRESSION;
   INHIBITION; IMMUNOSUPPRESSION; PROLIFERATION
AB Problem Immunosuppressive drugs change gestational IDO activity at the maternal-fetal interface. Method of Study Analysis of placental IDO expression and activity, interferon gamma (IFN-), and IL-10 expression and NFkB activity in renal transplant recipient women under immunosuppressive treatment. Results We demonstrated a significant reduction in IDO activity (P=0.0275) and expression (P=0.026) and in NFkB activity (P=0.0176) in the villous region of renal transplanted mother. These findings did not correlate with the higher serum levels of kynurenine (P=0.002). In the decidual compartment, IDO was immunolocalized mainly on the extravillous cytotrophoblast but did not show significant differences among the experimental groups; kynurenine was significantly higher (P=0.036) and was inversely proportional to the decidual IFN- profile (P=0.0433). No change was seen in IL-10 levels. NFkB activity was significantly higher in decidual compartment correlating with the higher IDO activity and suggesting that in immunosuppressant pregnancy, IDO activity and expression remain regulated by NFkB. Conclusion The increased IDO activity in decidua may indicate an attempt to offset the low expression. These findings call attention to the relevance of IDO activity at the maternal interface in pregnant transplant recipients, likely modulated by immunosuppressive agents and associated with a high risk of associated gestational disorders.
C1 [do Prado, Karen Matias; Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Correa-Silva, Simone] UNESP Sao Paulo State Univ, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Botucatu, SP, Brazil.
   [Oliveira, Leandro Gustavo; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
   [Ono, Erica] Univ Fed Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil.
   [Sandri, Silvana; Tourino, Melissa Cavalheiro; Campa, Ana] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Lima, Larissa de Sa; Scavone, Cristoforo] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, SP, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011; Sandri, Silvana/A-1650-2015; camara,
   niels/AAX-3269-2020; Campa, Ana/D-4669-2012; De Oliveira,
   Leandro/G-3476-2012; Camara, Niels OS/G-8336-2011; Scavone,
   Cristoforo/C-1580-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; camara,
   niels/0000-0001-5436-1248; Campa, Ana/0000-0002-6183-3378; De Oliveira,
   Leandro/0000-0002-8422-9907; Camara, Niels OS/0000-0001-5436-1248;
   Scavone, Cristoforo/0000-0002-1206-0882
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenadoria de
   Aperfeicoamento do Ensino Superior (CAPES)CAPES; Conselho Nacional de
   Pesquisa e Desenvolvimento Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP),
   Coordenadoria de Aperfeicoamento do Ensino Superior (CAPES) and Conselho
   Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq).
CR Aivazoglou L, 2011, EUR J OBSTET GYN R B, V155, P129, DOI 10.1016/j.ejogrb.2010.11.020
   Babcock TA, 2000, CYTOKINE, V12, P588, DOI 10.1006/cyto.1999.0661
   Bar J, 2000, ISRAEL MED ASSOC J, V2, P178
   Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114
   Bouattar T, 2009, TRANSPL P, V41, P1586, DOI 10.1016/j.transproceed.2009.02.105
   Cardonick E, 2004, OBSTET GYNECOL SURV, V59, P214, DOI 10.1097/01.OGX.0000115774.42302.D4
   Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883
   Correa-Silva S, 2013, J MATERN-FETAL NEO M, V26, P1468, DOI 10.3109/14767058.2013.784736
   Curti A, 2009, BLOOD, V113, P2394, DOI 10.1182/blood-2008-07-144485
   Davison JM, 2003, J OBSTET GYNAECOL RE, V29, P227, DOI 10.1046/j.1341-8076.2003.00106.x
   Dharane P, 2010, PLACENTA, V31, P997, DOI 10.1016/j.placenta.2010.09.002
   Eiwegger T, 2011, ALLERGY, V66, P271, DOI 10.1111/j.1398-9995.2010.02475.x
   Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572
   Finger EB, 2002, NAT IMMUNOL, V3, P1056, DOI 10.1038/ni1102-1056
   Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407
   Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121
   HA J, 1994, TRANSPLANT P, V26, P2117
   Hirachan Padam, 2012, Arab J Nephrol Transplant, V5, P41
   Honig A, 2004, J REPROD IMMUNOL, V61, P79, DOI 10.1016/j.jri.2003.11.002
   Ingelsten M, 2009, TRANSPLANTATION, V88, P911, DOI 10.1097/TP.0b013e3181b72e49
   Irani RA, 2011, SEMIN NEPHROL, V31, P47, DOI 10.1016/j.semnephrol.2010.10.005
   Janssen NM, 2000, ARCH INTERN MED, V160, P610, DOI 10.1001/archinte.160.5.610
   Jia LN, 2009, TRANSPL IMMUNOL, V21, P18, DOI 10.1016/j.trim.2009.01.004
   Kudo Y, 2004, J REPROD IMMUNOL, V61, P87, DOI 10.1016/j.jri.2003.11.004
   Kudo Yoshiki, 2013, Obstet Gynecol Sci, V56, P209, DOI 10.5468/ogs.2013.56.4.209
   Lessan-Pezeshki M, 2002, NEPHROL DIAL TRANSPL, V17, P703, DOI 10.1093/ndt/17.5.703
   Ligam P, 2005, PLACENTA, V26, P498, DOI 10.1016/j.placenta.2004.08.009
   Liu XQ, 2011, MOL MED REP, V4, P53, DOI 10.3892/mmr.2010.395
   Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6
   Lunsford KE, 2011, CURR OPIN ORGAN TRAN, V16, P390, DOI 10.1097/MOT.0b013e328348b420
   Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y
   Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0
   Mellor AL, 2001, J REPROD IMMUNOL, V52, P5, DOI 10.1016/S0165-0378(01)00118-8
   Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457
   Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191
   Oliveira LG, 2007, CLIN TRANSPLANT, V21, P301, DOI 10.1111/j.1399-0012.2006.00627.x
   Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077
   Pawlak K, 2009, THROMB RES, V124, P452, DOI 10.1016/j.thromres.2009.04.011
   Pergola PE, 2001, TRANSPLANTATION, V71, P994, DOI 10.1097/00007890-200104150-00028
   Sebire NJ, 2008, J REPROD MED, V53, P789
   Sedlmayr P, 2002, MOL HUM REPROD, V8, P385, DOI 10.1093/molehr/8.4.385
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Umans JG, 2007, ADV CHRONIC KIDNEY D, V14, P191, DOI 10.1053/j.ackd.2007.01.009
   Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878
   von Rango U, 2007, J REPROD IMMUNOL, V74, P34, DOI 10.1016/j.jri.2006.11.001
   von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014
   Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092
   Wilczynski JR, 2008, FRONT BIOSCI-LANDMRK, V13, P2266, DOI 10.2741/2840
   Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008
   YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260
   Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035
   Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329
NR 52
TC 2
Z9 2
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD JUL
PY 2014
VL 72
IS 1
BP 45
EP 56
DI 10.1111/aji.12233
PG 12
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA AJ5TX
UT WOS:000337752700006
PM 24702758
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Daher, S
   Ishigai, MM
   Mattar, R
   Sun, SY
   Knofler, M
   Bevilacqua, E
   Oliveira, SF
AF Borbely, Alexandre U.
   Daher, Silvia
   Ishigai, Marcia M.
   Mattar, Rosiane
   Sun, Sue Y.
   Knoefler, Martin
   Bevilacqua, Estela
   Oliveira, Sergio F.
TI Decorin and biglycan immunolocalization in non-villous structures of
   healthy and pathological human placentas
SO HISTOPATHOLOGY
LA English
DT Article
DE immunohistochemistry; trophoblast invasion; placenta accreta;
   choriocarcinoma; invasive mole
ID TOLL-LIKE RECEPTOR-4; GROWTH-FACTOR-BETA; HUMAN TROPHOBLAST; SIGNALING
   PATHWAYS; EXPRESSION; PROLIFERATION; MIGRATION; PROTEOGLYCANS;
   INVASIVENESS; INHIBITION
AB Aims
   Decorin and biglycan are members of the small leucine-rich proteoglycan family, and constituents of both the extracellular matrix (ECM) and the cell surface. They are recognized as important factors in the control of proliferation, migration and invasion invivo and invitro. In this study, the localization patterns of decorin and biglycan were determined in healthy placentas and in highly invasive placental pathologies.
   Methods and results
   The study included immunolocalization of decorin and biglycan in samples of first-trimester and term placentas, placenta accreta, invasive mole, and choriocarcinoma. Extravillous cytotrophoblast (EVT) cells were positive for both proteoglycans in all pathologies and in first-trimester placentas, although not in term placentas. Biglycan was immunolocalized in the ECM of all healthy and pathological placentas, whereas decorin was observed only in term placenta ECM.
   Conclusions
   The expression of both proteoglycans was cell-specific and gestation time-dependent in healthy placentas, and was associated with invasive EVT cells in pathological placentas. In view of the biological properties of these molecules, it is possible that the biglycan pattern found here is intrinsically implicated in the invasive activity of EVT cells in both healthy and disordered placentas.
C1 [Borbely, Alexandre U.; Bevilacqua, Estela; Oliveira, Sergio F.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Daher, Silvia; Mattar, Rosiane; Sun, Sue Y.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Ishigai, Marcia M.] Univ Fed Sao Paulo, Dept Pathol, Paulista Med Sch, Sao Paulo, Brazil.
   [Knoefler, Martin] Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria.
RP Oliveira, SF (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM sfolivei@usp.br
RI Borbely, Alexandre Urban/Q-2884-2019; Borbely, Alexandre U/A-6649-2013;
   Bevilacqua, Estela/H-3354-2011; Sun, Sue Yazaki/N-4314-2018; DAHER,
   SILVIA/D-2180-2012
OI Borbely, Alexandre Urban/0000-0001-6737-0901; Bevilacqua,
   Estela/0000-0003-4178-4625; Sun, Sue Yazaki/0000-0001-6573-7386; DAHER,
   SILVIA/0000-0001-5312-7804
FU Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [01/09019-9, 01/006633-6];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [475581/2006-7]; CAPESCAPES [4178-11-4]
FX We thank the Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) (Grant
   numbers 01/09019-9 and 01/006633-6), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant number
   475581/2006-7) and (CAPES) (Grant number 4178-11-4) for financial
   support. Also, we are grateful to Dr Larry Fisher (National Institute of
   Dental and Cranial Research, NIH, Bethesda, USA) for the gift of the
   primary anti-decorin (LF-122) and anti-biglycan (LF-112) antibodies.
CR Al-Khan A, 2011, PLACENTA, V32, pS90, DOI 10.1016/j.placenta.2010.12.025
   ARKWRIGHT PD, 1993, J CLIN INVEST, V91, P2744, DOI 10.1172/JCI116515
   Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC
   Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108
   Bi XL, 2013, CHIN J CANCER, V32, P266, DOI 10.5732/cjc.012.10301
   Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141
   BIDANSET DJ, 1992, J CELL BIOL, V118, P1523, DOI 10.1083/jcb.118.6.1523
   Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P77
   Corvinus FM, 2003, AM J REPROD IMMUNOL, V50, P316, DOI 10.1034/j.1600-0897.2003.00099.x
   Durand S, 2003, PLACENTA, V24, P209, DOI 10.1053/plac.2002.0885
   Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004
   Fisher L., 1999, EXTRACELLULAR MATRIX, P365
   Holmlund U, 2002, IMMUNOLOGY, V107, P145, DOI 10.1046/j.1365-2567.2002.01491.x
   Iacob D, 2008, ENDOCRINOLOGY, V149, P6187, DOI 10.1210/en.2008-0780
   Iacob S, 2010, CONNECT TISSUE RES, V51, P347, DOI 10.3109/03008200903427695
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202
   Kinsella MG, 1997, J BIOL CHEM, V272, P318
   Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk
   Kraus FT, 2004, ATLAS NONTUMOR PATHO, P47
   LYSIAK JJ, 1995, PLACENTA, V16, P221, DOI 10.1016/0143-4004(95)90110-8
   Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846
   Nash MA, 1999, CANCER RES, V59, P6192
   San Martin S, 2003, REPRODUCTION, V125, P585, DOI 10.1530/rep.0.1250585
   Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755
   Schonherr E, 1995, J BIOL CHEM, V104, P509
   Shimizu-Hirota R, 2004, CIRC RES, V94, P1067, DOI 10.1161/01.RES.0000126049.79800.CA
   Tavassoli FA, 2003, TUMOURS BREAST FEMAL
   Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808
   Wang B, 2011, EXP BIOL MED, V236, P1247, DOI 10.1258/ebm.2011.011124
   Xu GX, 2003, BIOCHEM BIOPH RES CO, V300, P383, DOI 10.1016/S0006-291X(02)02845-0
   Xu GX, 2002, BIOL REPROD, V67, P681, DOI 10.1095/biolreprod67.2.681
   YAGEL S, 1990, CLIN EXP METASTAS, V8, P305, DOI 10.1007/BF01810677
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59
   Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200
NR 37
TC 8
Z9 9
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-0167
EI 1365-2559
J9 HISTOPATHOLOGY
JI Histopathology
PD APR
PY 2014
VL 64
IS 5
BP 616
EP 625
DI 10.1111/his.12304
PG 10
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AC8MY
UT WOS:000332788400002
PM 24117774
DA 2020-12-01
ER

PT J
AU Perez-Tito, L
   Bevilacqua, E
   Cebral, E
AF Perez-Tito, Leticia
   Bevilacqua, Estela
   Cebral, Elisa
TI Peri-implantational in vivo and in vitro embryo-trophoblast development
   after perigestational alcohol exposure in the CD-1 mouse
SO DRUG AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Alcohol; blastocyst; differentiation; growth; mouse; trophoblast
ID FEMALE MICE; BLASTOCYST OUTGROWTH; ETHANOL; CONSUMPTION; PREGNANCY;
   ORGANOGENESIS; PLACENTATION; ACETALDEHYDE; OOCYTES; INVITRO
AB Long-term pregestational ethanol exposure induced altered fertilization and preimplantation embryogenesis. We evaluated preimplantational embryo-trophoblast differentiation, growth and invasiveness after perigestational ethanol 10% ingestion for 15 days preceding and up to day 4 (treated females [TF]: TF-D4 group) or 5 (TF-D5) of CD-1 gestation (control females [CF] with water). In TF-D4, expanded and hatched blastocyst numbers were significantly reduced (p<0.05) versus CF-D4. Abnormal embryos and percentage of pyknotic nuclei were increased, and early blastocyst growth (nuclear number/embryo) and mitotic index was reduced (p<0.05) versus CF-D4. On day 5 of gestation, TF-D5 presented significantly reduced total embryos and advanced embryo type 3 number versus CF-D5 (p<0.05). During in vitro development, up to 72-hour culture, TF-D5 had reduced embryo type 1 (the least developed) and 3 percentages (p<0.05) versus controls, whereas embryo type 2 percentage increased (p<0.05) versus CF-D5. Embryo-trophoblast growth was studied during culture by morphometry. Embryo size ranges were classified as small, medium and large embryos. At 48-hour culture, small and medium embryos of TF had significantly increased mean area versus CF (p<0.05), whereas large embryos had reduced mean area at 24-hour culture. Perigestational alcohol exposure up to days 4-5 induced embryo differentiation retardation, abnormal blastocyst growth and alterations of embryo-trophoblast growth and expansion during implantation, suggesting impaired regulation of trophoblast invasion and a relation with early pregnancy loss after mouse perigestational alcohol consumption.
C1 [Perez-Tito, Leticia; Cebral, Elisa] Univ Buenos Aires, Fac Ciencias Exactas & Nat FCEyN, Inst Fisiol Biol sMol & Neurociencias IFIBYNE CON, Dept Biodiversidad & Biol Expt,Lab Reprod & Fisio, Buenos Aires, DF, Argentina.
   [Perez-Tito, Leticia; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Cebral, E (corresponding author), UBA, IFIBYNE CONICET, Intendente Guiraldes 2160,Ciudad Univ,Pabellon 2, RA-1428 Buenos Aires, DF, Argentina.
EM ecebral@hotmail.com
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
FU PLISSER [PLC/389/2008]; Consejo Nacional de Investigaciones Cientificas
   y Tecnicas (CONICET), ArgentinaConsejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET) [PIP-CONICET 114-200801-00014];
   National Agency (Argentina) [BID-PICT-2008-2210]; University of Buenos
   Aires, ArgentinaUniversity of Buenos Aires [UBACYT 20020090200655];
   FAPESP-CNPQ-CAPESNational Council for Scientific and Technological
   Development (CNPq)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)CAPES
FX This work was supported by a PLISSER PLC/389/2008 fellowship of LPT, EC
   grants PIP-CONICET 114-200801-00014 from the Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET), Argentina,
   BID-PICT-2008-2210 from the National Agency (Argentina) and UBACYT
   20020090200655 from the University of Buenos Aires, Argentina, and by EB
   grants from FAPESP-CNPQ-CAPES.
CR Antezak M, 1997, MOL HUM REPROD, V3, P1067
   Astley SJ, 2004, PAEDIATR PERINAT EP, V18, P344, DOI 10.1111/j.1365-3016.2004.00582.x
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Brison Daniel R., 1994, Zygote, V2, P69
   Cebral E, 1998, PROSTAG LEUKOTR ESS, V58, P381, DOI 10.1016/S0952-3278(98)90075-8
   Cebral E, 1998, PROSTAG LEUKOTR ESS, V58, P249, DOI 10.1016/S0952-3278(98)90033-3
   Cebral E, 2001, REPROD TOXICOL, V15, P123, DOI 10.1016/S0890-6238(01)00116-2
   Cebral E, 1997, ALCOHOL ALCOHOLISM, V32, P563
   Cebral E, 2000, ALCOHOL ALCOHOLISM, V35, P336, DOI 10.1093/alcalc/35.4.336
   Cebral E, 1999, ALCOHOL ALCOHOLISM, V34, P551, DOI 10.1093/alcalc/34.4.551
   Cebral E, 2007, PROSTAG LEUKOTR ESS, V76, P141, DOI 10.1016/j.plefa.2006.12.001
   Coll TA, 2011, BIRTH DEFECTS RES B, V92, P560, DOI 10.1002/bdrb.20329
   Hard ML, 2001, THER DRUG MONIT, V23, P427, DOI 10.1097/00007691-200108000-00018
   HARDY K, 1993, J REPROD FERTIL, V98, P549
   Haycock PC, 2009, BIOL REPROD, V81, P618, DOI 10.1095/biolreprod.108.074682
   Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259
   Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh
   KALMUS GW, 1989, EXPERIENTIA, V45, P484, DOI 10.1007/BF01952040
   Kaufman MH, 1997, ALCOHOL ALCOHOLISM, V32, P113
   Kaufman MH, 1990, EARLY MAMMALIAN DEV, P144
   KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286
   KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x
   KHONG TY, 1987, BRIT J OBSTET GYNAEC, V94, P649, DOI 10.1111/j.1471-0528.1987.tb03169.x
   Kowalczyk JJ, 1996, ALCOHOL CLIN EXP RES, V20, P566
   LAU CF, 1991, REPROD TOXICOL, V5, P405, DOI 10.1016/0890-6238(91)90003-X
   LEACH RE, 1993, TERATOLOGY, V47, P57, DOI 10.1002/tera.1420470110
   Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929
   Pringle KG, 2007, PLACENTA, V28, P286, DOI 10.1016/j.placenta.2006.04.006
   Rout UK, 2002, REPROD TOXICOL, V16, P253, DOI 10.1016/S0890-6238(02)00022-9
   Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x
   SHIINA Y, 1993, J REPROD FERTIL, V97, P143, DOI 10.1530/jrf.0.0970143
   Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009
   STACHECKI JJ, 1994, BIOL REPROD, V50, P1, DOI 10.1095/biolreprod50.1.1
   STACHECKI JJ, 1994, J REPROD FERTIL, V101, P611, DOI 10.1530/jrf.0.1010611
   Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56
   SWANN AC, 1990, ALCOHOL CLIN EXP RES, V14, P922, DOI 10.1111/j.1530-0277.1990.tb01839.x
   TAKASE K, 1995, TOHOKU J EXP MED, V175, P69, DOI 10.1620/tjem.175.69
   TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914
   Theiler K., 1989, HOUSE MOUSE ATLAS EM
   TOURNAYE H, 1993, HUM REPROD, V8, P1948, DOI 10.1093/oxfordjournals.humrep.a137966
   YELIAN FD, 1995, MOL REPROD DEV, V41, P435, DOI 10.1002/mrd.1080410406
NR 41
TC 5
Z9 5
U1 0
U2 6
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0148-0545
EI 1525-6014
J9 DRUG CHEM TOXICOL
JI Drug Chem. Toxicol.
PD APR
PY 2014
VL 37
IS 2
BP 184
EP 197
DI 10.3109/01480545.2013.834358
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology
SC Chemistry; Pharmacology & Pharmacy; Toxicology
GA AB8IZ
UT WOS:000332034900010
PM 24116715
DA 2020-12-01
ER

PT J
AU Sandri, S
   Borbely, AU
   Fernandes, I
   de Oliveira, EM
   Knebel, FH
   Ruano, R
   Zugaib, M
   Filippin-Monteiro, F
   Bevilacqua, E
   Campa, A
AF Sandri, Silvana
   Borbely, Alexandre Urban
   Fernandes, Isabella
   de Oliveira, Edson Mendes
   Knebel, Franciele Hinterholz
   Ruano, Rodrigo
   Zugaib, Marcelo
   Filippin-Monteiro, Fabiola
   Bevilacqua, Estela
   Campa, Ana
TI Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion
SO PLOS ONE
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; CELL-MIGRATION; ADHESION MOLECULES; FETAL
   MEMBRANES; EXPRESSION; INTERLEUKIN-8; ANGIOGENESIS; ADIPONECTIN;
   ADIPOCYTE; RELEASE
AB The serum amyloid A (SAA) protein is known to function in the acute phase response and immunoregulation. Recently, SAA has been shown to be involved in cell proliferation, differentiation and migratory behavior in different cell types. Here, we evaluated whether exogenous SAA could influence trophoblast invasion and differentiation using both the trophoblast-like BeWo cell line and fully differentiated human extravillous trophoblast cells (EVT) isolated from term placentae. SAA stimulated BeWo cell invasion, as measured in Matrigel invasion assays, and induced metalloprotease mRNA expression and activity. Given that BeWo cells express Toll-like receptor 4 (TLR4), a known receptor for SAA, we examined the role of TLR4 in SAA-induced invasion using a TLR4 neutralizing antibody. We also tested whether SAA could affect markers of trophoblast syncytialization in BeWo cells. We observed that SAA decreased beta hCG secretion and did not influence trophoblast syncytialization. Using EVT cells isolated from human term basal plates, we confirmed that SAA at 1 and 10 mu g/mL doubled EVT invasion in a TLR4-dependent manner, but at 20 mu g/mL inhibited EVT cells invasiveness. In addition, we observed that SAA was expressed in both BeWo cells and human term placentae, specifically in the syncytiotrophoblast, decidual cells and EVT. In conclusion, SAA was identified as a molecule that functions in the placental microenvironment to regulate metalloprotease activity and trophoblast invasion, which are key processes in placentation and placental homeostasis.
C1 [Sandri, Silvana; de Oliveira, Edson Mendes; Knebel, Franciele Hinterholz; Campa, Ana] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil.
   [Borbely, Alexandre Urban; Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil.
   [Fernandes, Isabella] Univ Sao Paulo, Dept Cirurgia, Fac Vet & Zootecnia, Sao Paulo, Brazil.
   [Ruano, Rodrigo; Zugaib, Marcelo] Univ Sao Paulo, Fac Med, Dept Obstet & Ginecol, Sao Paulo, Brazil.
   [Filippin-Monteiro, Fabiola] Univ Fed Santa Catarina, Dept Anal Clin, Florianopolis, SC, Brazil.
RP Sandri, S (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil.
EM ssandri@usp.br
RI Zugaib, Marcelo/A-5724-2013; Campa, Ana/D-4669-2012; Borbely, Alexandre
   U/A-6649-2013; Bevilacqua, Estela/H-3354-2011; Filippin Monteiro,
   Fabiola/D-6509-2018; Sandri, Silvana/A-1650-2015; de Oliveira, Edson
   M/C-9885-2014; Borbely, Alexandre Urban/Q-2884-2019
OI Zugaib, Marcelo/0000-0003-1155-2671; Campa, Ana/0000-0002-6183-3378;
   Bevilacqua, Estela/0000-0003-4178-4625; Filippin Monteiro,
   Fabiola/0000-0003-4313-1783; de Oliveira, Edson M/0000-0002-7330-7826;
   Borbely, Alexandre Urban/0000-0001-6737-0901; Knebel,
   Franciele/0000-0001-8275-9499
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2009/05354-0]
FX This research was supported by grant from the Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (2009/05354-0). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6
   Aplin JD, 2009, PLACENTA, V30, P293, DOI 10.1016/j.placenta.2008.12.001
   BADOLATO R, 1995, J IMMUNOL, V155, P4004
   Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351
   Benaitreau D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-128
   Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170
   Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7
   Connolly M, 2011, ANN RHEUM DIS, V70, P1296, DOI 10.1136/ard.2010.142240
   Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941
   de Oliveira EM, 2013, INFLAMMATION, V36, P1107, DOI 10.1007/s10753-013-9644-9
   Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335
   Filippin-Monteiro FB, 2012, INT J OBESITY, V36, P1032, DOI 10.1038/ijo.2011.193
   Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Gutfeld O, 2006, J HISTOCHEM CYTOCHEM, V54, P63, DOI 10.1369/jhc.5A6645.2005
   Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003
   Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x
   Huppertz B, 1998, CELL TISSUE RES, V291, P133
   Jovanovic M, 2009, PLACENTA, V30, P320, DOI 10.1016/j.placenta.2009.01.013
   Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341
   Knebel FH, 2013, MEDIAT INFLAMM, V2013
   Kovacevic A, 2006, FEBS LETT, V580, P161, DOI 10.1016/j.febslet.2005.11.067
   Lakota K, 2011, J BIOMED BIOTECHNOL, V90, P2233
   Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069
   Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585
   Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066
   Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929
   Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6
   Malassine A, 2002, ENDOCRINE, V19, P3, DOI 10.1385/ENDO:19:1:3
   Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518
   O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301
   Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001
   Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6
   Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040
   PreciadoPatt L, 1996, J IMMUNOL, V156, P1189
   Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046
   Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897
   Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203
   Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002
   Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830
   Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x
   Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317
   Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295
   Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012
   Wang FP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080480, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0069284]
   Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005
   Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353
   Yamada T, 2000, SCAND J IMMUNOL, V52, P7
NR 50
TC 12
Z9 12
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 10
PY 2014
VL 9
IS 3
AR e90881
DI 10.1371/journal.pone.0090881
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC9FH
UT WOS:000332839300049
PM 24614130
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Haslinger, P
   Biadasiewicz, K
   Sandri, S
   Steponavicius-Cruz, K
   Oliveira, SF
   Meinhardt, G
   Otti, G
   Fock, V
   Fiala, C
   Pollheimer, J
   Knofler, M
   Bevilacqua, E
AF Borbely, Alexandre U.
   Haslinger, Peter
   Biadasiewicz, Katarzyna
   Sandri, Silvana
   Steponavicius-Cruz, Karen
   Oliveira, Sergio F.
   Meinhardt, Gudrun
   Otti, Gerlinde
   Fock, Valerie
   Fiala, Christian
   Pollheimer, Jurgen
   Knofler, Martin
   Bevilacqua, Estela
TI Biglycan Promotes Trophoblast Motility through AKT Signaling
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 61st Annual Scientific Meeting of the
   Society-for-Gynecologic-Investigation (SGI)
CY MAR 26-29, 2014
CL Florence, ITALY
SP Soc Gynecol Invest
C1 [Borbely, Alexandre U.; Oliveira, Sergio F.; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
   [Haslinger, Peter; Biadasiewicz, Katarzyna; Meinhardt, Gudrun; Otti, Gerlinde; Fock, Valerie; Pollheimer, Jurgen; Knofler, Martin] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, Vienna, Austria.
   [Sandri, Silvana] Univ Sao Paulo, Dept Clin Anal, Fac Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Steponavicius-Cruz, Karen] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
RI Sandri, Silvana/A-1650-2015
NR 0
TC 0
Z9 0
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2014
VL 21
IS 3
SU S
BP 176A
EP 177A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AE2OO
UT WOS:000333813001290
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Farah, SC
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon, Aline R.
   Farah, Shaker C.
   Fisher, Susan J.
   Bevilacqua, Estela
TI Stromal Cell Derived Factor-2 (SDF2): A New Factor Associated with
   Placental Development.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 61st Annual Scientific Meeting of the
   Society-for-Gynecologic-Investigation (SGI)
CY MAR 26-29, 2014
CL Florence, ITALY
SP Soc Gynecol Invest
C1 [Lorenzon, Aline R.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Farah, Shaker C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Fisher, Susan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2014
VL 21
IS 3
SU S
BP 289A
EP 289A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AE2OO
UT WOS:000333813002316
DA 2020-12-01
ER

PT J
AU Ietta, F
   Carotenuto, C
   Ferretti, C
   Bevilacqua, E
   Paulesu, L
AF Ietta, Francesca
   Carotenuto, Claudio
   Ferretti, Cristina
   Bevilacqua, Estela
   Paulesu, Luana
TI The Protective Role of the Macrophage Migration Inhibitory Factor (MIF)
   Against Apoptosis in Human Placenta.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 61st Annual Scientific Meeting of the
   Society-for-Gynecologic-Investigation (SGI)
CY MAR 26-29, 2014
CL Florence, ITALY
SP Soc Gynecol Invest
C1 [Ietta, Francesca; Carotenuto, Claudio; Paulesu, Luana] Univ Siena, I-53100 Siena, Italy.
   [Ferretti, Cristina] Hosp Campostaggia Siena, Siena, Italy.
   [Bevilacqua, Estela] Univ Sao Paulo, Sao Paulo, Brazil.
RI Ferretti, Cristina/AAC-4871-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2014
VL 21
IS 3
SU S
BP 295A
EP 295A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AE2OO
UT WOS:000333813002333
DA 2020-12-01
ER

PT J
AU Bevilacqua, E
   Paulesu, L
   Ferro, EAV
   Ietta, F
   Faria, MR
   Lorenzon, AR
   Costa, AF
   Martucci, M
AF Bevilacqua, E.
   Paulesu, L.
   Ferro, E. A. V.
   Ietta, F.
   Faria, M. R.
   Lorenzon, A. R.
   Costa, A. F.
   Martucci, M.
TI Review: Putative roles for the macrophage migratory inhibitory factor at
   the maternal fetal interface
SO PLACENTA
LA English
DT Review
DE Decidual cells; MIF; Apoptosis; AKT signaling pathway; Mdm2; Cell
   survival
ID FACTOR MIF; TOXOPLASMA-GONDII; IMMUNE-RESPONSES; CELL-SURVIVAL;
   EXPRESSION; INNATE; IMPLANTATION; INFLAMMATION; TROPHOBLAST; ACTIVATION
AB Complex and dynamic networks of molecules participate in the essential interactions between maternal organism, placenta and fetus in a healthy and successful pregnancy. Macrophage migratory inhibitory factor (MIF) is one of several molecules produced at implantation sites; MIF is mostly expressed by trophoblast cells. This has led to expectations of MIF's relevance as a partner in the maternal/fetal dialog. MIF is known by its biological interactions and functional roles as an activator of innate immunity, regulating subsequent adaptive responses, which include inhibition of migration of mononuclear cells in vitro, antagonism of glucocorticoids, and regulation of expression of Toll-like receptor 4. Beyond roles in the inflammatory response, MIF can interfere with proliferative activities in different cell types, as well as with cell death pathways. This intriguing factor found at the human, porcine, ovine, bovine and rodent maternal fetal interfaces is present in a time- and spatially-dependent manner, indicating regulatory roles in the process of embryo implantation, placental development, maintenance of pregnancy and birth. Here, we will review MIF participation in placental physiology, including new evidence for a dialog with uterine cells, and a potential role in protection of uterine decidual cells. (C) 2013 Published by IFPA and Elsevier Ltd.
C1 [Bevilacqua, E.; Faria, M. R.; Lorenzon, A. R.; Costa, A. F.; Martucci, M.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Paulesu, L.; Ietta, F.] Univ Siena, Dept Life Sci, I-53100 Siena, Italy.
   [Ferro, E. A. V.] Univ Fed Uberlandia, Inst Biomed Sci, Lab Histol & Embryol, BR-38400 Uberlandia, MG, Brazil.
   [Costa, A. F.] Univ Sao Paulo, Sch Dent, Dept Stomatol, Lab Cell Biol, BR-05508900 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Ferro, Eloisa/B-2185-2008; Lorenzon, Aline R/G-8733-2014; Bevilacqua,
   Estela/H-3354-2011; Ferro, Eloisa/K-5533-2016
OI Ferro, Eloisa/0000-0002-7447-2583; Lorenzon, Aline
   R/0000-0002-6052-6296; Bevilacqua, Estela/0000-0003-4178-4625; Ferro,
   Eloisa/0000-0002-7447-2583; Ietta, Francesca/0000-0002-2160-8790
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX This study was supported by FAPESP, CNPq and CAPES grants and
   fellowships.
CR ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610
   Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200
   Arcuri F, 1999, BIOL REPROD, V60, P1299, DOI 10.1095/biolreprod60.6.1299
   Arcuri F, 2007, BIOL REPROD, V76, P433, DOI 10.1095/biolreprod.106.054189
   Bondza PK, 2008, FERTIL STERIL, V90, P1433, DOI 10.1016/j.fertnstert.2007.08.046
   Borbely AU, 2012, AM J REPROD IMMUNOL, V67, P73, DOI 10.1111/j.1600-0897.2011.01060.x
   Bove SE, 2000, BIOL REPROD, V62, P879, DOI 10.1095/biolreprod62.4.879
   Bucala R, 2007, MIF MOST INTERESTING, P332
   Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Calandra T, 2003, J INFECT DIS, V187, pS385, DOI 10.1086/374752
   CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0
   Cardaropoli S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639342
   Castro AS, 2013, PLACENTA, V34, P240, DOI 10.1016/j.placenta.2012.12.006
   Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322
   Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x
   DEOLIVEIRA GA, 2011, AM J PATHOL, V178, P2792
   Elsby LA, 2009, ARTHRITIS RHEUM-US, V60, P2220, DOI 10.1002/art.24659
   Faria MR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-95
   Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100
   Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065
   Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200
   Granot I, 2012, REPRODUCTION, V144, P661, DOI 10.1530/REP-12-0217
   Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4
   Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375
   Ietta F, 2007, AM J PHYSIOL-ENDOC M, V292, P272
   Ietta F, 2010, AM J PHYSIOL-ENDOC M, V298, pE411, DOI 10.1152/ajpendo.00522.2009
   Jain Vidhan, 2009, BMC Res Notes, V2, P36, DOI 10.1186/1756-0500-2-36
   Kats R, 2005, HUM REPROD, V20, P3518, DOI 10.1093/humrep/dei234
   Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559
   Leng L, 2009, CYTOKINE, V48, P177, DOI 10.1016/j.cyto.2009.07.002
   Letta F, 2002, AM J REPROD IMMUNOL, V48, P404, DOI 10.1034/j.1600-0897.2002.01152.x
   Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318
   Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013
   Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599
   Mizue Y, 2000, INT J MOL MED, V5, P397
   Moll SJ, 2007, APOPTOSIS, V12, P1611, DOI 10.1007/s10495-007-0092-6
   Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200
   Paulesu L, 2005, BIOL REPROD, V72, P949, DOI 10.1095/biolreprod.104.029058
   Paulesu L, 2012, PLACENTA, V33, P157, DOI 10.1016/j.placenta.2011.12.005
   Pearce BD, 2010, GYNECOL OBSTET INVES, V70, P40, DOI 10.1159/000284949
   Pearce BD, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.066
   Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571
   SCHLAFKE S, 1975, BIOL REPROD, V12, P41, DOI 10.1095/biolreprod12.1.41
   Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020
   Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S
   Suzuki H, 1996, IMMUNOL LETT, V51, P141, DOI 10.1016/0165-2478(96)02543-6
   Suzuki H, 1996, BIOCHEM MOL BIOL INT, V38, P409
   Todros T, 2005, EUR J OBSTET GYN R B, V123, P162, DOI 10.1016/j.ejogrb.2005.03.014
   Veillat V, 2010, J CLIN ENDOCR METAB, V95, pE403, DOI 10.1210/jc.2010-0417
   Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432
   Vigano P, 2007, SEMIN IMMUNOPATHOL, V29, P135, DOI 10.1007/s00281-007-0074-3
   Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173
   Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428
   Yamada H, 2003, HUM REPROD, V18, P616, DOI 10.1093/humrep/deg147
   ZENG FY, 1993, ARCH BIOCHEM BIOPHYS, V303, P74, DOI 10.1006/abbi.1993.1257
NR 58
TC 15
Z9 15
U1 0
U2 15
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD FEB
PY 2014
VL 35
SU A
BP S51
EP S56
DI 10.1016/j.placenta.2013.10.015
PG 6
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA AD8DF
UT WOS:000333496000011
PM 24215782
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Sandri, S
   Fernandes, IR
   Prado, KM
   Cardoso, EC
   Correa-Silva, S
   Albuquerque, R
   Knofler, M
   Beltrao-Braga, P
   Campa, A
   Bevilacqua, E
AF Borbely, Alexandre U.
   Sandri, Silvana
   Fernandes, Isabella R.
   Prado, Karen M.
   Cardoso, Elaine C.
   Correa-Silva, Simone
   Albuquerque, Renata
   Knoefler, Martin
   Beltrao-Braga, Patricia
   Campa, Ana
   Bevilacqua, Estela
TI The term basal plate of the human placenta as a source of functional
   extravillous trophoblast cells
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Basal plate; Cell isolation; Extravillous trophoblast cells;
   Invasiveness; Term placenta
ID IN-VITRO; HLA-G; EXTRACELLULAR-MATRIX; FLOW-CYTOMETRY; INVASION;
   DIFFERENTIATION; EXPRESSION; CYTOTROPHOBLAST; 1ST-TRIMESTER; PREGNANCY
AB Background: Extravillous trophoblast (EVT) cells are of pivotal importance in human embryo implantation and homeostasis of the maternal fetal interface. Invasion of the endometrium by EVT contributes to placental anchorage, spiral artery remodeling, immunological defense, tolerogenic responses, and several collaborative cross talks involved in establishing and maintaining a successful pregnancy. We report here an improved protocol for the isolation of fully differentiated EVT cells from the basal plate of the human term placenta.
   Methods: The basal plate was carefully dissected from the villous tissue and the amniochorion membrane prior to enzymatic digestion. Term basal EVT cells were isolated using a 30 and 60% Percoll gradient. A panel of markers and characteristics of the isolated cells were used to confirm the specificity and efficiency of the method so that their potential as an investigative tool for placental research could be ascertained.
   Results: Isolated cells were immunoreactive for cytokeratin-7 (CK-7), placental growth factor, placental alkaline phosphatase, human leukocyte antigen G1 (HLA-G1), and alpha 1 and alpha 5 integrins, similarly to the EVT markers from first trimester placental villi. Around 95% of the isolated cells labeled positively for CK-7 and 82% for HLA-G1. No significant change in viability was observed during 48 h of EVT culture as indicated by propidium iodide incorporation and trypan blue test exclusion. Genes for metalloproteinases MMP-2 and MMP9 (positive regulators of trophoblast invasiveness) were expressed up to 48 h of culturing, as also the gelatinolytic activity of the isolated cells. Transforming growth factor (TGF)-beta, which inhibits proliferation, migration, and invasiveness of first-trimester EVT cells, also reduced invasion of isolated term EVT cells in transwell assays, whereas epidermal growth factor was a positive modulator.
   Conclusions: Term basal plate may be a viable source of functional EVT cells that is an alternative to villous explant-derived EVT cells and cell lines. Isolated term EVT cells may be particularly useful in investigation of the role of trophoblast cells in pathological gestations, in which the precise regulation and interactive ability of extravillous trophoblast has been impaired.
C1 [Borbely, Alexandre U.; Prado, Karen M.; Cardoso, Elaine C.; Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil.
   [Sandri, Silvana; Albuquerque, Renata; Campa, Ana] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin Chem, BR-05508000 Sao Paulo, Brazil.
   [Fernandes, Isabella R.; Beltrao-Braga, Patricia] Univ Sao Paulo, Vet Med & Zootechnol Sch, Dept Surg, BR-05508000 Sao Paulo, Brazil.
   [Knoefler, Martin] Med Univ Vienna, Dept Obstet & Fetal Maternal Med, Reprod Biol Unit, A-1090 Vienna, Austria.
   [Beltrao-Braga, Patricia] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-03828000 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Beltrao-Braga, Patricia C B/D-6450-2013; Borbely, Alexandre
   U/A-6649-2013; Campa, Ana/D-4669-2012; Sandri, Silvana/A-1650-2015;
   Borbely, Alexandre Urban/Q-2884-2019; Bevilacqua, Estela/H-3354-2011
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Campa,
   Ana/0000-0002-6183-3378; Borbely, Alexandre Urban/0000-0001-6737-0901;
   Bevilacqua, Estela/0000-0003-4178-4625
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2009/05354-0, 2013/12243-5];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [140088/2010-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [4178-11-4]; Austrian Science FundsAustrian Science Fund
   (FWF) [P-22687-B13]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo [grant no. 2009/05354-0; 2013/12243-5]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [grant no. 140088/2010-5];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [grant no.
   4178-11-4] and the Austrian Science Funds [grant number P-22687-B13]. We
   thank Rosangela Augusto de Oliveira Farias and Katarzyna Biadasiewicz
   for essential assistance with in vitro preparations in Brazil and
   Austria, respectively; to Karen Steponavicius Cruz for assistance with
   invasion assays and flow cytometry analysis; and to Renato Massaro and
   professor Silvya Stuchi Maria-Engler for support with zymography assays.
   We also thank professors Sergio Ferreira de Oliveira and Ruy Gastaldoni
   Jaeger for donating some antibodies and for the use of their
   laboratories.
CR Altieri A, 2003, LANCET ONCOL, V4, P670, DOI 10.1016/S1470-2045(03)01245-2
   Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828
   APLIN JD, 1993, PLACENTA, V14, P203, DOI 10.1016/S0143-4004(05)80261-9
   BEHAM A, 1988, PLACENTA, V9, P479, DOI 10.1016/0143-4004(88)90020-3
   Biadasiewicz K, 2011, ENDOCRINOLOGY, V152, P1458, DOI 10.1210/en.2010-0936
   Bischof P, 2001, ANN NY ACAD SCI, V943, P157, DOI 10.1111/j.1749-6632.2001.tb03799.x
   Borbely A, 2013, HISTOPATHOLOGY, DOI [10.1111/his.12304, DOI 10.1111/HIS.12304.[]
   Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380
   Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977
   Choy MY, 1998, HUM REPROD, V13, P2941, DOI 10.1093/humrep/13.10.2941
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   DAMSKY CH, 1994, DEVELOPMENT, V120, P3657
   ELLIS SA, 1986, IMMUNOLOGY, V59, P595
   FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891
   Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644
   Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003
   Kemp B, 2002, HISTOCHEM CELL BIOL, V117, P401, DOI 10.1007/s00418-002-0396-0
   Khaliq A, 1996, GROWTH FACTORS, V13, P579
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Kumpel BM, 2012, VOX SANG, V102, P2, DOI 10.1111/j.1423-0410.2011.01533.x
   Le Bouteiller P, 1999, IMMUNOL REV, V167, P233
   Leitner K, 2001, J HISTOCHEM CYTOCHEM, V49, P1155, DOI 10.1177/002215540104900909
   LOKE YW, 1988, PLACENTA, V9, P173, DOI 10.1016/0143-4004(88)90015-X
   Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929
   Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109
   MCMASTER MT, 1995, J IMMUNOL, V154, P3771
   Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002
   MUHLHAUSER J, 1995, J HISTOCHEM CYTOCHEM, V43, P579, DOI 10.1177/43.6.7539466
   Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352
   Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023
   Pollheimer J, 2011, ENDOCRINOLOGY, V152, P4431, DOI 10.1210/en.2011-1196
   Potgens AJG, 2001, PLACENTA, V22, P251, DOI 10.1053/plac.2000.0597
   Quenby S, 2005, FERTIL STERIL, V83, P691, DOI 10.1016/j.fertnstert.2004.07.978
   SHORTER SC, 1990, PLACENTA, V11, P505, DOI 10.1016/S0143-4004(05)80196-1
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5
   Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x
   Talaulikar VS, 2014, J OBSTET GYNAECOL RE, V40, P80, DOI 10.1111/jog.12127
   Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334
   von Rango U, 2003, PLACENTA, V24, P929, DOI 10.1016/S0143-4004(03)00168-1
   Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489
   Wu HX, 2010, HUM REPROD, V25, P1146, DOI 10.1093/humrep/deq051
NR 45
TC 17
Z9 21
U1 0
U2 15
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD JAN 28
PY 2014
VL 12
AR 7
DI 10.1186/1477-7827-12-7
PG 12
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA AB2QN
UT WOS:000331637300001
PM 24467708
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bandeira, CL
   Borbely, AU
   Francisco, RPV
   Schultz, R
   Zugaib, M
   Bevilacqua, E
AF Bandeira, Carla Leticia
   Borbely, Alexandre Urban
   Vieira Francisco, Rossana Pulcineli
   Schultz, Regina
   Zugaib, Marcelo
   Bevilacqua, Estela
TI Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous
   Cytotrophoblast in Placenta Creta
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GROWTH-FACTOR; GENE-EXPRESSION; RISK-FACTORS; ACCRETA; DIFFERENTIATION
AB CRIPTO-(CR)1 is a protein associated with tumorigenesis and metastasis. Here we demonstrate that CR-1 expression in normal and creta placentas is associated with various degrees of uterine invasion. Cytokeratin (CK) and CR-1 protein expression was visualized by immunohistochemical staining of formalin-fixed, paraffin-embedded placental specimens (control placentas, n = 9; accreta, n = 6; increta, n = 10; percreta, n = 15). The pattern of extravillous trophoblast (EVT) cell morphology was distinctive in creta placentas: densely-compacted cell columns and large star-shaped cells with a typically migratory phenotype, not common among third trimester control placentas. Quantification revealed higher CR-1 immunoreactivities in accreta (P = 0.001), increta (P = 0.0002), and percreta placentas (P = 0.001) than in controls. In contrast to controls, there was a significant positive relationship between CR-1 and CK reactivity in all creta placentas (accreta, P = 0.02; increta, P = 0.0001, and percreta, P = 0.025). This study demonstrated CR-1 expression in the placental bed, its increased expression in creta placentas, and EVT cells as the main CR-1-producing cell type. Morphological examination revealed an immature and invasive trophoblast profile in creta placentas, suggesting impairment of the trophoblast differentiation pathway. These findings provide important new insights into the pathophysiology of abnormal creta placentation and its gestational consequences.
C1 [Bandeira, Carla Leticia; Borbely, Alexandre Urban; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil.
   [Vieira Francisco, Rossana Pulcineli; Zugaib, Marcelo] Univ Sao Paulo, Sch Med, Clin Hosp, Dept Obstet, BR-05403000 Sao Paulo, Brazil.
   [Schultz, Regina] Univ Sao Paulo, Sch Med, Clin Hosp, Div Pathol, BR-05403000 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Zugaib, Marcelo/A-5724-2013; Borbely, Alexandre U/A-6649-2013;
   Francisco, Rossana PV/C-5648-2012; Bevilacqua, Estela/H-3354-2011;
   Borbely, Alexandre Urban/Q-2884-2019; Bandeira, Carla
   Leticia/U-8685-2017
OI Zugaib, Marcelo/0000-0003-1155-2671; Francisco, Rossana
   PV/0000-0002-9981-8069; Bevilacqua, Estela/0000-0003-4178-4625; Borbely,
   Alexandre Urban/0000-0001-6737-0901; Bandeira, Carla
   Leticia/0000-0002-0796-3462
CR Adamson ED, 2002, J CELL PHYSIOL, V190, P267, DOI 10.1002/jcp.10072
   Al-Khan A, 2011, PLACENTA, V32, pS90, DOI 10.1016/j.placenta.2010.12.025
   Bauer ST, 2009, SEMIN PERINATOL, V33, P88, DOI 10.1053/j.semperi.2008.12.003
   Belfort MA, 2010, AM J OBSTET GYNECOL, V203, P430, DOI 10.1016/j.ajog.2010.09.013
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC
   Bianco C, 2005, J NATL CANCER I, V97, P132, DOI 10.1093/jnci/dji011
   Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7
   Chou MM, 2002, ULTRASOUND OBST GYN, V19, P625, DOI 10.1046/j.1469-0705.2002.00731_2.x
   Clark EAS, 2011, AM J OBSTET GYNECOL, V205, pS2, DOI 10.1016/j.ajog.2011.09.028
   Daskalakis G, 2007, ACTA OBSTET GYN SCAN, V86, P223, DOI 10.1080/00016340601088448
   Ebert AD, 1999, CANCER RES, V59, P4502
   Fox H, 2007, PATHOLOGY PLACENTA
   Hoffman M, 2010, AM J OBSTET GYNECOL, V202, P618, DOI 10.1016/j.ajog.2010.03.009
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Irving FC, 1937, SURG GYNECOL OBSTET, V64, P178
   Jauniaux E, 2012, PLACENTA, V33, P244, DOI 10.1016/j.placenta.2011.11.010
   Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076
   Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202
   KHONG TY, 1987, PLACENTA, V8, P399, DOI 10.1016/0143-4004(87)90067-1
   Kim KR, 2004, MODERN PATHOL, V17, P1483, DOI 10.1038/modpathol.3800210
   Kraus FT, 2004, ATLAS NONTUMOR PATHO, P47
   Mancino M, 2008, J CELL PHYSIOL, V215, P192, DOI 10.1002/jcp.21301
   Marzioni D., 2005, Italian Journal of Anatomy and Embryology, V110, P183
   Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0
   MUHLHAUSER J, 1993, J HISTOCHEM CYTOCHEM, V41, P165, DOI 10.1177/41.2.8093455
   OHLSSON R, 1989, CELL DIFFER DEV, V28, P1, DOI 10.1016/0922-3371(89)90018-X
   Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686
   PRIDJIAN G, 1991, OBSTET GYNECOL, V77, P195, DOI 10.1097/00006250-199102000-00006
   Rangel MC, 2012, AM J PATHOL, V180, P2188, DOI 10.1016/j.ajpath.2012.02.031
   Salomon DS, 2000, ENDOCR-RELAT CANCER, V7, P199, DOI 10.1677/erc.0.0070199
   Shellhaas CS, 2009, OBSTET GYNECOL, V114, P224, DOI 10.1097/AOG.0b013e3181ad9442
   Shih JC, 2002, ULTRASOUND OBST GYN, V19, P623, DOI 10.1046/j.1469-0705.2002.00731_1.x
   Sofiah S, 2009, Med J Malaysia, V64, P298
   Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003
   Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008
   Tseng JJ, 2006, PLACENTA, V27, P70, DOI 10.1016/j.placenta.2004.12.011
   Usta IM, 2005, AM J OBSTET GYNECOL, V193, P1045, DOI 10.1016/j.ajog.2005.06.037
   Watanabe K, 2007, J BIOL CHEM, V282, P31643, DOI 10.1074/jbc.M702713200
   Watanabe K, 2010, STEM CELLS, V28, P1303, DOI 10.1002/stem.463
   Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074
NR 40
TC 7
Z9 7
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 892856
DI 10.1155/2014/892856
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AN2BD
UT WOS:000340387400001
PM 25165718
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Santos, JH
   Rocha, CR
   Damasceno, DC
   Morceli, G
   Rudge, MV
   Bevilacqua, E
   Calderon, IMP
AF Moreli, Jusciele Brogin
   Santos, Janine Hertzog
   Rocha, Clarissa Ribeiro
   Damasceno, Debora Cristina
   Morceli, Glilciane
   Rudge, Marilza Vieira
   Bevilacqua, Estela
   Paranhos Calderon, Iracema Mattos
TI DNA Damage and Its Cellular Response in Mother and Fetus Exposed to
   Hyperglycemic Environment
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID GESTATIONAL DIABETES-MELLITUS; OXIDATIVE STRESS; CORD BLOOD; SIGNALING
   PATHWAYS; PREGNANCY OUTCOMES; MITOCHONDRIAL-DNA; REPAIR MECHANISMS;
   VITAMIN-C; GENOME; HEALTH
AB The increased production of reactive oxygen species (ROS) plays a key role in pathogenesis of diabetic complications. ROS are generated by exogenous and endogenous factors such as during hyperglycemia. When ROS production exceeds the detoxification and scavenging capacity of the cell, oxidative stress ensues. Oxidative stress induces DNA damage and when DNA damage exceeds the cellular capacity to repair it, the accumulation of errors can overwhelm the cell resulting in cell death or fixation of genome mutations that can be transmitted to future cell generations. These mutations can lead to and/or play a role in cancer development. This review aims at (i) understanding the types and consequences of DNA damage during hyperglycemic pregnancy; (ii) identifying the biological role of DNA repair during pregnancy, and (iii) proposing clinical interventions to maintain genome integrity. While hyperglycemia can damage the maternal genetic material, the impact of hyperglycemia on fetal cells is still unclear. DNA repair mechanisms may be important to prevent the deleterious effects of hyperglycemia both in mother and in fetus DNA and, as such, prevent the development of diseases in adulthood. Hence, in clinical practice, maternal glycemic control may represent an important point of intervention to prevent the deleterious effects of maternal hyperglycemia to DNA.
C1 [Moreli, Jusciele Brogin; Damasceno, Debora Cristina; Morceli, Glilciane; Rudge, Marilza Vieira; Paranhos Calderon, Iracema Mattos] Sao Paulo State Univ, Grad Program Gynecol Obstet & Mastol, UNESP, Sao Paulo, Brazil.
   [Santos, Janine Hertzog] NIEHS, Mol Carcinogenesis Lab, Durham, NC USA.
   [Rocha, Clarissa Ribeiro] Univ Sao Paulo, Dept Microbiol, BR-05508 Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Paranhos Calderon, Iracema Mattos] Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynecol, UNESP, BR-18618000 Botucatu, SP, Brazil.
RP Calderon, IMP (corresponding author), Sao Paulo State Univ, Grad Program Gynecol Obstet & Mastol, UNESP, Sao Paulo, Brazil.
EM calderon@fmb.unesp.br
RI Bevilacqua, Estela/H-3354-2011; Rudge, Marilza V C/C-8338-2012; Rocha,
   Clarissa Ribeiro Reily/O-8946-2015; Calderon, Iracema/W-4336-2019;
   Morceli, Glilciane/C-7487-2012; Morceli, Glilciane/AAX-4554-2020;
   Morceli, Glilciane/AAX-4624-2020; Rudge, Marilza/S-9057-2018; FAPESP,
   CDMF/J-3591-2015; Damasceno, Debora Cristina/C-7234-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; Rudge, Marilza V
   C/0000-0002-9227-832X; Calderon, Iracema/0000-0003-4761-4336; Morceli,
   Glilciane/0000-0001-8216-9931; Morceli, Glilciane/0000-0001-8216-9931;
   FAPESP, CDMF/0000-0002-4464-0937; Damasceno, Debora
   Cristina/0000-0002-7003-9643; Moreli, Jusciele/0000-0002-0945-9462
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/18240-2,
   2011/13562-1, 2012/23296-0]
FX The authors acknowledge Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) (Grant no. 2011/18240-2, 2011/13562-1, and 2012/23296-0).
   The authors would like to thank Carlos Frederico Martins Menck for
   scientific support.
CR Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e
   Agnez-Lima LF, 2012, MUTAT RES-REV MUTAT, V751, P15, DOI 10.1016/j.mrrev.2011.12.005
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014
   American Diabetes Association (ADA), 2010, DIABETES CARE, V33, P676
   Berra CM, 2006, QUIM NOVA, V29, P1340, DOI 10.1590/S0100-40422006000600032
   Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011
   Brewster S, 2013, J AM COLL CARDIOL, V62, P677, DOI 10.1016/j.jacc.2013.01.080
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Castorino K, 2011, CLIN CHEM, V57, P221, DOI 10.1373/clinchem.2010.155382
   Cederberg J, 2005, BIRTH DEFECTS RES A, V73, P498, DOI 10.1002/bdra.20144
   Collins AR, 1998, FREE RADICAL BIO MED, V25, P373, DOI 10.1016/S0891-5849(98)00053-7
   Cross JA, 2010, DIABETIC MED, V27, P1264, DOI 10.1111/j.1464-5491.2010.03099.x
   Rudge MVC, 2005, REV BRAS GINECOL OBS, V27, P691, DOI 10.1590/S0100-72032005001100010
   Damasceno DC, 2002, ANIM REPROD SCI, V72, P235, DOI 10.1016/S0378-4320(02)00094-5
   Dawson SI, 2004, CANCER, V100, P149, DOI 10.1002/cncr.20013
   Decordier I, 2007, TOXICOL LETT, V172, P68, DOI 10.1016/j.toxlet.2007.05.014
   del Rosario MC, 2014, METABOLISM, V63, P654, DOI 10.1016/j.metabol.2014.01.007
   Dincer Y, 2003, MUTAT RES-FUND MOL M, V527, P49, DOI 10.1016/S0027-5107(03)00073-3
   Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016
   Endemann DH, 2004, CURR HYPERTENS REP, V6, P85, DOI 10.1007/s11906-004-0081-x
   Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006
   Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fraser A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0489-x
   Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408
   Friedberg EC, 2008, CELL RES, V18, P3, DOI 10.1038/cr.2007.113
   Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666
   Goodarzi MT, 2010, J CLIN LAB ANAL, V24, P72, DOI 10.1002/jcla.20328
   Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Kasznicki J, 2009, POL ARCH MED WEWN, V119, P128, DOI 10.20452/pamw.626
   Kitzmiller JL, 2008, DIABETES CARE, V31, P1060, DOI 10.2337/dc08-9020
   Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62
   Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016
   Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024
   Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Li P, 2014, DIABETES RES CLIN PR, V103, P310, DOI 10.1016/j.diabres.2013.12.024
   Lima PHO, 2012, EXP CLIN ENDOCR DIAB, V120, P303, DOI 10.1055/s-0031-1299766
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Merlob Paul, 2002, Paediatr Drugs, V4, P755, DOI 10.2165/00128072-200204110-00007
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070
   Moreli J. B., DYNAMICS CHANGES TNF
   Moreli JB, 2012, J CLIN IMMUNOL, V32, P604, DOI 10.1007/s10875-011-9634-3
   Moslehi R, 2010, CLIN GENET, V77, P365, DOI 10.1111/j.1399-0004.2009.01336.x
   Moslehi R, 2012, EUR J HUM GENET, V20, P626, DOI 10.1038/ejhg.2011.249
   Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021
   Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41
   Nomura Y, 2014, REPROD SCI, V21, P131, DOI 10.1177/1933719113492206
   Ornoy A, 2011, REPROD TOXICOL, V32, P205, DOI 10.1016/j.reprotox.2011.05.002
   Lima PHO, 2008, MUTAT RES-GEN TOX EN, V653, P44, DOI 10.1016/j.mrgentox.2008.02.008
   Lima PHO, 2007, MUTAT RES-GEN TOX EN, V628, P117, DOI 10.1016/j.mrgentox.2006.12.004
   Pacal Lukas, 2011, Archives of Physiology and Biochemistry, V117, P222, DOI 10.3109/13813455.2010.551135
   Paranhos Calderon Iracema Mattos, 2007, ARBS Annual Review of Biomedical Sciences, V9, P1
   Perrin MC, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-25
   Pitozzi V, 2003, MUTAT RES-FUND MOL M, V529, P129, DOI 10.1016/S0027-5107(03)00114-3
   Qiu CF, 2011, CLIN BIOCHEM, V44, P804, DOI 10.1016/j.clinbiochem.2011.04.023
   Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001
   Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196
   Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057
   Rumbold A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004072.pub2
   Rumbold AR, 2005, EUR J OBSTET GYN R B, V119, P67, DOI 10.1016/j.ejogrb.2004.06.027
   Saadat I, 2012, ARCH GYNECOL OBSTET, V286, P1459, DOI 10.1007/s00404-012-2471-7
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Sella T, 2011, CANCER CAUSE CONTROL, V22, P1513, DOI 10.1007/s10552-011-9825-5
   Sharma NK, 2014, DNA REPAIR, V13, P22, DOI 10.1016/j.dnarep.2013.11.002
   Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f
   Steenken S, 1997, BIOL CHEM, V378, P1293
   Moraes MCS, 2012, FRONT BIOSCI-LANDMRK, V17, P1362, DOI 10.2741/3992
   Tatsch E, 2012, MUTAT RES-FUND MOL M, V732, P16, DOI 10.1016/j.mrfmmm.2012.01.004
   Troisi R, 1998, EPIDEMIOLOGY, V9, P641, DOI 10.1097/00001648-199811000-00014
   Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002
   Verhaeghe J, 2011, METABOLISM, V60, P71, DOI 10.1016/j.metabol.2010.04.013
   Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087
   Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23
   West Nancy A, 2013, Immunometabolism, V1, P1
   Witczak M., 2014, MUTAT RES, pS1383
   Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036727
   Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47
   Zelenko Z, 2014, ENDOCRIN METAB CLIN, V43, P167, DOI 10.1016/j.ecl.2013.09.008
NR 85
TC 15
Z9 15
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 676758
DI 10.1155/2014/676758
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AN7BJ
UT WOS:000340753200001
PM 25197655
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Kirsten, TB
   Lippi, LL
   Bevilacqua, E
   Bernardi, MM
AF Kirsten, Thiago B.
   Lippi, Luciana L.
   Bevilacqua, Estela
   Bernardi, Maria M.
TI LPS Exposure Increases Maternal Corticosterone Levels, Causes Placental
   Injury and Increases IL-1B Levels in Adult Rat Offspring: Relevance to
   Autism
SO PLOS ONE
LA English
DT Article
ID PRENATAL IMMUNE ACTIVATION; INFLAMMATORY RESPONSE; EXPERIMENTAL-MODEL;
   SOCIAL-BEHAVIOR; AMNIOTIC-FLUID; BRAIN; INFECTION; CYTOKINES;
   EXPRESSION; CHALLENGE
AB Maternal immune activation can induce neuropsychiatric disorders, such as autism and schizophrenia. Previous investigations by our group have shown that prenatal treatment of rats on gestation day 9.5 with lipopolysaccharide (LPS; 100 mu g/kg, intraperitoneally), which mimics infections by gram-negative bacteria, induced autism-like behavior in male rats, including impaired communication and socialization and induced repetitive/restricted behavior. However, the behavior of female rats was unchanged. Little is known about how LPS-induced changes in the pregnant dam subsequently affect the developing fetus and the fetal immune system. The present study evaluated the hypothalamic-pituitary-adrenal (HPA) axis activity, the placental tissue and the reproductive performance of pregnant Wistar rats exposed to LPS. In the adult offspring, we evaluated the HPA axis and pro-inflammatory cytokine levels with or without a LPS challenge. LPS exposure increased maternal serum corticosterone levels, injured placental tissue and led to higher post-implantation loss, resulting in fewer live fetuses. The HPA axis was not affected in adult offspring. However, prenatal LPS exposure increased IL-1 beta serum levels, revealing that prenatal LPS exposure modified the immune response to a LPS challenge in adulthood. Increased IL-1 beta levels have been reported in several autistic patients. Together with our previous studies, our model induced autistic-like behavioral and immune disturbances in childhood and adulthood, indicating that it is a robust rat model of autism.
C1 [Kirsten, Thiago B.; Lippi, Luciana L.] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Bernardi, Maria M.] Univ Paulista, Grad Program Environm & Expt Pathol, Sao Paulo, Brazil.
   [Bernardi, Maria M.] Univ Paulista, Grad Program Dent, Sao Paulo, Brazil.
RP Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.
EM thik@hotmail.com
RI Bevilacqua, Estela/H-3354-2011; Bernardi, Maria/T-6813-2019
OI Bevilacqua, Estela/0000-0003-4178-4625; Bernardi, Maria
   Martha/0000-0002-6860-9416; Kirsten, Thiago Berti/0000-0002-4032-4355
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2008/53861-5, 2012/07007-8, 2009/51886-3]
FX This research was supported by the Sao Paulo Research Foundation (FAPESP
   grant 2008/53861-5, 2012/07007-8 and thematic grant 2009/51886-3). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748
   Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4
   Bell MJ, 2004, PEDIATR RES, V56, P541, DOI 10.1203/01.PDR.0000139407.89883.6B
   Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005
   Burton GJ, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P189
   Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013
   CASEY ML, 1989, J CLIN INVEST, V83, P430, DOI 10.1172/JCI113901
   Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022
   Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665
   de Lima CB, 2010, INT IMMUNOPHARMACOL, V10, P1335, DOI 10.1016/j.intimp.2010.08.015
   Dey SK, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P147
   Dunn AJ, 2006, CLIN NEUROSCI RES, V6, P52, DOI 10.1016/j.cnr.2006.04.002
   Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003
   Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261
   Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023
   HALL GA, 1974, AM J PATHOL, V77, P299
   HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6
   Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0
   KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U
   Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089
   Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040
   Kirsten TB, 2011, PHYSIOL BEHAV, V104, P417, DOI 10.1016/j.physbeh.2011.04.049
   Kirsten TB, 2011, LIFE SCI, V89, P15, DOI 10.1016/j.lfs.2011.04.023
   Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009
   Kwon O, 2002, BIOL PHARM BULL, V25, P1165, DOI 10.1248/bpb.25.1165
   Lenczowski MJP, 1997, AM J PHYSIOL-REG I, V273, pR1870
   Levario-Carrillo M, 2004, EXP TOXICOL PATHOL, V55, P489, DOI 10.1078/0940-2993-00346
   Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002
   MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005
   Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887
   McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4
   Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196
   Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001
   Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119
   REUL JMHM, 1994, J CLIN INVEST, V93, P2600, DOI 10.1172/JCI117272
   RICHARDS IS, 2008, PRINCIPLES PRACTICE, P139
   Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44
   SILEN ML, 1989, AM J PATHOL, V135, P239
   SUTANTO W, 1987, ENDOCRINOLOGY, V121, P1405, DOI 10.1210/endo-121-4-1405
   Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3
   Vismari L, 2012, IMMUNOPHARM IMMUNOT, V34, P578, DOI 10.3109/08923973.2011.638305
   Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002
   Xu DX, 2006, TOXICOL LETT, V163, P20, DOI 10.1016/j.toxlet.2005.09.009
   Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027
NR 45
TC 50
Z9 53
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 2
PY 2013
VL 8
IS 12
AR e82244
DI 10.1371/journal.pone.0082244
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 265IN
UT WOS:000327944500130
PM 24312647
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   do Prado, KM
   Oliveira, LG
   Ono, E
   Camara, NOS
   Bevilacqua, E
AF Correa-Silva, Simone
   do Prado, Karen Matias
   Oliveira, Leandro Gustavo
   Ono, Erica
   Saraiva Camara, Niels Olsen
   Bevilacqua, Estela
TI Compartmentalization of pro-inflammatory cytokine levels in
   renal-transplanted pregnant women
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Cytokines; immune response; immunosuppressive drugs; inflammation;
   placenta
ID NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; INTERLEUKIN-6; CYCLOSPORINE
AB Objective: We evaluated whether chronic exposure to immunosuppression in transplant recipients modulate the placental inflammatory cytokine levels associated to gestational tolerance mechanisms.
   Methods: Serum samples were collected from 12 renal transplanted pregnant under immunosuppressive regimen treatment and 10 healthy women in second/third trimester of gestation. Term placental tissues (decidua and chorionic villi) were also obtained after elective caesarean. Serum IL-1 beta, IL-6, IL-8, IL-12p70 and TNF-alpha were measured, as also in placental homogenates, by Cytometric Bead Array (CBA) combined with flow cytometry and, TGF-beta and IL-18 were measured by ELISA.
   Results: Serum levels of IL-6 (p = 0.0001) and TNF-alpha (0.0112) were higher in the 2nd and 3rd trimesters and in decidua the spectrum of increased pro inflammatory cytokines was wider: IL-1 beta (p = 0.0001), IL-6 (p = 0.0001), IL-8 (p = 0.0001), IL-12p70 (p = 0.0001), TGF-beta (p = 0.0089) and TNF-alpha (p = 0.0002). TGF-beta 1 was particularly increased in decidual compartment (p = 0.001). In the chorionic villous, pro inflammatory profile also were maintained. High IL-1 beta (p = 0.0001), IL-6 (p = 0.0001), IL-8 (p = 0.0001) and TNF-alpha (p = 0.0001) levels establish a similar pattern to that seem in decidua.
   Conclusion: Immunosuppressors may impair the immune response, but when associated with pregnancy the cytokine levels seems to shift a proinflammatory profile in placental compartments, which might also impact on the gestational outcomes in transplanted mothers.
C1 [Correa-Silva, Simone; do Prado, Karen Matias; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, BR-05508900 Sao Paulo, SP, Brazil.
   [Correa-Silva, Simone; Saraiva Camara, Niels Olsen] UNESP Sao Paulo State Univ, Botucatu Med Sch, Grad Program Gynecol Obstet & Mastol, Sao Paulo, SP, Brazil.
   [Oliveira, Leandro Gustavo] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, SP, Brazil.
   [Oliveira, Leandro Gustavo; Ono, Erica] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, SP, Brazil.
EM bevilacq@usp.br
RI De Oliveira, Leandro/G-3476-2012; Bevilacqua, Estela/H-3354-2011;
   Camara, Niels OS/G-8336-2011; camara, niels/AAX-3269-2020
OI De Oliveira, Leandro/0000-0002-8422-9907; Bevilacqua,
   Estela/0000-0003-4178-4625; Camara, Niels OS/0000-0001-5436-1248;
   camara, niels/0000-0001-5436-1248
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenadoria de
   Aperfeicoamento do Ensino Superior (CAPES)CAPES; Conselho Nacional de
   Pesquisa e Desenvolvimento Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX The authors declare that they have no competing interests. This project
   has received financial support from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP), Coordenadoria de Aperfeicoamento do Ensino
   Superior (CAPES) and Conselho Nacional de Pesquisa e Desenvolvimento
   Tecnologico (CNPq).
CR Blaschitz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021774
   Brandacher G, 2007, KIDNEY INT, V71, P60, DOI 10.1038/sj.ki.5002023
   Cardonick E, 2004, OBSTET GYNECOL SURV, V59, P214, DOI 10.1097/01.OGX.0000115774.42302.D4
   Chai JG, 2005, TRANSPLANTATION, V79, P1310, DOI 10.1097/01.TP.0000159147.56408.9C
   Chen LM, 2010, PLACENTA, V31, P75, DOI 10.1016/j.placenta.2009.11.005
   Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008
   DAVISON JM, 1991, AM J KIDNEY DIS, V17, P127, DOI 10.1016/S0272-6386(12)81116-4
   Davison JM, 2003, J OBSTET GYNAECOL RE, V29, P227, DOI 10.1046/j.1341-8076.2003.00106.x
   Dimeny EM, 2002, KIDNEY INT, V61, pS78, DOI 10.1046/j.1523-1755.61.s80.14.x
   Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407
   Groth K, 2010, HUM REPROD, V25, P697, DOI 10.1093/humrep/dep470
   Jones CA, 1997, BIOL REPROD, V57, P303, DOI 10.1095/biolreprod57.2.303
   Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007
   Kusec V, 2004, CALCIFIED TISSUE INT, V75, P1, DOI 10.1007/s00223-004-0044-x
   Lessan-Pezeshki M, 2002, NEPHROL DIAL TRANSPL, V17, P703, DOI 10.1093/ndt/17.5.703
   Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025
   Miroux C, 2009, TRANSPL P, V41, P3371, DOI 10.1016/j.transproceed.2009.08.043
   Moraes-Vieira PMM, 2012, CLIN IMMUNOL, V142, P117, DOI 10.1016/j.clim.2011.08.015
   Oliveira LG, 2007, CLIN TRANSPLANT, V21, P301, DOI 10.1111/j.1399-0012.2006.00627.x
   Pergola PE, 2001, TRANSPLANTATION, V71, P994, DOI 10.1097/00007890-200104150-00028
   Petraglia F, 1996, J CLIN ENDOCR METAB, V81, P852, DOI 10.1210/jc.81.2.852
   Raghupathy R, 2001, SEMIN IMMUNOL, V13, P219, DOI 10.1006/smim.2001.0316
   Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7
   Schilling B, 2000, GYNECOL OBSTET INVES, V50, P19, DOI 10.1159/000010272
   Singh A, 2010, AM J REPROD IMMUNOL, V63, P244, DOI 10.1111/j.1600-0897.2009.00781.x
   Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942
   Wilczynski JR, 2005, EUR J OBSTET GYN R B, V122, P136, DOI 10.1016/j.ejogrb.2005.03.008
   Xie C, 2011, CYTOKINE, V56, P550, DOI 10.1016/j.cyto.2011.09.021
NR 28
TC 1
Z9 1
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD OCT
PY 2013
VL 26
IS 15
BP 1468
EP 1473
DI 10.3109/14767058.2013.784736
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 220MK
UT WOS:000324588200002
PM 23514270
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Moreli, JB
   De Rosa, L
   Damasceno, DC
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Correa-Silva, S.
   Moreli, J. B.
   De Rosa, L.
   Damasceno, D. C.
   Rudge, M. V. C.
   Bevilacqua, E.
   Calderon, I. M. P.
TI INFLUENCE OF HYPERGLICEMIA IN PRO-INFLAMATORY CYTOKINE LEVELS IN SERUM
   AND PLACENTA
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 11-14, 2013
CL Whistler, CANADA
SP Int Federat Placenta Assoc (IFPA)
C1 [Correa-Silva, S.; Moreli, J. B.; De Rosa, L.; Damasceno, D. C.; Rudge, M. V. C.; Calderon, I. M. P.] UNESP Sao Paulo State Univ, Botucatu Med Sch, Sao Paulo, Brazil.
   [Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Lab Biol Trophoblast Res, Inst Biomed Sci, Sao Paulo, Brazil.
RI Calderon, Iracema/W-4336-2019; Rudge, Marilza/S-9057-2018
OI Calderon, Iracema/0000-0003-4761-4336; 
NR 0
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2013
VL 34
IS 9
BP A99
EP A99
DI 10.1016/j.placenta.2013.06.296
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 207GW
UT WOS:000323587900304
DA 2020-12-01
ER

PT J
AU Galdino, DA
   Azevedo, GM
   Bevilacqua, EM
   Vaz, NM
   Carvalho, CR
AF Galdino, Daniel Antero
   Azevedo-Junior, Geraldo Magela
   Bevilacqua, Estela Maris
   Vaz, Nelson Monteiro
   Carvalho, Claudia Rocha
TI SUBCUTANEOUS INJECTION OF ORALLY TOLERATED PROTEINS IN THE MOTHER
   DISTURBS EMBRYO IMPLANTATION IN MICE
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 11-14, 2013
CL Whistler, CANADA
SP Int Federat Placenta Assoc (IFPA)
C1 [Galdino, Daniel Antero; Azevedo-Junior, Geraldo Magela; Vaz, Nelson Monteiro; Carvalho, Claudia Rocha] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Bevilacqua, Estela Maris] Univ Sao Paulo, Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 1
Z9 1
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2013
VL 34
IS 9
BP A30
EP A30
DI 10.1016/j.placenta.2013.06.090
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 207GW
UT WOS:000323587900099
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Guzzo, CR
   Farah, CS
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon, Aline R.
   Guzzo, Cristiane R.
   Farah, Chuck S.
   Fisher, Susan J.
   Bevilacqua, Estela
TI STROMAL CELL DERIVED FACTOR 2: NEW INSIGHTS OF FUNCTION
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 11-14, 2013
CL Whistler, CANADA
SP Int Federat Placenta Assoc (IFPA)
C1 [Lorenzon, Aline R.; Guzzo, Cristiane R.; Bevilacqua, Estela] Univ Sao Paulo, Insitute Biomed Sci, Sao Paulo, Brazil.
   [Farah, Chuck S.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil.
   [Fisher, Susan J.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
RI Lorenzon, Aline R/G-8733-2014; Carvalho, Cristiane R. G/K-2855-2016
OI Lorenzon, Aline R/0000-0002-6052-6296; Carvalho, Cristiane R.
   G/0000-0002-5664-8055
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2013
VL 34
IS 9
BP A99
EP A99
DI 10.1016/j.placenta.2013.06.294
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 207GW
UT WOS:000323587900302
DA 2020-12-01
ER

PT J
AU Martucci, M
   Paris, AF
   Gomes, SZ
   Farias, MR
   Pinto, D
   Oliveira, SF
   Letta, F
   Paulesu, L
   Bevilacqua, E
AF Martucci, M.
   Fraga Paris, A.
   Zago Gomes, S.
   Rubio Farias, M.
   Pinto, D., Jr.
   Oliveira, S. F.
   Letta, F.
   Paulesu, L.
   Bevilacqua, E.
TI MAY TROPHOBLAST PARTICIPATE IN REGULATION OF DECIDUAL CELL SURVIVAL? A
   PUTATIVE ROLE FOR MIF, THE MACROPHAGE MIGRATORY INHIBITORY FACTOR
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 11-14, 2013
CL Whistler, CANADA
SP Int Federat Placenta Assoc (IFPA)
C1 [Fraga Paris, A.; Pinto, D., Jr.] Univ Sao Paulo, Fac Dent, Sao Paulo, Brazil.
   [Letta, F.; Paulesu, L.] Univ Siena, Dept Life Sci, I-53100 Siena, Italy.
   [Martucci, M.; Zago Gomes, S.; Rubio Farias, M.; Oliveira, S. F.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RI Pinto, Decio/B-6041-2011
OI Pinto, Decio/0000-0001-6198-5155
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2013
VL 34
IS 9
BP A3
EP A4
DI 10.1016/j.placenta.2013.06.015
PG 2
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 207GW
UT WOS:000323587900024
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Haslinger, P
   Biadasiewicz, K
   Sandri, S
   Steponavicius-Cruz, K
   Oliveira, SF
   Meinhardt, G
   Otti, G
   Fock, V
   Fiala, C
   Pollheimer, J
   Knofler, M
   Bevilacqua, E
AF Borbely, A. U.
   Haslinger, P.
   Biadasiewicz, K.
   Sandri, S.
   Steponavicius-Cruz, K.
   Oliveira, S. F.
   Meinhardt, G.
   Otti, G.
   Fock, V
   Fiala, C.
   Pollheimer, J.
   Knoefler, M.
   Bevilacqua, E.
TI Biglycan promotes trophoblast motility through AKT signaling by
   Toll-like receptor 2 and 4 activation
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE AKT; Biglycan; Extravillous Trophoblast; Invasion; TLR; signaling
   pathway
C1 [Borbely, A. U.; Oliveira, S. F.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Haslinger, P.; Biadasiewicz, K.; Meinhardt, G.; Otti, G.; Fock, V; Pollheimer, J.; Knoefler, M.] Med Univ Vienna, Reprod Biol Unit, Dept Obstet & Fetal Maternal Med, Vienna, Austria.
   [Sandri, S.] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil.
   [Steponavicius-Cruz, K.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
   [Fiala, C.] Gynmed Clin, Vienna, Austria.
RI Sandri, Silvana/A-1650-2015
NR 0
TC 0
Z9 0
U1 0
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A65
EP A65
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100148
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Farias, R
   Camara, NO
   Bevilacqua, E
AF Correa-Silva, S.
   Farias, R.
   Camara, N. O.
   Bevilacqua, E.
TI Is trophoblast able to interfere with peripheral blood T regulatory and
   dendritic cells?
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
C1 [Correa-Silva, S.; Farias, R.; Camara, N. O.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Correa-Silva, S.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Postgrad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil.
RI camara, niels/AAX-3269-2020; Correa-Silva, Simone/J-9540-2012; Camara,
   Niels OS/G-8336-2011
OI camara, niels/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A71
EP A71
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100160
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Moreli, JB
   Paixao-Alencar, A
   Damasceno, DC
   De Rosa, L
   Rudge, MVC
   Bevilacqua, E
   Calderon, IMP
AF Correa-Silva, S.
   Moreli, J. B.
   Paixao-Alencar, A.
   Damasceno, D. C.
   De Rosa, L.
   Rudge, M. V. C.
   Bevilacqua, E.
   Calderon, I. M. P.
TI Women with glycemic disorders presents elevated levels of interleukin-1
   beta (IL-1 beta) and inducible nitric oxide sintase (inos) in
   placental-fetal interface
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
C1 [Correa-Silva, S.; Moreli, J. B.; Damasceno, D. C.; De Rosa, L.; Rudge, M. V. C.; Calderon, I. M. P.] Univ Estadual Paulista, UNESP, Lab Expt Res Gynecol & Obstet, Botucatu, SP, Brazil.
   [Correa-Silva, S.; Paixao-Alencar, A.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
RI Rudge, Marilza/S-9057-2018; Correa-Silva, Simone/J-9540-2012; Calderon,
   Iracema/W-4336-2019; Calderon, Iracema MP/C-8136-2012
OI Calderon, Iracema/0000-0003-4761-4336; Calderon, Iracema
   MP/0000-0003-4761-4336
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A26
EP A26
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100070
DA 2020-12-01
ER

PT J
AU Gomes, SZ
   Bevilacqua, E
AF Gomes, S. Z.
   Bevilacqua, E.
TI NOX-2 and ROS generation at the maternal-fetal interface
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Trophoblast; NAD(P)H-oxidase; NOX-2; Superoxide anion
C1 [Gomes, S. Z.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A59
EP A59
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100135
DA 2020-12-01
ER

PT J
AU Grasso, E
   Weingrill, RB
   Silva, SC
   Ramhorst, R
   Bevilacqua, E
   Leiros, CP
AF Grasso, E.
   Weingrill, R. B.
   Silva, S. C.
   Ramhorst, R.
   Bevilacqua, E.
   Leiros, C. P.
TI VIP is produced by trophoblast cells and induces an alternative
   activation profile in decidual and cord blood macrophages
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE VIP; Placenta; Cord Blood; macrophages profile; immunotolerance
C1 [Grasso, E.; Weingrill, R. B.; Silva, S. C.; Ramhorst, R.; Leiros, C. P.] Univ Buenos Aires, Sch Sci, Inmunopharmacol Lab, IQUIBICEN CONICET, RA-1053 Buenos Aires, DF, Argentina.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A55
EP A55
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100127
DA 2020-12-01
ER

PT J
AU Hoshida, MS
   Costa, RA
   Bevilacqua, E
   Francisco, RPV
   Zugaib, M
AF Hoshida, M. S.
   Costa, R. A.
   Bevilacqua, E.
   Francisco, R. P., V
   Zugaib, M.
TI Effect of BPP-10c in angiogenic factor expression at the placental
   villous in preeclampsia
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE preeclampsia; bradykinin-potentiating peptide-10c; VEGF; PIGF; VEGFR1;
   VEGFR2
C1 [Hoshida, M. S.; Costa, R. A.; Francisco, R. P., V; Zugaib, M.] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Med Invest Lab LIM 57, Sao Paulo, Brazil.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RI Francisco, Rossana Pulcineli Vieira/AAG-7461-2020; Zugaib,
   Marcelo/A-5724-2013; Francisco, Rossana PV/C-5648-2012; HCFMUSP,
   Pos-Graduacao DOG -/F-1162-2013
OI Francisco, Rossana Pulcineli Vieira/0000-0002-9981-8069; Zugaib,
   Marcelo/0000-0003-1155-2671; Francisco, Rossana PV/0000-0002-9981-8069; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A75
EP A75
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100167
DA 2020-12-01
ER

PT J
AU Ietta, F
   Romagnoli, R
   Bechi, N
   Bevilacqua, E
   Paulesu, L
AF Ietta, F.
   Romagnoli, R.
   Bechi, N.
   Bevilacqua, E.
   Paulesu, L.
TI Evidence of trophoblast target cells for the cytokine MIF (Macrophage
   Migration Inhibitory Factor) in human placenta
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Human trophoblast; cytokine signal transduction; placentation
C1 [Ietta, F.; Romagnoli, R.; Bechi, N.; Paulesu, L.] Univ Siena, Dept Life Sci, I-53100 Siena, Italy.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
RI Ietta, Francesca/I-5307-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A70
EP A70
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100157
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Guzzo, CR
   Fisher, SJ
   Farah, SC
   Bevilacqua, E
AF Lorenzon, A. R.
   Guzzo, C. R.
   Fisher, S. J.
   Farah, S. C.
   Bevilacqua, E.
TI Possible role of Stromal Cell Derived Factor-2 (SDF-2) in pregnancy
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE SDF-2; trophoblast differentiation; placenta
C1 [Lorenzon, A. R.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Guzzo, C. R.; Farah, S. C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Guzzo, C. R.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   [Lorenzon, A. R.; Fisher, S. J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
RI Lorenzon, Aline R/G-8733-2014; Carvalho, Cristiane R. G/K-2855-2016
OI Lorenzon, Aline R/0000-0002-6052-6296; Carvalho, Cristiane R.
   G/0000-0002-5664-8055
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A75
EP A75
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100168
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Morceli, G
   Correa-Silva, S
   De Rosa, L
   Damasceno, DC
   Bevilacqua, E
   Rudge, MVC
   Calderon, IMP
AF Moreli, J. B.
   Morceli, G.
   Correa-Silva, S.
   De Rosa, L.
   Damasceno, D. C.
   Bevilacqua, E.
   Rudge, M. V. C.
   Calderon, I. M. P.
TI Proinflammatory cytokines in pregnant women with different degrees of
   hyperglycemia
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Proinflammatory cytokines; diabetes; pregnancy
C1 [Moreli, J. B.; Morceli, G.; Correa-Silva, S.; De Rosa, L.; Damasceno, D. C.; Rudge, M. V. C.; Calderon, I. M. P.] Univ Estadual Paulista, UNESP, Lab Expt Res Gynecol & Obstet, Botucatu, SP, Brazil.
   [Correa-Silva, S.; De Rosa, L.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Lab Cytophysiol Trophoblast, BR-05508 Sao Paulo, Brazil.
RI Calderon, Iracema MP/C-8136-2012; Rudge, Marilza/S-9057-2018;
   Correa-Silva, Simone/J-9540-2012; Morceli, Glilciane/AAX-4554-2020;
   Calderon, Iracema/W-4336-2019; Morceli, Glilciane/AAX-4624-2020
OI Calderon, Iracema MP/0000-0003-4761-4336; Calderon,
   Iracema/0000-0003-4761-4336; Morceli, Glilciane/0000-0001-8216-9931
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A24
EP A24
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100066
DA 2020-12-01
ER

PT J
AU Moreli, JB
   Correa-Silva, S
   Rocha, CR
   Fagundes, DLG
   Menck, CF
   Bevilacqua, E
   Damasceno, DC
   Rudge, MVC
   Calderon, IMP
AF Moreli, J. B.
   Correa-Silva, S.
   Rocha, C. R.
   Fagundes, D. L. G.
   Menck, C. F.
   Bevilacqua, E.
   Damasceno, D. C.
   Rudge, M. V. C.
   Calderon, I. M. P.
TI The effect of hyperglycemia on apoptosis in peripheral blood mononuclear
   cells of newborns: An in vitro study
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Apoptosis; hyperglycemia; newborn
C1 [Moreli, J. B.; Correa-Silva, S.; Fagundes, D. L. G.; Damasceno, D. C.; Rudge, M. V. C.; Calderon, I. M. P.] Univ Estadual Paulista, UNESP, Lab Expt Res Gynecol & Obstet, Botucatu, SP, Brazil.
   [Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Lab Cytophysiol Trophoblast, BR-05508 Sao Paulo, Brazil.
   [Rocha, C. R.; Menck, C. F.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, BR-05508 Sao Paulo, Brazil.
RI Rudge, Marilza/S-9057-2018; Correa-Silva, Simone/J-9540-2012; Calderon,
   Iracema/W-4336-2019; Calderon, Iracema MP/C-8136-2012; Rocha, Clarissa
   Ribeiro Reily/O-8946-2015
OI Calderon, Iracema/0000-0003-4761-4336; Calderon, Iracema
   MP/0000-0003-4761-4336; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A24
EP A24
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100065
DA 2020-12-01
ER

PT J
AU Olivera, LVM
   Bevilacqua, E
AF Olivera, L. V. M.
   Bevilacqua, E.
TI Macrophages migration during embryo implantation in alpacas
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE Embryo-implantation alpaca; macrophages; Andean camelids
C1 [Olivera, L. V. M.] Univ Nacl Altiplano, Lab Histopatol, Puno, Peru.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A2
EP A2
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100021
DA 2020-12-01
ER

PT J
AU Ridano, ME
   Racca, AC
   Fretes, R
   Bevilacqua, E
   Genti-Raimondi, S
   Panzetta-Dutari, GM
AF Ridano, M. E.
   Racca, A. C.
   Fretes, R.
   Bevilacqua, E.
   Genti-Raimondi, S.
   Panzetta-Dutari, G. M.
TI Chlorpyrifos pesticide effect on villous trophoblast and explant
   cultures from human normal term placentas
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
DE organophosphate pesticide; placental villi; Pg-p; ABCG2; beta hCG
C1 [Ridano, M. E.; Racca, A. C.; Genti-Raimondi, S.; Panzetta-Dutari, G. M.] Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI CONICET, RA-5000 Cordoba, Argentina.
   [Fretes, R.] Univ Nacl Cordoba, Fac Med, Dept Histol & Embriol, RA-5000 Cordoba, Argentina.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A9
EP A9
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100035
DA 2020-12-01
ER

PT J
AU Weingrill, RB
   Hoshida, MS
   Martinhago, CD
   Bevilacqua, E
AF Weingrill, R. B.
   Hoshida, M. S.
   Martinhago, C. D.
   Bevilacqua, E.
TI Cross-talk between trophoblastic cells and maternal immune cells
   coordinated by Ccl25 Ccr9 during mouse embryo implantation
SO PLACENTA
LA English
DT Meeting Abstract
CT 5th Latin American Symposium on Maternal Fetal Interaction and Placenta
   (SLIMP) / 4th Latin American Symposium on Reproductive Immunology
   (LASRI)
CY FEB 18-20, 2013
CL Foz do Iguacu, BRAZIL
SP USP, ICBUSP, CAPES, SBBC, FMB, UNIFESP, UNICAMP, FAPESP, Int Federat Placenta Assoc (IFPA), Univ Fed Alfenas (Unifal) MG, Amer Soc Reproduct Immunol (LASRI), Latin Amer Chapter (CLA)
C1 [Weingrill, R. B.; Hoshida, M. S.] Univ Sao Paulo, Fac Med, Dept Obstet, Sao Paulo, Brazil.
   [Martinhago, C. D.] Clin RDO, Sao Paulo, Brazil.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RI Dresch Martinhago, Ciro/M-4596-2016
OI Dresch Martinhago, Ciro/0000-0002-7802-8906
NR 0
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD FEB
PY 2013
VL 34
IS 2
BP A64
EP A64
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 088SJ
UT WOS:000314857100146
DA 2020-12-01
ER

PT J
AU Mess, AM
   Favaron, PO
   Pfarrer, C
   Osmann, C
   Melo, APF
   Rodrigues, RF
   Ambrosio, CE
   Bevilacqua, E
   Miglino, MA
AF Mess, Andrea M.
   Favaron, Phelipe O.
   Pfarrer, Christiane
   Osmann, Christine
   Melo, Allan P. F.
   Rodrigues, Rosangela F.
   Ambrosio, Carlos E.
   Bevilacqua, Estela
   Miglino, Maria A.
TI Placentation in the anteaters Myrmecophaga tridactyla and Tamandua
   tetradactyla (Eutheria, Xenarthra)
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
DE Evolution; Vermilingua; Trophoblast; Interhaemal barrier; Villous
   placenta
ID VILLOUS HAEMOCHORIAL PLACENTA; EVOLUTION
AB Background: Since Xenarthra are serious candidates for being basal to Eutheria, their characteristics, e.g. the placental system, influence perceptions of evolution. However, in the subgroup containing the anteaters, data are very limited. The present study aims to elucidate the nature of the feto-maternal interface in the anteater placenta and to interpret these data within an evolutionary context.
   Methods: Placentas of two species were investigated with histology, immunohistochemistry and transmission electron microscopy.
   Results: Remnants of the maternal vessel endothelium were absent, resulting in a fully haemochorial barrier throughout the placenta. Two structurally different parts, the villous and trabecular areas were complex and intermingled. In particular, the trabeculae which consisted of cellular, proliferative trophoblast, associated with connective tissue, were attached to the decidua. The villi contained fetal capillaries and hypertrophied mesenchymal cells that occured near the surface near the end of gestation. The surface of the villi consisted of flat, syncytial trophoblast, interspersed with proliferative trophoblast cells.
   Conclusions: Based on fundamental differences between anteaters and armadillos, we inferred that placental evolution was more complex than previously thought. The haemochorial pattern of anteaters was likely an ancient condition of xenarthrans. Consequently, villous placentation may be attributed, at least in part, by convergent evolution, but was also characterized by some features that were widespread among xenarthrans.
C1 [Mess, Andrea M.; Favaron, Phelipe O.; Melo, Allan P. F.; Rodrigues, Rosangela F.; Miglino, Maria A.] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, BR-05508270 Sao Paulo, Brazil.
   [Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, D-30173 Hannover, Germany.
   [Osmann, Christine] Zoo Dortmund, D-44225 Dortmund, Germany.
   [Ambrosio, Carlos E.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Basic Sci, BR-13635900 Pirassununga, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil.
RP Mess, AM (corresponding author), Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Av Prof Dr Orlando Marques de Paiva,87,Cidade Uni, BR-05508270 Sao Paulo, Brazil.
EM drandrmss@aol.com
RI Favaron, Phelipe O/E-4636-2013; Ambrosio, Carlos Eduardo/F-3402-2010;
   Bevilacqua, Estela/H-3354-2011; Miglino, Maria Angelica/B-9519-2012
OI Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Bevilacqua,
   Estela/0000-0003-4178-4625; Miglino, Maria Angelica/0000-0003-4979-115X;
   Favaron, Phelipe/0000-0002-6431-6886; Felipe Rodrigues,
   Rosangela/0000-0003-1836-6628
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX This project was supported by CNPq and FAPESP. We thank members of the
   University of Sao Paulo, Brazil, for technical support. We warmly thank
   Rose and John Kastelic for help with the English.
CR Adamoli VC, 2001, BIOCELL, V25, P17
   [Anonymous], 1879, J Anat Physiol, V14, P147
   BECHER H, 1931, MORPHOL JB, V67, P381
   Benirschke K, 2007, GIANT ANTEATER MYRME
   Capellini I, 2012, PLACENTA, V33, P763, DOI 10.1016/j.placenta.2012.07.004
   Carter AM, J MORPHOL IN PRESS
   de Oliveira MF, 2012, J EXP ZOOL PART B, V318B, P13, DOI 10.1002/jez.b.21428
   Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989
   Delsuc Frederic, 2008, P11
   Eisenberg JF, 1999, MAMMALS NEOTROPICS C
   Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004
   Emmons L, 1990, NEOTROPICAL RAINFORE
   Enders AC, 2012, PLACENTA, V33, P319, DOI 10.1016/j.placenta.2012.02.008
   Enders AC, 2012, PLACENTA, V33, pS92, DOI 10.1016/j.placenta.2011.10.009
   ENDERS AC, 1960, J ANAT, V94, P34
   ENDERS AC, 1960, J ANAT, V94, P205
   Enders Allen C., 2008, P172
   Fernandez M., 1914, Anatomischer Anzeiger, V46
   Gaudin Timothy J., 2008, P24
   KING BF, 1982, ANAT REC, V202, P15, DOI 10.1002/ar.1092020104
   Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028
   Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079
   Mess A, 2007, COMP BIOCHEM PHYS A, V148, P769, DOI 10.1016/j.cbpa.2007.01.029
   Montgomery GG, 1985, EVOLUION ECOLOGY ARM
   Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550
   Osmann C, 2004, ZOOTIERHALTUNG, P253
   Redford Kent A., 1994, Edentata, V1, P4
   REDFORD KH, 1992, MAMMALS NEOTROPICS S
   Rezende LC, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-38
   Schauerte N, 2005, THESIS JUSTUS LIEBIG
   Schauerte N, 2012, MANUTENCAO TAMANDUAS, P134
   Springer MS, 2007, BIOL REV, V82, P375, DOI 10.1111/j.1469-185X.2007.00016.x
   Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006
   Strahl VH, 1913, ANAT ANZEIGER, V44, P440
   Walls EW, 1939, J ANAT, V73, P311
   Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103
   Wilson D., 2005, MAMMAL SPECIES WORLD
   Wislocki GB, 1928, ANAT REC, V39, P69, DOI 10.1002/ar.1090390106
NR 38
TC 6
Z9 6
U1 0
U2 28
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD NOV 30
PY 2012
VL 10
AR 102
DI 10.1186/1477-7827-10-102
PG 7
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA 058QH
UT WOS:000312648200001
PM 23199198
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Costa, AF
   Paulesu, L
   Faria, MR
   de Oliveira, SF
   Pinto, DS
   Bevilacqua, E
AF Costa, Adriana Fraga
   Paulesu, Luana
   Faria, Miriam R.
   de Oliveira, Sergio Ferreira
   Pinto Junior, Decio S.
   Bevilacqua, Estela
TI MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) PRODUCED BY TROPHOBLAST
   CELLS AT MATERNAL-FETAL INTERFACE AS A POSSIBLE SURVIVAL FACTOR FOR
   DECIDUAL CELLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 18-21, 2012
CL Hiroshima, JAPAN
SP Int Federat Placenta Assoc (IFPA)
C1 [Costa, Adriana Fraga; Faria, Miriam R.; de Oliveira, Sergio Ferreira; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Paulesu, Luana] Univ Siena, I-53100 Siena, Italy.
   [Costa, Adriana Fraga; Pinto Junior, Decio S.] Univ Sao Paulo, Sch Dent, Sao Paulo, Brazil.
RI Pinto, Decio/B-6041-2011
OI Pinto, Decio/0000-0001-6198-5155
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2012
VL 33
IS 9
BP A68
EP A68
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 007NV
UT WOS:000308896300148
DA 2020-12-01
ER

PT J
AU Bevilacqua, E
   Gomes, SZ
   Lorenzon, AR
   Hoshida, MS
   Amarante-Paffaro, AM
AF Bevilacqua, Estela
   Gomes, Sara Zago
   Lorenzon, Aline Rodrigues
   Hoshida, Mara Sandra
   Amarante-Paffaro, Andrea M.
TI NADPH oxidase as an important source of reactive oxygen species at the
   mouse maternal-fetal interface: putative biological roles
SO REPRODUCTIVE BIOMEDICINE ONLINE
LA English
DT Review
DE ectoplacental cone; immune defence; NAD(P)H oxidase; placenta; ROS;
   trophoblast
ID MEDIATED SUPEROXIDE GENERATION; PLACENTAL NAD(P)H OXIDASE; OXIDATIVE
   STRESS; HYDROGEN-PEROXIDE; XANTHINE-OXIDASE; FREE-RADICALS;
   PHAGOCYTIC-ACTIVITY; TROPHOBLAST CELLS; THYROID-HORMONE; NOX FAMILY
AB Oxygen derivatives that comprise the large family of reactive oxygen species (ROS) are actively involved in placental biology. They are generated at the maternal-fetal interface at the level of decidual, trophoblast and mesenchymal components. In normal conditions, ROS produced in low concentrations participate in different functions as signalling molecules, regulating activation of redox-sensitive transcription factors and protein kinases involved in cell survival, proliferation and apoptosis, hence much of cell functioning. Physiological ROS generation is also associated with such defence mechanisms as phagocytosis and microbiocidal activities. In mice, particularly but not exclusively, trophoblast cells phagocytose intensively during implantation and post-implantation periods and express enzymic machinery to address a ROS-producing response to changes in the environment. The cells directly associated with ROS production are trophoblast giant cells, which mediate each and every relationship with the maternal organism. In this review, the production of ROS by the implanting mouse trophoblast is discussed, focusing on NADPH oxidase expression, regulatory mechanisms and similarities with NOX2 from phagocytes. Some of the current controversies are assessed by attempting to integrate data from studies in human trophoblast and mouse models. (C) 2012, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
C1 [Bevilacqua, Estela; Gomes, Sara Zago; Lorenzon, Aline Rodrigues; Hoshida, Mara Sandra; Amarante-Paffaro, Andrea M.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Hoshida, Mara Sandra] Univ Sao Paulo, Sch Med, Dept Obstet & Gynecol, Lab Med Invest LIM57, BR-01246903 Sao Paulo, Brazil.
   [Amarante-Paffaro, Andrea M.] Univ Fed Alfenas, Inst Biomed Sci, Dept Cell Tissue & Dev Biol, BR-37130000 Alfenas, MG, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Lorenzon, Aline R/G-8733-2014; Hoshida, Mara S/D-3900-2012; Bevilacqua,
   Estela/H-3354-2011
OI Lorenzon, Aline R/0000-0002-6052-6296; Hoshida, Mara
   S/0000-0003-2232-4631; Bevilacqua, Estela/0000-0003-4178-4625
CR Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9
   Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34
   Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214
   Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277
   Ardanaz N, 2006, EXP BIOL MED, V231, P237
   Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   BEUTLER E, 1975, RED CELL METABOLISM, P88
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Bevilacqua E, 2010, INT J DEV BIOL, V54, P495, DOI 10.1387/ijdb.082761eb
   Burdon C, 2007, PLACENTA, V28, P724, DOI 10.1016/j.placenta.2006.12.001
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016
   Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200
   Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734
   Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004
   De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200
   De Vito P, 2011, THYROID, V21, P879, DOI 10.1089/thy.2010.0429
   Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1
   Droge W, 2002, PHYSIOL REV, V82, P47
   Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006
   Fernandez V, 2006, COMP BIOCHEM PHYS C, V142, P231, DOI 10.1016/j.cbpc.2005.10.007
   Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   Geiszt M, 2006, CARDIOVASC RES, V71, P289, DOI 10.1016/j.cardiores.2006.05.004
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Gomes S.Z., 2011, BIOL REPROD
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040
   Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]
   Hong JA, 2004, J IMMUNOL, V172, P5870, DOI 10.4049/jimmunol.172.10.5870
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008
   JOHNSON MH, 1994, BIOESSAYS, V16, P31, DOI 10.1002/bies.950160105
   Jones ML, 2010, BIOL REPROD, V83, P254, DOI 10.1095/biolreprod.110.083907
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Kumar A, 2004, INT J GYNECOL OBSTET, V84, P252, DOI 10.1016/S0020-7292(03)00326-6
   Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172
   Manes C, 2001, PLACENTA, V22, P58, DOI 10.1053/plac.2000.0589
   Many A, 1996, PLACENTA, V17, P361, DOI 10.1016/S0143-4004(96)90061-2
   Many A, 2000, AM J PATHOL, V156, P321, DOI 10.1016/S0002-9440(10)64733-5
   Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993
   MARUO T, 1991, ACTA ENDOCRINOL-COP, V125, P58, DOI 10.1530/acta.0.1250058
   Matsubara S, 2001, MOL HUM REPROD, V7, P779, DOI 10.1093/molehr/7.8.779
   MATSUBARA S, 1991, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V43, P117
   McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003
   Milczarek R, 2008, J STEROID BIOCHEM, V110, P230, DOI 10.1016/j.jsbmb.2007.11.004
   Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107
   Mochizuki M, 1998, INT J GYNECOL OBSTET, V60, pS21, DOI 10.1016/S0020-7292(95)02403-4
   Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021
   NASRESFAHANI MM, 1991, DEVELOPMENT, V113, P551
   Nau G.J., 2002, PNAS, V99, P1502
   Ohye H, 2010, EXP BIOL MED, V235, P424, DOI 10.1258/ebm.2009.009241
   Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005
   Poovassery J, 2009, INFECT IMMUN, V77, P4998, DOI 10.1128/IAI.00617-09
   Poston L, 2004, PLACENTA, V25, pS72, DOI 10.1016/j.placenta.2004.01.003
   Raijmakers MTM, 2006, PLACENTA, V27, P158, DOI 10.1016/j.placenta.2005.02.013
   Sathishkumar K., 2011, J PERINATOL
   Sato E, 2011, J BIOCHEM, V150, P173, DOI 10.1093/jb/mvr051
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009
   Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/en.142.11.4589
   Sugino N, 2000, MOL HUM REPROD, V6, P19, DOI 10.1093/molehr/6.1.19
   Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210
   Takeya R, 2003, MOL CELLS, V16, P271
   Takeya R, 2006, FEBS J, V273, P3663, DOI 10.1111/j.1742-4658.2006.05371.x
   Telfer JF, 1997, HUM REPROD, V12, P2306, DOI 10.1093/humrep/12.10.2306
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Tsai LY, 2008, J FORMOS MED ASSOC, V107, P513, DOI 10.1016/S0929-6646(08)60163-1
   Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wang DS, 1996, P NATL ACAD SCI USA, V93, P13182, DOI 10.1073/pnas.93.23.13182
   Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2
   Wendel A, 1981, Methods Enzymol, V77, P325
   Weyemi U, 2010, ENDOCR-RELAT CANCER, V17, P27, DOI 10.1677/ERC-09-0175
   Yildirim A, 2004, CELL BIOCHEM FUNCT, V22, P213, DOI 10.1002/cbf.1090
   Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2
NR 88
TC 13
Z9 13
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1472-6483
EI 1472-6491
J9 REPROD BIOMED ONLINE
JI Reprod. Biomed. Online
PD JUL
PY 2012
VL 25
IS 1
BP 31
EP 43
DI 10.1016/j.rbmo.2012.03.016
PG 13
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 968UB
UT WOS:000306009400006
PM 22560120
OA Bronze
DA 2020-12-01
ER

PT J
AU Faria, M
   Martucci, M
   Costa, A
   Oliveira, S
   Pinto, D
   Paulesu, L
   Bevilacqua, E
AF Faria, M.
   Martucci, M.
   Costa, A.
   Oliveira, S.
   Pinto, D., Jr.
   Paulesu, L.
   Bevilacqua, E.
TI Decidual cells as target for Macrophage Inhibitory Migration Factor
   (MIF): receptors and signaling pathways associated responses
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT Joint International Congress of the
   American-Society-for-Reproductive-Immunology (ASRI) and the
   European-Society-for-Reproductive-Immunology (ESRI)
CY MAY 30-JUN 02, 2012
CL Hamburg, GERMANY
SP Amer Soc Reproduct Immunol (ASRI), European Soc Reproduct Immunol (ESRI)
C1 [Faria, M.; Martucci, M.; Costa, A.; Oliveira, S.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Pinto, D., Jr.] Univ Sao Paulo, Dept Oral Pathol, BR-05508 Sao Paulo, Brazil.
   [Paulesu, L.] Univ Siena, Dept Physiol, I-53100 Siena, Italy.
RI Pinto, Decio/B-6041-2011
OI Pinto, Decio/0000-0001-6198-5155
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD MAY
PY 2012
VL 94
IS 1
BP 95
EP 95
DI 10.1016/j.jri.2012.03.419
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 949MD
UT WOS:000304579400173
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Prado, K
   Oliveira, LG
   Ono, E
   Camara, N
   Bevilacqua, E
AF Correa-Silva, S.
   Prado, K.
   Oliveira, L. G.
   Ono, E.
   Camara, N.
   Bevilacqua, E.
TI Comparison between cytokines in peripheral and placental compartment in
   renal-transplanted pregnant women
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT Joint International Congress of the
   American-Society-for-Reproductive-Immunology (ASRI) and the
   European-Society-for-Reproductive-Immunology (ESRI)
CY MAY 30-JUN 02, 2012
CL Hamburg, GERMANY
SP Amer Soc Reproduct Immunol (ASRI), European Soc Reproduct Immunol (ESRI)
C1 [Correa-Silva, S.; Prado, K.; Oliveira, L. G.; Camara, N.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
   [Correa-Silva, S.] Med Sch UNESP, Botucatu, SP, Brazil.
   [Ono, E.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RI camara, niels/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Correa-Silva,
   Simone/J-9540-2012
OI camara, niels/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248;
   
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD MAY
PY 2012
VL 94
IS 1
BP 96
EP 97
DI 10.1016/j.jri.2012.03.422
PG 2
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 949MD
UT WOS:000304579400176
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Farah, SC
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon, A. R.
   Farah, S. C.
   Fisher, S. J.
   Bevilacqua, E.
TI Expression of the presumptive chemokine Stromal Cell Derived Factor-2
   (SDF-2) by different cell types in human placenta: function insights
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT Joint International Congress of the
   American-Society-for-Reproductive-Immunology (ASRI) and the
   European-Society-for-Reproductive-Immunology (ESRI)
CY MAY 30-JUN 02, 2012
CL Hamburg, GERMANY
SP Amer Soc Reproduct Immunol (ASRI), European Soc Reproduct Immunol (ESRI)
C1 [Lorenzon, A. R.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Sao Paulo, Brazil.
   [Lorenzon, A. R.; Fisher, S. J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [Farah, S. C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD MAY
PY 2012
VL 94
IS 1
BP 96
EP 96
DI 10.1016/j.jri.2012.03.421
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 949MD
UT WOS:000304579400175
DA 2020-12-01
ER

PT J
AU Gomes, SZ
   Lorenzon, AR
   Vieira, JS
   Rocha, CRR
   Bandeira, C
   Hoshida, MS
   Lopes, LR
   Bevilacqua, E
AF Gomes, Sara Z.
   Lorenzon, Aline R.
   Vieira, Juliana S.
   Rocha, Clarissa R. R.
   Bandeira, Clara
   Hoshida, Mara S.
   Lopes, Lucia Rosseti
   Bevilacqua, Estela
TI Expression of NADPH Oxidase by Trophoblast Cells: Potential Implications
   for the Postimplanting Mouse Embryo
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
DE cell culture; ectoplacental cone; embryo implantation; innate immune
   response; phagocytosis; reactive oxygen species; superoxide anion;
   trophoblast giant cells
ID SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; NAD(P)H OXIDASE; MAJOR SOURCE;
   SYSTEMS; ANION; ATHEROSCLEROSIS; ENDOTHELIUM; NEUTROPHILS; ACTIVATION
AB Cytochemical localization of hydrogen peroxide-generating sites suggests NADPH (nicotinamide adenine dinucleotide 3-phosphate [ reduced form]) oxidase expression at the maternal-fetal interface. To explore this possibility, we have characterized the expression and activity of the NADPH oxidase complex in trophoblast cells during the postimplantation period. Implantation sites and ectoplacental cones (EPCs) from 7.5-gestational day embryos from CD1 mice were used as a source for expression analyses of NADPH oxidase catalytic and regulatory subunits. EPCs grown in primary culture were used to investigate the production of superoxide anion through dihydroxyethidium oxidation in confocal microscopy and immunohistochemical assays. NADPH subunits Cybb (gp91phox), Cyba (p22phox), Ncf4 (p40phox), Ncf1 (p47phox), Ncf2 (p67phox), and Rac1 were expressed by trophoblast cells. The fundamental subunits of membrane CYBB and cytosolic NCF2 were markedly upregulated after phorbol-12-myristate-13-acetate (PMA) treatment, as detected by quantitative real-time PCR, Western blotting, and immunohistochemistry. Fluorescence microscopy imaging showed colocalization of cytosolic and plasma membrane NADPH oxidase subunits mainly after PMA treatment, suggesting assembly of the complex after enzyme activation. Cultured EPCs produced superoxide in a NADPH-dependent manner, associating the NADPH oxidase-mediated superoxide production with postimplantation trophoblast physiology. NADPH-oxidase cDNA subunit sequencing showed a high degree of homology between the trophoblast and neutrophil isoforms of the oxidase, emphasizing a putative role for reactive oxygen species production in phagocytic activity and innate immune responses.
C1 [Gomes, Sara Z.; Lorenzon, Aline R.; Vieira, Juliana S.; Rocha, Clarissa R. R.; Bandeira, Clara; Hoshida, Mara S.; Lopes, Lucia Rosseti; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Lopes, Lucia Rosseti] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes,1524 Butantan, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Lorenzon, Aline R/G-8733-2014; Bandeira, Carla Leticia/U-8685-2017;
   Bevilacqua, Estela/H-3354-2011; Hoshida, Mara S/D-3900-2012; Lopes,
   Lucia R/B-9063-2012; Rocha, Clarissa Ribeiro Reily/O-8946-2015
OI Lorenzon, Aline R/0000-0002-6052-6296; Bandeira, Carla
   Leticia/0000-0002-0796-3462; Bevilacqua, Estela/0000-0003-4178-4625;
   Hoshida, Mara S/0000-0003-2232-4631; Lopes, Lucia R/0000-0003-0530-7805;
   
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenadoria de
   Aperfeicoamento do Ensino Superior (CAPES)CAPES; Conselho Nacional de
   Pesquisa e Desenvolvimento Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX Supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP), Coordenadoria de Aperfeicoamento do Ensino Superior (CAPES),
   and Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq).
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476
   BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Bevilacqua E, 2010, INT J DEV BIOL, V54, P495, DOI 10.1387/ijdb.082761eb
   Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021
   Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028
   Collin B, 2007, MOL CELL BIOCHEM, V294, P225, DOI 10.1007/s11010-006-9263-y
   Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008
   Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347
   El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3
   Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   Goncalves CR, 2003, HISTOCHEM CELL BIOL, V119, P189, DOI 10.1007/s00418-003-0500-0
   Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26
   HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993
   Innis M. A., 1990, PCR PROTOCOLS GUIDE, P3
   Li JM, 2002, CIRC RES, V90, P143, DOI 10.1161/hh0202.103615
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopes LR, 2004, BIOCHEMISTRY-US, V43, P3723, DOI 10.1021/bi035636s
   Matsubara S, 2001, HISTOCHEM CELL BIOL, V116, P1
   Meyer JW, 2000, FEBS LETT, V472, P1, DOI 10.1016/S0014-5793(00)01397-1
   MOHAZZABH KM, 1994, AM J PHYSIOL, V266, pH2568
   Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x
   Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021
   Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x
   Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8
   Pithon-Curi TC, 2002, CLIN SCI, V103, P403, DOI 10.1042/cs1030403
   Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216
   Raijmakers MTM, 2006, PLACENTA, V27, P158, DOI 10.1016/j.placenta.2005.02.013
   Rey FE, 2002, CIRCULATION, V106, P2497, DOI 10.1161/01.CIR.0000038108.71560.70
   SIES H, 1992, TOXICOL LETT, V64-5, P547, DOI 10.1016/0378-4274(92)90230-H
   Takeya R, 2006, METHOD ENZYMOL, V406, P456, DOI 10.1016/S0076-6879(06)06034-4
   Takeya R, 2003, MOL CELLS, V16, P271
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556
   Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Watanabe K, 2010, MOL IMMUNOL, V47, P1989, DOI 10.1016/j.molimm.2010.04.013
   Wolin MS, 2000, ARTERIOSCL THROM VAS, V20, P1430, DOI 10.1161/01.ATV.20.6.1430
   Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4
NR 46
TC 4
Z9 5
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0006-3363
EI 1529-7268
J9 BIOL REPROD
JI Biol. Reprod.
PD FEB
PY 2012
VL 86
IS 2
AR 56
DI 10.1095/biolreprod.111.094748
PG 11
WC Reproductive Biology
SC Reproductive Biology
GA 906JN
UT WOS:000301341500015
PM 22075471
OA Bronze
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Fontenele-Neto, JD
   Vidsiunas, AK
   Gomes, SZ
   Hoshida, MS
   de Oliveira, SF
   Bevilacqua, E
AF Borbely, Alexandre U.
   Fontenele-Neto, Jose D.
   Vidsiunas, Alex K.
   Gomes, Sara Z.
   Hoshida, Mara S.
   de Oliveira, Sergio F.
   Bevilacqua, Estela
TI Ectoplacental Cone Induces Resistance to Apoptosis in High Doses of
   Interferon (IFN)-gamma-Treated Decidual Cells
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE Cell death; coculture assay; interferon-; mesometrial decidual cells;
   trophoblast; TUNEL reaction
ID NATURAL-KILLER-CELLS; NF-KAPPA-B; IFN-GAMMA; MOUSE TROPHOBLAST;
   GENE-EXPRESSION; RAT; IMPLANTATION; DEATH; DIFFERENTIATION; ACTIVATION
AB Problem
   In this study, we explored the relationship between decidual cells (DC) and interferon (IFN)-gamma, in the presence or absence of ectoplacental cone (EC) using a coculture system.
   Method of study
   Decidual cells and EC were isolated from pregnant mice on gestation day 7.5. DCs were cultured for 48 hr and then treated with fresh EC. After characterization, they were treated with IFN-gamma, and cell death was evaluated.
   Results
   Interferon-gamma drastically increased decidual apoptosis, which was partially reverted by the addition of EC to the IFN-gamma-treated decidual culture. Moreover, the addition of EC to non-treated DC cultures was also capable of attenuating death rates.
   Conclusion Resistance to apoptosis may be induced in DC by the EC. This suggests that EC may participate in the inhibition of IFN-gamma-dependent apoptosis and, therefore, play important role for DC survival in a cytokineenriched placental environment.
C1 [Borbely, Alexandre U.; Gomes, Sara Z.; de Oliveira, Sergio F.; Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508900 Sao Paulo, Brazil.
   [Fontenele-Neto, Jose D.] Country Fed Univ Semi Arid, Dept Anim Sci, Mossoro, Brazil.
   [Vidsiunas, Alex K.] Nove de Julho Univ, Sao Paulo, Brazil.
   [Hoshida, Mara S.] Univ Sao Paulo, Sch Med, Lab Med Invest, Dept Obstet & Gynecol, BR-05508900 Sao Paulo, Brazil.
RP de Oliveira, SF (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM sfolivei@usp.br
RI Hoshida, Mara S/D-3900-2012; Borbely, Alexandre Urban/Q-2884-2019;
   Bevilacqua, Estela/H-3354-2011; Fontenele-Neto, Jose/K-4681-2014;
   Borbely, Alexandre/G-4859-2012; Borbely, Alexandre U/A-6649-2013
OI Hoshida, Mara S/0000-0003-2232-4631; Borbely, Alexandre
   Urban/0000-0001-6737-0901; Bevilacqua, Estela/0000-0003-4178-4625;
   Fontenele-Neto, Jose Domingues/0000-0002-4308-7754
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This study was supported by FAPESP and CNPq grants. We thank Rosangela
   Augusto de Oliveira Farias and Ana Lucia Mota for assistance with in
   vitro preparations and Gaspar Ferreira de Lima, Gerson Batista (In
   memorian), and Edson Rocha de Oliveira for technical assistance at the
   EM facilities.
CR ABRAHAMSOHN PA, 2002, ENDOMETRIUM, P279
   Afonso S, 2002, MOL REPROD DEV, V61, P155, DOI 10.1002/mrd.1142
   Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34
   Almeida A, 2007, MOL REPROD DEV, V74, P371, DOI 10.1002/mrd.20524
   Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3
   Ashkar AA, 2001, SEMIN IMMUNOL, V13, P235, DOI 10.1006/smim.2000.0319
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Audus KL, 2002, J PHARMACOL EXP THER, V301, P402, DOI 10.1124/jpet.301.2.402
   Augstein P, 2009, HORM METAB RES, V41, P207, DOI 10.1055/s-0028-1093343
   BABIARZ BS, 1992, IN VITRO CELL DEV-AN, V28A, P500, DOI 10.1007/BF02634133
   BELL SC, 1981, J REPROD FERTIL, V61, P425
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X
   Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9
   Correia-da-Silva G, 2005, PLACENTA, V26, P796, DOI 10.1016/j.placenta.2004.09.008
   Croy BA, 2002, J REPROD IMMUNOL, V57, P151, DOI 10.1016/S0165-0378(02)00005-0
   Dai BJ, 2003, ENDOCRINE, V21, P123, DOI 10.1385/ENDO:21:2:123
   DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15
   Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023
   Ekmekcioglu S, 2008, CYTOKINE, V43, P34, DOI 10.1016/j.cyto.2008.04.010
   El-Hashash AHK, 2004, REPRODUCTION, V128, P53, DOI 10.1530/rep.1.00149
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   Esadeg S, 2003, PLACENTA, V24, P912, DOI 10.1016/S0143-4004(03)00148-6
   Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11
   Foulds KE, 2008, J IMMUNOL, V180, P842, DOI 10.4049/jimmunol.180.2.842
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   GarciaLloret MI, 1996, J CELL PHYSIOL, V167, P324, DOI 10.1002/(SICI)1097-4652(199605)167:2<324::AID-JCP17>3.0.CO;2-7
   Guimond MJ, 1997, BIOL REPROD, V56, P169, DOI 10.1095/biolreprod56.1.169
   Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791
   Hollenbaugh JA, 2006, J IMMUNOL, V177, P3004, DOI 10.4049/jimmunol.177.5.3004
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Idziorek T, 1998, CLIN EXP IMMUNOL, V112, P84
   JACOBS AL, 1991, J BIOL CHEM, V266, P15464
   Joswig A, 2003, REPROD BIOL ENDOCRIN, V26, P1
   Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142
   LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735
   Liu Z, 2003, CYTOKINE, V24, P201, DOI 10.1016/j.cyto.2003.09.002
   Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334
   Mincheva-Nilsson Lucia, 2003, Reprod Biol Endocrinol, V1, P120, DOI 10.1186/1477-7827-1-120
   MUNTENER M, 1977, ACTA ANAT, V98, P241
   Peng S, 2008, REPRODUCTION, V135, P367, DOI 10.1530/REP-07-0191
   Piva M, 1996, BIOL REPROD, V55, P1333, DOI 10.1095/biolreprod55.6.1333
   Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393
   Redline RW, 2000, J EXP MED, V192, pF1, DOI 10.1084/jem.192.2.F1
   Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666
   Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852
   ROSSANT J, 1981, J EMBRYOL EXP MORPH, V62, P217
   SANANES N, 1978, ENDOCRINOLOGY, V103, P86, DOI 10.1210/endo-103-1-86
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   Shiokawa S, 1996, BIOL REPROD, V54, P745, DOI 10.1095/biolreprod54.4.745
   Spinetti G, 2003, J LEUKOCYTE BIOL, V73, P201, DOI 10.1189/jlb.0302105
   Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008
   SRIVASTAVA RK, 1995, ENDOCRINOLOGY, V136, P1913, DOI 10.1210/en.136.5.1913
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   Tomita Y, 1996, APOPTOSIS, V1, P209
   VLADIMIRSKY F, 1977, J REPROD FERTIL, V49, P61
   Wu AJ, 1996, J CELL PHYSIOL, V167, P297, DOI 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5
   Wu XY, 2006, CELL MOL IMMUNOL, V3, P131
   YUI J, 1994, PLACENTA, V15, P819, DOI 10.1016/S0143-4004(05)80184-5
   Zou GM, 2000, DEV GROWTH DIFFER, V42, P257
   Zourbas S, 2001, CLIN EXP IMMUNOL, V126, P519, DOI 10.1046/j.1365-2249.2001.01607.x
NR 62
TC 3
Z9 3
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD JAN
PY 2012
VL 67
IS 1
BP 73
EP 83
DI 10.1111/j.1600-0897.2011.01060.x
PG 11
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 860BK
UT WOS:000297920700009
PM 21883617
DA 2020-12-01
ER

PT J
AU Correa, IP
   Ruano, R
   Takiuti, NH
   Francisco, RPV
   Bevilacqua, E
   Zugaib, M
AF Correa, Isis Paloppi
   Ruano, Rodrigo
   Takiuti, Nilton Hideto
   Vieira Francisco, Rossana Pulcinelli
   Bevilacqua, Estela
   Zugaib, Marcelo
TI Expression of angiogenic factors in placenta of stressed rats
SO REPRODUCTION FERTILITY AND DEVELOPMENT
LA English
DT Article
DE animal models; maternal-fetal interaction; stress
ID ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; PSYCHOLOGICAL STRESS;
   PSYCHOSOCIAL STRESS; TROPHOBLAST CELLS; FACTOR RECEPTOR-1;
   GENE-EXPRESSION; MATERNAL STRESS; PRENATAL STRESS; BIRTH-WEIGHT
AB The aim of the present study was to analyse the influence of stress on pregnant rats, particularly in terms of maternal, placental and fetal weight, placental morphology and placental gene expression of the angiogenic factors Vegfa and Pgf and their receptors. The parameters were evaluated on gestation Day 20. Maternal, fetal and placental weights were statistically lower in stressed animals than controls, suggesting abnormalities in gestational physiology. Morphologically the placentas of rats subjected to stress were reduced in size and weight, with few glycogen cells and a significant increase in the number of apoptotic cells. Stress caused an increase in placental gene expression of Vegfa (P < 0.05) and a reduction in Pgf, Flt1 and Kdr expression (P < 0.05). It has been suggested that increased VEGF is associated with vasodilatation and hypotension, but in this model persistent hypertension was present. This study suggests that the limited hypotensive Vegfa response to stress-induced hypertension could result from reduced expression of Flt1/Kdr disrupting specific VEGF pathways. These findings may elucidate one of the multiple possible factors underlying how stress modulates placental physiology, and could aid the understanding of stress-induced gestational disorders.
C1 [Correa, Isis Paloppi; Ruano, Rodrigo; Takiuti, Nilton Hideto; Vieira Francisco, Rossana Pulcinelli; Zugaib, Marcelo] Univ Sao Paulo, Fac Med, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Ruano, R (corresponding author), Univ Sao Paulo, Fac Med, Dept Obstet & Gynecol, Sao Paulo, Brazil.
EM rodrigoruano@usp.br
RI Francisco, Rossana Pulcineli Vieira/AAG-7461-2020; HCFMUSP,
   Pos-Graduacao DOG -/F-1162-2013; Francisco, Rossana PV/C-5648-2012;
   Bevilacqua, Estela/H-3354-2011; Zugaib, Marcelo/A-5724-2013
OI Francisco, Rossana Pulcineli Vieira/0000-0002-9981-8069; Francisco,
   Rossana PV/0000-0002-9981-8069; Bevilacqua, Estela/0000-0003-4178-4625;
   Zugaib, Marcelo/0000-0003-1155-2671
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX This work was supported by FAPESP, CNPq, CAPES. The authors gratefully
   acknowledge the technical contributions of Rosangela Farias and Salet
   Terezinha de Solza.
CR Ahmed A, 1997, LAB INVEST, V76, P779
   Asberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003590
   Baisden B, 2007, PLACENTA, V28, P1082, DOI 10.1016/j.placenta.2007.04.002
   Balanos GM, 2010, BIOL PSYCHOL, V85, P104, DOI 10.1016/j.biopsycho.2010.06.001
   Barker DJP, 2007, HYPERTENSION, V50, P565, DOI 10.1161/HYPERTENSIONAHA.107.091512
   Bernatova I, 2006, LIFE SCI, V78, P1726, DOI 10.1016/j.lfs.2005.08.005
   Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x
   Chan J, 2007, J ENDOCRINOL, V195, P7, DOI 10.1677/JOE-07-0289
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003
   Djordjevic J, 2007, GEN COMP ENDOCR, V153, P217, DOI 10.1016/j.ygcen.2007.02.004
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x
   Haelterman E, 2007, SCAND J WORK ENV HEA, V33, P304, DOI 10.5271/sjweh.1147
   Hewitt DP, 2006, ENDOCRINOLOGY, V147, P5568, DOI 10.1210/en.2006-0825
   Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Houdijk ECAM, 2000, J ENDOCRINOL, V166, P599, DOI 10.1677/joe.0.1660599
   Kanayama N, 1997, J HYPERTENS, V15, P383, DOI 10.1097/00004872-199715040-00009
   KU DD, 1993, AM J PHYSIOL, V265, pH586
   Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241
   Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291
   Li B, 2002, HYPERTENSION, V39, P1095, DOI 10.1161/01.HYP.0000018588.56950.7A
   Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098
   Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004
   Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006
   Manni L, 2005, BASIC RES CARDIOL, V100, P121, DOI 10.1007/s00395-004-0502-7
   Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189
   MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942
   Mondo CK, 2006, CLIN EXP HYPERTENS, V28, P73, DOI 10.1080/10641960500468219
   O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539
   Oliveira AO, 2004, BRAZ J MED BIOL RES, V37, P907, DOI 10.1590/S0100-879X2004000600017
   Osol G, 2008, AM J PHYSIOL-HEART C, V294, pH1381, DOI 10.1152/ajpheart.00922.2007
   Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Plante GE, 2002, METABOLISM, V51, P25, DOI 10.1053/meta.2002.33187
   Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4
   Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705
   Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049
   Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469
   Steptoe A, 2008, HYPERTENSION, V52, P220, DOI 10.1161/HYPERTENSIONAHA.108.115477
   Takiuti NH, 2002, AM J OBSTET GYNECOL, V186, P544, DOI 10.1067/mob.2002.121102
   Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478
   Teixeira PG, 2008, HYPERTENS PREGNANCY, V27, P65, DOI 10.1080/10641950701825937
   Torok J, 2008, PHYSIOL RES, V57, P813
   Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528
   Vieira JM, 2010, ORGANOGENESIS, V6, P97, DOI 10.4161/org.6.2.11686
   Waddell BJ, 2000, BIOL REPROD, V63, P1913, DOI 10.1095/biolreprod63.6.1913
   Wisborg K, 2008, BJOG-INT J OBSTET GY, V115, P882, DOI 10.1111/j.1471-0528.2008.01734.x
   Wong ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002350
   Yamazaki Y, 2007, BIOCHEM BIOPH RES CO, V355, P693, DOI 10.1016/j.bbrc.2007.02.038
   Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011
   Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178
NR 53
TC 0
Z9 0
U1 0
U2 5
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 1031-3613
J9 REPROD FERT DEVELOP
JI Reprod. Fertil. Dev.
PY 2012
VL 24
IS 6
BP 851
EP 858
DI 10.1071/RD11202
PG 8
WC Developmental Biology; Reproductive Biology; Zoology
SC Developmental Biology; Reproductive Biology; Zoology
GA 972QP
UT WOS:000306292600009
PM 22781936
DA 2020-12-01
ER

PT J
AU da Silva, FC
   Magaldi, FM
   Sato, H
   Bevilacqua, E
AF da Silva, Fernanda Carini
   Magaldi, Fernanda Milani
   Sato, Helena
   Bevilacqua, Estela
TI YELLOW FEVER VACCINATION IN MOUSE PREGNANT FEMALES: GESTATIONAL
   PERFORMANCE AND VIRAL ANTIGEN DISTRIBUTION IN PLACENTA AND FETUSES
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [da Silva, Fernanda Carini; Magaldi, Fernanda Milani; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Sato, Helena] Univ Sao Paulo, Dept Hlth, Immunizat Program, Sao Paulo, Brazil.
RI amsalu, ribka/G-8780-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A126
EP A126
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200282
DA 2020-12-01
ER

PT J
AU Faria, M
   Nascimento, K
   Martucci, M
   Costa, A
   Silva, SC
   Paulesu, L
   Bevilacqua, E
AF Faria, Miriam
   Nascimento, Karollina
   Martucci, Mariane
   Costa, Adriana
   Silva, Simone Correa
   Paulesu, Luana
   Bevilacqua, Estela
TI INFLAMMATION INDUCED BY LPS AFFECTS MACROPHAGE MIGRATION INHIBITORY
   FACTOR (MIF) AND RECEPTOR EXPRESSION AT MATERNAL-FETAL INTERFACE
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [Faria, Miriam; Nascimento, Karollina; Martucci, Mariane; Costa, Adriana; Silva, Simone Correa; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Paulesu, Luana] Univ Siena, I-53100 Siena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A35
EP A35
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200090
DA 2020-12-01
ER

PT J
AU Fernandes, I
   Russo, F
   Pignatari, G
   Borbely, A
   Sandri, S
   Miglino, M
   Bevilacqua, E
   Beltrao-Braga, P
AF Fernandes, Isabella
   Russo, Fabiele
   Pignatari, Graciela
   Borbely, Alexandre
   Sandri, Silvana
   Miglino, Maria
   Bevilacqua, Estela
   Beltrao-Braga, Patricia
TI EXTRAVILLOUS TROPHOBLAST (EVT) FROM HUMAN TERM PLACENTA MAY NOT BE GOOD
   CANDIDATES FOR USING IN CELL THERAPY PROTOCOLS
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [Fernandes, Isabella; Russo, Fabiele; Pignatari, Graciela; Miglino, Maria; Beltrao-Braga, Patricia] Univ Sao Paulo, Dept Surg FMVZ, Stem Cell Lab, BR-09500900 Sao Paulo, Brazil.
   [Fernandes, Isabella; Russo, Fabiele; Pignatari, Graciela; Miglino, Maria; Beltrao-Braga, Patricia] Natl Inst Stem Cell INCT, Ribeirao Preto, Sao Paulo, Brazil.
   [Borbely, Alexandre; Sandri, Silvana; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol ICBI, Trophoblast Res Lab, BR-09500900 Sao Paulo, Brazil.
   Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-09500900 Sao Paulo, Brazil.
RI Miglino, Maria Angelica/B-9519-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013; Sandri, Silvana/A-1650-2015; Borbely,
   Alexandre/G-4859-2012
OI Miglino, Maria Angelica/0000-0003-4979-115X; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A65
EP A65
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200155
DA 2020-12-01
ER

PT J
AU Lorenzon, A
   Farah, S
   Fisher, S
   Bevilacqua, E
AF Lorenzon, Aline
   Farah, Shaker
   Fisher, Susan
   Bevilacqua, Estela
TI IS STROMAL CELL DERIVED FACTOR-2 INVOLVED IN TROPHOBLAST
   DIFFERENTIATION?
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [Lorenzon, Aline; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Lorenzon, Aline; Fisher, Susan] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.
   [Farah, Shaker] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A32
EP A32
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200083
DA 2020-12-01
ER

PT J
AU Sandri, S
   Borbely, A
   Fernandes, I
   Prado, K
   Correa-Silva, S
   Albuquerque, R
   Braga, PCB
   Campa, A
   Bevilacqua, E
AF Sandri, Silvana
   Borbely, Alexandre
   Fernandes, Isabella
   Prado, Karen
   Correa-Silva, Simone
   Albuquerque, Renata
   Beltrao Braga, Patricia Cristina
   Campa, Ana
   Bevilacqua, Estela
TI ISOLATED EXTRAVILLOUS TROPHOBLAST CELLS FROM BASAL PLATE OF TERM
   PLACENTA: EXPRESSION OF INTEGRINS AND INVASIVENESS ACTIVITY
SO PLACENTA
LA English
DT Meeting Abstract
CT Meeting of the International-Federation-of-Placenta-Associations (IFPA)
CY SEP 14-17, 2011
CL Geilo, NORWAY
SP Int Federat Placenta Assoc
C1 [Borbely, Alexandre; Prado, Karen; Correa-Silva, Simone; Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil.
   [Sandri, Silvana; Albuquerque, Renata; Campa, Ana] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil.
   [Fernandes, Isabella; Beltrao Braga, Patricia Cristina] Univ Sao Paulo, Fac Med Vet & Zootecn, BR-05508 Sao Paulo, Brazil.
   [Beltrao Braga, Patricia Cristina] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, BR-05508 Sao Paulo, Brazil.
RI Beltrao-Braga, Patricia C B/D-6450-2013; Borbely, Alexandre/G-4859-2012;
   Correa-Silva, Simone/J-9540-2012; Sandri, Silvana/A-1650-2015; Campa,
   Ana/D-4669-2012
OI Beltrao-Braga, Patricia C B/0000-0003-0004-1091; Campa,
   Ana/0000-0002-6183-3378
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2011
VL 32
IS 9
BP A61
EP A61
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 822TJ
UT WOS:000295072200146
DA 2020-12-01
ER

PT J
AU Sandri, S
   Oliveira, EM
   Knebel, FH
   Contesini, CGI
   Bevilacqua, E
   Campa, A
AF Sandri, S.
   Oliveira, E. M.
   Knebel, F. H.
   Contesini, C. G. I.
   Bevilacqua, E.
   Campa, A.
TI SERUM AMYLOID A IN PLACENTAL VILLOUS EXPLANTS: EFFECT OF HYPOXIA
SO INFLAMMATION RESEARCH
LA English
DT Meeting Abstract
CT 10th World Congress on Inflammation
CY JUN 25-29, 2011
CL Paris, FRANCE
SP Int Assoc Inflammation Soc, Grp Res & Study Mediators Inflammat
C1 [Sandri, S.; Oliveira, E. M.; Knebel, F. H.; Contesini, C. G. I.; Campa, A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
RI Sandri, Silvana/A-1650-2015; Campa, Ana/D-4669-2012; Oliveira, Edilamar
   M/AAG-1082-2019
OI Campa, Ana/0000-0002-6183-3378; Oliveira, Edilamar M/0000-0002-7101-312X
NR 0
TC 0
Z9 0
U1 0
U2 3
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1023-3830
J9 INFLAMM RES
JI Inflamm. Res.
PD JUN
PY 2011
VL 60
SU 1
BP 109
EP 109
PG 1
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA 774CM
UT WOS:000291358900287
DA 2020-12-01
ER

PT J
AU Amarante-Paffaro, AM
   Hoshida, MS
   Yokota, S
   Goncalves, CR
   Joazeiro, PP
   Bevilacqua, E
   Yamada, AT
AF Amarante-Paffaro, A. M.
   Hoshida, M. S.
   Yokota, S.
   Goncalves, C. R.
   Joazeiro, P. P.
   Bevilacqua, E.
   Yamada, A. T.
TI Localization of Cathepsins D and B at the Maternal-Fetal Interface and
   the Invasiveness of the Trophoblast during the Postimplantation Period
   in the Mouse
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Ectoplacental cone; Placenta; Cathepsin D; Cathepsin B; Phagocytosis;
   Lysosomal proteinases
ID LYSOSOMAL ENZYME-ACTIVITY; BREAST-CANCER CELLS; CYSTATIN-C;
   EXTRACELLULAR-MATRIX; EMBRYO IMPLANTATION; IN-VITRO; IMMUNOCYTOCHEMICAL
   LOCALIZATION; BLASTOCYST IMPLANTATION; PLASMINOGEN-ACTIVATOR;
   PROTEOLYTIC ACTIVITY
AB A survey of existing data suggests that trophoblast cells produce factors involved in extracellular matrix degradation. In this study, we correlated the expression of cathepsins D and B in the murine ectoplacental cone with the ultrastructural progress of decidual invasion by trophoblast cells. Both proteases were immunolocalized at implantation sites in lysosome-endosome-like compartments of trophoblast giant cells. Cathepsin D, but not cathepsin B, was also detected ultrastructurally in extracellular compartments surrounded by processes of the invading trophoblast containing extracellular matrix components and endometrial cell debris. The expression of cathepsins D and B by trophoblast cells was confirmed by RT-PCR in ectoplacental cones isolated from implantation chambers at gestation day 7.5. Our data addressed a positive relationship between the expression and presence of cathepsin D at the extracellular compartment of the maternal-fetal interface and the invasiveness of the trophoblast during the postimplantation period, suggesting a participation of invading trophoblast cells in the cathepsin D release. Such findings indicate that mouse trophoblast cells might exhibit a proteolytic ability to partake in the decidual invasion process at the maternal-fetal interface. Copyright (C) 2010 S. Karger AG, Basel
C1 [Amarante-Paffaro, A. M.; Hoshida, M. S.; Goncalves, C. R.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Amarante-Paffaro, A. M.; Joazeiro, P. P.; Yamada, A. T.] Univ Estadual Campinas, Inst Biol, Lab Cytochem & Immunocytochem, Campinas, SP, Brazil.
   [Amarante-Paffaro, A. M.] Univ Fed Alfenas, Inst Biomed Sci, Dept Cell & Struct Biol, Alfenas, Brazil.
   [Yokota, S.] Yamanashi Med Univ, Dept Biol, Yamanashi, Japan.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011; Hoshida, Mara S/D-3900-2012; JOAZEIRO,
   PAULO/C-6733-2014; Yamada, Aureo T/F-7752-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; Hoshida, Mara
   S/0000-0003-2232-4631; Yamada, Aureo T/0000-0003-3620-9685; Goncalves,
   Claudia Regina/0000-0002-4287-0560
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   FAEP/UNICAMP; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX Previous versions of the manuscript were greatly improved by the
   comments of B. Anne Croy. The authors wish to thank Mrs. Antonia
   Oliveira and Mrs. Adriana Silva (Electron Microscopy Laboratory,
   Institute of Biology, UNICAMP) for their technical assistance. A.M.A.-P.
   was the recipient of a graduate student scholarship from FAPESP. This
   work was supported by grants from FAPESP, FAEP/UNICAMP, and CNPq awarded
   to A.T.Y. and E.B.
CR ABRAHAM R, 1970, EXP MOL PATHOL, V13, P329, DOI 10.1016/0014-4800(70)90095-X
   ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610
   Afonso S, 1999, DEV DYNAM, V216, P374, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<374::AID-DVDY6>3.0.CO;2-N
   Afonso S, 2002, MOL REPROD DEV, V61, P155, DOI 10.1002/mrd.1142
   Afonso S, 1997, DEVELOPMENT, V124, P3415
   Alexander CM, 1996, DEVELOPMENT, V122, P1723
   Baston-Buest DM, 2010, REPRODUCTION, V139, P741, DOI 10.1530/REP-09-0381
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Bevilacqua E, 2010, INT J DEV BIOL, V54, P495, DOI 10.1387/ijdb.082761eb
   Bischof P, 1995, Early Pregnancy, V1, P263
   BLANKENSHIP TN, 1992, ANAT REC, V233, P196, DOI 10.1002/ar.1092330204
   BRIOZZO P, 1988, CANCER RES, V48, P3688
   Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734
   Creemers LB, 1998, MATRIX BIOL, V16, P575, DOI 10.1016/S0945-053X(98)90068-3
   Denker H.-W., 1980, PROGRESS IN REPRODUCTIVE BIOLOGY, V7, P28
   Denker H W, 1977, Adv Anat Embryol Cell Biol, V53, P3
   Denker H-W, 1982, PROTEINS STEROIDS EA, P183
   DENKER HW, 1986, CELL TISSUE RES, V246, P279, DOI 10.1007/BF00215890
   DENKER HW, 1978, ANAT EMBRYOL, V154, P39, DOI 10.1007/BF00317953
   DICKSON AD, 1966, J ANAT, V100, P335
   Dong Z, 2001, EUR J BIOCHEM, V268, P6408, DOI 10.1046/j.0014-2956.2001.02607.x
   EBERT W, 1994, ANTICANCER RES, V14, P895
   ELANGOVAN S, 1980, BIOL REPROD, V23, P663, DOI 10.1095/biolreprod23.3.663
   ENDERS AC, 1993, J EXP ZOOL, V266, P578, DOI 10.1002/jez.1402660608
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   FAZLEABAS AT, 1983, BIOL REPROD, V29, P225, DOI 10.1095/biolreprod29.1.225
   Gan Y, 2008, CELL DEATH DIFFER, V15, P1481, DOI 10.1038/cdd.2008.73
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   GLASS RH, 1983, J CELL BIOL, V96, P1108, DOI 10.1083/jcb.96.4.1108
   GRAHAM CH, 1992, BIOCHEM CELL BIOL, V70, P867, DOI 10.1139/o92-135
   GU Y, 1994, ENDOCRINOLOGY, V135, P1272, DOI 10.1210/en.135.3.1272
   Henskens YMC, 1996, BIOL CHEM H-S, V377, P71
   Heylen N, 2002, INT J ONCOL, V20, P761
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276
   Jokimaa V, 2001, MOL HUM REPROD, V7, P73, DOI 10.1093/molehr/7.1.73
   Joswig Anike, 2003, Reprod Biol Endocrinol, V1, P44
   KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057
   LI WG, 1991, BIOL REPROD, V44, P625, DOI 10.1095/biolreprod44.4.625
   Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007
   Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396
   LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361
   MOULTON BC, 1974, BIOL REPROD, V10, P543, DOI 10.1095/biolreprod10.5.543
   MOULTON BC, 1978, BIOL REPROD, V19, P167, DOI 10.1095/biolreprod19.1.167
   MUNTENER M, 1977, ACTA ANAT, V98, P241
   Mylonas I, 2003, ACTA HISTOCHEM, V105, P245, DOI 10.1078/0065-1281-00715
   Nakanishi T, 2005, MOL HUM REPROD, V11, P351, DOI 10.1093/molehr/gah172
   OWERS NO, 1971, BIOL BLASTOCYST, P207
   OWERS NO, 1971, BIOL BLASTOCYST, P225
   PARR EL, 1987, BIOL REPROD, V36, P211, DOI 10.1095/biolreprod36.1.211
   Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044
   Rageh MAE, 2001, J CLIN PATHOL-MOL PA, V54, P338, DOI 10.1136/mp.54.5.338
   SCAMBIA G, 1994, EUR J CANCER, V30A, P935, DOI 10.1016/0959-8049(94)90118-X
   SCHULTZ DC, 1994, CANCER RES, V54, P48
   Screen M, 2008, DEVELOPMENT, V135, P3311, DOI 10.1242/dev.025627
   Sharma RK, 1998, IN VIVO, V12, P209
   SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4
   Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009
   Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P1251, DOI 10.3748/wjg.v11.i9.1251
   Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005
   Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004
   Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929
   SUKOH N, 1994, CANCER, V74, P46, DOI 10.1002/1097-0142(19940701)74:1<46::AID-CNCR2820740109>3.0.CO;2-G
   Talieri M, 2004, CANCER LETT, V205, P97, DOI 10.1016/j.canlet.2003.09.033
   Teesalu T, 1998, DEV DYNAM, V213, P27, DOI 10.1002/(SICI)1097-0177(199809)213:1<27::AID-AJA3>3.3.CO;2-0
   Teesalu T, 1999, DEV DYNAM, V214, P248, DOI 10.1002/(SICI)1097-0177(199903)214:3<248::AID-AJA8>3.0.CO;2-N
   Weisinger G, 1999, BBA-GENE STRUCT EXPR, V1446, P225, DOI 10.1016/S0167-4781(99)00091-3
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   YOKOTA S, 1985, J HISTOCHEM CYTOCHEM, V33, P191, DOI 10.1177/33.3.2579120
   YOKOTA S, 1986, J HISTOCHEM CYTOCHEM, V34, P891, DOI 10.1177/34.7.3519752
NR 72
TC 14
Z9 14
U1 1
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2011
VL 193
IS 6
BP 417
EP 425
DI 10.1159/000320546
PG 9
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 763SO
UT WOS:000290580200007
PM 21116106
DA 2020-12-01
ER

PT J
AU Pietro, L
   Daher, S
   Rudge, MVC
   Calderon, IMP
   Damasceno, DC
   Sinzato, YK
   Bandeira, C
   Bevilacqua, E
AF Pietro, L.
   Daher, S.
   Rudge, M. V. C.
   Calderon, I. M. P.
   Damasceno, D. C.
   Sinzato, Y. K.
   Bandeira, C.
   Bevilacqua, E.
TI Vascular endothelial growth factor (VEGF) and VEGF-receptor expression
   in placenta of hyperglycemic pregnant women
SO PLACENTA
LA English
DT Article
DE Angiogenesis; Gestational diabetes; Hyperglycemia; Overt diabetes;
   Trophoblast; VEGF
ID SIGNAL-TRANSDUCTION; ANGIOGENESIS; VASCULOGENESIS; DYSFUNCTION; FLT-1;
   VILLI; RATS; KDR
AB Hyperglycemia occurs in a variety of conditions such as overt diabetes, gestational diabetes and mild hyperglycemia, all of which are generally defined based on the oral glucose tolerance test and glucose profiles. Whereas diabetes has received considerable attention in recent decades, few studies have examined the mechanisms of mild hyperglycemia and its associated disturbances. Mild gestational hyperglycemia is associated with macrosomia and a high risk of perinatal mortality. Morphologically, the placenta of these women is characterized by an increase in the number of terminal villi and capillaries, presumably as part of a compensatory mechanism to maintain homeostasis at the maternal-fetal interface. In this study, we analised the expression of VEGF and its receptors VEGFR-1 (Flt-1) and VEGFR-2 (KDR) in placentas from mildly hyperglycemic women. This expression was compared with that of normoglycemic women and women with gestational and overt diabetes. Immunohistochemistry revealed strong staining for VEGF and VEGFR-2 in vascular and trophoblastic cells of mildly hyperglycemic women, whereas the staining for VEGFR-1 was discrete and limited to the trophoblast. The pattern of VEGF and VEGF-receptor reactivity in placentas from women with overt diabetes was similar to that of normoglycemic women. In women with gestational diabetes, strong staining for VEGFR-1 was observed in vascular and trophoblastic cells whereas VEGF and VEGFR-2 were detected only in the trophoblast. The expression of these proteins was confirmed by western blotting, which revealed the presence of an additional band of 75 kDa. In the decidual compartment, only extravillous trophoblast reacted with all antibodies. Morphological analysis revealed collagen deposition around large arteries in all groups with altered glycemia. These findings indicate a placental response to altered glycemia that could have important consequences for the fetus. The change in the placental VEGF/VEGFR expression ratio in mild hyperglycemia may favor angiogenesis in placental tissue and could explain the hypercapillarization of villi seen in this gestational disturbance. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Pietro, L.; Bandeira, C.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Daher, S.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Rudge, M. V. C.; Calderon, I. M. P.; Damasceno, D. C.; Sinzato, Y. K.] Sao Paulo State Univ, Inst Gynecol & Obstet, Sao Paulo, Brazil.
RP Pietro, L (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
EM lucianapietro@ig.com.br
RI Damasceno, Debora C/C-7234-2012; Bevilacqua, Estela/H-3354-2011; Rudge,
   Marilza/S-9057-2018; Rudge, Marilza V C/C-8338-2012; Calderon,
   Iracema/W-4336-2019; Sinzato, Yuri K/E-8626-2019; DAHER,
   SILVIA/D-2180-2012; Calderon, Iracema MP/C-8136-2012; Bandeira, Carla
   Leticia/U-8685-2017
OI Damasceno, Debora C/0000-0002-7003-9643; Bevilacqua,
   Estela/0000-0003-4178-4625; Rudge, Marilza V C/0000-0002-9227-832X;
   Calderon, Iracema/0000-0003-4761-4336; Sinzato, Yuri
   K/0000-0002-2973-1099; DAHER, SILVIA/0000-0001-5312-7804; Calderon,
   Iracema MP/0000-0003-4761-4336; Bandeira, Carla
   Leticia/0000-0002-0796-3462
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenadoria de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Conselho
   Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
FX This research was supported by Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP), Coordenadoria de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) and Conselho Nacional de Pesquisa e
   Desenvolvimento Tecnologico (CNPq).
CR [Anonymous], 2004, DIABETES CARE S1, V27, ps88, DOI DOI 10.2337/DIACARE.27.2007.S88
   Breier G, 2000, PLACENTA, V21, pS11, DOI 10.1053/plac.1999.0525
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509
   Calderon IMP, 2007, DIABETES RES CLIN PR, V78, P65, DOI 10.1016/j.diabres.2007.01.023
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004
   Cooper JC, 1995, J REPROD FERTIL, V105, P205
   Rudge MVC, 2005, REV BRAS GINECOL OBS, V27, P691, DOI 10.1590/S0100-72032005001100010
   Demir R, 2006, PLACENTA, V27, P535, DOI 10.1016/j.placenta.2005.05.011
   Demir R, 2004, PLACENTA, V25, P560, DOI 10.1016/j.placenta.2003.11.011
   ERIKSSON UJ, 1991, DIABETES, V40, P94, DOI 10.2337/diab.40.2.S94
   Esper RJ, 2008, ADV CARDIOL, V45, P17, DOI 10.1159/000115120
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   GILLMER MD, 1975, BMJ-BRIT MED J, V16, P399
   Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853
   Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205
   Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081
   Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405
   Iino K, 1997, DIABETES RES CLIN PR, V34, P163, DOI 10.1016/S0168-8227(96)01349-6
   Jansson T, 2001, AM J OBSTET GYNECOL, V184, P111, DOI 10.1067/mob.2001.108075
   Jin SM, 2008, J KOREAN MED SCI, V23, P77, DOI 10.3346/jkms.2008.23.1.77
   Jirkovska M, 2002, J VASC RES, V39, P268, DOI 10.1159/000063692
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533
   Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1
   KLIP A, 1992, DIABETES CARE, V15, P1747, DOI 10.2337/diacare.15.11.1747
   Kumazaki K, 2002, HUM PATHOL, V33, P1069, DOI 10.1053/hupa.2002.129420
   Li Qing, 2007, Zhonghua Yi Xue Za Zhi, V87, P2994
   Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3
   MELOAN SN, 1978, HISTOCHEMISTRY, V58, P163, DOI 10.1007/BF00495715
   Kerche LTRL, 2005, REV BRAS GINECOL OBS, V27, P580, DOI 10.1590/S0100-72032005001000003
   Rudge M V, 1999, Sao Paulo Med J, V117, P49
   RUDGE MVC, 1995, BRAZ J MED BIOL RES, V28, P219
   RUDGE MVC, 1990, BRAZ J MED BIOL RES, V23, P1079
   RUDGE MVC, 1983, PERFIL GLICEMICO TES, P83
   Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012
   Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370
   Taskinen MR, 1996, DIABETES, V45, pS120, DOI 10.2337/diab.45.3.S120
   VLASSARA H, 1984, J EXP MED, V160, P197, DOI 10.1084/jem.160.1.197
   Vranes D, 1999, MICROVASC RES, V57, P8, DOI 10.1006/mvre.1998.2107
   Vuorela P, 2006, AM J PERINAT, V23, P255, DOI 10.1055/s-2006-939562
   VUORELA P, 2000, VASCULAR ENDOTHELIAL
   Watala C, 1996, INT J BIOCHEM CELL B, V28, P1393, DOI 10.1016/S1357-2725(96)00087-8
   Zhao B, 2004, MICROVASC RES, V68, P239, DOI 10.1016/j.mvr.2004.07.004
NR 45
TC 39
Z9 41
U1 0
U2 10
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP 770
EP 780
DI 10.1016/j.placenta.2010.07.003
PG 11
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100004
PM 20674013
DA 2020-12-01
ER

PT J
AU Bandeira, CL
   Albieri-Borges, A
   Hoshida, MS
   Santelli, GM
   Porto, LC
   Bevilacqua, E
AF Bandeira, C. L.
   Albieri-Borges, A.
   Hoshida, M. S.
   Santelli, G. M.
   Porto, L. C.
   Bevilacqua, E.
TI CRIPTO-1: A TUMORAL MARKER AT THE MATERNAL-PLACENTAL INTERFACE
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Cripto-1; Trophoblast; Decidua; Maternal-placental interface
C1 [Bandeira, C. L.; Hoshida, M. S.; Santelli, G. M.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Albieri-Borges, A.; Porto, L. C.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
RI Machado-Santelli, Glaucia M/C-6775-2013
OI Machado-Santelli, Glaucia M/0000-0003-2046-9693
NR 0
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A85
EP A85
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100196
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Daher, S
   Mattar, R
   Sun, SY
   Bevilacqua, E
   Oliveira, SF
AF Borbely, A. U.
   Daher, S.
   Mattar, R.
   Sun, S. Y.
   Bevilacqua, E.
   Oliveira, S. F.
TI DIFFERENTIAL EXPRESSION AND LOCALIZATION OF DECORIN AND BIGLYCAN IN
   HUMAN NORMAL TERM PLACENTA AND IN HIGHLY INVASIVE PATHOLOGIES
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Biglycan; Decorin; Extravillous Cytotrophoblast; Placental Pathologies
C1 [Borbely, A. U.; Bevilacqua, E.; Oliveira, S. F.] Univ Sao Paulo, Inst Biomed Sci, Dept Dev & Cellular Biol, BR-05508 Sao Paulo, Brazil.
   [Daher, S.; Mattar, R.; Sun, S. Y.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
RI DAHER, SILVIA/D-2180-2012; Sun, Sue Yazaki/N-4314-2018; Borbely,
   Alexandre/G-4859-2012
OI DAHER, SILVIA/0000-0001-5312-7804; Sun, Sue Yazaki/0000-0001-6573-7386; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A59
EP A59
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100141
DA 2020-12-01
ER

PT J
AU Cordeiro, LAV
   Lima, PHC
   Kadyrov, M
   Borges, AA
   Bevilacqua, E
   Frank, HG
   Kaufmann, P
AF Cordeiro, L. A. V.
   Lima, P. H. C.
   Kadyrov, M.
   Borges, A. A.
   Bevilacqua, E.
   Frank, H. G.
   Kaufmann, P.
TI ANTI-PLACENTA ANTIBODIES CONSTRUCTED BY PHAGE DISPLAY TECHNOLOGY
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
C1 [Borges, A. A.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Kadyrov, M.] Rhein Westfal TH Aachen, Inst Anat, Aachen, Germany.
RI Frank, Hans-Georg/G-6038-2012; Cordeiro, Luiz A.V./F-2328-2019
OI Frank, Hans-Georg/0000-0002-3562-138X; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A95
EP A95
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100216
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Oliveira, L
   Camara, N
   Bevilacqua, E
AF Correa-Silva, Simone
   Oliveira, Leandro
   Camara, Niels
   Bevilacqua, Estela
TI PRESENCE OF T REGULATORY CELLS LAP(+) IN RENAL TRANSPLANTED PREGNANT
   WOMEN
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE T regulatory cells; TGF-beta; maternal-fetal tolerance; renal transplant
C1 [Correa-Silva, Simone; Oliveira, Leandro; Camara, Niels; Bevilacqua, Estela] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI camara, niels/AAX-3269-2020; Correa-Silva, Simone/J-9540-2012; Camara,
   Niels OS/G-8336-2011
OI camara, niels/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A86
EP A86
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100198
DA 2020-12-01
ER

PT J
AU Faria, MR
   Ferro, EAV
   Paulesu, L
   Bevilacqua, E
AF Faria, M. R.
   Ferro, E. A. V.
   Paulesu, L.
   Bevilacqua, E.
TI ANTENATAL DEXAMETHASONE TREATMENT LEADS TO CHANGES IN MIF GENE
   EXPRESSION IN THE DEVELOPING PLACENTA
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE MIF; Cytokine; Trophoblast; Placenta
C1 [Faria, M. R.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Ferro, E. A. V.] Univ Fed Uberlandia, Dept Morphol, Uberlandia, MG, Brazil.
   [Paulesu, L.] Univ Siena, Dept Physiol, I-53100 Siena, Italy.
RI Ferro, Eloisa/K-5533-2016
OI Ferro, Eloisa/0000-0002-7447-2583
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A95
EP A95
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100218
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Guzzo, CR
   Gormley, M
   Farah, SC
   Fisher, SJ
   Bevilacqua, E
AF Lorenzon, A. R.
   Guzzo, C. R.
   Gormley, M.
   Farah, S. C.
   Fisher, S. J.
   Bevilacqua, E.
TI STUDYING A NEW PROTEIN AT MATERNAL-FETAL INTERFACE, SDF-2
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Trophoblast; SDF-2; Placenta; Blastocyst
C1 [Lorenzon, A. R.; Bevilacqua, E.] Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
   [Lorenzon, A. R.; Gormley, M.; Fisher, S. J.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Sch Med, San Francisco, CA 94143 USA.
   [Guzzo, C. R.; Farah, S. C.] Univ Sao Paulo, Dept Biochem, Inst Chem, BR-05508 Sao Paulo, Brazil.
RI Carvalho, Cristiane R. G/K-2855-2016; Lorenzon, Aline R/G-8733-2014
OI Carvalho, Cristiane R. G/0000-0002-5664-8055; Lorenzon, Aline
   R/0000-0002-6052-6296
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A84
EP A84
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100194
DA 2020-12-01
ER

PT J
AU Martucci, MF
   Faria, MR
   Paulesu, L
   Bevilacqua, E
AF Martucci, M. F.
   Faria, M. R.
   Paulesu, L.
   Bevilacqua, E.
TI LOCALIZATION OF MIF RECEPTORS AT THE MATERNAL-PLACENTAL INTERFACE IN
   MICE
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE MW; CD74; CD44; Placenta
C1 [Martucci, M. F.; Faria, M. R.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Paulesu, L.] Univ Siena, I-53100 Siena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A41
EP A41
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100103
DA 2020-12-01
ER

PT J
AU Mendes, C
   Nascimento, K
   Faria, M
   Bacchi, E
   Moraes, S
   Bevilacqua, E
AF Mendes, Camila
   Nascimento, Karollina
   Faria, Miriam
   Bacchi, Elfriede
   Moraes, Suzana
   Bevilacqua, Estela
TI PLACENTAL AND FETAL MORPHOLOGICAL CHANGES ASSOCIATED WITH INGESTION OF
   MYKANIA GLOMERATA
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE mykania glomerata; placenta; birth defects; abortion
C1 [Mendes, Camila; Nascimento, Karollina; Faria, Miriam; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
   [Bacchi, Elfriede] Univ Sao Paulo, Coll Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Moraes, Suzana] Pontifical Catholic Univ Sao Paulo, Dept Morphol & Pathol, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A66
EP A66
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100156
DA 2020-12-01
ER

PT J
AU Nascimento, KF
   Faria, MR
   Ferro, EAV
   Paulesu, L
   Bevilacqua, E
AF Nascimento, K. F.
   Faria, M. R.
   Ferro, E. A. V.
   Paulesu, L.
   Bevilacqua, E.
TI CAN INFLAMMATION INDUCED BY LPS AFFECT MIF EXPRESSION AT MATERNAL-FETAL
   INTERFACE?
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE MIF; LPS; Trophoblast cells; inflammation
C1 [Nascimento, K. F.; Faria, M. R.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Ferro, E. A. V.] Univ Fed Uberlandia, Uberlandia, MG, Brazil.
   [Paulesu, L.] Univ Siena, I-53100 Siena, Italy.
RI Ferro, Eloisa/K-5533-2016
OI Ferro, Eloisa/0000-0002-7447-2583
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A83
EP A83
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100192
DA 2020-12-01
ER

PT J
AU Prado, KM
   Borbely, AU
   Fernandes, IR
   Sandri, S
   Correa-Silva, S
   Bevilacqua, E
AF Prado, K. M.
   Borbely, A. U.
   Fernandes, I. R.
   Sandri, S.
   Correa-Silva, S.
   Bevilacqua, E.
TI ISOLATION, CULTURE AND CHARACTERIZATION OF EXTRAVILLOUS TROPHOBLAST
   CELLS FROM TERM PLACENTA: A DIFFERENT APPROACH
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Extravillous Trophoblast Cells; Term Placenta; Culture; Cellular
   Characterization
C1 [Prado, K. M.; Borbely, A. U.; Fernandes, I. R.; Sandri, S.; Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI Borbely, Alexandre/G-4859-2012; Sandri, Silvana/A-1650-2015;
   Correa-Silva, Simone/J-9540-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A61
EP A61
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100145
DA 2020-12-01
ER

PT J
AU Sanches, JCT
   Favaro, RR
   Salgado, RM
   Uchiyama, MA
   Bevilacqua, E
   Zom, TM
AF Sanches, J. C. T.
   Favaro, R. R.
   Salgado, R. M.
   Uchiyama, M. A.
   Bevilacqua, E.
   Zom, T. M.
TI EFFECTS OF LONG-TERM TYPE 1 DIABETES ON THE MOUSE PLACENTA
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
C1 [Sanches, J. C. T.; Favaro, R. R.; Salgado, R. M.; Uchiyama, M. A.; Bevilacqua, E.; Zom, T. M.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI De Mayrinck Salgado, Renato/S-7896-2017
OI De Mayrinck Salgado, Renato/0000-0002-1078-2275
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A73
EP A73
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100171
DA 2020-12-01
ER

PT J
AU Cordeiro, LAV
   Lima, PHC
   Bevilacqua, E
AF Vieira Cordeiro, Luiz Augusto
   Costa Lima, Paulo Henrique
   Bevilacqua, Estela
TI ANTI-SINEPTHELIOCHORIAL PLACENTA ANTIBODIES CONSTRUCTED BY PHAGE DISPLAY
   TECHNOLOGY
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Placenta; Phage Display; Sineptheliochorial; scFv
C1 [Bevilacqua, Estela] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI Cordeiro, Luiz A.V./F-2328-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A94
EP A94
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100215
DA 2020-12-01
ER

PT J
AU Weingrill, RB
   Hoshida, MS
   Martinhago, CD
   Bevilacqua, E
AF Weingrill, R. B.
   Hoshida, M. S.
   Martinhago, C. D.
   Bevilacqua, E.
TI EXPRESSION OF CHEMOKINE (C-C MOTIF) LIGAND 25 AND ITS RECEPTOR CCR9
   DURING EMBRYO IMPLANTATION IN MOUSE
SO PLACENTA
LA English
DT Meeting Abstract
CT International-Federation-of-Placental-Associations Meeting 2010
CY OCT 19-22, 2010
CL Santiago, CHILE
DE Embryo Implantation; Blastocyst; Chemokine; Real-Time PCR
C1 [Weingrill, R. B.; Hoshida, M. S.; Bevilacqua, E.] Univ Sao Paulo, Lab Trophoblast Biol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
   [Martinhago, C. D.] RDO Diagnost Med, Sao Paulo, Brazil.
RI Dresch Martinhago, Ciro/M-4596-2016
OI Dresch Martinhago, Ciro/0000-0002-7802-8906
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 2010
VL 31
IS 9
BP A15
EP A15
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 654CW
UT WOS:000282147100048
DA 2020-12-01
ER

PT J
AU Faria, MR
   Hoshida, MS
   Ferro, EAV
   Ietta, F
   Paulesu, L
   Bevilacqua, E
AF Faria, Miriam R.
   Hoshida, Mara S.
   Ferro, Eloisa A. V.
   Ietta, Francesca
   Paulesu, Luana
   Bevilacqua, Estela
TI Spatiotemporal patterns of macrophage migration inhibitory factor (Mif)
   expression in the mouse placenta
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; INNATE IMMUNE-RESPONSES; TROPHOBLAST
   GIANT-CELLS; NATURAL-KILLER-CELLS; HUMAN ENDOMETRIUM; METRIAL GLAND;
   PREGNANCY; MURINE; IMPLANTATION; INVASION
AB Background: Macrophage migration inhibitory factor (MIF) has special pro-inflammatory roles, affecting the functions of macrophages and lymphocytes and counter-regulating the effects of glucocorticoids on the immune response. The conspicuous expression of MIF during human implantation and early embryonic development also suggests this factor acts in reproductive functions. The overall goal of this study was to evaluate Mif expression by trophoblast and embryo placental cells during mouse pregnancy.
   Methods: Mif was immunolocalized at implantation sites on gestation days (gd) 7.5, 10.5, 13.5 and 17.5. Ectoplacental cones and fetal placentas dissected from the maternal tissues were used for Western blotting and qRT-PCR assays on the same gestation days.
   Results: During the post-implantation period (gd7.5), trophoblast giant cells showed strong Mif reactivity. In later placentation phases (gds 10.5-17.5), Mif appeared to be concentrated in the junctional zone and trophoblast giant cells. Mif protein expression increased significantly from gd7.5 to 10.5 (p = 0.005) and from gd7.5 to 13.5 (p = 0.03), remaining at high concentration as gestation proceeded. Higher mRNA expression was found on gd10.5 and was significantly different from gd13.5 (p = 0.048) and 17.5 (p = 0.009).
   Conclusions: The up-regulation of Mif on gd10.5 coincides with the stage in which the placenta assumes its three-layered organization (giant cells, spongiotrophoblast and labyrinth zones), fetal blood circulation begins and population of uNK cells reaches high proportions at the maternal counter part of the placenta, suggesting that Mif may play a role in either the placentation or in the adaptation of the differentiated placenta to the uterus or still in gestational immunomodulatory responses. Moreover, it reinforces the possibility of specific activities for Mif at the maternal fetal interface.
C1 [Faria, Miriam R.; Hoshida, Mara S.; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Ferro, Eloisa A. V.] Univ Fed Uberlandia, Dept Morphol, Uberlandia, MG, Brazil.
   [Ietta, Francesca; Paulesu, Luana] Univ Siena, Dept Physiol, I-53100 Siena, Italy.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Ferro, Eloisa/B-2185-2008; Ferro, Eloisa/K-5533-2016; Hoshida, Mara
   S/D-3900-2012; Bevilacqua, Estela/H-3354-2011; Ietta,
   Francesca/I-5307-2013
OI Ferro, Eloisa/0000-0002-7447-2583; Ferro, Eloisa/0000-0002-7447-2583;
   Hoshida, Mara S/0000-0003-2232-4631; Bevilacqua,
   Estela/0000-0003-4178-4625; Ietta, Francesca/0000-0002-2160-8790
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX This work was supported by FAPESP, CNPq and CAPES. The authors would
   like to thank Adriana F. Costa for providing excellent technical
   assistance and Dr Ricardo Carneiro Borra for helpful statistical
   support.
CR Abe R, 2000, BBA-MOL BASIS DIS, V1500, P1, DOI 10.1016/S0925-4439(99)00080-0
   Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773
   Aeberli D, 2006, RHEUMATOLOGY, V45, P937, DOI 10.1093/rheumatology/kel142
   Ain R, 2004, J REPROD IMMUNOL, V61, P129, DOI 10.1016/j.jri.2004.01.002
   Ain R, 2003, DEV BIOL, V260, P176, DOI 10.1016/S0012-1606(03)00210-0
   Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA
   Apte RS, 1998, J IMMUNOL, V160, P5693
   Arcuri F, 2006, REPRODUCTION, V131, P175, DOI 10.1530/rep.1.00857
   Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200
   Arcuri F, 1999, BIOL REPROD, V60, P1299, DOI 10.1095/biolreprod60.6.1299
   Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200
   Bilinski MJ, 2008, REPROD BIOMED ONLINE, V16, P218, DOI 10.1016/S1472-6483(10)60577-9
   Bondza PK, 2008, FERTIL STERIL, V90, P1433, DOI 10.1016/j.fertnstert.2007.08.046
   Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341
   CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0
   Chen L, 2007, REPRODUCTION, V133, P405, DOI 10.1530/rep.1.01020
   Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166
   Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015
   Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2
   Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065
   GARDNER RL, 1973, J EMBRYOL EXP MORPH, V30, P561
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200
   HANSEN KA, 1992, AM J OBSTET GYNECOL, V166, P87, DOI 10.1016/0002-9378(92)91835-X
   Hemberger M, 2003, DEV DYNAM, V227, P185, DOI 10.1002/dvdy.10291
   Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200
   Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007
   Houdeau E, 2007, GASTROENTEROLOGY, V132, P982, DOI 10.1053/j.gastro.2006.12.028
   Hurskainen T, 1998, J HISTOCHEM CYTOCHEM, V46, P221, DOI 10.1177/002215549804600211
   Ietta F, 2007, AM J PHYSIOL-ENDOC M, V292, pE272, DOI 10.1152/ajpendo.00086.2006
   Ji RP, 2003, CIRC RES, V92, P133, DOI 10.1161/01.RES.0000056532.18710.C0
   Kats R, 2005, HUM REPROD, V20, P3518, DOI 10.1093/humrep/dei234
   Krockenberger M, 2008, J IMMUNOL, V180, P7338, DOI 10.4049/jimmunol.180.11.7338
   Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286
   Letta F, 2002, AM J REPROD IMMUNOL, V48, P404, DOI 10.1034/j.1600-0897.2002.01152.x
   Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318
   Ma GT, 2000, BIOL REPROD, V63, P570, DOI 10.1095/biolreprod63.2.570
   Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730
   Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599
   Muller H, 1999, ENDOCRINOLOGY, V140, P2711, DOI 10.1210/en.140.6.2711
   Nemajerova A, 2007, CELL CYCLE, V6, P1030, DOI 10.4161/cc.6.9.4163
   Ogren L, 1988, Int Rev Cytol, V112, P1
   Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200
   Paulesu L, 2005, BIOL REPROD, V72, P949, DOI 10.1095/biolreprod.104.029058
   PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2
   Roger T, 2005, EUR J IMMUNOL, V35, P3405, DOI 10.1002/eji.200535413
   Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a
   SALINOVICH O, 1986, ANAL BIOCHEM, V156, P341, DOI 10.1016/0003-2697(86)90263-0
   Sashinami H, 2006, MICROB PATHOGENESIS, V41, P111, DOI 10.1016/j.micpath.2006.06.001
   Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020
   SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x
   Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334
   Suzuki H, 1996, IMMUNOL LETT, V51, P141, DOI 10.1016/0165-2478(96)02543-6
   Suzuki H, 1996, BIOCHEM MOL BIOL INT, V38, P409
   SZEKERESBARTHO J, 1985, J REPROD IMMUNOL, V7, P121, DOI 10.1016/0165-0378(85)90066-X
   Temmerman L, 2010, GROWTH HORM IGF RES, V20, P255, DOI 10.1016/j.ghir.2010.03.002
   VANVOORHIS BJ, 1989, J CLIN ENDOCR METAB, V69, P1195
   Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230
   Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280
   Zhang XM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-26
NR 64
TC 18
Z9 21
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD AUG 4
PY 2010
VL 8
AR 95
DI 10.1186/1477-7827-8-95
PG 9
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA 659GX
UT WOS:000282556100001
PM 20684790
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Akamine, EH
   Marcal, AC
   Camporez, JP
   Hoshida, MS
   Caperuto, LC
   Bevilacqua, E
   Carvalho, CRO
AF Akamine, Eliana H.
   Marcal, Anderson C.
   Camporez, Joao Paulo
   Hoshida, Mara S.
   Caperuto, Luciana C.
   Bevilacqua, Estela
   Carvalho, Carla R. O.
TI Obesity induced by high-fat diet promotes insulin resistance in the
   ovary
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID FOLLICLE-STIMULATING-HORMONE; FEMALE REPRODUCTIVE FUNCTION; HUMAN
   GRANULOSA-CELLS; LUTEINIZING-HORMONE; POLYCYSTIC-OVARY; SIGNALING
   PATHWAYS; GLUCOSE-UPTAKE; 3T3-L1 ADIPOCYTES; THECA CELLS; RECEPTOR
AB Besides the effects on peripheral energy homeostasis, insulin also has an important role in ovarian function. Obesity has a negative effect on fertility, and may play a role in the development of the polycystic ovary syndrome in susceptible women. Since insulin resistance in the ovary could contribute to the impairment of reproductive function in obese women, we evaluated insulin signaling in the ovary of high-fat diet-induced obese rats. Female Wistar rats were submitted to a high-fat diet for 120 or 180 days, and the insulin signaling pathway in the ovary was evaluated by immunoprecipitation and immunoblotting. At the end of the diet period, we observed insulin resistance, hyperinsulinemia, an increase in progesterone serum levels, an extended estrus cycle, and altered ovarian morphology in obese female rats. Moreover, in female obese rats treated for 120 days with the high-fat diet, the increase in progesterone levels occurred together with enhancement of LH levels. The ovary from high-fat-fed female rats showed a reduction in the insulin receptor substrate/phosphatidylinositol 3-kinase/AKT intracellular pathway, associated with an increase in FOXO3a, IL1B, and TNF alpha protein expression. These changes in the insulin signaling pathway may have a role in the infertile state associated with obesity. Journal of Endocrinology (2010) 206, 65-74
C1 [Akamine, Eliana H.; Marcal, Anderson C.; Camporez, Joao Paulo; Carvalho, Carla R. O.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508900 Sao Paulo, Brazil.
   [Akamine, Eliana H.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, BR-05508900 Sao Paulo, Brazil.
   [Hoshida, Mara S.; Bevilacqua, Estela] Univ Sao Paulo, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Caperuto, Luciana C.] Univ Fed Sao Paulo, Dept Biol Sci, BR-04023900 Diadema, SP, Brazil.
RP Carvalho, CRO (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508900 Sao Paulo, Brazil.
EM croc@icb.usp.br
RI Carvalho, Carla R. O./H-6476-2018; Bevilacqua, Estela/H-3354-2011;
   Camporez, Joao Paulo G/B-9122-2015; Akamine, Eliana Hiromi/C-5231-2012;
   Hoshida, Mara S/D-3900-2012; Caperuto, Luciana/K-2489-2012
OI Carvalho, Carla R. O./0000-0001-5824-8656; Bevilacqua,
   Estela/0000-0003-4178-4625; Akamine, Eliana Hiromi/0000-0003-2715-7158;
   Hoshida, Mara S/0000-0003-2232-4631; Chagas Caperuto,
   Luciana/0000-0002-6008-4010
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/52163-7,
   2006/60215-7]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [477906/2006-0]; FAPESPFundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP); EHA
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo-FAPESP (2006/52163-7; 2006/60215-7) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq
   (477906/2006-0). ACM and JPC were supported by fellowships from FAPESP,
   and EHA was the recipient of fellowships from FAPESP and CNPq in
   different phases of the project.
CR ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441
   Adashi EY, 1997, ENDOCRINOLOGY, V138, P3881, DOI 10.1210/en.138.9.3881
   ADASHI EY, 1989, J BIOL CHEM, V264, P11591
   BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x
   Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551
   BARBIERI RL, 1983, FERTIL STERIL, V40, P237
   Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426
   Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022
   Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105
   Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706
   Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336
   CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117
   Check JH, 2009, CLIN EXP OBSTET GYN, V36, P214
   Dorn C, 2004, AM J OBSTET GYNECOL, V191, P132, DOI 10.1016/j.ajog.2004.01.054
   Franks S, 1999, ENDOCRIN METAB CLIN, V28, P361, DOI 10.1016/S0889-8529(05)70074-8
   Gerard N, 2004, J ENDOCRINOL, V180, P203, DOI 10.1677/joe.0.1800203
   Ghersevich S, 2001, MOL CELL ENDOCRINOL, V172, P21, DOI 10.1016/S0303-7207(00)00396-8
   GIORGETTI S, 1994, EUR J BIOCHEM, V223, P195, DOI 10.1111/j.1432-1033.1994.tb18983.x
   Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229
   Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372
   Kol S, 1997, J CLIN INVEST, V99, P2274, DOI 10.1172/JCI119403
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400
   Lawson MA, 2008, J CLIN ENDOCR METAB, V93, P2089, DOI 10.1210/jc.2007-2656
   Legro RS, 2000, ANN NY ACAD SCI, V900, P193, DOI 10.1111/j.1749-6632.2000.tb06230.x
   Lima MHM, 2006, J ENDOCRINOL, V190, P451, DOI 10.1677/joe.1.06226
   Liu L, 2007, J MOL ENDOCRINOL, V38, P137, DOI 10.1677/jme.1.02027
   Machelon V, 1997, EUR CYTOKINE NETW, V8, P137
   MCGEE E, 1995, J SOC GYNECOL INVEST, V2, P535, DOI 10.1016/1071-5576(94)00061-5
   Metwally M, 2007, OBES REV, V8, P515, DOI 10.1111/j.1467-789X.2007.00406.x
   Moret M, 2009, NEUROENDOCRINOLOGY, V89, P131, DOI 10.1159/000160911
   Neganova I, 2007, BIOL REPROD, V76, P1045, DOI 10.1095/biolreprod.106.059360
   Nelson-Degrave VL, 2005, MOL ENDOCRINOL, V19, P379, DOI 10.1210/me.2004-0178
   Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001
   NESTLER JE, 1991, ENDOCRIN METAB CLIN, V20, P807, DOI 10.1016/S0889-8529(18)30245-7
   Odukoya OA, 1997, MOL HUM REPROD, V3, P393, DOI 10.1093/molehr/3.5.393
   PASQUALI R, 1993, CLIN ENDOCRINOL, V39, P1, DOI 10.1111/j.1365-2265.1993.tb01744.x
   PATTI ME, 1995, J BIOL CHEM, V270, P24670, DOI 10.1074/jbc.270.42.24670
   PORETSKY L, 1991, ENDOCR REV, V12, P3, DOI 10.1210/edrv-12-1-3
   PORETSKY L, 1984, J CLIN ENDOCR METAB, V59, P809, DOI 10.1210/jcem-59-4-809
   Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535
   RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0
   Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3
   Schaffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003
   Sekar N, 2001, ENDOCRINOLOGY, V142, P2921, DOI 10.1210/en.142.7.2921
   Shaw MA, 1997, J NUTR, V127, P64
   SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835
   Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311
   Umezawa M, 2008, CYTOKINE, V43, P105, DOI 10.1016/j.cyto.2008.04.016
   Wada T, 2010, AM J PHYSIOL-ENDOC M, V298, pE881, DOI 10.1152/ajpendo.00649.2009
   Weiss J. M., 2003, Archives of Gynecology and Obstetrics, V269, P45, DOI 10.1007/s00404-003-0506-9
   Willis D, 1996, J CLIN ENDOCR METAB, V81, P302, DOI 10.1210/jc.81.1.302
   WILLIS D, 1995, J CLIN ENDOCR METAB, V80, P3788, DOI 10.1210/jc.80.12.3788
   Zhang GQ, 2000, ENDOCRINOLOGY, V141, P2735, DOI 10.1210/en.141.8.2735
NR 54
TC 64
Z9 67
U1 0
U2 12
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JUL
PY 2010
VL 206
IS 1
BP 65
EP 74
DI 10.1677/JOE-09-0461
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 612CE
UT WOS:000278873600007
PM 20453076
OA Bronze
DA 2020-12-01
ER

PT J
AU Bevilacqua, E
   Hoshida, MS
   Amarante-Paffaro, A
   Albieri-Borges, A
   Gomes, SZ
AF Bevilacqua, Estela
   Hoshida, Mara-Sandra
   Amarante-Paffaro, Andrea
   Albieri-Borges, Andrea
   Gomes, Sara Zago
TI Trophoblast phagocytic program: roles in different placental systems
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE trophoblast; placenta; phagocytosis; erythrophagocytosis; defense
   mechanism
ID TOLL-LIKE RECEPTORS; MOUSE IMPLANTING TROPHOBLAST; NITRIC-OXIDE
   SYNTHASE; EMBRYO IMPLANTATION; INTERFERON-GAMMA; EXTRAVILLOUS
   TROPHOBLAST; ANTIMESOMETRIAL DECIDUA; COLLAGEN PHAGOCYTOSIS; MATERNAL
   ERYTHROCYTES; UTERINE EPITHELIUM
AB Although not belonging to the class of professional phagocytes, in many species trophoblast cells exhibit intense phagocytic activity. The complete range of physiological functions of trophoblast phagocytosis has not yet been fully characterized. Close association between the trophoblast and nutrition was determined many years ago. Hubrecht (1889) when proposing for the first time the name trophoblast to the external layer of the blastocyst, directly established the nutritive significance of this embryonic layer. Indeed, histotrophic phagocytosis, i.e. the internalization of maternal cells and secreted materials, is considered an important function of the trophoblast before the completion of the placenta. Recently, however, unexpected characteristics of the trophoblast have significantly enhanced our understanding of this process. Roles in acquisition of space for embryo development, in tissue remodeling during implantation and placentation and in defense mechanisms are highlighting how this cellular activity may be relevant for the maternal-fetal relationship beyond its nutritional function.
C1 [Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508900 Sao Paulo, Brazil.
   [Albieri-Borges, Andrea] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Av Prof Lineu Prestes,1524 Butanta, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Hoshida, Mara S/D-3900-2012; Bevilacqua, Estela/H-3354-2011
OI Hoshida, Mara S/0000-0003-2232-4631; Bevilacqua,
   Estela/0000-0003-4178-4625
CR Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010
   Afonso S, 1997, DEVELOPMENT, V124, P3415
   ALABBASS AH, 1966, J ANAT, V100, P349
   Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34
   Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   ALBIERI A, 2001, PLACENTA, V22, pA11
   Alexander CM, 1996, DEVELOPMENT, V122, P1723
   Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214
   Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x
   Assemat E, 2005, BIOL REPROD, V72, P1079, DOI 10.1095/biolreprod.104.036913
   Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   BAUMBACH GA, 1990, ANAT EMBRYOL, V182, P563
   BEVILACQUA E, 1994, ACTA ANAT, V150, P246
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   BRIGGS RT, 1975, J CELL BIOL, V64, P254, DOI 10.1083/jcb.64.1.254
   Burrows TD, 1996, HUM REPROD UPDATE, V2, P307, DOI 10.1093/humupd/2.4.307
   Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954
   BURTON GJ, 1982, PLACENTA, V3, P407, DOI 10.1016/S0143-4004(82)80033-7
   Choy MY, 1998, HUM REPROD, V13, P2941, DOI 10.1093/humrep/13.10.2941
   CLINT JM, 1979, PROC R SOC SER B-BIO, V204, P345, DOI 10.1098/rspb.1979.0031
   Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734
   CONTRACTOR SF, 1976, J CELL SCI, V21, P595
   Coopman PJ, 1998, CLIN CANCER RES, V4, P507
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   DELGADO MA, 1978, AM J TROP MED HYG, V27, P1108, DOI 10.4269/ajtmh.1978.27.1108
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6
   Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013
   ENDERS AC, 1973, AM J ANAT, V138, P277, DOI 10.1002/aja.1001380302
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   ENDERS AC, 1976, J REPROD FERTIL    S, V25, P1
   Enders AC, 2006, CELLS TISSUES ORGANS, V183, P141, DOI 10.1159/000095988
   FERRO EAV, 1994, J MORPHOL, V221, P139, DOI 10.1002/jmor.1052210204
   FOLDES JJ, 1973, INT J FERTIL, V20, P228
   FRAULI M, 1987, EUR J OBSTET GYN R B, V26, P135, DOI 10.1016/0028-2243(87)90048-7
   Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   GARDNER RL, 1975, S SOC DEV BIOL, V33, P207
   Gattoni A, 2006, Clin Ter, V157, P457
   Gomes SZ, 2008, PLACENTA, V29, P114
   Goncalves CR, 2003, HISTOCHEM CELL BIOL, V119, P189, DOI 10.1007/s00418-003-0500-0
   GORETZKI L, 1992, FEBS LETT, V297, P112, DOI 10.1016/0014-5793(92)80339-I
   HARVEY MB, 1995, DEVELOPMENT, V121, P1005
   HATA T, 1981, ACTA OBSTET GYN JPN, V33, P537
   HEYNER S, 1989, DEV BIOL, V134, P48, DOI 10.1016/0012-1606(89)90077-8
   Hoshida MS, 2007, PLACENTA, V28, P1059, DOI 10.1016/j.placenta.2007.03.009
   Hubrecht A. A. W., 1889, Q J MICROSC SCI, V30, P283
   Jones CJP, 2001, PLACENTA, V22, P440, DOI 10.1053/plac.2001.0680
   Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289
   KATZ S, 1987, ANAT EMBRYOL, V176, P251, DOI 10.1007/BF00310059
   KNOTH M, 1972, ACTA OBSTET GYN SCAN, V51, P385, DOI 10.3109/00016347209156879
   Lafuse WP, 2006, J INTERF CYTOK RES, V26, P548, DOI 10.1089/jir.2006.26.548
   Leanza EC, 2007, AM J REPROD IMMUNOL, V58, P537, DOI 10.1111/j.1600-0897.2007.00537.x
   Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X
   Leslie RGQ, 2004, IMMUNOLOGY, V111, P86, DOI 10.1111/j.1365-2567.2004.01780.x
   Lorenzon AR, 2008, PLACENTA, V29, P115
   Ma Y, 2007, PLACENTA, V28, P1024, DOI 10.1016/j.placenta.2007.05.003
   Manyonda IT, 1999, J SOC GYNECOL INVEST, V6, P158, DOI 10.1016/S1071-5576(99)00010-6
   Matsubara S, 2000, PLACENTA, V21, P273, DOI 10.1053/plac.1999.0463
   Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079
   Minazaki CK, 2008, RES VET SCI, V84, P326, DOI 10.1016/j.rvsc.2007.06.013
   Murphy G, 1992, Matrix Suppl, V1, P224
   Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x
   NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670
   Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608
   O'Mahony D Shane, 2008, Int J Med Sci, V5, P1
   PARKENING TA, 1976, J ANAT, V122, P211
   PARR MB, 1974, BIOL REPROD, V11, P220, DOI 10.1095/biolreprod11.2.220
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   Peters TJ, 1999, CELL TISSUE RES, V295, P287, DOI 10.1007/s004410051235
   Rassoulzadegan M, 2000, EMBO J, V19, P3295, DOI 10.1093/emboj/19.13.3295
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Rocha CR, 2007, PLACENTA, V28, pA10
   Salminen A, 2008, PEDIATR RES, V63, P280, DOI 10.1203/PDR.0b013e318163a8b2
   SCHLESINGER M, 1967, FERTIL STERIL, V18, P95
   SEAL US, 1972, AM J ANAT, V134, P263, DOI 10.1002/aja.1001340209
   Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7
   Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009
   SMITH RM, 1993, BIOL REPROD, V49, P1, DOI 10.1095/biolreprod49.1.1
   Stoffel MH, 2000, J REPROD FERTIL, V118, P315, DOI 10.1530/reprod/118.2.315
   Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439
   Teesalu T, 1996, MECH DEVELOP, V56, P103, DOI 10.1016/0925-4773(96)00515-1
   Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744
   Varanou A, 2006, J MOL MED, V84, P305, DOI 10.1007/s00109-005-0032-2
   WANG T, 1983, PLACENTA, V4, P185, DOI 10.1016/S0143-4004(83)80031-9
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   WELSH AO, 1991, AM J ANAT, V192, P215, DOI 10.1002/aja.1001920302
   Zybina TG, 2005, CELL BIOL INT, V29, P1071, DOI 10.1016/j.cellbi.2005.10.015
NR 92
TC 25
Z9 27
U1 0
U2 3
PU U B C PRESS
PI BILBAO
PA UNIV BASQUE COUNTRY, EDITORIAL SERVICES, PO BOX 1397, E-48080 BILBAO,
   SPAIN
SN 0214-6282
J9 INT J DEV BIOL
JI Int. J. Dev. Biol.
PY 2010
VL 54
IS 2-3
SI SI
BP 495
EP 505
DI 10.1387/ijdb.082761eb
PG 11
WC Developmental Biology
SC Developmental Biology
GA 573PR
UT WOS:000275927200026
PM 19757392
OA Bronze
DA 2020-12-01
ER

PT J
AU Sandri, S
   Correa-Silva, S
   Knebel, FH
   Oliveira, LG
   Bevilacqua, E
   Campa, A
AF Sandri, S.
   Correa-Silva, S.
   Knebel, F. H.
   Oliveira, L. G.
   Bevilacqua, E.
   Campa, A.
TI Expression of acute phase and constitutive serum amyloid A in term human
   placenta from normal pregnancy
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT 7th European Congress of Reproductive Immunology
CY SEP 17-20, 2009
CL Marathon, GREECE
SP European Soc Reprod Immunol, Helena Venizelou Hosp, Immunobiol Dept, Helen Soc Immunol
C1 [Sandri, S.; Knebel, F. H.; Campa, A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, Brazil.
   [Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil.
   [Oliveira, L. G.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Correa-Silva, S.] Univ Fed Ouro Preto, Escola Nutr, Ouro Preto, MG, Brazil.
RI De Oliveira, Leandro/G-3476-2012; Sandri, Silvana/A-1650-2015;
   Correa-Silva, Simone/J-9540-2012; Campa, Ana/D-4669-2012
OI De Oliveira, Leandro/0000-0002-8422-9907; Campa, Ana/0000-0002-6183-3378
CR Kovacevic A, 2006, FEBS LETT, V580, P161, DOI 10.1016/j.febslet.2005.11.067
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD SEP
PY 2009
VL 81
IS 2
BP 153
EP 153
DI 10.1016/j.jri.2009.06.211
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 494WP
UT WOS:000269850500083
DA 2020-12-01
ER

PT J
AU Correa-Silva, S
   Oliveira, LG
   Sass, N
   Camara, NO
   Bevilacqua, E
AF Correa-Silva, S.
   Oliveira, L. G.
   Sass, N.
   Camara, N. O.
   Bevilacqua, E.
TI Immunophenotype of dendritic cells in renal transplanted pregnant women
   at first, second and third trimester
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT 7th European Congress of Reproductive Immunology
CY SEP 17-20, 2009
CL Marathon, GREECE
SP European Soc Reprod Immunol, Helena Venizelou Hosp, Immunobiol Dept, Helen Soc Immunol
C1 [Camara, N. O.] Univ Sao Paulo, Dept Imunol, BR-05508 Sao Paulo, Brazil.
   [Oliveira, L. G.; Sass, N.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Correa-Silva, S.; Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
   [Correa-Silva, S.] Univ Fed Ouro Preto, Escola Nutr, Ouro Preto, MG, Brazil.
RI Camara, Niels OS/G-8336-2011; camara, niels/AAX-3269-2020; Correa-Silva,
   Simone/J-9540-2012; Sass, Nelson/AAD-8259-2020
OI Camara, Niels OS/0000-0001-5436-1248; camara, niels/0000-0001-5436-1248;
   Sass, Nelson/0000-0001-7187-1004
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD SEP
PY 2009
VL 81
IS 2
BP 161
EP 161
DI 10.1016/j.jri.2009.06.226
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 494WP
UT WOS:000269850500098
DA 2020-12-01
ER

PT J
AU Daher, S
   Guimaraes, AJ
   Mattar, R
   Zenclussen, AC
   Paulesu, LR
   Bevilacqua, E
AF Daher, S.
   Guimaraes, A. J.
   Mattar, R.
   Zenclussen, A. C.
   Paulesu, L. R.
   Bevilacqua, E.
TI Immunolocalization of pro- and anti-apoptotic molecules in early human
   placentas in abortion and healthy pregnancies
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT 7th European Congress of Reproductive Immunology
CY SEP 17-20, 2009
CL Marathon, GREECE
SP European Soc Reprod Immunol, Helena Venizelou Hosp, Immunobiol Dept, Helen Soc Immunol
C1 [Daher, S.; Guimaraes, A. J.; Mattar, R.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Zenclussen, A. C.] Otto Von Guericke Univ, Fac Med, Dept Expt Obstet & Gynecol, Magdeburg, Germany.
   [Paulesu, L. R.] Univ Siena, Dept Physiol, I-53100 Siena, Italy.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RI Zenclussen, Ana C/G-2186-2013; DAHER, SILVIA/D-2180-2012; Zenclussen,
   Ana/AAE-8760-2020
OI Zenclussen, Ana C/0000-0003-3544-4552; DAHER,
   SILVIA/0000-0001-5312-7804; Zenclussen, Ana/0000-0003-3544-4552
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD SEP
PY 2009
VL 81
IS 2
BP 163
EP 163
DI 10.1016/j.jri.2009.06.231
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 494WP
UT WOS:000269850500103
DA 2020-12-01
ER

PT J
AU Klisch, K
   Bevilacqua, E
AF Klisch, K.
   Bevilacqua, E.
TI The Sd (a)-glycotope, recognized by the CT1 monoclonal antibody, is a
   surface-marker for mouse uterine natural killer cells
SO JOURNAL OF ANATOMY
LA English
DT Meeting Abstract
C1 [Klisch, K.] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RI Klisch, Karl/G-8248-2011; Klisch, Karl/B-5055-2018
OI Klisch, Karl/0000-0003-2176-5451
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8782
J9 J ANAT
JI J. Anat.
PD MAY
PY 2009
VL 214
IS 5
BP 787
EP 787
PG 1
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 436QH
UT WOS:000265428900041
DA 2020-12-01
ER

PT J
AU Daher, S
   Guimaraes, AJ
   Mattar, R
   Ishigai, MMS
   Barreiro, EG
   Bevilacqua, E
AF Daher, Silvia
   Guimaraes, Alberto J.
   Mattar, Rosiane
   Ishigai, Marcia M. S.
   Barreiro, Erica G.
   Bevilacqua, Estela
TI Bcl-2 and Bax expressions in pre-term, term and post-term placentas
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE apoptosis; parturition; placenta; post-term birth; premature labor
ID PROTEIN EXPRESSION; PREMATURE RUPTURE; APOPTOSIS; LABOR
AB Problem
   Placental apoptosis-associated protein imbalance might contribute to the pathogenesis of pre- and post-term birth. Therefore, we evaluated the expression and distribution of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) molecules in term, pre-term and post-term placentas.
   Method of Study
   Placental samples were collected from women with term (n = 25), pre-term (n = 7) and post-term (n = 10) deliveries. The expression of Bcl-2 and Bax was assessed by immunochemistry on paraffin-embedded placental specimens.
   Results
   The pattern of immunostaining for Bcl-2 and Bax was the same in all samples, but not the intensity. The Bax/Bcl-2 ratio was higher in both pre-term and post-term placental samples compared with term placentas as a result of intense reactivity for the pro-apoptotic factor, Bax in pre-term and post-term placentas and, for Bcl-2 decrease in pre-term placentas.
   Conclusion
   These findings suggest that different unbalance mechanisms in placental apoptotic-associated protein expressions may be involved in the physiopathology of pre-term and post-term births.
C1 [Daher, Silvia; Guimaraes, Alberto J.; Mattar, Rosiane; Barreiro, Erica G.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Obstet, Sao Paulo, Brazil.
   [Ishigai, Marcia M. S.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Pathol, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Fed Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, Sao Paulo, Brazil.
RP Daher, S (corresponding author), Rua Bela Cintra 1920,Ap 41, BR-01415002 Sao Paulo, Brazil.
EM silviadaher@hotmail.com
RI Bevilacqua, Estela/H-3354-2011; DAHER, SILVIA/D-2180-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; DAHER,
   SILVIA/0000-0001-5312-7804
CR Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4
   Axt R., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P56
   Barrio E, 2004, J PEDIATR ENDOCR MET, V17, P451
   Cirelli N, 1999, BIOL REPROD, V61, P458, DOI 10.1095/biolreprod61.2.458
   De Falco M, 2001, HISTOCHEM J, V33, P421, DOI 10.1023/A:1013728012048
   Fortunato SJ, 2001, AM J OBSTET GYNECOL, V184, P1399, DOI 10.1067/mob.2001.115122
   Halperin R, 2000, GYNECOL OBSTET INVES, V50, P84, DOI 10.1159/000010287
   Ishihara N, 2000, ENDOCR J, V47, P317, DOI 10.1507/endocrj.47.317
   Kanduc D, 2002, INT J ONCOL, V21, P165
   Langston C, 1997, ARCH PATHOL LAB MED, V121, P449
   McLaren J, 1999, HUM REPROD, V14, P2895, DOI 10.1093/humrep/14.11.2895
   Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453
   Ratts VS, 2000, PLACENTA, V21, P361, DOI 10.1053/plac.1999.0486
   Sagol S, 2002, J REPROD MED, V47, P809
   Sakuragi N, 1998, INT J CANCER, V79, P153, DOI 10.1002/(SICI)1097-0215(19980417)79:2<153::AID-IJC10>3.0.CO;2-B
   Sgarbosa F, 2006, DIABETES RES CLIN PR, V73, P143, DOI 10.1016/j.diabres.2005.12.014
   Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1
   Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003
   Tanir H. Mete, 2005, Archives of Gynecology and Obstetrics, V273, P98, DOI 10.1007/s00404-005-0028-8
NR 19
TC 15
Z9 19
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD AUG
PY 2008
VL 60
IS 2
BP 172
EP 178
DI 10.1111/j.1600-0897.2008.00609.x
PG 7
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 324JB
UT WOS:000257513800009
PM 18705844
DA 2020-12-01
ER

PT J
AU Ambrosio, CE
   Ferreira, JR
   Morini, AC
   Favaron, PO
   Franciolli, ALR
   Bevilacqua, E
   Pfarrer, C
   Miglino, MA
AF Ambrosio, C. E.
   Ferreira, J. R.
   Morini, A. C.
   Favaron, P. O.
   Franciolli, A. L. R.
   Bevilacqua, E.
   Pfarrer, C.
   Miglino, M. A.
TI Female reproductive system and placentation in tamandua tetradactyla
SO PLACENTA
LA English
DT Meeting Abstract
CT 14th Meeting of the
   International-Federation-of-Placental-Associations/12th Meeting of the
   European-Placenta-Group (IFPA/EPG)
CY SEP 10-13, 2008
CL Seggau Castle, AUSTRIA
SP Int Federat Placenta Assoc, European Placenta Grp
C1 [Ambrosio, C. E.; Morini, A. C.; Favaron, P. O.; Franciolli, A. L. R.; Miglino, M. A.] Univ Sao Paulo, Fac Vet Med, Dept Surg, BR-05508 Sao Paulo, Brazil.
   [Ferreira, J. R.] Univ Brasilia, Sch Med, BR-70910900 Brasilia, DF, Brazil.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Pfarrer, C.] Vet Univ Hannover, Dept Anat, Hannover, Germany.
RI Miglino, Maria Angelica/B-9519-2012; Morini, Adriana/K-2028-2012;
   Favaron, Phelipe O/E-4636-2013; Ambrosio, Carlos Eduardo/F-3402-2010;
   Franciolli, Andre Luis/K-6739-2012
OI Miglino, Maria Angelica/0000-0003-4979-115X; Morini,
   Adriana/0000-0001-8731-9935; Ambrosio, Carlos
   Eduardo/0000-0002-8224-5022; Franciolli, Andre Luis/0000-0002-1127-9129
NR 0
TC 1
Z9 1
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD AUG
PY 2008
VL 29
IS 8
BP A34
EP A34
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 345XM
UT WOS:000259031100132
DA 2020-12-01
ER

PT J
AU Hoshida, MS
   Gorjao, R
   Cori, R
   Bevilacqua, E
AF Hoshida, Mara S.
   Gorjao, Renata
   Cori, Rui
   Bevilacqua, Estela
TI Expression of Ccl25 by the implanting mouse trophoblast
SO PLACENTA
LA English
DT Meeting Abstract
CT 14th Meeting of the
   International-Federation-of-Placental-Associations/12th Meeting of the
   European-Placenta-Group (IFPA/EPG)
CY SEP 10-13, 2008
CL Seggau Castle, AUSTRIA
SP Int Federat Placenta Assoc, European Placenta Grp
C1 [Hoshida, Mara S.; Gorjao, Renata; Cori, Rui; Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
RI Gorjao, Renata/D-4130-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD AUG
PY 2008
VL 29
IS 8
BP A21
EP A21
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 345XM
UT WOS:000259031100082
DA 2020-12-01
ER

PT J
AU Jones, CJP
   Skidmore, JA
   Bevilacqua, E
   Wooding, FBP
   Aplin, JD
AF Jones, C. J. P.
   Skidmore, J. A.
   Bevilacqua, E.
   Wooding, F. B. P.
   Aplin, J. D.
TI Evolutionary aspects of trophoblast glycosylation in a CA MA
   (camel-llama cross) and related species
SO PLACENTA
LA English
DT Meeting Abstract
CT 14th Meeting of the
   International-Federation-of-Placental-Associations/12th Meeting of the
   European-Placenta-Group (IFPA/EPG)
CY SEP 10-13, 2008
CL Seggau Castle, AUSTRIA
SP Int Federat Placenta Assoc, European Placenta Grp
C1 [Jones, C. J. P.; Aplin, J. D.] Univ Manchester, Manchester M13 9PL, Lancs, England.
   [Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Wooding, F. B. P.] Univ Cambridge, Cambridge CB2 1TN, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD AUG
PY 2008
VL 29
IS 8
BP A29
EP A29
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 345XM
UT WOS:000259031100112
DA 2020-12-01
ER

PT J
AU Minazaki, CK
   Gagioti, S
   Zago, D
   Terra, W
   Araujo, VC
   Oliveira, RA
   Bevilacqua, E
AF Minazaki, C. K.
   Gagioti, S.
   Zago, D.
   Terra, W.
   Araujo, V. C.
   Oliveira, R. A.
   Bevilacqua, E.
TI Acid phosphatase and cathepsin D are active expressed enzymes in the
   placenta of the cat
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE placenta; chorionic villi; phagocytosis; lysosomes; trophoblasts; cats
ID NEAR-TERM PARAPLACENTA; NADPH OXIDASE; DOMESTIC CAT; IN-VIVO;
   LOCALIZATION; TROPHOBLAST; PROTEINASES; MACROPHAGES; LEUKOCYTES;
   APOPTOSIS
AB Enzymes are crucial for the metabolism of macromolecular substrates. In the great majority of cells, most enzymes are constitutive. Nevertheless, inducible enzymes can predominate, determining specialized cell functions. Within this context, histochemistry/immunohistochemistry and biochemistry were used to investigate expression of peroxidase and reduced nicotinamide-adenine dinucleotide phosphate (NADPH)-oxidase, as well as the expression and activity of cathepsin D and acid phosphatase, in trophoblast cells within the endotheliochorial labyrinth and marginal hematoma of the term cat placenta. In the marginal hematoma, elevated Cathepsin D expression and activity was accompanied by erythrophagocytosis. In contrast, acid phosphatase activity was much more intense in the labyrinth, where metabolic exchanges occur. Peroxidase and NAD(P)H-oxidase were predominantly active in trophoblast cells within endosomal vesicles of different placental compartments, indicating that, although reactive oxygen species might participate in endosomal/lysosomal processes, they are not territorially specific or functional markers. These findings highlight differential characteristics of cathepsin D and acid phosphatase activity within each placental compartment, thereby contributing to the comprehension of the territorial role played by the placenta and facilitating future metabolic studies. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Minazaki, C. K.; Oliveira, R. A.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   [Gagioti, S.] Univ Ibirapuera, Postgrad Biodent Program, Sao Paulo, SP, Brazil.
   [Gagioti, S.; Zago, D.] Univ Santo Amaro, Dept Morphol, Sao Paulo, SP, Brazil.
   [Terra, W.] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, SP, Brazil.
   [Araujo, V. C.] Univ Sao Paulo, Fac Dent, Dept Pathol, BR-05508900 Sao Paulo, SP, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011; Araujo, Vera C/G-3586-2014
OI Bevilacqua, Estela/0000-0003-4178-4625; 
CR Afonso S, 1999, DEV DYNAM, V216, P374, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<374::AID-DVDY6>3.0.CO;2-N
   ARAKI N, 1995, EXP CELL RES, V217, P469, DOI 10.1006/excr.1995.1111
   Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476
   Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745
   Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200
   Blankenship TN, 1997, ACTA ANAT, V158, P227
   Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952
   BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566
   Champion EE, 2005, PLACENTA, V26, P608, DOI 10.1016/j.placenta.2004.07.010
   CHAMPION EE, 2004, J PHYSL REGULATORY I, V287, P1369
   CHRISTIE GA, 1968, HISTOCHEMISTRY, V12, P189, DOI 10.1007/BF00305996
   Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004
   ELANGOVAN S, 1980, BIOL REPROD, V23, P663, DOI 10.1095/biolreprod23.3.663
   Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   GARESSE R, 1979, EUR J BIOCHEM, V99, P253, DOI 10.1111/j.1432-1033.1979.tb13252.x
   Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843
   Gomori G, 1936, AM J PATHOL, V12, P655
   Green J, 1998, ADV EXP MED BIOL, V436, P163
   Jones CJP, 2005, PLACENTA, V26, P585, DOI 10.1016/j.placenta.2004.10.015
   Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078
   LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275
   LEISER R, 1980, ACTA ANAT, V106, P293, DOI 10.1159/000145194
   LEISER R, 1980, ACTA ANAT, V106, P312
   LEISER R, 1993, J EXP ZOOL, V266, P642, DOI 10.1002/jez.1402660612
   Malassine A, 2001, Gynecol Obstet Fertil, V29, P489, DOI 10.1016/S1297-9589(01)00173-4
   MALASSINE A, 1976, HISTOCHEMISTRY, V47, P191, DOI 10.1007/BF00489962
   Malassine A, 1982, BIBL ANAT, V22, P108
   MALASSINE A, 2006, ANAT EMBRYOL, V151, P267
   Manyonda IT, 1999, J SOC GYNECOL INVEST, V6, P158, DOI 10.1016/S1071-5576(99)00010-6
   MATSUBARA S, 1991, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V43, P117
   Miyoshi M, 2004, REPROD DOMEST ANIM, V39, P125, DOI 10.1111/j.1439-0531.2004.00484.x
   MORTON RE, 1992, ANAL BIOCHEM, V204, P332, DOI 10.1016/0003-2697(92)90248-6
   MOSSMAN HW, 1987, CARNIVORA VERTEBRATE, P250
   NELSON JL, 1986, BIOCHEM INT, V13, P131
   Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200
   RODMAN JS, 1990, J LEUKOCYTE BIOL, V48, P116
   Segal AW, 1997, ANN NY ACAD SCI, V832, P215, DOI 10.1111/j.1749-6632.1997.tb46249.x
   TERRA WR, 1979, J INSECT PHYSIOL, V25, P487, DOI 10.1016/S0022-1910(79)80007-4
NR 39
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
J9 RES VET SCI
JI Res. Vet. Sci.
PD JUN
PY 2008
VL 84
IS 3
BP 326
EP 334
DI 10.1016/j.rvsc.2007.06.013
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA 300OD
UT WOS:000255832900002
PM 17881018
DA 2020-12-01
ER

PT J
AU Portes, KF
   Ikegami, CM
   Getz, J
   Martins, AP
   De Noronha, L
   Zischler, LF
   Klassen, G
   Camargo, AA
   Zanata, SM
   Bevilacqua, E
   Nakao, LS
AF Portes, Kelly F.
   Ikegami, Cecilia M.
   Getz, Joselito
   Martins, Ana P.
   De Noronha, Lucia
   Zischler, Luciana F.
   Klassen, Giseli
   Camargo, Anamaria A.
   Zanata, Silvio M.
   Bevilacqua, Estela
   Nakao, Lia S.
TI Tissue distribution of quiescin Q6/sulfhydryl oxidase (QSOX) in
   developing mouse
SO JOURNAL OF MOLECULAR HISTOLOGY
LA English
DT Article
DE redox state; mouse development; quiescin sulfhydryl oxidase; mesoderm
ID DISULFIDE BOND FORMATION; WHITE SULFHYDRYL OXIDASE;
   CENTRAL-NERVOUS-SYSTEM; MYELIN PROTEIN ZERO; Q6 GENE FAMILY; EGG-WHITE;
   RAT-BRAIN; INTEGRIN ACTIVATION; EXPRESSION; REDOX
AB Quiescin Q6/sulfhydryl oxidases (QSOX) are revisited thiol oxidases considered to be involved in the oxidative protein folding, cell cycle control and extracellular matrix remodeling. They contain thioredoxin domains and introduce disulfide bonds into proteins and peptides, with the concomitant hydrogen peroxide formation, likely altering the redox environment. Since it is known that several developmental processes are regulated by the redox state, here we assessed if QSOX could have a role during mouse fetal development. For this purpose, an anti-recombinant mouse QSOX antibody was produced and characterized. In E-13.5, E-16.5 fetal tissues, QSOX immunostaining was confined to mesoderm- and ectoderm-derived tissues, while in P1 neonatal tissues it was slightly extended to some endoderm-derived tissues. QSOX expression, particularly by epithelial tissues, seemed to be developmentally-regulated, increasing with tissue maturation. QSOX was observed in loose connective tissues in all stages analyzed, intra and possibly extracellularly, in agreement with its putative role in oxidative folding and extracellular matrix remodeling. In conclusion, QSOX is expressed in several tissues during mouse development, but preferentially in those derived from mesoderm and ectoderm, suggesting it could be of relevance during developmental processes.
C1 [Portes, Kelly F.; Getz, Joselito; Martins, Ana P.; De Noronha, Lucia; Zischler, Luciana F.; Nakao, Lia S.] Pontificia Univ Catolica Parana, Ctr Adv Mol Invest, BR-80215901 Curitiba, Parana, Brazil.
   [Ikegami, Cecilia M.; Klassen, Giseli; Zanata, Silvio M.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [Camargo, Anamaria A.] Ludwig Inst Canc Res, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RP Nakao, LS (corresponding author), Pontificia Univ Catolica Parana, Ctr Adv Mol Invest, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
EM lia.nakao@pucpr.br
RI Bevilacqua, Estela/H-3354-2011; Nakao, Lia S/M-1507-2018; Klassen,
   Giseli/AAF-3962-2019; Klassen, Giseli/F-8753-2012; noronha,
   lucia/F-6339-2015; Camargo, Anamaria A/E-9388-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; Nakao, Lia
   S/0000-0001-9647-6350; Klassen, Giseli/0000-0001-5336-6178; Klassen,
   Giseli/0000-0001-5336-6178; noronha, lucia/0000-0003-0310-7164; Camargo,
   Anamaria A/0000-0002-6076-9597; Zischler, Luciana/0000-0001-8169-7601;
   Zanata, Silvio/0000-0003-2818-6954
CR ALLEN RG, 1989, FREE RADICAL BIO MED, V6, P631, DOI 10.1016/0891-5849(89)90071-3
   Amiot C, 2004, MOL BRAIN RES, V125, P13, DOI 10.1016/j.molbrainres.2004.02.024
   Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200
   Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510
   CHANG TSK, 1978, BIOL REPROD, V18, P745, DOI 10.1095/biolreprod18.5.745
   Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324
   COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483
   Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605
   Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300
   Das KC, 2004, ANTIOXID REDOX SIGN, V6, P105, DOI 10.1089/152308604771978408
   Dennery PA, 2004, ANTIOXID REDOX SIGN, V6, P147, DOI 10.1089/152308604771978453
   FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808
   Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gullberg D, 1995, INT J DEV BIOL, V39, P845
   Harlow E, 1988, ANTIBODIES LAB MANUA
   Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479
   Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032
   Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816
   Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759
   Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147
   Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510
   Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312
   Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200
   Kobayashi M, 2000, ANTIOXID REDOX SIGN, V2, P653, DOI 10.1089/ars.2000.2.4-653
   Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6
   Mairet-Coello G, 2005, J COMP NEUROL, V484, P403, DOI 10.1002/cne.20411
   Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126
   Mairet-Coello G, 2002, NEUROREPORT, V13, P2049, DOI 10.1097/00001756-200211150-00012
   Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033
   Matsuba S, 2002, J DERMATOL SCI, V30, P50, DOI 10.1016/S0923-1811(02)00061-0
   Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208
   Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208
   Musard JF, 2001, BIOCHEM BIOPH RES CO, V287, P83, DOI 10.1006/bbrc.2001.5440
   OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0
   Pfend G, 2001, NEUROCHEM RES, V26, P503, DOI 10.1023/A:1010908828134
   Radom J, 2006, BBA-GENE STRUCT EXPR, V1759, P225, DOI 10.1016/j.bbaexp.2006.04.008
   Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797
   Spiryda LB, 1998, J NEUROSCI RES, V54, P137, DOI 10.1002/(SICI)1097-4547(19981015)54:2<137::AID-JNR2>3.0.CO;2-F
   Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5
   Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200
   Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x
   Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842
   Wittke I, 2003, CANCER RES, V63, P7742
   Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i
   Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200
   Zanata SM, 2005, REDOX REP, V10, P319, DOI 10.1179/135100005X83699
   ZHANG KJ, 1994, J NEUROCHEM, V63, P367
NR 50
TC 18
Z9 18
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1567-2379
J9 J MOL HISTOL
JI J. Mol. Histol.
PD APR
PY 2008
VL 39
IS 2
BP 217
EP 225
DI 10.1007/s10735-007-9156-8
PG 9
WC Cell Biology
SC Cell Biology
GA 275ZI
UT WOS:000254110500010
PM 18034316
DA 2020-12-01
ER

PT J
AU Bollos, RH
   Nakamura, MU
   Lapchick, VBV
   Bevilacqua, EMAF
   Correa, M
   Daher, S
   Ishigai, MMS
   Jasiulionis, MG
AF Bollos, Rubens H.
   Nakamura, Mary U.
   Lapchick, Valderez B. V.
   Bevilacqua, Estela M. A. F.
   Correa, Mariangela
   Daher, Silvia
   Ishigai, Marcia M. S.
   Jasiulionis, Miriam G.
TI Metastatic melanoma positively influences pregnancy outcome in a mouse
   model: could a deadly tumor support embryo life?
SO CLINICAL & EXPERIMENTAL METASTASIS
LA English
DT Article
DE pregnant; melanoma; placental disease; metastatic melanoma; experimental
   model; cancer; embryo implantation; reproductive biology
ID PLACENTA GROWTH-FACTOR; MALIGNANT-MELANOMA; CANCER; METHYLATION;
   PATTERNS; CELLS; TRANSMISSION; TRENDS; CPG
AB The incidence of melanoma is increasing worldwide. It is one of the leading cancers in pregnancy and the most common malignancy to metastasize to placenta and fetus. There are no publications about experimental models of melanoma and pregnancy. We propose a new experimental murine model to study the effects of melanoma on pregnancy and its metastatic process. We tested several doses of melanoma cells until we arrived at the optimal dose, which produced tumor growth and allowed animal survival to the end of pregnancy. Two control groups were used: control (C) and stress control (SC) and three different routes of inoculation: intravenous (IV), intraperitoneal (IP) and subcutaneous (SC). All the fetuses and placentas were examined macroscopically and microscopically. The results suggest that melanoma is a risk factor for intrauterine growth restriction but does not affect placental weight. When inoculated by the SC route, the tumor grew only in the site of implantation. The IP route produced peritoneal tumoral growth and also ovarian and uterine metastases in 60% of the cases. The IV route produced pulmonary tumors. No placental or fetal metastases were obtained, regardless of the inoculation route. The injection of melanoma cells by any route did not increase the rate of fetal resorptions. Surprisingly, animals in the IV groups had no resorptions and a significantly higher number of fetuses. This finding may indicate that tumoral factors released in the host organism to favor tumor survival may also have a pro-gestational action and consequently improve the reproductive performance of these animals.
C1 [Bollos, Rubens H.; Nakamura, Mary U.; Daher, Silvia] Univ Fed Sao Paulo, Dept Obstet, Sch Med, Sao Paulo, Brazil.
   [Lapchick, Valderez B. V.] Univ Fed Sao Paulo, Sch Med, Natl Inst Pharmacol, Anim Expt Lab, Sao Paulo, Brazil.
   [Bevilacqua, Estela M. A. F.] Univ Sao Paulo, Dept Cellular Biol & Dev, Inst Biomed Sci, Sao Paulo, Brazil.
   [Correa, Mariangela; Jasiulionis, Miriam G.] Univ Fed Sao Paulo, Sch Med, Dept Immunol & Pharmacol, Sao Paulo, Brazil.
   [Ishigai, Marcia M. S.] Univ Fed Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
RP Bollos, RH (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Sch Med, Rua Botucatu 862, Sao Paulo, Brazil.
EM rubensbollos@teofilo.com.br
RI Correa, Mariangela/A-6666-2010; DAHER, SILVIA/D-2180-2012; Jasiulionis,
   Miriam/G-2207-2012; Bevilacqua, Estela/H-3354-2011; Correa,
   Mariangela/K-8700-2019; HARB BOLLOS, RUBENS/C-2867-2012; Correa,
   Mariangela/B-3426-2019
OI DAHER, SILVIA/0000-0001-5312-7804; Jasiulionis,
   Miriam/0000-0002-4135-0440; Bevilacqua, Estela/0000-0003-4178-4625; HARB
   BOLLOS, RUBENS/0000-0003-2142-5692; Correa,
   Mariangela/0000-0003-4856-7578
CR Alexander A, 2003, J CLIN ONCOL, V21, P2179, DOI 10.1200/JCO.2003.12.149
   Alexander A, 2004, J AM ACAD DERMATOL, V50, P293, DOI 10.1016/j.jaad.2003.07.009
   Altman JF, 2003, J AM ACAD DERMATOL, V49, P1150, DOI 10.1016/S0190-9622(03)00124-5
   Baergen RN, 1997, ARCH PATHOL LAB MED, V121, P508
   Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2
   BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324
   Borden EC, 2000, SEMIN ONCOL, V27, P654
   Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X
   Cohn-Cedermark G, 2000, CANCER-AM CANCER SOC, V89, P348, DOI 10.1002/1097-0142(20000715)89:2<348::AID-CNCR20>3.0.CO;2-X
   Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673
   Daryanani D, 2003, CANCER, V97, P2248, DOI 10.1002/cncr.11321
   Dildy G A 3rd, 1989, Obstet Gynecol Surv, V44, P535, DOI 10.1097/00006254-198907000-00008
   Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9
   Gourley C, 2002, CLIN ONCOL-UK, V14, P213, DOI 10.1053/clon.2002.0074
   Graeven U, 2000, J INVEST DERMATOL, V115, P118, DOI 10.1046/j.1523-1747.2000.00022.x
   Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106
   Jirtle Randy L., 2000, Environmental Health Perspectives, V108, P271, DOI 10.2307/3454445
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Katz VL, 2002, OBSTET GYNECOL SURV, V57, P112, DOI 10.1097/00006254-200202000-00023
   Koutsopoulos Anastassios V, 2005, World J Surg Oncol, V3, P51, DOI 10.1186/1477-7819-3-51
   Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x
   Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614
   Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887
   MACKIE RM, 1991, LANCET, V337, P653, DOI 10.1016/0140-6736(91)92462-B
   MacKie RM, 2004, BRIT J CANCER, V90, P770, DOI 10.1038/sj.bjc.6601595
   Mackie Rona M., 1999, Current Opinion in Oncology, V11, P129, DOI 10.1097/00001622-199903000-00009
   Marrett LD, 2001, INT J CANCER, V92, P457, DOI 10.1002/ijc.1203
   Mintz A, 2000, CRIT REV ONCOGENESIS, V11, P77
   MULLEN CA, 1985, J EXP MED, V162, P1665, DOI 10.1084/jem.162.5.1665
   O'Meara AT, 2005, CANCER, V103, P1217, DOI 10.1002/cncr.20925
   Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781
   Oduncu FS, 2003, J CANCER RES CLIN, V129, P133, DOI 10.1007/s00432-002-0406-6
   Pavlidis NA, 2002, ONCOLOGIST, V7, P279
   Pennoyer JW, 1997, J AM ACAD DERMATOL, V36, P378, DOI 10.1016/S0190-9622(97)80212-5
   Peros-Golubicic T, 2005, MT SINAI J MED, V72, P274
   Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4
   Rodriguez-Cuesta J, 2005, CLIN EXP METASTAS, V22, P549, DOI 10.1007/s10585-005-5261-9
   Saenz-Badillos J, 2000, J SURG ONCOL, V73, P231
   Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7
   Sakaki M, 2004, VIRCHOWS ARCH, V444, P345, DOI 10.1007/s00428-003-0970-4
   Schwartz JL, 2002, CANCER, V95, P1562, DOI 10.1002/cncr.10880
   SHIH IM, 1993, J INVEST DERMATOL, V100, pS196
   SLINGLUFF CL, 1990, ANN SURG, V211, P552, DOI 10.1097/00000658-199005000-00005
   Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15
   SRINIVAS S, 2000, J CELL SCI, V113, P3549
   Tolar J, 2003, J PEDIAT HEMATOL ONC, V25, P430, DOI 10.1097/00043426-200306000-00002
   Trumble ER, 2005, J NEUROSURG, V103, P191, DOI 10.3171/ped.2005.103.2.0191
   Weisz B, 2001, HUM REPROD UPDATE, V7, P384, DOI 10.1093/humupd/7.4.384
NR 50
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0262-0898
EI 1573-7276
J9 CLIN EXP METASTAS
JI Clin. Exp. Metastasis
PD MAR
PY 2008
VL 25
IS 1
BP 65
EP 73
DI 10.1007/s10585-007-9102-x
PG 9
WC Oncology
SC Oncology
GA 257NR
UT WOS:000252806300006
PM 17932775
DA 2020-12-01
ER

PT J
AU Ferro, EAV
   Mineo, JR
   Letta, F
   Bechi, N
   Romagnoli, R
   Silva, DA
   Sorda, G
   Bevilacqua, E
   Paulesu, LR
AF Vieira Ferro, Eloisa Amalia
   Mineo, Jose Roberto
   Letta, Francesca
   Bechi, Nicoletta
   Romagnoli, Roberta
   Oliveira Silva, Deise Aparecida
   Sorda, Giuseppina
   Bevilacqua, Estela
   Paulesu, Luana Ricci
TI Macrophage migration inhibitory factor is up-regulated in human
   first-trimester placenta stimulated by soluble antigen of Toxoplasma
   gondii, resulting in increased monocyte adhesion on villous explants
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID CELL-MEDIATED-IMMUNITY; INTERFERON-GAMMA; IFN-GAMMA; TNF-ALPHA;
   NITRIC-OXIDE; INFECTION; EXPRESSION; TROPHOBLASTS; MOLECULE-1; PREGNANCY
AB Considering the potential role of macrophage migration inhibitory factor (MIF) in the inflammation process in placenta when infected by pathogens, we investigated the production of this cytokine in chorionic villous explants obtained from human first-trimester placentas stimulated with soluble antigen from Toxoplasma gondii (STAg). Parallel cultures were performed with villous explants stimulated with STAB, interferon-gamma (IFN-gamma), or STAB plus IFN-gamma. To assess the role of placental MIF on monocyte adhesiveness to human trophoblast, explants were co-cultured with human myelomonocytic THP-1 cells in the presence or absence of supernatant from cultures treated with STAB (SPN), SPN plus anti-MIF antibodies, or recombinant MIF. A significantly higher concentration of MIF was produced and secreted by villous explants treated with STAB or STAB plus IFN-gamma after 24-hour culture. Addition of SPN or recombinant MIF was able to increase THP-1 adhesion, which was inhibited after treatment with anti-MIF antibodies. This phenomenon was associated with intercellular adhesion molecule expression by villous explants. Considering that the processes leading to vertical dissemination of T. gondii remain widely unknown, our results demonstrate that MIF production by human first-trimester placenta is up-regulated by parasite antigen and may play an essential role as an autocrine/paracrine mediator in placental infection by T. gondii.
C1 [Vieira Ferro, Eloisa Amalia; Mineo, Jose Roberto; Oliveira Silva, Deise Aparecida] Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38405320 Uberlandia, MG, Brazil.
   [Letta, Francesca; Bechi, Nicoletta; Romagnoli, Roberta; Sorda, Giuseppina; Paulesu, Luana Ricci] Univ Siena, Dipartimento Fisiol, I-53100 Siena, Italy.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
RP Ferro, EAV (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Av Para 1720, BR-38405320 Uberlandia, MG, Brazil.
EM eloisa@umuarama.ufu.br
RI Mineo, Jose R/B-4151-2009; Ietta, Francesca/I-5307-2013; Mineo, Jose
   Roberto/M-6573-2019; Ferro, Eloisa/B-2185-2008; Bevilacqua,
   Estela/H-3354-2011; Ferro, Eloisa/K-5533-2016
OI Mineo, Jose R/0000-0002-9010-7228; Mineo, Jose
   Roberto/0000-0002-9010-7228; Ferro, Eloisa/0000-0002-7447-2583;
   Bevilacqua, Estela/0000-0003-4178-4625; Ferro,
   Eloisa/0000-0002-7447-2583; Ietta, Francesca/0000-0002-2160-8790
CR Abou-Bacar A, 2004, INFECT IMMUN, V72, P1397, DOI 10.1128/IAI.72.3.1397-1401.2004
   Arcuri F, 2001, BIOL REPROD, V64, P1200, DOI 10.1095/biolreprod64.4.1200
   Arcuri F, 1999, BIOL REPROD, V60, P1299, DOI 10.1095/biolreprod60.6.1299
   Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5
   Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x
   Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204
   Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977
   Chaisavaneeyakorn S, 2005, INFECT IMMUN, V73, P3287, DOI 10.1128/IAI.73.6.3287-3293.2005
   Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322
   Chan G, 2004, BIOL REPROD, V71, P797, DOI 10.1095/biolreprod.104.028118
   CHANG HR, 1990, IMMUNOLOGY, V69, P33
   Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569
   DRAPIER JC, 1988, EUR J IMMUNOL, V18, P1587, DOI 10.1002/eji.1830181018
   FOX H, 1997, PATHOLOGY PLACENTA, P294
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HERRIOTT MJ, 1993, J IMMUNOL, V150, P4524
   Huang SH, 2001, CELL MICROBIOL, V3, P277, DOI 10.1046/j.1462-5822.2001.00116.x
   Juliano PB, 2006, PLACENTA, V27, P750, DOI 10.1016/j.placenta.2005.07.008
   Juttner S, 1998, J IMMUNOL, V161, P2383
   Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629
   Kerr JR, 1999, J CLIN PATHOL-MOL PA, V52, P220, DOI 10.1136/mp.52.4.220
   Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x
   Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455
   LETTA F, 2007, AM J PHYSIOL-ENDOC M, V292, pE272
   LINDBERG RE, 1977, INFECT IMMUN, V15, P855, DOI 10.1128/IAI.15.3.855-862.1977
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martiney JA, 2000, INFECT IMMUN, V68, P2259, DOI 10.1128/IAI.68.4.2259-2267.2000
   MCCABE RE, 1984, J INFECT DIS, V150, P961, DOI 10.1093/infdis/150.6.961
   MINEO JR, 1980, INFECT IMMUN, V27, P283, DOI 10.1128/IAI.27.2.283-287.1980
   Moore MK, 2000, ANAL BIOCHEM, V279, P241, DOI 10.1006/abio.2000.4482
   Nagineni CN, 2000, INFECT IMMUN, V68, P407, DOI 10.1128/IAI.68.1.407-410.2000
   Oliveira JG, 2006, PLACENTA, V27, P691, DOI 10.1016/j.placenta.2005.06.006
   Pfaff AW, 2005, IMMUNOL CELL BIOL, V83, P483, DOI 10.1111/j.1440-1711.2005.01356.x
   Remington J.S., 2001, INFECT DIS FETUS NEW, P205
   Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051
   SCHLUTER D, 1991, J NEUROIMMUNOL, V31, P185, DOI 10.1016/0165-5728(91)90040-E
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869
   VLEUGELS MPH, 1987, BRIT J OBSTET GYNAEC, V94, P758, DOI 10.1111/j.1471-0528.1987.tb03722.x
   Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X
   WEINBERG ED, 1984, REV INFECT DIS, V6, P814
   Xiao J, 1997, AM J PATHOL, V150, P1845
NR 42
TC 31
Z9 32
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN
PY 2008
VL 172
IS 1
BP 50
EP 58
DI 10.2353/ajpath.2008.070432
PG 9
WC Pathology
SC Pathology
GA 251MC
UT WOS:000252376600007
PM 18165264
OA Green Published
DA 2020-12-01
ER

PT J
AU Hoshida, MS
   Gorjao, R
   Curi, R
   Bevilacqua, E
AF Hoshida, M. S.
   Gorjao, R.
   Curi, R.
   Bevilacqua, E.
TI Profiling expression patterns of interferon-gamma treated trophoblast
   cells by cDNA macroarray
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Hoshida, M. S.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Gorjao, R.; Curi, R.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.
RI Gorjao, Renata/D-4130-2013
NR 0
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 103
EP 103
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700015
DA 2020-12-01
ER

PT J
AU Olivera, L
   Bevilacqua, E
AF Olivera, L.
   Bevilacqua, E.
TI Characterization of the early stages of implantation and
   microvascularization in alpacas
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 105
EP 105
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700023
DA 2020-12-01
ER

PT J
AU Albieri-Borges, A
   Bandeira, C
   Porto, LC
   Bevilacqua, E
AF Albieri-Borges, A.
   Bandeira, C.
   Porto, L. C.
   Bevilacqua, E.
TI Expression of Cripto-1 in the mouse placenta
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Albieri-Borges, A.; Porto, L. C.] Univ Estado Rio De Janeiro, Dept Histol & Embryol, Rio De Janeiro, Brazil.
   [Bandeira, C.; Bevilacqua, E.] Univ Sao Paulo, Dept Cellular & Dev Biol, BR-05508 Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 106
EP 106
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700027
DA 2020-12-01
ER

PT J
AU Bandeira, C
   Albieri-Borges, A
   Nascimento, K
   Galvez Rojas, RL
   Hoshida, MS
   Ferrari, MFR
   Porto, LC
   Bevilacqua, E
AF Bandeira, C.
   Albieri-Borges, A.
   Nascimento, K.
   Galvez Rojas, R. L.
   Hoshida, M. S.
   Ferrari, M. F. R.
   Porto, L. C.
   Bevilacqua, E.
TI Expression of hyperglycosylated Cripto-1 during mouse placenta
   development
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Bandeira, C.; Nascimento, K.; Galvez Rojas, R. L.; Hoshida, M. S.; Ferrari, M. F. R.; Bevilacqua, E.] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Bandeira, C.; Albieri-Borges, A.; Porto, L. C.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
RI Ferrari, Merari F. R./N-1210-2019; Ferrari, Merari F.R./D-9159-2012
OI Ferrari, Merari F. R./0000-0001-7396-2196; Ferrari, Merari
   F.R./0000-0001-7396-2196
NR 0
TC 0
Z9 0
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 106
EP 106
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700028
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Borges, M
   Ishigai, MMS
   Daher, S
   Mattar, R
   Sun, SY
   Bevilac-Qua, EMF
   Oliveira, SF
AF Borbely, A. U.
   Borges, M.
   Ishigai, M. M. S.
   Daher, S.
   Mattar, R.
   Sun, S. Y.
   Bevilac-Qua, E. M. F.
   Oliveira, S. F.
TI Expression of small leucine-rich proteoglycans: Decorin and biglycan in
   human normal term placenta and in placentas with altered trophoblast
   invasion
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Borbely, A. U.; Bevilac-Qua, E. M. F.; Oliveira, S. F.] Univ Sao Paulo, Inst Biomed Sci, Dept Dev & Cell Biol, Sao Paulo, Brazil.
   [Borges, M.; Daher, S.; Mattar, R.; Sun, S. Y.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Ishigai, M. M. S.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil.
RI Sun, Sue Yazaki/N-4314-2018; DAHER, SILVIA/D-2180-2012; Borbely,
   Alexandre/G-4859-2012
OI Sun, Sue Yazaki/0000-0001-6573-7386; DAHER, SILVIA/0000-0001-5312-7804; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 112
EP 112
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700052
DA 2020-12-01
ER

PT J
AU Gomes, SZ
   Bevilacqua, E
AF Gomes, S. Z.
   Bevilacqua, E.
TI NAD(P)H-oxidase expression in trophoblast cells
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Gomes, S. Z.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Trophoblast Res Lab, Sao Paulo, Brazil.
EM saragom@usp.br
NR 0
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 114
EP 114
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700061
DA 2020-12-01
ER

PT J
AU Lorenzon, AR
   Rocha, CRR
   Vieira, JS
   Gomes, SZ
   Bevilacqua, E
AF Lorenzon, A. R.
   Rocha, C. R. R.
   Vieira, J. S.
   Gomes, S. Z.
   Bevilacqua, E.
TI Activation of NAD(P)H-oxidase and xanthine-oxidase and trophoblast
   reactive oxygen species production
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Lorenzon, A. R.; Rocha, C. R. R.; Vieira, J. S.; Gomes, S. Z.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Trophobiast Res Lab, Sao Paulo, Brazil.
EM aline_rl@yahoo.com.br
RI Lorenzon, Aline R/G-8733-2014
OI Lorenzon, Aline R/0000-0002-6052-6296
NR 0
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 115
EP 115
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700066
DA 2020-12-01
ER

PT J
AU Bollos, RH
   Nakamura, MU
   Lapchick, VBL
   Bevilacqua, E
   Correa, M
   Daher, S
   Ishigai, MMS
   Jasiulionis, MG
AF Bollos, R. H.
   Nakamura, M. U.
   Lapchick, V. B. L.
   Bevilacqua, E.
   Correa, M.
   Daher, S.
   Ishigai, M. M. S.
   Jasiulionis, M. G.
TI Metastatic melanoma positively influences pregnancy outcome in a mouse
   model: Could a deadly tumor support embryo life?
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Bollos, R. H.; Nakamura, M. U.; Daher, S.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Lapchick, V. B. L.] Univ Fed Sao Paulo, Anim Expt Lab, Sao Paulo, Brazil.
   [Bevilacqua, E.] Univ Sao Paulo, Dept Cell Biol & Dev, Sao Paulo, Brazil.
   [Jasiulionis, M. G.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil.
   [Correa, M.; Jasiulionis, M. G.] Univ Fed Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil.
   [Ishigai, M. M. S.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil.
RI DAHER, SILVIA/D-2180-2012; HARB BOLLOS, RUBENS/C-2867-2012
OI DAHER, SILVIA/0000-0001-5312-7804; HARB BOLLOS,
   RUBENS/0000-0003-2142-5692
NR 0
TC 0
Z9 0
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 116
EP 116
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700069
DA 2020-12-01
ER

PT J
AU Borges, MH
   Borges, AA
   Bandeira, CL
   Porto, LC
   Sun, SY
   Bevilacqua, E
   Daher, S
AF Borges, M. H.
   Borges, A. Albieri
   Bandeira, C. L.
   Porto, L. C.
   Sun, S. Y.
   Bevilacqua, E.
   Daher, S.
TI Immunolocalization of cripto-1 in placentas with abnormal invasion
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Borges, M. H.; Sun, S. Y.; Daher, S.] Univ Fed Sao Paulo, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Borges, A. Albieri; Porto, L. C.] Univ Estado Rio De Janeiro, Dept Histol & Embryol, Rio De Janeiro, Brazil.
   [Bandeira, C. L.; Bevilacqua, E.] Univ Sao Paulo, Dept Cellular & Dev Biol, Sao Paulo, Brazil.
RI DAHER, SILVIA/D-2180-2012; Sun, Sue Yazaki/N-4314-2018
OI DAHER, SILVIA/0000-0001-5312-7804; Sun, Sue Yazaki/0000-0001-6573-7386
NR 0
TC 0
Z9 0
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 118
EP 118
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700077
DA 2020-12-01
ER

PT J
AU Barreiro, EC
   Rudge, M
   Calderon, I
   Damasceno, D
   Sinzato, Y
   Daher, S
   Bevilacqua, E
AF Barreiro, E. C.
   Rudge, M.
   Calderon, I.
   Damasceno, D.
   Sinzato, Y.
   Daher, S.
   Bevilacqua, E.
TI Placentas from hyperglycemic pregnant women - Preliminary results on
   VEGF gene polymorphism
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Barreiro, E. C.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil.
   [Daher, S.] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil.
   [Rudge, M.; Calderon, I.; Damasceno, D.; Sinzato, Y.] Sao Paulo State Univ, Botucatu Med Sch, Dept Obstet & Gynecol, Diabet & Pregnancy Serv, Sao Paulo, Brazil.
RI Rudge, Marilza/S-9057-2018; DAHER, SILVIA/D-2180-2012; Calderon,
   Iracema/W-4336-2019
OI DAHER, SILVIA/0000-0001-5312-7804; Calderon, Iracema/0000-0003-4761-4336
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 123
EP 123
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700098
DA 2020-12-01
ER

PT J
AU Borbely, AU
   Gomes, SZ
   Silva, LO
   Bevilacqua, EMF
   Oliveira, SF
AF Borbely, A. U.
   Gomes, S. Z.
   Silva, L. O.
   Bevilacqua, E. M. F.
   Oliveira, S. F.
TI Effects of IFN-gamma on in vitro interaction of mouse trophoblast and
   mesometrial decidual cells
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Borbely, A. U.; Gomes, S. Z.; Silva, L. O.; Bevilacqua, E. M. F.; Oliveira, S. F.] Univ Sao Paulo, Inst Biomed Sci, Dept Dev & Cell Biol, BR-05508 Sao Paulo, Brazil.
RI Borbely, Alexandre/G-4859-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 125
EP 125
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700105
DA 2020-12-01
ER

PT J
AU Ferreira, M
   Hoshida, M
   Gomes, S
   Lima, C
   Galvez Rojas, RL
   Bevilacqua, E
AF Ferreira, M.
   Hoshida, M.
   Gomes, S.
   Lima, C.
   Galvez Rojas, R. L.
   Bevilacqua, E.
TI Expression of interleukin-10 and interleukin-10 receptor type 1 in
   ectoplacental cones upon interferon-gamma treatment
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Ferreira, M.; Hoshida, M.; Gomes, S.; Bevilacqua, E.] Univ Sao Paulo, Dept Cellular & Dev Biol, BR-05508 Sao Paulo, Brazil.
   [Galvez Rojas, R. L.] Univ Sao Paulo, Dept Microbiol, BR-05508 Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 126
EP 126
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700108
DA 2020-12-01
ER

PT J
AU Faria, MR
   Albien, A
   Hoshida, MS
   Ferro, EAV
   Paulesu, L
   Bevilacqua, E
AF Faria, M. R.
   Albien, A.
   Hoshida, M. S.
   Ferro, E. A. V.
   Paulesu, L.
   Bevilacqua, E.
TI Expression of macrophage migration inhibitory factor in the
   developmental mouse placenta
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Faria, M. R.; Albien, A.; Hoshida, M. S.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Faria, M. R.] Univ Ibirapuera, Sao Paulo, Brazil.
   [Albien, A.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Ferro, E. A. V.] Univ Fed Uberlandia, BR-38400 Uberlandia, MG, Brazil.
   [Paulesu, L.] Univ Siena, I-53100 Siena, Italy.
RI Ferro, Eloisa/K-5533-2016
OI Ferro, Eloisa/0000-0002-7447-2583
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 131
EP 131
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700130
DA 2020-12-01
ER

PT J
AU Ferro, EAV
   Mineo, JR
   Letta, F
   Bechi, N
   Romagnoli, R
   Silva, DAO
   Giuseppina, S
   Bevilacqua, E
   Paulesu, LR
AF Ferro, E. A. V.
   Mineo, J. R.
   Letta, F.
   Bechi, N.
   Romagnoli, R.
   Silva, D. A. O.
   Giuseppina, S.
   Bevilacqua, E.
   Paulesu, L. R.
TI Macrophage migration inhibitory factor is up-regulated in human
   first-trimester placenta stimulated by soluble antigen of Toxoplasma
   gondii resulting in increased monocyte adhesion on villous explants
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Ferro, E. A. V.; Mineo, J. R.; Silva, D. A. O.] Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil.
   [Letta, F.; Bechi, N.; Romagnoli, R.; Giuseppina, S.; Paulesu, L. R.] Univ Siena, Dipartimento Fisiol, I-53100 Siena, Italy.
   [Bevilacqua, E.] Univ Sao Paulo, Inst Ciencias Biomed, Sao Paulo, Brazil.
RI Mineo, Jose Roberto/M-6573-2019; Mineo, Jose R/B-4151-2009; Ferro,
   Eloisa/K-5533-2016
OI Mineo, Jose Roberto/0000-0002-9010-7228; Mineo, Jose
   R/0000-0002-9010-7228; Ferro, Eloisa/0000-0002-7447-2583
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 132
EP 132
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700131
DA 2020-12-01
ER

PT J
AU Silva, F
   Magaldi, F
   Galves, B
   Sato, H
   Bevilacqua, E
AF Silva, F.
   Magaldi, F.
   Galves, B.
   Sato, H.
   Bevilacqua, E.
TI Vaccination against yellow fever in pregnant mice: Repercussions in the
   reproductive performance and fetal and placental morphology
SO PLACENTA
LA English
DT Meeting Abstract
CT 3rd Latin-American Symposium on Maternal-Fetal Interaction and Placenta
CY NOV 04-07, 2007
CL Los Cocos, ARGENTINA
C1 [Silva, F.; Magaldi, F.; Galves, B.; Bevilacqua, E.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Sato, H.] Dept Hlth State Sao Paulo, Immunizat Program, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI amsalu, ribka/G-8780-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD JAN
PY 2008
VL 29
IS 1
BP 132
EP 132
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 255SM
UT WOS:000252677700134
DA 2020-12-01
ER

PT J
AU Leanza, EC
   Hoshida, MS
   Costa, AF
   Fernandes, CM
   Teixeira, CDP
   Bevilacqua, E
AF Leanza, Eduardo Cava
   Hoshida, Mara Sandra
   Costa, Adriana Fraga
   Fernandes, Cristina Maria
   Pereira Teixeira, Catarina de Fatima
   Bevilacqua, Estela
TI Signaling molecules involved in IFN-gamma-inducible nitric oxide
   synthase expression in the mouse trophoblast
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE ectoplacental cone; IFN-gamma R; iNOS; JAK-STAT pathway
ID NATURAL-KILLER-CELLS; TRANSCRIPTIONAL ACTIVATION; TARGETED DISRUPTION;
   INTERFERON; GENE; IMPLANTATION; CONTRIBUTES; INHIBITION; PREGNANCY; MICE
AB Problem
   We have previously shown that trophoblast can generate nitric oxide (NO) and express inducible isoform of nitric oxide synthase (iNOS). Moreover, this production was changed by the presence of interferon-gamma (IFN-gamma) establishing a relationship between trophoblast inductive response and this proinflammatory cytokine.
   Method of study
   As the intracellular signal transduction pathway used by IFN-gamma in target cells is the Janus kinase (JAK)-signal transducer and transcription activator (STAT), here we analyzed in the mouse trophoblast the effect of IFN-gamma and staurosporine on mRNA and protein expressions of IFN-gamma signaling molecules correlating them with iNOS expression.
   Results
   Interferon-gamma induced iNOS expression and upregulated Jaks and Stat1, but not Stat2 transcriptions. The protein distribution matched the mRNA expression pattern. These effects were abrogated when IFN-gamma receptor was blocked by staurosporine.
   Conclusion
   Due to the biological effects of NO-iNOS generated on induction of apoptosis and inflammatory responses, interaction between iNOS expression and IFN-gamma-mediated signaling is very important for understanding the physiology of trophoblast at the maternal-fetal interface. Our data indicate IFN-gamma acts specifically on trophoblast, regulating the expression of signaling molecules and is fundamental for iNOS expression.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   Butantan Inst, Pharmacol Lab, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Hoshida, Mara S/D-3900-2012; Teixeira, Catarina/C-6124-2013; Bevilacqua,
   Estela/H-3354-2011; Fernandes, Cristina/B-5555-2016
OI Hoshida, Mara S/0000-0003-2232-4631; Bevilacqua,
   Estela/0000-0003-4178-4625; Fernandes, Cristina/0000-0001-8054-0362;
   Teixeira, Catarina/0000-0001-5887-7663
CR Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214
   Arck PC, 1997, CURR TOP MICROBIOL, V222, P45
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Athanassakis I, 2000, DEV COMP IMMUNOL, V24, P663, DOI 10.1016/S0145-305X(00)00023-9
   BLANKENSHIP TN, 1992, ANAT REC, V233, P196, DOI 10.1002/ar.1092330204
   Chang YJ, 2004, MOL PHARMACOL, V65, P589, DOI 10.1124/mol.65.3.589
   CHEN HL, 1994, PLACENTA, V15, P109, DOI 10.1016/S0143-4004(05)80448-5
   Croy BA, 2000, PLACENTA, V21, pS77, DOI 10.1053/plac.1999.0518
   Croy BA, 2003, J REPROD IMMUNOL, V59, P175, DOI 10.1016/S0165-0378(03)00046-9
   CROY BA, 1991, CELL IMMUNOL, V133, P116, DOI 10.1016/0008-8749(91)90184-D
   Darnell JE, 1998, J INTERF CYTOK RES, V18, P549, DOI 10.1089/jir.1998.18.549
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   Darnell JE, 1996, P NATL ACAD SCI USA, V93, P6221, DOI 10.1073/pnas.93.13.6221
   Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267
   Decker T, 1997, IMMUNOBIOLOGY, V198, P99, DOI 10.1016/S0171-2985(97)80031-9
   Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1
   FOWLER AK, 1980, NATURE, V286, P266, DOI 10.1038/286266a0
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853
   HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432
   Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638
   Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828
   Ihle JN, 1996, PHILOS T R SOC B, V351, P159, DOI 10.1098/rstb.1996.0012
   Li HY, 2001, MOL HUM REPROD, V7, P755, DOI 10.1093/molehr/7.8.755
   Liao QP, 1996, HUM REPROD, V11, P2777
   Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X
   Meyer T, 2003, GENE DEV, V17, P1992, DOI 10.1101/gad.268003
   MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166
   Myatt L, 1997, PLACENTA, V18, P261, DOI 10.1016/S0143-4004(97)80060-4
   Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868
   Pilz A, 2003, EMBO REP, V4, P368, DOI 10.1038/sj.embor.embor802
   Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393
   Purcell TL, 1997, MOL HUM REPROD, V3, P485, DOI 10.1093/molehr/3.6.485
   Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467
   RayChaudhury A, 1996, J CELL BIOCHEM, V63, P125, DOI 10.1002/(SICI)1097-4644(19961101)63:2<125::AID-JCB1>3.0.CO;2-#
   Rogers PAW, 1995, REPROD FERT DEVELOP, V7, P1395, DOI 10.1071/RD9951395
   SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201
   Shaamash AH, 2001, INT J GYNECOL OBSTET, V72, P127, DOI 10.1016/S0020-7292(00)00314-3
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751
   Truchet S, 2001, MOL REPROD DEV, V60, P319, DOI 10.1002/mrd.1094
   Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103
   YAMAMOTO Y, 1992, J REPROD FERTIL, V95, P559, DOI 10.1530/jrf.0.0950559
NR 46
TC 7
Z9 7
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD DEC
PY 2007
VL 58
IS 6
BP 537
EP 546
DI 10.1111/j.1600-0897.2007.00537.x
PG 10
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 229OX
UT WOS:000250815000009
PM 17997753
DA 2020-12-01
ER

PT J
AU Hoshida, MS
   Gorjao, R
   Lima, C
   Daher, S
   Curi, R
   Bevilacqua, E
AF Hoshida, M. S.
   Gorjao, R.
   Lima, C.
   Daher, S.
   Curi, R.
   Bevilacqua, E.
TI Regulation of gene expression in mouse trophoblast cells by
   interferon-gamma
SO PLACENTA
LA English
DT Article
DE ectoplacental cone; IFN-gamma; cytokine; postimplantation; mouse
   pregnancy; gene expression
ID X DBA/2 MICE; IMPLANTING TROPHOBLAST; SUCCESSFUL PREGNANCY; MURINE
   PREGNANCY; NUCLEAR FACTOR; FETAL; DIFFERENTIATION; LOCALIZATION;
   STIMULATION; CONTRIBUTES
AB We have previously shown that interferon-gamma (IFN-gamma) activates phagocytosis and induces nitric oxide production in cultured mouse trophoblast cells. In the present study we examined the effect of this cytokine on ectoplacental cone and gene expression in trophoblast cells. Ectoplacental cones were obtained during the postimplantation period on gestational day 7.5 from CD-I mice and exposed to 100 U/mL IFN-gamma. Ectoplacental cone morphology, cell proliferation and death were also determined upon IFN-gamma treatment. Complementary DNA macroarray and semiquantitative RT-PCR were used to analyze gene expression. IFN-gamma treatment did not alter ectoplacental cone morphology, trophoblast cell proliferation or death. However, using gene array technology, we observed that IFN-gamma affected the developing trophoblast, altering the level of mRNA expression, which resulted in upregulation of 35 genes and downregulation of seven others. The upregulation of transcription factors and immune response-associated genes suggests that IFN-gamma is involved in processes beyond immunological homeostasis and plays an important role in placental development and function. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05508 Sao Paulo, Brazil.
   Butantan Inst, Immunopathol Lab, BR-05503 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Paulista Med Sch, Dept Obstet, BR-04039 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Av Prof Lineu Prestes,1524, BR-05508 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011; DAHER, SILVIA/D-2180-2012; Lima,
   Carla/B-6750-2019; Gorjao, Renata/D-4130-2013; Curi, Rui/C-9351-2012;
   Hoshida, Mara S/D-3900-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; DAHER,
   SILVIA/0000-0001-5312-7804; Lima, Carla/0000-0002-8161-966X; Hoshida,
   Mara S/0000-0003-2232-4631; Gorjao, Renata/0000-0002-9655-1477
CR Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34
   Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214
   Arck PC, 1997, AM J REPROD IMMUNOL, V37, P87
   Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Athanassakis I, 2000, DEV COMP IMMUNOL, V24, P663, DOI 10.1016/S0145-305X(00)00023-9
   Athie-Morales V, 2004, J IMMUNOL, V172, P61, DOI 10.4049/jimmunol.172.1.61
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200
   Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100
   CHAOUAT G, 1990, J REPROD FERTIL, V89, P447
   CHEN HL, 1994, PLACENTA, V15, P109, DOI 10.1016/S0143-4004(05)80448-5
   Clark DA, 1998, J IMMUNOL, V160, P545
   Deng J, 2000, J IMMUNOL, V165, P5054, DOI 10.4049/jimmunol.165.9.5054
   El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609
   Espinoza LA, 2003, TOXICOLOGY, V189, P181, DOI 10.1016/S0300-483X(03)00128-8
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Goncalves CR, 2003, HISTOCHEM CELL BIOL, V119, P189, DOI 10.1007/s00418-003-0500-0
   Harigaya T, 1997, ENDOCR J, V44, P155, DOI 10.1507/endocrj.44.155
   Hemberger M, 2001, P NATL ACAD SCI USA, V98, P13126, DOI 10.1073/pnas.231396598
   HOSHIDA MS, 2005, AM J REPROD IMMUNOL, V54, P150
   Innis M. A., 1990, PCR PROTOCOLS GUIDE, P3
   Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749
   LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x
   Lima C, 2005, J IMMUNOL, V175, P3554, DOI 10.4049/jimmunol.175.6.3554
   Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240
   Liu Z, 2002, CONTRACEPTION, V65, P177, DOI 10.1016/S0010-7824(01)00277-3
   Marionnet C, 2003, ONCOGENE, V22, P3500, DOI 10.1038/sj.onc.1206571
   MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4
   Murphy Shawn P, 2004, Reprod Biol Endocrinol, V2, P52, DOI 10.1186/1477-7827-2-52
   Negus RPM, 1996, J ROY SOC MED, V89, P312
   Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873
   Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393
   Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4
   Reich NC, 2002, J INTERF CYTOK RES, V22, P103, DOI 10.1089/107999002753452719
   Rosenberger CM, 2000, J IMMUNOL, V164, P5894, DOI 10.4049/jimmunol.164.11.5894
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
   Wienands J, 2001, Int Rev Immunol, V20, P679, DOI 10.3109/08830180109045585
   Wu CY, 2000, EUR J IMMUNOL, V30, P1364, DOI 10.1002/(SICI)1521-4141(200005)30:5<1364::AID-IMMU1364>3.0.CO;2-U
   Yamazaki K, 2002, BIOCHEM BIOPH RES CO, V290, P1114, DOI 10.1006/bbrc.2001.6319
   Zhao SH, 2003, J ANIM SCI, V81, P2179
NR 42
TC 21
Z9 21
U1 0
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD OCT
PY 2007
VL 28
IS 10
BP 1059
EP 1072
DI 10.1016/j.placenta.2007.03.009
PG 14
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA 213FB
UT WOS:000249650500012
PM 17544503
DA 2020-12-01
ER

PT J
AU Ferro, E
   Mineo, JR
   Letta, F
   Romagnoli, R
   Sorda, G
   Bevilacqua, E
   Paulesu, L
AF Ferro, E.
   Mineo, J. R.
   Letta, F.
   Romagnoli, R.
   Sorda, G.
   Bevilacqua, E.
   Paulesu, L.
TI Potential role of macrophage Migration Inhibitory Factor (MIF) in first
   trimester chorionic villous explants stimulated by antigen of Toxoplasma
   gondii
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT 3rd International Conference on Experimental and Clinical Reproductive
   Immunobiology
CY NOV 15-18, 2006
CL Banff, CANADA
DE cytokines; pathology; pregnancy; immunoregulation
C1 Univ Fed Uberlandia, BR-38400 Uberlandia, MG, Brazil.
   Univ Siena, I-53100 Siena, Italy.
   Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
RI Mineo, Jose Roberto/M-6573-2019; Bevilacqua, Estela/H-3354-2011; Mineo,
   Jose R/B-4151-2009
OI Mineo, Jose Roberto/0000-0002-9010-7228; Bevilacqua,
   Estela/0000-0003-4178-4625; Mineo, Jose R/0000-0002-9010-7228
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD OCT
PY 2006
VL 71
IS 2
BP 173
EP 173
DI 10.1016/j.jri.2006.08.072
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 087BA
UT WOS:000240716000076
DA 2020-12-01
ER

PT J
AU Sgarbosa, F
   Barbisan, LF
   Brasil, MAM
   Costa, E
   Calderon, IMP
   Goncalves, CR
   Bevilacqua, E
   Rudge, MVC
AF Sgarbosa, Fabio
   Barbisan, Luis Fernando
   Brasil, Maria A. M.
   Costa, Elaine
   Calderon, Iracema M. P.
   Goncalves, Claudia R.
   Bevilacqua, Estela
   Rudge, Marilza V. C.
TI Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term
   placental trophoblast
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE diabetes; cell death; proliferation; syncytiotrophoblast; TUNEL reaction
ID PROLIFERATION; PROTEIN; SYNCYTIOTROPHOBLAST; DECIDUA; LIGAND; BAX
AB Apoptosis and its associated regulatory mechanisms are physiological events crucial to the maintenance of placental homeostasis; imbalance of these processes, however, such as occurs under various pathological conditions, may compromise placenta function and, consequently, pregnancy success. Increased apoptosis occurs in the placentas of pregnant women with several developmental disabilities, while increased Bcl-2 expression is generally associated with pregnancy-associated tumors. Herein, we tested the hypothesis that apoptosis-associated disturbs might be involved in the placental physiopathology subjected to different maternal hyperglycemic conditions.
   Thus, in the present study we investigated and compared the incidence of apoptosis using TUNEL reaction and Bcl-2 expression, in term-placentas of normoglycemic, diabetic and daily hyperglycemic patients. Tissue samples were collected from 37 placentas, being 15 from healthy mothers with normally delivered healthy babies, and 22 from mothers with glucose disturbances. From these latter 22 patients, 10 showed maternal daily hyperglycemia and 12 were clinically diabetics. Both Bcl-2 expression and apoptotic DNA fragmentation were established and quantified in the trophoblasts of healthy mothers. Compared to these reference values, a higher apoptosis index and lower Bcl-2 expression were disclosed in the placentas of the diabetic women, while in the daily hyperglycemic group, values were intermediate between the diabetic and normoglycemic patients. The TUNEL/Bcl-2 index ratio in the placentas varied from 0.02 to 0.09 for pregnant normoglycemic and diabetic women, respectively, revealing a predominance of apoptosis in the diabetic group. Our findings suggest that hyperglycemia may be a key factor evoking apoptosis in the placental trophoblast, and therefore, is relevant to diabetic placenta function. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 UNESP, Sch Med, Dept Gynecol & Obstet, BR-18618000 Botucatu, SP, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, BR-05508900 Sao Paulo, Brazil.
RP Rudge, MVC (corresponding author), UNESP, Sch Med, Dept Gynecol & Obstet, BR-18618000 Botucatu, SP, Brazil.
EM mrudge@fmb.unesp.br
RI Rudge, Marilza/S-9057-2018; Barbisan, Luis/D-8526-2012; Calderon,
   Iracema/W-4336-2019; Calderon, Iracema MP/C-8136-2012; Bevilacqua,
   Estela/H-3354-2011; Rudge, Marilza V C/C-8338-2012
OI Calderon, Iracema/0000-0003-4761-4336; Calderon, Iracema
   MP/0000-0003-4761-4336; Bevilacqua, Estela/0000-0003-4178-4625; Rudge,
   Marilza V C/0000-0002-9227-832X; Goncalves, Claudia
   Regina/0000-0002-4287-0560; Barbisan, Luis Fernando/0000-0002-2180-1814
CR American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103
   Burleigh DW, 2004, J SOC GYNECOL INVEST, V11, P36, DOI 10.1016/j.jsgi.2003.06.001
   Chan CCW, 1999, PLACENTA, V20, P223, DOI 10.1053/plac.1998.0375
   Danihel L, 2002, ACTA HISTOCHEM, V104, P335, DOI 10.1078/0065-1281-00683
   De Falco M, 2001, HISTOCHEM J, V33, P421, DOI 10.1023/A:1013728012048
   Fulop V, 1998, J REPROD MED, V43, P101
   Halperin R, 2000, GYNECOL OBSTET INVES, V50, P84, DOI 10.1159/000010287
   Hammer A, 1999, AM J REPROD IMMUNOL, V41, P41
   Huppertz B, 1999, TROPHOBLAST RES, V20, P215
   Ishihara N, 2000, ENDOCR J, V47, P317, DOI 10.1507/endocrj.47.317
   Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671
   KAWIAK J, 1998, CYTOBIOLOGIE, V36, P99
   Kim CJ, 1995, PATHOL RES PRACT, V191, P1239, DOI 10.1016/S0344-0338(11)81132-5
   Kokawa K, 1998, PLACENTA, V19, P21, DOI 10.1016/S0143-4004(98)90094-7
   Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614
   Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906
   Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004
   Moley KH, 2001, TRENDS ENDOCRIN MET, V12, P78, DOI 10.1016/S1043-2760(00)00341-6
   Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013
   Murakoshi H, 2003, ENDOCR J, V50, P199, DOI 10.1507/endocrj.50.199
   Ratts VS, 2000, PLACENTA, V21, P361, DOI 10.1053/plac.1999.0486
   Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293
   SAKURAGI N, 1997, TROPHOBLAST RES, V9, P63, DOI DOI 10.1016/S0143-4004(05)80161-4]
   Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4
   Smith SC, 1997, AM J OBSTET GYNECOL, V177, P57, DOI 10.1016/S0002-9378(97)70438-1
   Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003
   Toki T, 1999, MOL HUM REPROD, V5, P246, DOI 10.1093/molehr/5.3.246
   Weiss U, 2001, DIABETOLOGIA, V44, P209, DOI 10.1007/s001250051601
   Yamada Z, 2001, MOL HUM REPROD, V7, P1179, DOI 10.1093/molehr/7.12.1179
   Yamauchi H, 2004, BIOL REPROD, V70, P1762, DOI 10.1095/biolreprod.103.026252
NR 30
TC 49
Z9 49
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD AUG
PY 2006
VL 73
IS 2
BP 143
EP 149
DI 10.1016/j.diabres.2005.12.014
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 067EY
UT WOS:000239285800004
PM 16563550
DA 2020-12-01
ER

PT J
AU Lima, MHM
   Souza, LC
   Caperuto, LC
   Bevilacqua, E
   Gasparetti, AL
   Zanuto, R
   Saad, MJA
   Carvalho, CR
AF Lima, Maria H. M.
   Souza, Lilian C.
   Caperuto, Luciana C.
   Bevilacqua, Estela
   Gasparetti, Alessandra L.
   Zanuto, Ricardo
   Saad, Mario J. A.
   Carvalho, Carla R.
TI Up-regulation of the phosphatidylinositol 3-kinase/protein kinase B
   pathway in the ovary of rats by chronic treatment with hCG and insulin
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID ACTIVATION; RECEPTOR; CELLS; HYPERINSULINEMIA; PHOSPHORYLATION;
   TRANSCRIPTION; RESISTANCE; GROWTH; WOMEN
AB Polycystic ovary syndrome (PCOS) manifests as chronic anovulation, ovarian hyperandrogenisin, and follicular cysts, which are amplified by insulin as well as the inability of the hormone to stimulate glucose uptake in classic target tissues such as muscle and fat. in the present study, we evaluated the regulation of the insulin-signaling pathways by using immunoprecipitation and immunoblotting in whole extracts of ovaries from non-pregnant human chorionic gonadotropin (hCG)-treated rats, hyperinsulinemic-induced rats and hyperinsulinemic-induced rats, treated with hCG for 22 consecutive days. There were increased associations of insulin receptor substrate (IRS)-1 and IRS-2 with phosphatidylinositol (PI) 3-kinase, followed by enhanced protein kinase B (Akt) serine and threonine phosphorylation, in the ovaries of rats that were treated with hCG, either alone or with insulin. In contrast, the skeletal muscle demonstrated a reduced IRS-1/PI 3-kinase/Akt pathway in hyperinsulinemic-induced rats. These intracellular modifications were accompanied by follicular cysts, detected by optical microscopy, and increased androstenedione serum levels. In summary, our data show that chronic treatment with hCG or hCG plus insulin can induce changes in ovaries that simulate PCOS. In these situations, an increase in the insulin-induced IKS/PI 3-kinase/Akt pathway occurs in the ovary, suggesting that the activation of this pathway may have a role in the development of PCOS.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-05509690 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, BR-05509690 Sao Paulo, Brazil.
RP Carvalho, CR (corresponding author), Univ Sao Paulo, ICB, Dept Fisiol Biofis, Rua Prof Lineu Prestes 1524,Sala 121,ICB1,Cidade, BR-05509690 Sao Paulo, Brazil.
EM croc@icb.usp.br
RI Lima, Maria Helena M/E-9595-2012; Lima, Maria Helena Melo/R-3974-2019;
   Carvalho, Carla R. O./H-6476-2018; Caperuto, Luciana/K-2489-2012; Saad,
   Mario/ABD-8262-2020; Bevilacqua, Estela/H-3354-2011; Lima, Maria Helena
   Melo/C-5389-2018
OI Lima, Maria Helena M/0000-0001-6521-8324; Lima, Maria Helena
   Melo/0000-0001-6521-8324; Carvalho, Carla R. O./0000-0001-5824-8656;
   Bevilacqua, Estela/0000-0003-4178-4625; Lima, Maria Helena
   Melo/0000-0001-6521-8324; Chagas Caperuto, Luciana/0000-0002-6008-4010
CR Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706
   DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165
   Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774
   Franks S, 1999, ENDOCRIN METAB CLIN, V28, P361, DOI 10.1016/S0889-8529(05)70074-8
   Johnson AL, 2001, BIOL REPROD, V64, P1566, DOI 10.1095/biolreprod64.5.1566
   Lawlor MA, 2001, J CELL SCI, V114, P2903
   Legro RS, 1999, FERTIL STERIL, V72, P990, DOI 10.1016/S0015-0282(99)00401-X
   Munir I, 2004, ENDOCRINOLOGY, V145, P175, DOI 10.1210/en.2003-0329
   Nelson-Degrave VL, 2005, MOL ENDOCRINOL, V19, P379, DOI 10.1210/me.2004-0178
   Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001
   Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535
   PORETSKY L, 1992, METABOLISM, V41, P903, DOI 10.1016/0026-0495(92)90175-A
   Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767
   Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sewer MB, 2003, J BIOL CHEM, V278, P8106, DOI 10.1074/jbc.M210264200
   Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6
   WILLIS D, 1995, J CLIN ENDOCR METAB, V80, P3788, DOI 10.1210/jc.80.12.3788
NR 18
TC 19
Z9 22
U1 0
U2 3
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD AUG
PY 2006
VL 190
IS 2
BP 451
EP 459
DI 10.1677/joe.1.06226
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 077HS
UT WOS:000240020500025
PM 16899578
OA Bronze
DA 2020-12-01
ER

PT J
AU Bevilacqua, EMAF
   da Silva, JRMC
AF Bevilacqua, EMAF
   da Silva, JRMC
TI Tribute to Dr Luis Fernando Bicludo Pereira Costa Rosa (GG) - Obituary
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Biographical-Item
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Lab Histofisiol Evolut, BR-05508900 Sao Paulo, Brazil.
RP da Silva, JRMC (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, Lab Histofisiol Evolut, Av Prof Lineu Prestes 1524,Sala 409, BR-05508900 Sao Paulo, Brazil.
EM jrmcs@usp.br
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PD MAR
PY 2006
VL 3
IS 1
BP 161
EP 161
DI 10.1093/ecam/neh144
PG 1
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 020VF
UT WOS:000235940300024
OA DOAJ Gold, Green Accepted
DA 2020-12-01
ER

PT J
AU Carvalho, AF
   Klisch, K
   Miglino, MA
   Pereira, FTV
   Bevilacqua, E
AF Carvalho, AF
   Klisch, K
   Miglino, MA
   Pereira, FTV
   Bevilacqua, E
TI Binucleate trophoblast giant cells in the water buffalo (Bubalus
   bubalis) placenta
SO JOURNAL OF MORPHOLOGY
LA English
DT Article
DE lactogen; chorion; ruminant; prolactin; pregnancy
ID PROTEIN-B; SYNEPITHELIOCHORIAL PLACENTA; BOVINE; PREGNANCY;
   PROGESTERONE; LOCALIZATION; GLYCANS; GLYCOPROTEINS; ENDOMETRIUM;
   RUMINANTS
AB The binucleate trophoblast giant cells (BNC) of the water buffalo, Bubalus bubalis, placenta were studied, with emphasis on the synthesis of BNC-specific proteins. Placentomal tissues of 27 water buffalos (2-10 months of pregnancy) were processed for light and electron microscopy. The frequency of BNCs was 20% of the trophoblastic cells in 2-3-month placentas and increased to 27% in the later stages. Ultrastructurally, binucleate cells displayed a prominent granular endoplasmic reticulum and Golgi apparatus, typical of cells involved with protein synthesis and exportation. The buffalo BNCs contained periodic acid-Schiff (PAS)-positive granules and reacted with antisera against bovine placental lactogen, prolactin-related protein-I, and pregnancy-associated glycoproteins. Lectin histochemistry with Dolichos biflorus agglutinin, Vicia villosa agglutinin, and Phaseolus vulgaris leucoagglutinin showed specific staining of BNCs. Different stages of BNC migration and fusion with uterine epithelial cells were observed. Trinucleate feto-maternal hybrid cells were the typical outcome of cell fusions. These cells underwent degeneration, with typical morphological features of apoptosis. The results revealed a strong homology between water buffalo and cattle BNCs concerning cell morphology, protein expression, glycosylation pattern, and characteristics of cell migration and fusion. J. Morphol. 267:50-56, 2006. (c) 2005 Wiley-Liss, Inc.
C1 Fac Vet Med Sao Joao Boa Vista, Dept Morphol, BR-13870000 Sao Joao Da Boa Vista, SP, Brazil.
   Univ Sao Paulo, Dept Anat, Fac Vet Med & Zootechnol, BR-05508900 Sao Paulo, Brazil.
   Med Sch Hanover, Ctr Anat, D-30625 Hannover, Germany.
   State Univ Dracena, Dept Histol & Embryol, BR-17900000 Dracena, SP, Brazil.
   Univ Sao Paulo, Dept Cellular & Dev Biol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil.
RP Carvalho, AF (corresponding author), Fac Vet Med Sao Joao Boa Vista, Dept Morphol, BR-13870000 Sao Joao Da Boa Vista, SP, Brazil.
EM anaflaviac@uol.com.br
RI Miglino, Maria Angelica/B-9519-2012; Bevilacqua, Estela/H-3354-2011;
   Klisch, Karl/G-8248-2011; Klisch, Karl/B-5055-2018
OI Miglino, Maria Angelica/0000-0003-4979-115X; Bevilacqua,
   Estela/0000-0003-4178-4625; Klisch, Karl/0000-0003-2176-5451
CR ABDEL-RAOUF M, 1969, Zentralblatt fuer Veterinaermedizin Reihe A, V16, P838
   ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4
   ANTHONY RV, 1995, J REPROD FERTIL, P83
   Austin KJ, 1999, ENDOCRINOLOGY, V140, P542, DOI 10.1210/en.140.1.542
   DEBENEDETTI A, 2001, BIOTECHNOLOGIE AG S, V5, P61
   DelVecchio RP, 1995, PROSTAGLANDINS, V50, P137, DOI 10.1016/0090-6980(95)00108-5
   DUELLO TM, 1986, ENDOCRINOLOGY, V119, P1351, DOI 10.1210/endo-119-3-1351
   Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624
   GROSS TS, 1991, PLACENTA, V12, P27, DOI 10.1016/0143-4004(91)90507-C
   GROSS TS, 1988, BIOL REPROD, V38, P1027, DOI 10.1095/biolreprod38.5.1027
   HAMMARSTROM S, 1982, P NATL ACAD SCI-BIOL, V79, P1611, DOI 10.1073/pnas.79.5.1611
   Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619
   Hsu TC, 1970, ATLAS MAMMALIAN CHRO
   Hsu TC, 1967, ATLAS MAMMALIAN CHRO
   JONES CJP, 1994, CELL TISSUE RES, V278, P601
   KATHIRESAN D, 1992, INDIAN VET J, V69, P326
   Kessler MA, 1997, PLACENTA, V18, P29, DOI 10.1016/S0143-4004(97)90068-0
   Klisch K, 2003, HISTOCHEM CELL BIOL, V119, P211, DOI 10.1007/s00418-003-0507-6
   Klisch K, 1999, ANAT EMBRYOL, V200, P229, DOI 10.1007/s004290050275
   Klisch K, 1999, PLACENTA, V20, P451, DOI 10.1053/plac.1999.0402
   MORGAN G, 1983, J ULTRA MOL STRUCT R, V83, P148, DOI 10.1016/S0022-5320(83)90072-2
   PILLER V, 1990, EUR J BIOCHEM, V191, P461, DOI 10.1111/j.1432-1033.1990.tb19144.x
   REIMERS TJ, 1985, BIOL REPROD, V33, P1227, DOI 10.1095/biolreprod33.5.1227
   Ritz LR, 2000, ANIM GENET, V31, P178, DOI 10.1046/j.1365-2052.2000.00621.x
   WANGO EO, 1990, PLACENTA, V11, P381, DOI 10.1016/S0143-4004(05)80214-0
   Weems YS, 1999, PROSTAG OTH LIPID M, V58, P139, DOI 10.1016/S0090-6980(99)00034-9
   WIMSATT WA, 1951, AM J ANAT, V89, P233, DOI 10.1002/aja.1000890204
   WOODING FBP, 1983, PLACENTA, V4, P527
   Wooding FBP, 1997, MICROSC RES TECHNIQ, V38, P88
   WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O
   WOODING FBP, 1987, CELL TISSUE RES, V247, P667, DOI 10.1007/BF00215761
NR 31
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0362-2525
EI 1097-4687
J9 J MORPHOL
JI J. Morphol.
PD JAN
PY 2006
VL 267
IS 1
BP 50
EP 56
DI 10.1002/jmor.10387
PG 7
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 996EI
UT WOS:000234156800003
PM 16240388
DA 2020-12-01
ER

PT J
AU Lima, C
   Souza, VMO
   Faquim-Mauro, EL
   Hoshida, MS
   Bevilacqua, E
   Macedo, MS
   Tavares-De-Lima, W
   Vargaftig, BB
AF Lima, C
   Souza, VMO
   Faquim-Mauro, EL
   Hoshida, MS
   Bevilacqua, E
   Macedo, MS
   Tavares-De-Lima, W
   Vargaftig, BB
TI Modulation of the induction of lung and airway allergy in the offspring
   of IFN-gamma-treated mother mice
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID INDUCED EOSINOPHIL RECRUITMENT; DENDRITIC CELLS; PHENOTYPIC
   CHARACTERIZATION; IMMUNE-RESPONSES; MURINE PREGNANCY; T-CELLS; MOUSE;
   CYTOKINE; ASTHMA; IL-4
AB Recent studies have highlighted the influence of fetal/maternal interactions on the development of asthma. Because IFN-gamma reduces Th2-mediated allergic responses, we assessed its capacity to modulate asthma in the offspring when injected into mothers during pregnancy. IFN-gamma was injected in CD1 female mice on day 6.5 of gestation. Immediately after birth, male newborns were housed in cages with interchanged mothers: the offspring from IFN-gamma-treated mothers were breastfed by normal mothers (IFN/nor), and those from normal mothers were breastfed by IFN-gamma-treated (Nor/IFN) or normal mothers (Nor/nor). Immediately after weaning, the spleen cells from IFN/nor and Nor/IFN mice produced less IL-4 and more IFN-gamma than Nor/nor mice when stimulated with Con A. At the age of 6-7 wk, mice were immunized with OVA on days 0 and 7. From day 14 to 16, they were exposed to aerosolized OVA. The bronchoalveolar lavage fluid from Nor/nor mice showed eosinophilia, a large number of these cells being present in perivascular and peribronchial regions of lung tissues. IFN/nor or Nor/IFN mice showed greatly reduced eosinophil numbers in bronchoalveolar lavage fluid. In addition, lung sections from IFN/nor, but not Nor/IFN mice showed almost normal histology. In OVA-sensitized IFN/nor and Nor/IFN mice, the production of IFN-gamma, IL-4, and IL-5 by spleen cells was significantly reduced as compared with cells from the OVA-sensitized Nor/nor group. IgE and anaphylactic IgG1 were also reduced in plasma of IFN/nor mice. In conclusion, the presence of IFN-gamma during pregnancy confers to the fetus a protection against allergenic provocations in the adult life.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Cellular & Dev Biol, Sao Paulo, Brazil.
RP Lima, C (corresponding author), Avenida Profess Lineu Prestes 1524,Sala 215, BR-05508900 Sao Paulo, Brazil.
EM clmeyer@usp.br
RI Lima, Carla/B-6750-2019; Faquim-Mauro, Eliana/M-2489-2017; Vargaftig,
   Bernardo Boris/C-3323-2013; Hoshida, Mara S/D-3900-2012; Faquim-Mauro,
   Eliana L/C-9636-2012; Tavares-de-Lima, Wothan/H-7486-2013; Bevilacqua,
   Estela/H-3354-2011
OI Lima, Carla/0000-0002-8161-966X; Faquim-Mauro,
   Eliana/0000-0001-8083-4272; Hoshida, Mara S/0000-0003-2232-4631;
   Bevilacqua, Estela/0000-0003-4178-4625; Souza,
   Valdenia/0000-0002-4976-009X
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Barnes KC, 1998, IMMUNOL TODAY, V19, P325, DOI 10.1016/S0167-5699(97)01241-3
   Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640
   BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190
   Cara DC, 2000, HISTOL HISTOPATHOL, V15, P899, DOI 10.14670/HH-15.899
   CHAOUAT G, 1990, J REPROD FERTIL, V89, P447
   Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X
   COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x
   CROY BA, 1993, MICROSC RES TECHNIQ, V25, P189, DOI 10.1002/jemt.1070250302
   Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x
   Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572
   FINKELMAN FD, 1988, J IMMUNOL, V140, P1022
   Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574
   Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261
   Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683
   Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x
   Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x
   Herz U, 2000, AM J RESP CRIT CARE, V162, pS62, DOI 10.1164/ajrccm.162.supplement_2.ras-1
   IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573
   KAY AB, 1991, J ALLERGY CLIN IMMUN, V87, P893, DOI 10.1016/0091-6749(91)90408-G
   KING A, 1991, IMMUNOL TODAY, V12, P432, DOI 10.1016/0167-5699(91)90014-K
   Lagadari M, 2004, AM J REPROD IMMUNOL, V51, P49, DOI 10.1046/j.8755-8920.2003.00122.x
   Li XM, 1996, J IMMUNOL, V157, P3216
   Lima C., 2002, Clinical and Experimental Allergy, V32, P1659, DOI 10.1046/j.1365-2222.2002.01506.x
   Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4
   Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611
   Mochizuki M, 1998, J IMMUNOL, V160, P60
   MOTA I, 1969, LIFE SCI PT 1 PHYSI, V8, P813, DOI 10.1016/0024-3205(69)90099-X
   MOUULD AW, 1997, J CLIN INVEST, V99, P164
   NAKAJIMA H, 1993, AM REV RESPIR DIS, V148, P1102, DOI 10.1164/ajrccm/148.4_Pt_1.1102
   Ono SJ, 2000, ANNU REV IMMUNOL, V18, P347, DOI 10.1146/annurev.immunol.18.1.347
   OVARY Z, 1958, J IMMUNOL, V81, P355
   Proust B, 2003, CLIN EXP ALLERGY, V33, P119, DOI 10.1046/j.1365-2222.2003.01560.x
   RIVEST S, 1995, ENDOCR REV, V16, P177, DOI 10.1210/er.16.2.177
   Saito S, 2000, J REPROD IMMUNOL, V47, P87, DOI 10.1016/S0165-0378(00)00060-7
   SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086
   SCHULTZ CL, 1992, J IMMUNOL, V149, P60
   Srivatsa B, 2003, J PEDIATR-US, V142, P31, DOI 10.1067/mpd.2003.mpd0327
   Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817
   Trinchieri G, 1995, CIBA F SYMP, V195, P203
   Uthoff H, 2003, J IMMUNOL, V171, P3485, DOI 10.4049/jimmunol.171.7.3485
   Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507
   Wan WH, 2002, IMMUNOLOGY, V107, P261, DOI 10.1046/j.1365-2567.2002.01499.x
   WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D
NR 46
TC 21
Z9 21
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD SEP 15
PY 2005
VL 175
IS 6
BP 3554
EP 3559
DI 10.4049/jimmunol.175.6.3554
PG 6
WC Immunology
SC Immunology
GA 966HN
UT WOS:000232010800016
PM 16148098
OA Bronze
DA 2020-12-01
ER

PT J
AU Albieri, A
   Hoshida, MS
   Gagioti, SM
   Leanza, EC
   Abrahamsohn, I
   Croy, A
   Ashkar, AA
   Bevilacqua, E
AF Albieri, A
   Hoshida, MS
   Gagioti, SM
   Leanza, EC
   Abrahamsohn, I
   Croy, A
   Ashkar, AA
   Bevilacqua, E
TI Interferon-gamma alters the phagocytic activity of the mouse trophoblast
SO REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
LA English
DT Article
ID RECURRENT SPONTANEOUS-ABORTIONS; NORMAL HUMAN-PREGNANCY;
   NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; X DBA/2 MICE; MURINE
   PREGNANCY; IL-10 PRODUCTION; PLACENTAL CELLS; GENE-EXPRESSION; IFN-GAMMA
AB Interferon-gamma (IFN-gamma) mediates diverse functions in bone marrow-derived phagocytes, including phagocytosis and microbe destruction. This cytokine has also been detected at implantation sites under both physiological and pathological conditions in many different species. At these particular sites, the outermost embryonic cell layer in close contact with the maternal tissues, the trophoblast exhibits intense phagocytic activity. To determine whether IFN-gamma affects phagocytosis of mouse-trophoblast cells, ectoplacental cone-derived trophoblast was cultured and evaluated for erythrophagocytosis. Phagocytic activity was monitored ultrastructurally and expressed as percentage of phagocytic trophoblast in total trophoblast cells. Conditioned medium from concanavalin-A-stimulated spleen cells significantly enhanced trophoblast phagocytosis. This effect was blocked by pre-incubation with an anti-IFN-gamma neutralizing antibody. Introduction of mouse recombinant IFN-gamma (mrIFN-gamma) to cultures did not increase cell death, but augmented the percentage of phagocytic cells in a dose-dependent manner. Ectoplacental cones from mice deficient for IFN-gamma receptor alpha-chain showed a significant decrease of the phagocytosis, even under mrIFN-gamma stimulation, suggesting that IFN-gamma-induced phagocytosis are receptor-mediated. Reverse transcriptase-PCR analyses confirmed the presence of mRNA for IFN-gamma receptor alpha and beta-chains in trophoblast cells and detected a significant increase in the mRNA levels of IFN-gamma receptor beta-chain, mainly, when cultured cells were exposed to IFN-gamma. Immunohistochemistry and Western blot analyses also revealed protein expression of the IFN-gamma receptor alpha-chain. These results suggest that IFN-gamma may participate in the phagocytic activation of the mouse trophoblast, albeit the exact mechanism was not hereby elucidated. Protective and/or nutritional fetal benefit may result from this physiological response. In addition, our data also shed some light on the understanding of trophoblast tolerance to inflammatory/immune cytokines during normal gestation.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil.
   Univ Ibirapuera, Dept Morphol, Sao Paulo, Brazil.
   Univ Med & Dent New Jersey, Dept Obstet Gynecol & Womens Hlth, Newark, NJ 07103 USA.
   Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508900 Sao Paulo, Brazil.
EM abertazolli@hotmail.com; masaho@usp.br; sgagioti@uol.com.br;
   eclza@terra.com.br; iabraham@usp.br; croya@post.queens.ca;
   ashkara@mcmaster.ca; bevilacq@usp.br
RI Hoshida, Mara S/D-3900-2012; Bevilacqua, Estela/H-3354-2011
OI Hoshida, Mara S/0000-0003-2232-4631; Bevilacqua,
   Estela/0000-0003-4178-4625; Ashkar, Ali/0000-0003-1139-1468
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214
   Arck PC, 1997, AM J REPROD IMMUNOL, V37, P87
   Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Ashkar Ali A., 1999, Placenta, V20
   Athanassakis I, 2000, DEV COMP IMMUNOL, V24, P663, DOI 10.1016/S0145-305X(00)00023-9
   ATHANASSAKIS I, 1987, J IMMUNOL, V138, P37
   Athanassakis I, 1996, DEV IMMUNOL, V4, P247
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   Cameo M, 1999, HUM REPROD, V14, P959, DOI 10.1093/humrep/14.4.959
   CHAOUAT G, 1990, J REPROD FERTIL, V89, P447
   CHAOUAT G, 1995, J IMMUNOL, V154, P4261
   CHEN HL, 1994, PLACENTA, V15, P109, DOI 10.1016/S0143-4004(05)80448-5
   CLARK DA, 1991, ANN NY ACAD SCI, V626, P524, DOI 10.1111/j.1749-6632.1991.tb37944.x
   Clark DA, 2001, MOL HUM REPROD, V7, P185, DOI 10.1093/molehr/7.2.185
   Clark DA, 1998, J IMMUNOL, V160, P545
   CORRADIN SB, 1991, EUR J IMMUNOL, V21, P2553, DOI 10.1002/eji.1830211036
   Croy BA, 2002, J REPROD IMMUNOL, V57, P151, DOI 10.1016/S0165-0378(02)00005-0
   Daher S, 2004, J REPROD IMMUNOL, V62, P151, DOI 10.1016/j.jri.2003.10.004
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   DELASSUS S, 1994, J IMMUNOL, V152, P2411
   DELGADO MA, 1978, AM J TROP MED HYG, V27, P1108, DOI 10.4269/ajtmh.1978.27.1108
   DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6
   Fontana V, 2004, REPRODUCTION, V128, P717, DOI 10.1530/rep.1.00335
   FOWLER AK, 1980, NATURE, V286, P266, DOI 10.1038/286266a0
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5
   Guimond MJ, 1997, BIOL REPROD, V56, P169, DOI 10.1095/biolreprod56.1.169
   HAIMOVICI F, 1991, BIOL REPROD, V44, P69, DOI 10.1095/biolreprod44.1.69
   IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7
   KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419
   KINOSHITA T, 1992, ANAL BIOCHEM, V206, P231, DOI 10.1016/0003-2697(92)90358-E
   Krishnan L, 1996, J IMMUNOL, V156, P653
   LEWIS CE, 1992, MACROPHAGE
   LOKE YW, 1982, ADV PARASIT, V21, P155, DOI 10.1016/S0065-308X(08)60276-6
   Lucas DM, 1998, J IMMUNOL, V160, P4337
   Makhseed M, 2000, HUM REPROD, V15, P2011, DOI 10.1093/humrep/15.9.2011
   MATTSSON R, 1991, J REPROD IMMUNOL, V19, P115, DOI 10.1016/0165-0378(91)90012-F
   MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   Pijnenborg R, 2000, MOL HUM REPROD, V6, P635, DOI 10.1093/molehr/6.7.635
   Platt JS, 1998, J LEUKOCYTE BIOL, V64, P393
   Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532
   Raghupathy R, 2001, SEMIN IMMUNOL, V13, P219, DOI 10.1006/smim.2001.0316
   Ryu SY, 2000, ANTICANCER RES, V20, P3331
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   Truchet S, 2001, MOL REPROD DEV, V60, P319, DOI 10.1002/mrd.1094
   VANDIJK JP, 1991, CLIN CHIM ACTA, V203, P1, DOI 10.1016/0009-8981(91)90151-2
   VASSILIADIS S, 1994, ACTA PHYSIOL SCAND, V151, P485, DOI 10.1111/j.1748-1716.1994.tb09771.x
   Weisinger G, 1999, BBA-GENE STRUCT EXPR, V1446, P225, DOI 10.1016/S0167-4781(99)00091-3
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   YUI J, 1994, PLACENTA, V15, P819, DOI 10.1016/S0143-4004(05)80184-5
NR 58
TC 15
Z9 16
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-7827
J9 REPROD BIOL ENDOCRIN
JI Reprod. Biol. Endocrinol.
PD AUG 10
PY 2005
VL 3
AR 34
DI 10.1186/1477-7827-3-34
PG 11
WC Endocrinology & Metabolism; Reproductive Biology
SC Endocrinology & Metabolism; Reproductive Biology
GA 964SM
UT WOS:000231900800001
PM 16092971
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Klisch, K
   Bevilacqua, E
   Olivera, LVM
AF Klisch, K
   Bevilacqua, E
   Olivera, LVM
TI Mitotic polyploidization in trophoblast giant cells of the alpaca
SO CELLS TISSUES ORGANS
LA English
DT Article
DE genome multiplication; placenta; camelid
ID CAMEL CAMELUS-DROMEDARIUS; LAMA-PACOS; DEVELOPMENTAL-CHANGES; POLYTENE
   CHROMOSOMES; DNA-CONTENT; PLACENTA; PLOIDY; MITOSIS
AB Genome multiplication is a typical feature of trophoblast giant cell (TGC) development in many species. Elevated nuclear DNA contents can be achieved by modified cell cycles with a complete lack of mitosis (endoreduplication) or with incomplete mitoses. The aim of this study is to characterize genome multiplication in the alpaca TGC. Placental tissues of gestation days 150, 264 and 347 (near term) and term placentae were processed for light microscopy and for transmission electron microscopy. Each TGC showed many nuclear profiles. Observation of serial sections revealed that TGCs are truly multinucleate with several highly lobulated nuclei. Feulgen staining showed that TGC nuclei have a higher DNA content than nuclei of other trophoblast cells. The number of argyrophilic nucleolar organizer regions (AgNORs) in nuclear profiles of TGC was between 15 and 100, while other trophoblast cells showed 1 or 2 AgNORs. Large multipolar mitotic figures with maximal diameters of 80 mu m were observed in the alpaca placentas on gestation days 264 and 347. No cytokinesis was seen in TGC. The results show that the mode of genome multiplication in the alpaca TGC is mitotic polyploidization. Subsequent acytokinetic mitoses may lead to an accumulation of chromosomes and centrioles in TGC. With increasing ploidy levels, the shape of these polyploidizing mitoses becomes more irregular. The restitution of nuclei after these complex multipolar mitoses is likely to result in the irregular nuclear shape in TGC. Copyright (C) 2005 S. Karger AG, Basel.
C1 Hannover Med Sch, DE-30625 Hannover, Germany.
   Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   Natl Univ Altiplano, Fac Vet Med & Zootechnol, Puno, Peru.
RP Klisch, K (corresponding author), Hannover Med Sch, OE 4110,Carl Neuberg Str 1, DE-30625 Hannover, Germany.
EM klisch.karl@mh-hannover.de
RI Klisch, Karl/B-5055-2018; Klisch, Karl/G-8248-2011; Bevilacqua,
   Estela/H-3354-2011
OI Klisch, Karl/0000-0003-2176-5451; Bevilacqua, Estela/0000-0003-4178-4625
CR BOCK P, 1989, MIKROSKOPISCHE TECHN
   Brodsky VYa, 1985, GENOME MULTIPLICATIO
   FOWLER ME, 1990, AM J VET RES, V51, P1495
   Goncalves CR, 2003, HISTOCHEM CELL BIOL, V119, P189, DOI 10.1007/s00418-003-0500-0
   HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607
   HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855
   Jones CJP, 2002, REPRODUCTION, V123, P115, DOI 10.1530/reprod/123.1.115
   KEIGHREN M, 1993, HISTOCHEM J, V25, P30, DOI 10.1007/BF00161042
   Klisch K, 2004, REPROD FERT DEVELOP, V16, P301, DOI 10.1071/RD03101
   Klisch K, 1999, ANAT EMBRYOL, V200, P229, DOI 10.1007/s004290050275
   Klisch K, 1999, PLACENTA, V20, P451, DOI 10.1053/plac.1999.0402
   NAGL W, 1972, EXPERIENTIA, V28, P217, DOI 10.1007/BF01935770
   Olivera L, 2003, ANAT EMBRYOL, V207, P45, DOI 10.1007/s00429-003-0328-3
   Olivera LVM, 2003, ANAT EMBRYOL, V207, P317, DOI 10.1007/s00429-003-0346-1
   Skidmore JA, 1996, PLACENTA, V17, P253, DOI 10.1016/S0143-4004(96)90046-6
   STEVEN DH, 1980, PLACENTA, V1, P21, DOI 10.1016/S0143-4004(80)80013-0
   van LENNEP E. W., 1961, ACTA MORPHOL NEERLANDO SCAND, V4, P180
   VARMUZA S, 1988, DEVELOPMENT, V102, P127
   Vitrat N, 1998, BLOOD, V91, P3711
   Wooding FBP, 2003, REPRODUCTION, V126, P239, DOI 10.1530/reprod/126.2.239
   Zybina EV, 1996, INT REV CYTOL, V165, P53, DOI 10.1016/S0074-7696(08)62220-2
   Zybina TG, 2001, PLACENTA, V22, P490, DOI 10.1053/plac.2001.0675
NR 22
TC 13
Z9 14
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2005
VL 181
IS 2
BP 103
EP 108
DI 10.1159/000091099
PG 6
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 020NK
UT WOS:000235916100004
PM 16534204
DA 2020-12-01
ER

PT J
AU Amarante-Paffaro, A
   Queiroz, GS
   Correa, ST
   Spira, B
   Bevilacqua, E
AF Amarante-Paffaro, A
   Queiroz, GS
   Correa, ST
   Spira, B
   Bevilacqua, E
TI Phagocytosis as a potential mechanism for microbial defense of mouse
   placental trophoblast cells
SO REPRODUCTION
LA English
DT Article
ID MURINE UTERUS; MACROPHAGES; COMPONENT; DIFFERENTIATION; IMPLANTATION;
   SUPEROXIDE; INDUCTION; RECEPTOR; SYSTEM; OXYGEN
AB Trophoblast giant cells are active phagocytes during implantation and post-implantation. Phagocytosis decreases during placental maturation as the phagocytic function of nutrition is gradually replaced by the direct uptake of nutrients by the labyrinth zone trophoblast. We hypothesize that, after placental maturation, trophoblast cells maintain phagocytic functions for purposes other than nutrition. This study employs histological techniques to examine the ability of trophoblast cells to phagocytose microorganisms (yeast or bacteria) - in vivo in females receiving thioglycolate to activate macrophages and in vitro in the presence of phagocytic promoters such as interferon-gamma and complement component C3. Placental trophoblast cells from the second half of gestation show basal phagocytosis that can be dramatically up-regulated by these promoters when microorganisms are inoculated into pregnant animals or introduced into culture systems. Stimulated trophoblast cells phagocytosed organisms more rapidly and in greater numbers than non-stimulated trophoblast exposed to the same numbers of organisms. Taken together, our results indicate that trophoblast cells do not lose their ability to phagocytose during the placentation process, which may imply that trophoblast cells participate in embryonic and fetal innate immune defense through elimination of microorganisms present at the maternal-fetal interface.
C1 Univ Sao Paulo, Dept Histol & Embryol, Sao Paulo, Brazil.
   Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Dept Histol & Embryol, Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Spira, Beny/AAR-2287-2020; Spira, Beny/D-6928-2012; Bevilacqua,
   Estela/H-3354-2011
OI Spira, Beny/0000-0001-5394-9074; Spira, Beny/0000-0001-5394-9074;
   Bevilacqua, Estela/0000-0003-4178-4625
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   ALBIERI A, 2001, PLACENTA, V22, pA11
   Athanassakis I, 2000, DEV COMP IMMUNOL, V24, P663, DOI 10.1016/S0145-305X(00)00023-9
   ATHANASSAKIS I, 1987, J IMMUNOL, V138, P37
   ATHANASSAKIS I, 1990, CELL IMMUNOL, V129, P13, DOI 10.1016/0008-8749(90)90182-Q
   ATHANASSAKISVASSILIADIS I, 1993, J RECEPTOR RES, V13, P739, DOI 10.3109/10799899309073690
   BAUMGARTNER W, 1992, INFECT IMMUN, V60, P5232
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113
   Buendia AJ, 1998, INFECT IMMUN, V66, P2128
   Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X
   Clark DA, 2003, AM J REPROD IMMUNOL, V49, P297, DOI 10.1034/j.1600-0897.2003.00045.x
   COHEN MS, 1981, J IMMUNOL, V127, P1007
   COHN ZA, 1978, J IMMUNOL, V121, P813
   DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti Sonia, 1996, Ciencia e Cultura (Sao Paulo), V48, P37
   GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5
   Guleria I, 2000, NAT MED, V6, P589
   HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842
   HIRAI K, 1985, ACTA HISTOCHEM CYTOC, V18, P71
   KOHCHI C, 1991, NUCL ACIDS S SER, V25, P119
   LEWIS CE, 1992, MACROPHAGE
   LIMA AO, 1970, IMMUNOLOGIA IMUNOPAT
   MANTOVANI B, 1981, J IMMUNOL, V126, P127
   MANTOVANI B, 1987, EXP CELL RES, V173, P282, DOI 10.1016/0014-4827(87)90354-5
   MEHROTRA P K, 1988, Biological Structures and Morphogenesis, V1, P63
   MUNTENER M, 1977, ACTA ANAT, V98, P241
   Ouahrani-Bettache S, 1999, BIOTECHNIQUES, V26, P620, DOI 10.2144/99264bm05
   PAULESU L, 1991, LYMPHOKINE CYTOK RES, V10, P443
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   REDLINE RW, 1988, J IMMUNOL, V140, P3947
   Salins S, 2001, INFECT IMMUN, V69, P3605, DOI 10.1128/IAI.69.6.3605-3610.2001
   Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569
   Schaffer L, 2003, PLACENTA, V24, P941, DOI 10.1016/S0143-4004(03)00166-8
   Sharma RK, 1998, IN VIVO, V12, P431
   SIMMONS RL, 1962, ANN NY ACAD SCI, V99, P717, DOI 10.1111/j.1749-6632.1962.tb45356.x
   SOARES MJ, 1987, J REPROD FERTIL, V79, P335, DOI 10.1530/jrf.0.0790335
   Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X
   SOARES MJ, 1993, TROPHOBLAST CELLS PA, P45
   TOBIAS L, 1993, VET PATHOL, V30, P119, DOI 10.1177/030098589303000204
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   Whiteside EJ, 2003, CELL TISSUE RES, V314, P275, DOI 10.1007/s00441-003-0791-4
   Yamagishi A, 1996, APPL CLAY SCI, V11, P1, DOI 10.1016/0169-1317(96)00010-5
NR 50
TC 38
Z9 38
U1 0
U2 2
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 1470-1626
J9 REPRODUCTION
JI Reproduction
PD AUG
PY 2004
VL 128
IS 2
BP 207
EP 218
DI 10.1530/rep.1.00214
PG 12
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA 844AO
UT WOS:000223129400009
PM 15280560
OA Bronze
DA 2020-12-01
ER

PT J
AU Levario-Carrillo, M
   Olave, ME
   Corral, DC
   Alderete, JG
   Gagioti, SM
   Bevilacqua, E
AF Levario-Carrillo, M
   Olave, ME
   Corral, DC
   Alderete, JG
   Gagioti, SM
   Bevilacqua, E
TI Placental morphology of rats prenatally exposed to methyl parathion
SO EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE methyl parathion; placenta; morphology; pesticides
ID TOXICITY; EMBRYOTOXICITY; INSECTICIDES; CHLORPYRIFOS; PREGNANCY;
   EXPOSURES; PROTEIN; MICE
AB Although prenatal exposure to pesticides has been associated with numerous adverse reproductive effects, data on the effects of such toxics in the placenta is limited. Thus, the present study was carried out to determine the morphology of the rat placenta exposed to the organophosphate pesticide methyl parathion (MP) in ad libitum fed and restricted diet animals. The pregnant females were randomly divided into control groups and experimental groups. the latter of which received MP at the doses of 0.0, 1.0, 1.5 and 2.0 mg/kg. Most cells in the maternal-fetal interface showed significant alterations in the presence of MP. Trophoblast giant cells exhibited either prominent characteristics of degeneration or normal morphology with many phagosome vacuoles, apparently containing cell debris. Vascular congestion was also more frequent in the labyrinth of the treated animals. Areas of fibrosis and hemorrhage were found in the decidua, as well as decidual cells presenting pyknotic nuclei and acidophilic cytoplasm. In the placentas of females treated with both restricted diet and MP, such changes were much more severe. Together. these alterations suggest a direct, toxic effect of MP on the placental cells. The phagocytic activity exhibited by trophoblast cells, may be playing a role in the removal of death cells from the maternal-placental interface and/or in a compensatory mechanism to maintain the uptake of maternal nutrients, following decreased metabolic exchange functions of the labyrinth due to the toxic effect of the MP.
C1 Inst Mexicano Seguro Social, Unidad Invest Med & Epidemiol Clin, Chihuahua 31320, Mexico.
   Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, Sao Paulo, Brazil.
   Univ Santo Amaro, Dept Morfol, Santo Amaro, Brazil.
RP Levario-Carrillo, M (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Med & Epidemiol Clin, Av Div Norte 2300, Chihuahua 31320, Mexico.
EM margarita.levario@imss.gob.mx
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR Arbuckle TE, 1998, CRIT REV TOXICOL, V28, P229, DOI 10.1080/10408449891344218
   BENJAMINOV O, 1992, VET HUM TOXICOL, V34, P10
   Breslin WJ, 1996, FUND APPL TOXICOL, V29, P119, DOI 10.1006/faat.1996.0013
   CHEN BY, 1994, TOXICOL APPL PHARM, V128, P293, DOI 10.1006/taap.1994.1209
   DAVIES J, 1968, ACTA ANAT, V69, P542
   de Rijk EPCT, 2002, TOXICOL PATHOL, V30, P271, DOI 10.1080/019262302753559614
   DEACON MM, 1980, TOXICOL APPL PHARM, V54, P31, DOI 10.1016/0041-008X(80)90005-8
   Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P409, DOI 10.1289/ehp.99107s3409
   Fuentes M, 1996, PLACENTA, V17, P371, DOI 10.1016/S0143-4004(96)90063-6
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   GUPTA RC, 1984, TOXICOL APPL PHARM, V72, P457, DOI 10.1016/0041-008X(84)90122-4
   Gupta RC, 1995, PLACENTAL TOXICOLOGY, P257
   Jaskoll T, 1996, TERATOLOGY, V54, P34, DOI 10.1002/(SICI)1096-9926(199607)54:1<34::AID-TERA5>3.0.CO;2-3
   Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8
   LUKE B, 1994, CLIN OBSTET GYNECOL, V3, P493
   MARANGHI F, 1988, REPROD TOXICOLOGY IN, P129
   PASOTORE LM, 1997, OCCUP ENVIRON MED, V54, P511
   Sastry BVR, 1997, BIOCHEM PHARMACOL, V53, P1577, DOI 10.1016/S0006-2952(97)00017-8
   Sharara FI, 1998, FERTIL STERIL, V70, P613, DOI 10.1016/S0015-0282(98)00253-2
   SULTATOS LG, 1989, BIOCHEM PHARMACOL, V39, P799
   TAHA TE, 1993, B WORLD HEALTH ORGAN, V71, P317
   TREINEN KA, 1986, TOXICOL LETT, V30, P223, DOI 10.1016/0378-4274(86)90159-1
   WEITMAN SD, 1983, TOXICOL APPL PHARM, V71, P215, DOI 10.1016/0041-008X(83)90338-1
   WHITE FMM, 1988, CAN MED ASSOC J, V138, P117
NR 24
TC 21
Z9 26
U1 0
U2 1
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-2993
EI 1618-1433
J9 EXP TOXICOL PATHOL
JI Exp. Toxicol. Pathol.
PD JUL
PY 2004
VL 55
IS 6
BP 489
EP 496
DI 10.1078/0940-2993-00346
PG 8
WC Pathology; Toxicology
SC Pathology; Toxicology
GA 850PF
UT WOS:000223624200007
PM 15384254
DA 2020-12-01
ER

PT J
AU Olivera, LVM
   Zago, DA
   Jones, CJP
   Bevilacqua, E
AF Olivera, LVM
   Zago, DA
   Jones, CJP
   Bevilacqua, E
TI Develpmental changes at the materno-embryonic interface in early
   pregnancy of the alpaca, Lamos pacos
SO ANATOMY AND EMBRYOLOGY
LA English
DT Article
DE camelids; trophoblast; chorion; endometrium; implantation
ID CAMEL CAMELUS-DROMEDARIUS; BINUCLEATE CELLS; PLACENTAL-LACTOGEN;
   IMPLANTATION; LOCALIZATION; CONCEPTUS; REPRODUCTION; UTERINE; LLAMAS;
   PIG
AB This study analyses the manner in which trophoblast cells adhere to uterine epithelium and the subsequent interactions that contribute to the establishment of epitheliochorial placentation in the alpaca Lama pacos. Specimens at the luteal and follicular phases and at 22, 26, 30 and 45 days of pregnancy (op) were processed for morphological studies. On day 15 op, the blastocysts are completely free within the uterine lumen, with implantation starting around day 20. On days 22 and 26 of gestation, the trophoblast is apposed to the epithelial surface of the uterus, with areas of contact and adhesion by means of complex interdigitation. Implantation sites occur prevalently in the left uterine horn, but an expanded trophoblast also occupies large extensions of the right horn, where the maternofetal interaction shows peculiar areas of apposition. As development continues, attachment areas become more extensive. On days 30 and 45, many secretory granules can be seen in the uterine epithelium, while giant multinucleate cells appear interposed between the remaining trophoblast cells, showing intense alkaline phosphatase activity, deposits containing iron and PAS-positive granules. Placental lactogen hormone is not present within the cytoplasm of the binucleate or multinucleate trophoblast cells. By day 30 of gestation, the trophoblast layer is lined by an extraembryonic connective tissue that by day 45 is well vascularized, thus indicating the starting point of placental formation. Fetal and maternal capillaries indent the epithelium and the trophoblast, narrowing the specialized areas of exchange, which occur along the entire maternofetal interface, characterizing the diffuse nature of this placenta.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, BR-05508900 Sao Paulo, Brazil.
   Natl Univ Altiplano, Fac Med Vet & Zootechnol, Puno 291, Casilla, Peru.
   Univ Santo Amaro, Dept Morphol, Sao Paulo, Brazil.
   Univ Manchester, St Marys Hosp, Sch Med, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625; Jones,
   Carolyn/0000-0002-0026-9494
CR Aba MA, 1997, ANIM REPROD SCI, V47, P273, DOI 10.1016/S0378-4320(97)00028-6
   Abd-Elnaeim MM, 1999, CELLS TISSUES ORGANS, V164, P141, DOI 10.1159/000016652
   ADAMS CL, 1989, J VET REC, V16, P618
   ADAMS GP, 1991, ANIM REPROD SCI, V24, P127, DOI 10.1016/0378-4320(91)90088-H
   Bancroft J.D., 1996, THEORY PRACTICE HIST
   BASU S, 1987, J VET MED A, V34, P487, DOI 10.1111/j.1439-0442.1987.tb00309.x
   BIELANSKAOSUCHOWSKA Z, 1995, FOLIA HISTOCHEM CYTO, V33, P95
   BJORKMAN N, 1973, ACTA ANAT, V86, P1
   Bowen JA, 2000, SEMIN CELL DEV BIOL, V11, P93, DOI 10.1006/scdb.2000.0155
   BRAVO PW, 1989, ANIM REPROD SCI, V21, P271, DOI 10.1016/0378-4320(89)90034-1
   BRAVO PW, 1993, J AM VET MED ASSOC, V202, P268
   Bravo PW, 1996, J AM VET MED ASSOC, V208, P2027
   DANTZER V, 1985, ANAT EMBRYOL, V172, P281, DOI 10.1007/BF00318976
   DUELLO TM, 1986, ENDOCRINOLOGY, V119, P1351, DOI 10.1210/endo-119-3-1351
   ELWISHY AB, 1987, ANIM REPROD SCI, V15, P273, DOI 10.1016/0378-4320(87)90049-2
   FERNANDEZBACA S, 1970, J REPROD FERTIL, V22, P261, DOI 10.1530/jrf.0.0220261
   FERNANDEZBACA S, 1979, BIOL REPROD, V20, P586, DOI 10.1095/biolreprod20.3.586
   FERNANDEZBACA S, 1993, ANIM REPROD SCI, V33, P307, DOI 10.1016/0378-4320(93)90121-7
   FOWLER ME, 1990, AM J VET RES, V51, P1495
   FOWLER ME, 1989, MED SURG S AM CAMELI
   FRIESS AE, 1980, ANAT EMBRYOL, V158, P179, DOI 10.1007/BF00315905
   GOROKHOVSKII N L, 1975, Arkhiv Anatomii Gistologii i Embriologii, V69, P41
   Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608
   GUILLOMOT M, 1995, J REPROD FERTIL, P39
   GUILLOMOT M, 1982, ANAT REC, V204, P315, DOI 10.1002/ar.1092040404
   GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5
   Hunt JS, 2000, SEMIN CELL DEV BIOL, V11, P127, DOI 10.1006/scdb.2000.0158
   Johnson GA, 1999, BIOL REPROD, V61, P892, DOI 10.1095/biolreprod61.4.892
   JOHNSON LW, 1989, VET CLIN N AM-FOOD A, V5, P159, DOI 10.1016/S0749-0720(15)31008-2
   Jones CJP, 1997, MICROSC RES TECHNIQ, V38, P100
   Jones CJP, 2002, REPRODUCTION, V123, P115, DOI 10.1530/reprod/123.1.115
   JONES CJP, 1995, CELL TISSUE RES, V279, P551, DOI 10.1007/s004410050314
   KEYS JL, 1990, AM J ANAT, V188, P221, DOI 10.1002/aja.1001880302
   Kimber SJ, 2000, SEMIN CELL DEV BIOL, V11, P61, DOI 10.1006/scdb.2000.0152
   Mossman HW, 1987, VERTEBRATE FETAL MEM
   NOVOA C, 1970, J REPROD FERTIL, V22, P3, DOI 10.1530/jrf.0.0220003
   OLIVERA LV, 1998, THESIS U SAO PAULO
   RAUB TJ, 1985, ANAT EMBRYOL, V171, P253, DOI 10.1007/BF00341420
   SAMUEL CA, 1974, J REPROD FERTIL, V41, P441, DOI 10.1530/jrf.0.0410441
   SANMARTIN M, 1968, J REPROD FERTIL, V16, P395, DOI 10.1530/jrf.0.0160395
   SINOWATZ F, 1983, ANAT EMBRYOL, V166, P121, DOI 10.1007/BF00317948
   Skidmore JA, 1996, PLACENTA, V17, P253, DOI 10.1016/S0143-4004(96)90046-6
   SKIDMORE JA, 1994, J REPROD FERTIL, V101, P363, DOI 10.1530/jrf.0.1010363
   STEVEN DH, 1980, PLACENTA, V1, P21, DOI 10.1016/S0143-4004(80)80013-0
   SUMAR J, 1988, ACTA VET SCAND, P133
   SUMAR J, 1988, ACTA VET SCAND, V29, P339
   Sumar J., 2000, REPROD FARM ANIMALS, P218
   Van Lennep E. W., 1963, Acta Morphologica Neerlando-Scandinavica, V5, P373
   van LENNEP E. W., 1961, ACTA MORPHOL NEERLANDO SCAND, V4, P180
   WANGO EO, 1990, J ANAT, V171, P241
   WATHES DC, 1980, AM J ANAT, V159, P285, DOI 10.1002/aja.1001590305
   Wooding F.B.P., 1994, P233
   WOODING FBP, 1992, J HISTOCHEM CYTOCHEM, V40, P1001, DOI 10.1177/40.7.1607634
   WOODING FBP, 1980, J REPROD FERTIL, V59, P425, DOI 10.1530/jrf.0.0590425
   Wooding FBP, 1996, PLACENTA, V17, P75, DOI 10.1016/S0143-4004(05)80646-0
   WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O
   WOODING FBP, 1987, CELL TISSUE RES, V247, P667, DOI 10.1007/BF00215761
NR 57
TC 20
Z9 20
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-2061
J9 ANAT EMBRYOL
JI Anat. Embryol.
PD DEC
PY 2003
VL 207
IS 4-5
BP 317
EP 331
DI 10.1007/s00429-003-0346-1
PG 15
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 752JA
UT WOS:000187156300007
PM 14579154
DA 2020-12-01
ER

PT J
AU Olivera, L
   Zago, D
   Leiser, R
   Jones, C
   Bevilacqua, E
AF Olivera, L
   Zago, D
   Leiser, R
   Jones, C
   Bevilacqua, E
TI Placentation in the alpaca Lama pacos
SO ANATOMY AND EMBRYOLOGY
LA English
DT Article
DE camelid; trophoblast; chorion; endometrium; maternofetal interactions;
   placental lactogen hormone
ID CAMEL CAMELUS-DROMEDARIUS; SCANNING-ELECTRON-MICROSCOPY; BINUCLEATE
   CELL-MIGRATION; PIG PLACENTA; EQUINE PLACENTA; INITIAL VASCULARIZATION;
   CHORIONIC EPITHELIUM; FUNCTIONAL-ASPECTS; RUMINANT PLACENTA; BOVINE
   PLACENTOME
AB Reproduction in South American camelids is poorly studied. To extend our knowledge of the development and cellular physiology of the placenta in the alpaca Lama pacos, we have examined specimens from day 150 of pregnancy to term. Morphological investigations using light, transmission and scanning electron microscopy, the histochemical localization of iron, alkaline and acid phosphatase activity, and the immunodetection of placental lactogen hormone were performed. Throughout pregnancy there was a progressive increase in the depths of folds on the uterine mucosa surface together with a thickening of the endometrium. Glandular cells exhibited PAS and acid phosphatase (AcP) positive secretion granules. In the chorion, giant trophoblast polyploid cells gradually became more numerous and larger. Non-giant cells exhibited positive granules for PAS, alkaline phosphatase (AkP) reaction and immunostaining for bovine placental lactogen hormone (PLH). SDS -PAGE electrophoresis and Western blotting procedures also confirmed the presence of a bovine PLH-like glycoprotein in the fetal alpaca placenta. Over the glandular openings, the chorion formed typical areolae, where the trophoblast exhibited AcP and PAS positive reactions. At these sites, the fetal endothelial cells contained iron-storage granules in their cytoplasm. The trophoblast-epithelial interface exhibited a complex microvillous interdigitation, in which an AkP reaction was very prominent. The chorionic capillaries progressively indented adjacent trophoblast cells. These data suggest that although the epitheliochorial alpaca placenta is diffuse, various trophoblast cell types and specialized areas of the maternofetal interface give the placenta micro-regional functions where histiotrophic nutrition, hormone production and molecular exchange are prevalent.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
   Natl Univ Altiplano, Fac Vet Med & Zootechnol, Casilla, Peru.
   Univ Santo Amaro, Dept Morphol, BR-04829300 Sao Paulo, Brazil.
   Univ Giessen, Inst Vet Anat Histol & Embryol, D-35392 Giessen, Germany.
   Univ Manchester, St Marys Hosp, Sch Med, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR Abd-Elnaeim MM, 1999, CELLS TISSUES ORGANS, V164, P141, DOI 10.1159/000016652
   Ahmed A, 2000, PLACENTA, V21, pS16, DOI 10.1053/plac.1999.0524
   Bancroft J.D., 1996, THEORY PRACTICE HIST
   BERGER EG, 1982, EXPERIENTIA, V38, P1129, DOI 10.1007/BF01959725
   BEVILACQUA EMAF, 1991, AM J ANAT, V192, P382, DOI 10.1002/aja.1001920406
   BIELANSKAOSUCHOWSKA Z, 1995, FOLIA HISTOCHEM CYTO, V33, P95
   BIELANSKAOSUCHOWSKA Z, 1995, FOLIA HISTOCHEM CYTO, V33, P103
   BJORKMAN N, 1973, ACTA ANAT, V86, P1
   BURSTONE MS, 1958, J NATL CANCER I, V21, P523
   BURTON GJ, 1976, Q J EXP PHYSIOL CMS, V61, P275, DOI 10.1113/expphysiol.1976.sp002359
   BUTT WR, 1994, MARSHALLS PHYSL RE 3, P461
   BYATT JC, 1990, ENDOCRINOLOGY, V127, P1041, DOI 10.1210/endo-127-3-1041
   DANTZER V, 1985, ANAT EMBRYOL, V172, P281, DOI 10.1007/BF00318976
   DANTZER V, 1994, ANAT REC, V238, P177, DOI 10.1002/ar.1092380204
   DANTZER V, 1984, ACTA ANAT, V118, P96, DOI 10.1159/000145827
   DANTZER V, 1993, ANAT EMBRYOL, V188, P257
   Dantzer V., 1986, CELL BIOL ASPECT POR
   Dearden L, 1983, BIOL TROPHOBLAST, P69
   DUELLO TM, 1986, ENDOCRINOLOGY, V119, P1351, DOI 10.1210/endo-119-3-1351
   ELWISHY AB, 1987, ANIM REPROD SCI, V15, P273, DOI 10.1016/0378-4320(87)90049-2
   ENDERS AC, 1991, AM J ANAT, V192, P366, DOI 10.1002/aja.1001920405
   ENDERS AC, 1991, J REPROD FERTIL, P427
   FOWLER ME, 1990, AM J VET RES, V51, P1495
   FRIESS AE, 1980, ANAT EMBRYOL, V158, P179, DOI 10.1007/BF00315905
   GOROKHOVSKII N L, 1975, Arkhiv Anatomii Gistologii i Embriologii, V69, P41
   Hombach-Klonisch S, 2000, BIOL REPROD, V62, P839, DOI 10.1095/biolreprod62.4.839
   JOHANSSON S, 1994, ANAT EMBRYOL, V190, P287
   Jones CJP, 1997, MICROSC RES TECHNIQ, V38, P100
   JONES CJP, 1994, CELL TISSUE RES, V278, P601
   Jones CJP, 2002, REPRODUCTION, V123, P115, DOI 10.1530/reprod/123.1.115
   JONES CJP, 1976, J PATHOL, V118, P143, DOI 10.1002/path.1711180303
   JONES CJP, 1995, CELL TISSUE RES, V279, P551, DOI 10.1007/s004410050314
   Jones CJP, 1999, PLACENTA, V20, P45, DOI 10.1053/plac.1998.0354
   Kaufmann Peter, 1994, P441
   KEYS JL, 1988, BIOL REPROD, V39, P473, DOI 10.1095/biolreprod39.2.473
   KEYS JL, 1990, AM J ANAT, V188, P221, DOI 10.1002/aja.1001880302
   Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X
   Krebs C, 1997, PLACENTA, V18, P43, DOI 10.1016/S0143-4004(97)90070-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leiser R, 1997, J ANAT, V191, P517, DOI 10.1046/j.1469-7580.1997.19140517.x
   LEISER R, 1994, EXP CLIN ENDOCRINOL, V102, P122, DOI 10.1055/s-0029-1211275
   LEISER R, 1988, ANAT EMBRYOL, V177, P409, DOI 10.1007/BF00304738
   Leiser R, 1989, Prog Clin Biol Res, V296, P421
   LEISER R, 1994, ANAT REC, V238, P326, DOI 10.1002/ar.1092380307
   Macdonald AA, 2000, PLACENTA, V21, P565, DOI 10.1053/plac.2000.0510
   MARTAL J, 1977, CELL TISSUE RES, V184, P427, DOI 10.1007/BF00220966
   McComb R. B., 1979, ALKALINE PHOSPHATASE
   MILLAN JL, 1990, PROG CLIN BIOL RES, V344, P453
   MORGAN G, 1989, J REPROD FERTIL, V86, P745, DOI 10.1530/jrf.0.0860745
   Mossman HW, 1987, VERTEBRATE FETAL MEM
   MYAGKAYA GL, 1984, PLACENTA, V5, P551, DOI 10.1016/S0143-4004(84)80009-0
   NOVOA C, 1970, J REPROD FERTIL, V22, P3, DOI 10.1530/jrf.0.0220003
   OLIVERA LV, 1998, THESIS U SAO PAULO B
   PERRY JS, 1982, J ANAT, V134, P339
   RAUB TJ, 1985, ANAT EMBRYOL, V171, P253, DOI 10.1007/BF00341420
   REYNOLDS LP, 1992, BIOL REPROD, V47, P698, DOI 10.1095/biolreprod47.5.698
   ROSS HM, 1995, HISTOLOGY TEXT ATLAS
   SAMUEL CA, 1974, J REPROD FERTIL, V41, P441, DOI 10.1530/jrf.0.0410441
   SINOWATZ F, 1983, ANAT EMBRYOL, V166, P121, DOI 10.1007/BF00317948
   Skidmore JA, 1996, PLACENTA, V17, P253, DOI 10.1016/S0143-4004(96)90046-6
   STEVEN DH, 1980, PLACENTA, V1, P21, DOI 10.1016/S0143-4004(80)80013-0
   STEVEN DH, 1982, J REPROD FERTIL, P41
   SUMAR J, 1988, ACTA VET SCAND, P133
   SUMAR J, 1988, ACTA VET SCAND, V29, P339
   Towbin H, 1992, Biotechnology, V24, P145
   Van Lennep E. W., 1963, Acta Morphologica Neerlando-Scandinavica, V5, P373
   VANLENNEP E, 1963, ACTA MORPH NEERL SCA, V4, P180
   WATHES DC, 1980, AM J ANAT, V159, P285, DOI 10.1002/aja.1001590305
   WATKINS WB, 1980, J REPROD FERTIL, V58, P411, DOI 10.1530/jrf.0.0580411
   Wooding F.B.P., 1994, P233
   Wooding FBP, 2000, PLACENTA, V21, P635, DOI 10.1053/plac.2000.0550
   Wooding FBP, 1996, CELL TISSUE RES, V285, P477, DOI 10.1007/s004410050664
   WOODING FBP, 1992, J HISTOCHEM CYTOCHEM, V40, P1001, DOI 10.1177/40.7.1607634
   WOODING FBP, 1980, J REPROD FERTIL, V59, P425, DOI 10.1530/jrf.0.0590425
   WOODING FBP, 1982, J ANAT, V134, P507
   WOODING FBP, 1984, AM J ANAT, V170, P233, DOI 10.1002/aja.1001700208
   Wooding FBP, 1996, PLACENTA, V17, P75, DOI 10.1016/S0143-4004(05)80646-0
   WOODING FBP, 1986, J REPROD FERTIL, V76, P499, DOI 10.1530/jrf.0.0760499
   WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O
   WOODING FBP, 1987, CELL TISSUE RES, V247, P667, DOI 10.1007/BF00215761
NR 80
TC 22
Z9 23
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-2061
J9 ANAT EMBRYOL
JI Anat. Embryol.
PD JUL
PY 2003
VL 207
IS 1
BP 45
EP 62
DI 10.1007/s00429-003-0328-3
PG 18
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 698UY
UT WOS:000184018700006
PM 12802689
DA 2020-12-01
ER

PT J
AU Goncalves, CR
   Antonini, S
   Vianna-Morgante, AM
   Machado-Santelli, GM
   Bevilacqua, E
AF Goncalves, CR
   Antonini, S
   Vianna-Morgante, AM
   Machado-Santelli, GM
   Bevilacqua, E
TI Developmental changes in the ploidy of mouse implanting trophoblast
   cells in vitro
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE ectoplacental cone; trophoblast giant cells; endoreduplication;
   proliferation; DNA synthesis
ID POLYTENE CHROMOSOMES; GIANT-CELLS; DIFFERENTIATION; PLACENTA; GROWTH;
   ENDOMITOSIS; BLASTOCYSTS; POLYPLOIDY; EMBRYOS; TISSUES
AB Shortly after the onset of implantation, polar mouse trophoblast cells proliferate and give rise to the ectoplacental cone, constituted by two distinct cell populations: undifferentiated, diploid cells and giant cells. Giant cells characteristically exhibit exaggerated dimensions and polyploid nuclei. In this study, we employ ectoplacental cones as a dynamic source of trophoblast giant cells to analyze cell proliferation, cell death, and ploidy under in vitro conditions. Our results show that DNA synthesis and the increase in the cell number are relevant only during the first 24 h of culture. Subsequently, DNA synthesis still occurs, mainly in the giant cell compartment, while the number of cells gradually decreases. Cell death by injury and apoptosis was also observed in the non-giant cell compartment of the ectoplacental cone. These findings suggest that the first 24 h of culture are crucial to the mitotic activity of the ectoplacental cone cells that gradually ceases, favoring the endoreduplication process. The DNA synthesis index during the subsequent experimental intervals emphasizes accumulation of DNA for the polyploidization. There was clear correlation between DNA content and nuclear dimension. The ploidy values for the trophoblast giant cells varied from 2C up to 368C in the giant cells, but were not as expressive as those known from in vivo conditions, probably due to the absence of regulatory factors specific to the embryonic-maternal interface. In situ hybridization and histochemistry for the nucleolus-organizing region showed that trophoblast nuclei have only two marker signals, indicative of a typical polytenic process. This present study elucidates important aspects of trophoblast behavior and provides new information on trophoblast physiology in vivo and in vitro.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biosci, Dept Biol, BR-05508900 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, Av Prof Lineu Prestes,1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Machado-Santelli, Glaucia M/C-6775-2013; Bevilacqua, Estela/H-3354-2011
OI Machado-Santelli, Glaucia M/0000-0003-2046-9693; Bevilacqua,
   Estela/0000-0003-4178-4625; Goncalves, Claudia
   Regina/0000-0002-4287-0560
CR Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   APLIN JD, 1991, J CELL SCI, V99, P681
   Bancroft John D., 1996, P139
   BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447
   BEVILACQUA E, 1994, ACTA ANAT, V150, P246
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   Brison DR, 1998, BIOL REPROD, V59, P136, DOI 10.1095/biolreprod59.1.136
   DAMATO F, 1989, CARYOLOGIA, V42, P183, DOI 10.1080/00087114.1989.10796966
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63
   GARDNER RL, 1972, J EMBRYOL EXP MORPH, V28, P279
   GARDNER RL, 1973, J EMBRYOL EXP MORPH, V30, P561
   GOSSEYE S, 1984, PLACENTA, V5, P329, DOI 10.1016/S0143-4004(84)80014-4
   HALL J, 1984, J HISTOCHEM CYTOCHEM, V32, P379, DOI 10.1177/32.4.6368678
   HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390
   HAMLIN GP, 1995, ENDOCRINOLOGY, V136, P322, DOI 10.1210/en.136.1.322
   HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607
   HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855
   ILGREN EB, 1983, PLACENTA, V4, P307, DOI 10.1016/S0143-4004(83)80010-1
   ILGREN EB, 1981, J EMBRYOL EXP MORPH, V62, P183
   KOLB JP, 1984, J IMMUNOL, V132, P2305
   LIN H, 1993, J IMMUNOL, V151, P4562
   MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795
   ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183
   SARTO GE, 1982, HUM GENET, V62, P228, DOI 10.1007/BF00333525
   SARTO GE, 1984, AM J OBSTET GYNECOL, V148, P1014, DOI 10.1016/0002-9378(84)90545-3
   Sherman M, 1983, BIOL TROPHOBLAST, P401
   Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072
   THERMAN E, 1983, HUM GENET, V63, P13, DOI 10.1007/BF00285390
   THERMAN E, 1986, CANCER GENET CYTOGEN, V19, P301, DOI 10.1016/0165-4608(86)90059-2
   VARMUZA S, 1988, DEVELOPMENT, V102, P127
   Viegas-Pequignot E, 1992, IN SITU HYBRIDIZATIO, P137
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   Zybina E V, 2000, Early Pregnancy, V4, P39
   ZYBINA E V, 1970, Tsitologiya, V12, P585
   ZYBINA E V, 1970, Tsitologiya, V12, P1081
   Zybina EV, 1996, INT REV CYTOL, V165, P53, DOI 10.1016/S0074-7696(08)62220-2
   ZYBINA EV, 1998, TROPHOBLAST RES, V11, P51
   Zybina TG, 1996, CARYOLOGIA, V49, P137, DOI 10.1080/00087114.1996.10797358
NR 39
TC 14
Z9 15
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD MAR
PY 2003
VL 119
IS 3
BP 189
EP 198
DI 10.1007/s00418-003-0500-0
PG 10
WC Cell Biology; Microscopy
SC Cell Biology; Microscopy
GA 671BH
UT WOS:000182444800002
PM 12649733
DA 2020-12-01
ER

PT J
AU Ferro, EAV
   Silva, DAO
   Bevilacqua, E
   Mineo, JR
AF Ferro, EAV
   Silva, DAO
   Bevilacqua, E
   Mineo, JR
TI Effect of Toxoplasma gondii infection kinetics on trophoblast cell
   population in Calomys callosus, a model of congenital toxoplasmosis
SO INFECTION AND IMMUNITY
LA English
DT Article
ID LINKED IMMUNOSORBENT-ASSAY; IMMUNOGLOBULIN-G; MURINE UTERUS; PREGNANCY;
   PLACENTA; TRANSMISSION; DIAGNOSIS; INVASION; AVIDITY; RATS
AB This work evaluated the kinetics of events that occur in the placenta of Calomys callosus after Toxoplasma gondii infection. Animals on the first day of pregnancy (dop) and virgin nonpregnant females were perorally infected with 20 cysts of T. gondii strain ME49. After 100 days of infection, the virgin animals were mated and received an additional 20 cysts on the first dop. The placentas and the embryos from both acutely and chronically infected animals were analyzed up to day 20 of pregnancy by morphological and immunocytochemical assays. Noninfected and infected animals exhibited placenta with normal morphology. From the seventh dop and infection onwards, liver and spleen cells of the infected animals contained several parasitophorous vacuoles. On the 13th day, the maternal blood present at the placental blood spaces contained T. gondii-infected leukocytes. Infected placental cells were only seen on the 15th dop, being the trophoblast giant cells, the first cell type to contain signs of the parasite internalization, followed by labyrinth zone cells 24 h later and spongiotrophoblast cells only after the 19th dop. Fetal liver and brain were infected by T. gondii concomitantly to the labyrinth cell infection. No signals of infection were observed on placentas and embryos from chronically infected animals. Therefore, considering the sequence of events leading to the infection of the various organs, it could be hypothesized that the placenta is infected later on during pregnancy, which may be related to the defense roles played by this structure. However, trophoblast giant cells are unable to completely stop the progression of T. gondii infection towards the fetal tissues. C callosus was demonstrated to be a suitable experimental model to study the dynamics of congenital toxoplasmosis.
C1 Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38405320 Uberlandia, MG, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil.
RP Mineo, JR (corresponding author), Univ Fed Uberlandia, Inst Ciencias Biomed, Av Para 1720, BR-38405320 Uberlandia, MG, Brazil.
RI Mineo, Jose R/B-4151-2009; Bevilacqua, Estela/H-3354-2011; Mineo, Jose
   Roberto/M-6573-2019; Ferro, Eloisa/B-2185-2008; Ferro,
   Eloisa/K-5533-2016
OI Mineo, Jose R/0000-0002-9010-7228; Bevilacqua,
   Estela/0000-0003-4178-4625; Mineo, Jose Roberto/0000-0002-9010-7228;
   Ferro, Eloisa/0000-0002-7447-2583; Ferro, Eloisa/0000-0002-7447-2583
CR BAUMGARTNER W, 1992, INFECT IMMUN, V60, P5232
   BERVELY JKA, 1959, NATURE, V183, P1348
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   Buendia AJ, 1998, INFECT IMMUN, V66, P2128
   CAMARGO ME, 1991, REV I MED TROP, V33, P213, DOI 10.1590/S0036-46651991000300008
   CAMPBELL WJ, 1989, ENDOCRINOLOGY, V125, P1565, DOI 10.1210/endo-125-3-1565
   COWEN D, 1950, J EXP MED, V92, P393, DOI 10.1084/jem.92.5.393
   Cozon GJN, 1998, EUR J CLIN MICROBIOL, V17, P32, DOI 10.1007/BF01584360
   DJURKOVICDJAKOVIC O, 1995, GYNECOL OBSTET INVES, V40, P36, DOI 10.1159/000292299
   Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267
   Dubey JP, 1997, PARASITOLOGY, V115, P9, DOI 10.1017/S0031182097008950
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   FADUL CE, 1995, INFECT IMMUN, V63, P4290, DOI 10.1128/IAI.63.11.4290-4294.1995
   FERRO EAV, 1994, J MORPHOL, V221, P139, DOI 10.1002/jmor.1052210204
   Ferro EAV, 1999, PARASITOL RES, V85, P647, DOI 10.1007/s004360050609
   GRAHAM DI, 1984, J PATHOL, V142, P265, DOI 10.1002/path.1711420405
   HOLLIMAN RE, 1994, EPIDEMIOL INFECT, V112, P399, DOI 10.1017/S0950268800057812
   HUTCHISON WM, 1982, ANN TROP MED PARASIT, V76, P53, DOI 10.1080/00034983.1982.11687504
   MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232
   MINEO JR, 1980, INFECT IMMUN, V27, P283, DOI 10.1128/IAI.27.2.283-287.1980
   Mossman HW, 1987, VERTEBRATE FETAL MEM
   Paulino JP, 1999, PARASITE, V6, P63, DOI 10.1051/parasite/1999061063
   Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647
   REDLINE RW, 1988, J IMMUNOL, V140, P3947
   REMINGTON J, 1961, J INFECT DIS, V108, P163, DOI 10.1093/infdis/108.2.163
   ROBERTS CW, 1992, PARASITOLOGY, V104, P19, DOI 10.1017/S0031182000060753
   SCHOONDERMARKVANDEVEN E, 1993, EXP PARASITOL, V77, P200, DOI 10.1006/expr.1993.1077
   SIMS TA, 1988, J PATHOL, V156, P255, DOI 10.1002/path.1711560311
   Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   TANABE K, 1979, J GEN MICROBIOL, V113, P433, DOI 10.1099/00221287-113-2-433
   THIERMANN J. E., 1957, BIOLOGICA [SANTIAGO CHILE], V23, P59
   TOBIAS L, 1993, VET PATHOL, V30, P119, DOI 10.1177/030098589303000204
   TURUNEN H, 1983, SCAND J INFECT DIS, V15, P307, DOI 10.3109/inf.1983.15.issue-3.12
   WONG M M, 1979, Asian Journal of Infectious Diseases, V3, P61
   Zenner L, 1999, PARASITE IMMUNOL, V21, P261, DOI 10.1046/j.1365-3024.1999.00229.x
   ZUCKERMANN FA, 1986, PLACENTA, V7, P349, DOI 10.1016/S0143-4004(86)80153-9
NR 38
TC 34
Z9 35
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2002
VL 70
IS 12
BP 7089
EP 7094
DI 10.1128/IAI.70.12.7089-7094.2002
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 617TU
UT WOS:000179377600072
PM 12438390
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Montanari, T
   Bevilacqua, E
AF Montanari, T
   Bevilacqua, E
TI Effect of Maytenus ilicifolia Mart. on pregnant mice
SO CONTRACEPTION
LA English
DT Article
DE Maytenus ilicifolia; medicinal plants; abortifacient agents; pregnant
   mice
ID LABORATORY-ANIMALS; PLANTS; RATS
AB Maytenus ilicifolia Mart. is used in Brazilian herbal medicine particularly for stomach disorders, but it is also used, as in other parts of South America, for fertility control. To verify its potential as an abortifacient, the lyophilized hydroalcoholic extract of its leaves was administered orally at a dose of 1000 mg/kg/day to mice between the first and third day of pregnancy (DOP), between the forth and sixth DOP, or between the seventh and ninth DOP. The extract caused a pre-implantation embryonic loss, but it did not have an effect on implantation or organogenesis. Morphological alterations of the reproductive system, not an embryotoxic effect, were not found. Estrogenic activity of the extract, exhibited by an uterotrophic effect, suggests that it may be interfering with the uterine receptivity to the embryo. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Inst Hlth Basic Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, Sao Paulo, Brazil.
RP Montanari, T (corresponding author), Univ Fed Rio Grande do Sul, Inst Hlth Basic Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil.
EM t.montanari@bol.com.br
RI Bevilacqua, Estela/H-3354-2011; Montanari, Tatiana/J-4278-2014
OI Bevilacqua, Estela/0000-0003-4178-4625; Montanari,
   Tatiana/0000-0001-8267-4364
CR ARENAS P, 1977, ECON BOT, V31, P302, DOI 10.1007/BF02866880
   ARENAS P, 1977, ECON BOT, V31, P298, DOI 10.1007/BF02866879
   BARROW MV, 1969, J MORPHOL, V127, P291, DOI 10.1002/jmor.1051270303
   BHARGAVA SK, 1986, J ETHNOPHARMACOL, V18, P95, DOI 10.1016/0378-8741(86)90046-2
   CONWAY GA, 1979, J ETHNOPHARMACOL, V1, P241, DOI 10.1016/S0378-8741(79)80014-8
   Dawson AB, 1926, STAIN TECHNOL, V1, P123, DOI 10.3109/10520292609115636
   DENKER HW, 1994, REPROD BIOL, P17
   EMENTS CW, 1970, ANNU REV PHARMACOL, V10, P237
   GANDHI M, 1991, J ETHNOPHARMACOL, V34, P49, DOI 10.1016/0378-8741(91)90188-J
   Hnatyszyn O., 1974, REV SOC CIENT PARAGU, V14, P23
   MARTINEZ CR, 1987, AM IND, V47, P279
   OLIVEIRA MGM, 1991, J ETHNOPHARMACOL, V34, P29, DOI 10.1016/0378-8741(91)90186-H
   RUBIN BL, 1951, ENDOCRINOLOGY, V49, P429, DOI 10.1210/endo-49-4-429
   SALEWSKL E., 1964, ARCH EXP PATHOL PHARMAKOL [NAUNYN SCHMEEDEBERGS], V247, P367
   SHORR EPHRAIM, 1941, SCIENCE, V94, P545, DOI 10.1126/science.94.2449.545-a
   SOUZAFORMIGONI MLO, 1991, J ETHNOPHARMACOL, V34, P21, DOI 10.1016/0378-8741(91)90185-G
NR 16
TC 28
Z9 34
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
J9 CONTRACEPTION
JI Contraception
PD FEB
PY 2002
VL 65
IS 2
BP 171
EP 175
AR PII S0010-7824(01)00301-8
DI 10.1016/S0010-7824(01)00301-8
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 538ZB
UT WOS:000174844000008
PM 11927121
DA 2020-12-01
ER

PT J
AU Jones, CJP
   Abd-Elnaeim, M
   Bevilacqua, E
   Oliveira, LV
   Leiser, R
AF Jones, CJP
   Abd-Elnaeim, M
   Bevilacqua, E
   Oliveira, LV
   Leiser, R
TI Comparison of uteroplacental glycosylation in the camel (Camelus
   dromedarius) and alpaca (Lama pacos)
SO REPRODUCTION
LA English
DT Article
ID CARBOHYDRATE BINDING-SPECIFICITY; COMPLEX-TYPE OLIGOSACCHARIDES;
   ACID-SPECIFIC LECTIN; SLUG LIMAX-FLAVUS; DOLICHOS-BIFLORUS;
   HELIX-POMATIA; EPITHELIOCHORIAL PLACENTA; STRUCTURAL DETERMINANTS;
   LINKED OLIGOSACCHARIDES; ERYTHRINA-CRISTAGALLI
AB The recent birth of a camel-llama hybrid, after numerous failed attempts, has prompted an investigation into the glycosylation of apposing fetal and maternal tissues of pregnant camels and alpacas. This study was undertaken to determine whether interspecies differences in glycans are factors that may account in part for the difficulty in producing a viable hybrid. Specimens of camel placentae from day 60 to day 375 of gestation and alpaca placentae from day 22 to term (approximately 345 days) were fixed and embedded in resin, and sections were stained with a panel of 19 biotinylated lectins and an avidin-peroxidase revealing system. Several qualitative interspecies differences in tissue glycosylation were found, mainly in the trophoblast, and especially with respect to bi/tri-antennary bisected N-glycan, fucosylated structures, beta-galactosyl residues and sialyl termini. In the maternal uterine epithelium, differences were found mainly in bi/tri-antennary bisected complex N-glycan and beta-galactosyl residues, indicating that there is more conservation of glycosylation in maternal tissues compared with trophoblast. There were also many quantitative differences in the distribution of glycans. It is possible that a failure to effect the normal glycan-glycan complementation that occurs at the cell surface between maternal and fetal tissues during the implantation processes of apposition and adhesion may account in part for the difficulty in establishing a viable pregnancy between these two species.
C1 Univ Manchester, St Marys Hosp, Sch Med, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England.
   Assiut Univ, Fac Med Vet, Dept Anat & Histol, Assiut, Egypt.
   Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil.
   Univ Antiplano, Fac Med Vet & Zootecn, Puno, Peru.
   Univ Giessen, Inst Vet Anat Histol & Embryol, D-35392 Giessen, Germany.
RP Jones, CJP (corresponding author), Univ Manchester, St Marys Hosp, Sch Med, Acad Unit Obstet & Gynaecol, Whitworth Pk, Manchester M13 0JH, Lancs, England.
EM carolyn.jones@man.ac.uk
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625; Jones,
   Carolyn/0000-0002-0026-9494
CR Abd-Elnaeim MM, 1999, CELLS TISSUES ORGANS, V164, P141, DOI 10.1159/000016652
   ALLEN AK, 1973, BIOCHEM J, V135, P307, DOI 10.1042/bj1350307
   Allen W R, 1987, J Reprod Fertil Suppl, V35, P197
   ALLEN WR, 1982, J REPROD FERTIL, P57
   Allen WR, 1997, J HERED, V88, P384, DOI 10.1093/oxfordjournals.jhered.a023123
   Aplin J D, 1997, Rev Reprod, V2, P84, DOI 10.1530/ror.0.0020084
   Aplin JD, 1997, BIOCHEM SOC T, V25, P1184, DOI 10.1042/bst0251184
   BAKER DA, 1983, BIOCHEMISTRY-US, V22, P2741, DOI 10.1021/bi00280a023
   Baldus SE, 1996, GLYCOCONJUGATE J, V13, P585, DOI 10.1007/BF00731446
   BHATTACHARYYA L, 1988, BIOCHEMISTRY-US, V27, P1034, DOI 10.1021/bi00403a028
   Bowen JA, 1996, BIOL REPROD, V55, P1098, DOI 10.1095/biolreprod55.5.1098
   Carson D.D., 1990, TROPHOBLAST RES, V4, P211
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X
   CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230
   DEBOECK H, 1984, ARCH BIOCHEM BIOPHYS, V234, P297, DOI 10.1016/0003-9861(84)90352-7
   DEBRAY H, 1981, EUR J BIOCHEM, V117, P41
   ELWISHY AB, 1981, BRIT VET J, V137, P527
   ETZLER ME, 1970, BIOCHEMISTRY-US, V9, P869, DOI 10.1021/bi00806a022
   FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0
   GALLAGHER JT, 1985, BIOCHEM J, V231, P115, DOI 10.1042/bj2310115
   GEE H, 1999, NATURE SCI UPDA 0506
   GOROKHOVSKII N L, 1975, Arkhiv Anatomii Gistologii i Embriologii, V69, P41
   Gray A.P., 1972, MAMMALIAN HYBRIDS
   GREEN ED, 1987, J BIOL CHEM, V262, P12018
   HAMMARSTROM S, 1977, BIOCHEMISTRY-US, V16, P2750, DOI 10.1021/bi00631a025
   HAMMARSTROM S, 1982, P NATL ACAD SCI-BIOL, V79, P1611, DOI 10.1073/pnas.79.5.1611
   HINDSGAUL O, 1985, CAN J CHEM, V63, P2653, DOI 10.1139/v85-440
   HOFFMAN LH, 1993, J EXP ZOOL, V266, P559, DOI 10.1002/jez.1402660607
   IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x
   Johnson GA, 2000, BIOL REPROD, V62, P1315, DOI 10.1095/biolreprod62.5.1315
   Jones CJP, 1998, BIOL REPROD, V58, P20, DOI 10.1095/biolreprod58.1.20
   JONES CJP, 1987, HISTOCHEM J, V19, P264, DOI 10.1007/BF01675685
   JONES CJP, 1995, HISTOCHEM J, V27, P210
   Jones CJP, 2000, J REPROD FERTIL, V118, P397, DOI 10.1530/reprod/118.2.397
   KIMBER SJ, 1995, J REPROD FERTIL, V103, P75
   KNIBBS RN, 1993, J BIOL CHEM, V268, P18524
   KNIBBS RN, 1991, J BIOL CHEM, V266, P83
   Lotan R, 1978, Methods Enzymol, V50, P361
   MADDOX PH, 1987, J CLIN PATHOL, V40, P1256, DOI 10.1136/jcp.40.10.1256
   MEINECKETILLMANN S, 1984, NATURE, V307, P637, DOI 10.1038/307637a0
   MILLER RL, 1982, J BIOL CHEM, V257, P7574
   Murphy CR, 2000, J REPROD FERTIL, P23
   MYSTKOWSKA ET, 1975, J EMBRYOL EXP MORPH, V33, P731
   NACHBAR MS, 1980, J BIOL CHEM, V255, P2056
   Ozturk M., 1999, Journal of Physiology (Cambridge), V517P, p32P
   PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029
   PEREIRA MEA, 1974, CARBOHYD RES, V37, P89, DOI 10.1016/S0008-6215(00)87066-4
   Roemer I, 1999, NATURE, V401, P131
   ROSSANT J, 1982, J ANIM SCI, V55, P1241
   ROSSANT J, 1983, J EXP ZOOL, V228, P223, DOI 10.1002/jez.1402280208
   SARKAR M, 1981, ARCH BIOCHEM BIOPHYS, V209, P204, DOI 10.1016/0003-9861(81)90273-3
   SCHLAFKE S, 1975, BIOL REPROD, V12, P41, DOI 10.1095/biolreprod12.1.41
   SHIBUYA N, 1987, J BIOL CHEM, V262, P1596
   Sidhu SS, 1999, BIOL REPROD, V60, P147, DOI 10.1095/biolreprod60.1.147
   Skidmore JA, 1999, P ROY SOC B-BIOL SCI, V266, P649, DOI 10.1098/rspb.1999.0685
   Skidmore JA, 1996, PLACENTA, V17, P253, DOI 10.1016/S0143-4004(96)90046-6
   Solis D, 2001, CELLS TISSUES ORGANS, V168, P5, DOI 10.1159/000016802
   STANLEY HF, 1994, P ROY SOC B-BIOL SCI, V256, P1, DOI 10.1098/rspb.1994.0041
   STEVEN DH, 1980, PLACENTA, V1, P21, DOI 10.1016/S0143-4004(80)80013-0
   SUEYOSHI S, 1988, CARBOHYD RES, V178, P213, DOI 10.1016/0008-6215(88)80113-7
   SUGII S, 1980, BIOCHEMISTRY-US, V19, P1192, DOI 10.1021/bi00547a024
   TAYLOR P, 2000, ALPACA REGISTRY  SPR, V5
   TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0
   TROWBRIDGE IS, 1974, J BIOL CHEM, V249, P6004
   van LENNEP E. W., 1961, ACTA MORPHOL NEERLANDO SCAND, V4, P180
   WANG WC, 1988, J BIOL CHEM, V263, P4576
   Wegner C. C., 1994, Oxford Reviews of Reproductive Biology, V16, P87
   WHYTE A, 1985, PLACENTA, V6, P537, DOI 10.1016/S0143-4004(85)80007-2
   WRIGHT W, 1999, GULF NEWS       0225
   YAMASHITA K, 1987, J BIOL CHEM, V262, P1602
   YAMASHITA K, 1983, J BIOL CHEM, V258, P4753
NR 72
TC 24
Z9 25
U1 0
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 1470-1626
J9 REPRODUCTION
JI Reproduction
PD JAN
PY 2002
VL 123
IS 1
BP 115
EP 126
DI 10.1530/reprod/123.1.115
PG 12
WC Developmental Biology; Reproductive Biology
SC Developmental Biology; Reproductive Biology
GA 518EZ
UT WOS:000173654800013
PM 11869193
OA Bronze
DA 2020-12-01
ER

PT J
AU Visintin, JA
   Martins, JFP
   Bevilacqua, EM
   Mello, MRB
   Nicacio, AC
   Assumpcao, MEOA
AF Visintin, JA
   Martins, JFP
   Bevilacqua, EM
   Mello, MRB
   Nicacio, AC
   Assumpcao, MEOA
TI Cryopreservation of bos taurus vs bos indicus embryos: Are they really
   different?
SO THERIOGENOLOGY
LA English
DT Article; Proceedings Paper
CT 28th Annual Conference of the International-Embryo-Transfer-Society
   (IETS)
CY JAN 12-15, 2002
CL FOZ IGUASSU, BRAZIL
SP Int Embryo Transfer Soc
ID VITRIFIED BOVINE EMBRYOS; LIPID PHASE-TRANSITIONS; MATURE MOUSE OOCYTES;
   ETHYLENE-GLYCOL; IN-VITRO; POLYETHYLENE-GLYCOL; VITRIFICATION
   PROPERTIES; OVARIAN TISSUE; ONE-STEP; BLASTOCYSTS
AB Cryopreservation with storage at very low temperatures is essential to make full use of this technology for both biological and commercial reasons. However, most mammalian cells will die if exposed to these temperatures unless they are exposed to cryoprotectant solutions and cooled and warmed at specific rates. Lowering temperature below 0 degreesC introduces the risk of intracellular ice formation, which likely increases rapidly as the temperature falls. Evidence indicates that ice formation during cooling can cause significantly more damage than ice formation during warming. Comparisons of the toxicity of various cryoprotectants indicated that ethylene glycol (EG) is a nontoxic compound for murine and bovine embryos. The 3.6 M EG solution resulted in similar high survival rates when compared with nonfrozen embryos; deleterious effects of high concentrations of EG became apparent at 7.2 M. The use of EG provides a nontoxic method for the rapid and simplified controlled freezing of in vivo bovine compact morulae-early blastocyst, avoiding the risk of injury caused by high concentrations of cryoprotectants usually required for vitrification. However, in vivo embryos used for freezing and thawing require further studies to understand the ultrastructural changes during the freezing procedure with EG as the single cryoprotectant, especially between Holstein and Nelore cows. This paper describes the ultrastructure of bovine compact morulae-early blastocysts derived by in vivo methods from Holstein and Nelore cows to investigate the fresh morphology as well as that after exposure to cryoprotectant and cryopreservation by conventional slow freezing, quick freezing (nitrogen vapor), and vitrification. (C) 2001 by Elsevier Science inc.
C1 Univ Sao Paulo, Fac Vet Med, Dept Anim Reprod, BR-05508000 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, BR-05508000 Sao Paulo, Brazil.
RP Visintin, JA (corresponding author), Univ Sao Paulo, Fac Vet Med, Dept Anim Reprod, BR-05508000 Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011; visintin, jose a/D-8608-2012; Assumpcao,
   Mayra Elena O A/P-8683-2016; Nicacio, Alessandra/D-7806-2015
OI Bevilacqua, Estela/0000-0003-4178-4625; Assumpcao, Mayra Elena O
   A/0000-0002-5967-9316; MELLO, MARCO ROBERTO/0000-0002-9790-4764
CR ABE H, 1999, ANAT EMBRYOL BERL, P516
   ALVARENGA FCL, 1995, THESIS BOTUCATU SP B
   Arav A, 1996, CRYOBIOLOGY, V33, P589, DOI 10.1006/cryo.1996.0062
   BRACKE C, 1995, P 11 REUN AETE HANN, P101
   Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088
   CARROLL J, 1993, BIOL REPROD, V48, P606, DOI 10.1095/biolreprod48.3.606
   CASTELLINI C, 1996, 6 WORLD RABB C TOUL, P55
   CRITSER JK, 1997, REPROD TISSUE BANKIN, P332
   Crosier AE, 2000, BIOL REPROD, V62, P1459, DOI 10.1095/biolreprod62.5.1459
   DARINBENNETT A, 1973, AUST J BIOL SCI, V26, P1409, DOI 10.1071/BI9731409
   DIAS AJB, 1997, ARQ FAC VET UFRGS S, V25, P215
   DOCHI O, 1995, ANIM REPROD SCI, V38, P179, DOI 10.1016/0378-4320(94)01362-P
   DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413
   ENDERS AC, 1981, AM J ANAT, V162, P1, DOI 10.1002/aja.1001620102
   ENDERS AC, 1982, BIOL REPROD, V26, P353, DOI 10.1095/biolreprod26.2.353
   ESPER CR, 1986, THESIS JABOTICABAL S
   ESPER CR, 1991, C BRAS REPR AN MG BR
   Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N
   FARIN PW, 1995, THERIOGENOLOGY, V44, P339, DOI 10.1016/0093-691X(95)00189-F
   HINKOVSKAGALCHEVA V, 1989, CRYOBIOLOGY, V26, P70, DOI 10.1016/0011-2240(89)90034-5
   HOLT WV, 1984, J EXP ZOOL, V230, P473, DOI 10.1002/jez.1402300316
   Holt WV, 2000, THERIOGENOLOGY, V53, P47, DOI 10.1016/S0093-691X(99)00239-3
   HOLT WV, 1986, J REPROD FERTIL, V78, P445
   ISACHENKO VV, 1997, PROBLEMS CRYOBIOLOGY, V1, P100
   IWASAKI S, 1990, J REPROD FERTIL, V90, P279, DOI 10.1530/jrf.0.0900279
   Karlsson JOM, 1996, HUM REPROD, V11, P1296
   Kuleshova LL, 1999, CRYOBIOLOGY, V38, P119, DOI 10.1006/cryo.1999.2153
   Lane M, 1999, THERIOGENOLOGY, V51, P167, DOI 10.1016/S0093-691X(99)91726-0
   Le Gal F, 1999, CRYOBIOLOGY, V38, P290, DOI 10.1006/cryo.1999.2172
   Liu Y., 1996, Theriogenology, V45, P177, DOI 10.1016/0093-691X(96)84650-4
   MAHMOUDZADEH AR, 1993, THERIOGENOLOGY, V39, P1291, DOI 10.1016/0093-691X(93)90231-S
   Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059
   Martino A, 1996, MOL REPROD DEV, V45, P503, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;503::AID-MRD13&gt;3.0.CO;2-X
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   McIntosh A., 1994, Theriogenology, V41, P253, DOI 10.1016/S0093-691X(05)80163-3
   MELLO MRB, 1999, THESIS SAO PAULO SP
   MIYAKE T, 1993, THERIOGENOLOGY, V40, P121, DOI 10.1016/0093-691X(93)90346-7
   O'Neil L, 1998, CRYOLETTERS, V19, P141
   Ohboshi S, 1997, ANIM REPROD SCI, V48, P27, DOI 10.1016/S0378-4320(97)00034-1
   ONeil L, 1997, CRYOBIOLOGY, V34, P295, DOI 10.1006/cryo.1997.2007
   Otoi T, 1997, CRYOBIOLOGY, V34, P36, DOI 10.1006/cryo.1996.1988
   Paynter SJ, 1999, CRYOBIOLOGY, V38, P301, DOI 10.1006/cryo.1999.2170
   PEDERSEN RA, 1980, NATURE, V10, P550
   RALL WF, 1985, THERIOGENOLOGY, V23, P220, DOI 10.1016/0093-691X(85)90126-8
   RALL WF, 1987, J REPROD FERTIL, V80, P499, DOI 10.1530/jrf.0.0800499
   RODRIGUES JL, 1992, ARS VET, V8, P55
   RUFFING NA, 1993, CRYOBIOLOGY, V30, P562, DOI 10.1006/cryo.1993.1059
   Saha S, 1997, REPROD FERT DEVELOP, V9, P741, DOI 10.1071/R97024
   Saha S, 1996, CRYOBIOLOGY, V33, P291, DOI 10.1006/cryo.1996.0029
   SHAW JM, 1995, HUM REPROD, V10, P396, DOI 10.1093/oxfordjournals.humrep.a135951
   Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043
   Shaw JM, 2000, THERIOGENOLOGY, V53, P59, DOI 10.1016/S0093-691X(99)00240-X
   SHAW JM, 1999, HDB IN VITRO FERTILI, P1
   Sommerfeld V, 1999, CRYOBIOLOGY, V38, P95, DOI 10.1006/cryo.1999.2159
   Stachecki JJ, 1998, CRYOBIOLOGY, V37, P346, DOI 10.1006/cryo.1998.2130
   Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V
   VALDEZ CA, 1992, J REPROD FERTIL, V96, P793, DOI 10.1530/jrf.0.0960793
   VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9
   VOELKEL SA, 1992, THERIOGENOLOGY, V37, P23, DOI 10.1016/0093-691X(92)90245-M
   WHITE IG, 1976, 8 C AN REPR ART INS, P951
   Younis AI, 1996, HUM REPROD, V11, P156
   ZANENGA CA, 1993, 10 C BRAS REPR AN
   Zhu SE, 1996, J REPROD FERTIL, V107, P37, DOI 10.1530/jrf.0.1070037
NR 63
TC 31
Z9 35
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
J9 THERIOGENOLOGY
JI Theriogenology
PD JAN 1
PY 2002
VL 57
IS 1
SI SI
BP 345
EP 359
DI 10.1016/S0093-691X(01)00675-6
PG 15
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA 502CH
UT WOS:000172725800023
PM 11775979
DA 2020-12-01
ER

PT J
AU Moraes, N
   Zago, D
   Gagioti, S
   Hoshida, MS
   Bevilacqua, E
AF Moraes, N
   Zago, D
   Gagioti, S
   Hoshida, MS
   Bevilacqua, E
TI NADPH-diaphorase activity and nitric oxide synthase isoforms in the
   trophoblast of Calomys callosus
SO JOURNAL OF ANATOMY
LA English
DT Article
DE pregnancy; placenta; inducible nitric oxide synthase
ID HUMAN PLACENTA; IMMUNOHISTOCHEMICAL LOCALIZATION; EXTRAVILLOUS
   TROPHOBLAST; MACHUPO VIRUS; MOUSE UTERUS; PREGNANCY; IMPLANTATION;
   EXPRESSION; CELLS; SYNCYTIOTROPHOBLAST
AB The pattern of expression of a variety of placental nitric oxide synthase isoforms has contributed to elucidating the regulatory mechanisms of nitric oxide (NO) synthesis during gestation. The maintenance of vascular tone, attenuation of vasoconstriction, prevention of platelet and leukocyte adhesion to the trophoblast surface, and possible participation in uterine blood how seem to be the main functions of NO generated at the fetal-maternal interface in humans and mice. Extending this knowledge to other rodent species commonly used as laboratory animals, in this study we focus on NADPH-diaphorase activity and the distribution of nitric oxide synthase isoforms (NOS) in the trophoblast cells of Calomys callosus during different phases of pregnancy. NADPH-diaphorase activity was evaluated cytochemically and the presence of NOS isoforms detected by immunohistochemistry. These techniques were performed on pre- and postimplantation embryos in situ and in vitro, as well as in placentae on d 14 and 18 of pregnancy. Neither NADPH-diaphorase activity nor inducible or endothelial NOS isoforms were found in pre-implanting embryos except after culturing for at least 48 h, when some of the embryonic cells were positive for the diaphorase reaction. On d 6.5 of pregnancy, trophoblast cells showed intense diaphorase activity both in situ and under in vitro conditions. A positive reaction was also found in the different placental trophoblast cells on d 14 and is of pregnancy. The inducible NOS (iNOS) isoform, but not the endothelial isoform: was immunodetected in trophoblast cells from the placenta ansi from postimplantation embryos in situ and under in vitro conditions. These results strongly suggest the production of NO by the iNOS isoform in the trophoblast of Calomys callosus after embryo implantation. The data also emphasise a possible role for the trophoblast in producing and releasing cytotoxic molecules at the fetal-maternal interface.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
   Univ Fed Santa Catarina, Dept Morphol Sci, Florianopolis, SC, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Hoshida, Mara S/D-3900-2012; BEVILACQUA, ESTELA/H-3354-2011
OI Hoshida, Mara S/0000-0003-2232-4631; BEVILACQUA,
   ESTELA/0000-0003-4178-4625
CR Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   AMARANTE A, 1999, ACTA MICROSCOPICA, V8, P309
   Baylis SA, 1999, MOL HUM REPROD, V5, P277, DOI 10.1093/molehr/5.3.277
   BELLAVITE P, 1990, NATO ADV SCI I A-LIF, V189, P23
   BENIRSCHKE K, 1995, PATHOLOGY HUMAN PLAC, P219
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   Biswas S, 1998, J REPROD FERTIL, V114, P157, DOI 10.1530/jrf.0.1140157
   BREDT BT, 1991, P NATL ACAD SCI USA, V88, P2811
   BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0
   BUTTERY LDK, 1994, PLACENTA, V15, P257, DOI 10.1016/0143-4004(94)90017-5
   CHAVES MC, 1993, BRAZ J MED BIOL RES, V26, P853
   CONRAD KP, 1993, FASEB J, V7, P1269
   EIS ALW, 1995, PLACENTA, V16, P113, DOI 10.1016/0143-4004(95)90000-4
   Ferro EAV, 1999, PARASITOL RES, V85, P647, DOI 10.1007/s004360050609
   Gagioti S, 2000, BIOL REPROD, V62, P260, DOI 10.1095/biolreprod62.2.260
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   HADDAD EK, 1995, J EXP MED, V182, P1143, DOI 10.1084/jem.182.4.1143
   HOLCBERG G, 1995, AM J OBSTET GYNECOL, V173, P528
   HOPE BT, 1989, J HISTOCHEM CYTOCHEM, V37, P653, DOI 10.1177/37.5.2703701
   HUANG J, 1995, J LEUKOCYTE BIOL, V57, P27
   Hunt JS, 1997, BIOL REPROD, V57, P827, DOI 10.1095/biolreprod57.4.827
   IGUCHI T, 1993, BIOL REPROD, V48, P188, DOI 10.1095/biolreprod48.1.188
   JOHNSON KM, 1965, SCIENCE, V150, P1618, DOI 10.1126/science.150.3703.1618
   JUSTINES G, 1969, NATURE, V222, P1090, DOI 10.1038/2221090a0
   JUSTINES G, 1970, LAB ANIM CARE, V20, P57
   Kaufmann P., 1997, TROPHOBLAST RES, V10, P21, DOI DOI 10.1016/S0143-4004(97)80079-3
   Matejevic D, 1996, ACTA HISTOCHEM, V98, P173, DOI 10.1016/S0065-1281(96)80036-5
   MATSUMOTO T, 1993, NEUROSCI LETT, V155, P61, DOI 10.1016/0304-3940(93)90673-9
   MCKENDRICK JD, 1998, TROPHOBLAST RES, V11, P193
   MCLAUGHLIN MK, 1978, AM J OBSTET GYNECOL, V132, P430, DOI 10.1016/0002-9378(78)90780-9
   MEHROTRA P K, 1988, Biological Structures and Morphogenesis, V1, P63
   MELLO D, 1978, Revista Brasileira de Biologia, V38, P807
   MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   MOORHEAD CS, 1995, J HISTOCHEM CYTOCHEM, V43, P1053, DOI 10.1177/43.10.7560883
   MYATT L, 1993, PLACENTA, V14, P487, DOI 10.1016/S0143-4004(05)80202-4
   Myatt L, 1997, PLACENTA, V18, P261, DOI 10.1016/S0143-4004(97)80060-4
   MYATT L, 1992, AM J OBSTET GYNECOL, V166, P224, DOI 10.1016/0002-9378(92)91863-6
   NANAEV A, 1995, CELL TISSUE RES, V282, P407, DOI 10.1007/s004410050492
   NATUZZI ES, 1993, BIOCHEM BIOPH RES CO, V194, P1, DOI 10.1006/bbrc.1993.1776
   Novaro V, 1997, REPROD FERT DEVELOP, V9, P557, DOI 10.1071/R97005
   Purcell TL, 1997, MOL HUM REPROD, V3, P485, DOI 10.1093/molehr/3.6.485
   Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467
   RADOMSKI MW, 1995, ANN MED, V27, P321, DOI 10.3109/07853899509002585
   RIBEIRO R D, 1973, Revista Brasileira de Biologia, V33, P429
   WEINER CP, 1994, AM J OBSTET GYNECOL, V171, P838, DOI 10.1016/0002-9378(94)90108-2
   WELSH AO, 1987, ANAT REC, V217, P213
   WOLF G, 1995, BIOCHEMICAL, PHARMACOLOGICAL, AND CLINICAL ASPECTS OF NITRIC OXIDE, P213
   Zarlingo TJ, 1997, PLACENTA, V18, P511, DOI 10.1016/0143-4004(77)90004-2
NR 50
TC 7
Z9 7
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8782
J9 J ANAT
JI J. Anat.
PD APR
PY 2001
VL 198
BP 443
EP 453
PN 4
PG 11
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 425TC
UT WOS:000168306900006
PM 11327206
DA 2020-12-01
ER

PT J
AU Gagioti, S
   Scavone, C
   Bevilacqua, E
AF Gagioti, S
   Scavone, C
   Bevilacqua, E
TI Participation of the mouse implanting trophoblast in nitric oxide
   production during pregnancy
SO BIOLOGY OF REPRODUCTION
LA English
DT Article
ID NADPH-DIAPHORASE; RESPIRATORY BURST; VASCULAR INVASION;
   HUMAN-NEUTROPHILS; HUMAN PLACENTA; RAT PLACENTA; SYNTHASE; EXPRESSION;
   IMPLANTATION; LOCALIZATION
AB While considerable progress has been made in elucidating nitric oxide (NO) regulatory mechanisms in the later stages of gestation, much less is known about its synthesis and role during embryo implantation. Thus, to evaluate the participation of the trophoblast in the production of NO during this phase, this study focused on NADPH-diaphorase activity and the distribution of NO synthase isoforms (NOS) using immunohistochemistry in pre- and postimplantation mouse embryos in situ and in vitro, as well as on NO production itself, measured as total nitrite, in trophoblast culture supernatants (Griess reaction). No NADPH-diaphorase activity was found in preimplanting embryos except alter culturing for at least 48 h, when a few trophoblastic giant cells were positive. Conversely, postimplantation trophoblast cells either lodged into the implantation chamber (in situ) or after culturing (in vitro) showed intense NADPH-diaphorase activity. Also in the postimplantation trophoblast, the endothelial and inducible NOS (eNOS and iNOS) isoforms were immunodetected, under both in situ and in vitro conditions, although in different patterns. Extracts of ectoplacental cone also revealed bands of 135 and 130 kDa on SDS-PACE that reacted with anti-eNOS and anti-iNOS, respectively, on Western blot. Analysis of the culture supernatant demonstrated that the nitrite concentration was 1) proportional to the number of cultured tropho-blast cells, 2) almost completely abolished in the presence of N(omega)-nitro-L-arginine methyl ester, and 3) increased 2-fold in cultures stimulated with gamma-interferon, These results strongly suggest the production of NO from constitutive and inducible isoforms of NOS by the implanting mouse trophoblast, They also emphasize the possibility of the participation of these cells in vasodilatation and angiogenesis, and in cytotoxic mechanisms involved in the intense phagocytosis of injured maternal cells, which occur during the implantation process.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed, Dept Pharmacol, BR-05508900 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
EM bevilacq@usp.br
RI Scavone, Cristoforo/C-1580-2012; Bevilacqua, Estela/H-3354-2011
OI Scavone, Cristoforo/0000-0002-1206-0882; Bevilacqua,
   Estela/0000-0003-4178-4625
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343
   BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553
   BELLAVITE P, 1990, NATO ADV SCI I A-LIF, V189, P23
   BENIRSCHKE K, 1995, PATHOLOGY HUMAN PLAC, P219
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   Biswas S, 1998, J REPROD FERTIL, V114, P157, DOI 10.1530/jrf.0.1140157
   BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0
   BURROWS TD, 1994, PLACENTA, V15, P21, DOI 10.1016/S0143-4004(05)80233-4
   BUTTERY LD, 1994, PLACENMTA, V16, P257
   Casado M, 1997, BIOCHEM J, V324, P201, DOI 10.1042/bj3240201
   Chwalisz K, 1999, HUM REPROD, V14, P542, DOI 10.1093/humrep/14.2.542
   CONRAD KP, 1993, FASEB J, V7, P1269
   CURNUTTE JT, 1979, J CLIN INVEST, V63, P637, DOI 10.1172/JCI109346
   FARIA M, 1995, J MORPHOL, V226, P159, DOI 10.1002/jmor.1052260205
   GAGIOTI S, 1995, REPROD FERT DEVELOP, V7, P111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   Gouge RC, 1998, BIOL REPROD, V58, P875, DOI 10.1095/biolreprod58.4.875
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842
   HOLCBERG G, 1995, AM J OBSTET GYNECOL, V173, P528
   HON WM, 1997, BIOTECH HISTOCHEM, V78, P29
   HOPE BT, 1989, J HISTOCHEM CYTOCHEM, V37, P653, DOI 10.1177/37.5.2703701
   HOPE BT, 1991, P NATL ACAD SCI USA, V88, P281
   HUANG J, 1995, J LEUKOCYTE BIOL, V57, P27
   Hunt JS, 1997, BIOL REPROD, V57, P827, DOI 10.1095/biolreprod57.4.827
   HUSTIN J, 1988, TROPHOBLAST RES, V3, P49
   IIDA S, 1997, TROPHOBLAST RES, V9, P141
   Kaufmann P., 1997, TROPHOBLAST RES, V10, P21, DOI DOI 10.1016/S0143-4004(97)80079-3
   KRISTOFFERSEN EK, 1994, APMIS, V102, P509, DOI 10.1111/j.1699-0463.1994.tb05198.x
   LEWIS CE, 1992, MACROPHAGE
   Matejevic D, 1996, ACTA HISTOCHEM, V98, P173, DOI 10.1016/S0065-1281(96)80036-5
   MATSUMOTO T, 1993, NEUROSCI LETT, V155, P61, DOI 10.1016/0304-3940(93)90673-9
   MCKENDRICK JD, 1998, TROPHOBLAST RES, V11, P193
   MCLAUGHLIN MK, 1978, AM J OBSTET GYNECOL, V132, P430, DOI 10.1016/0002-9378(78)90780-9
   MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   MOORHEAD CS, 1995, J HISTOCHEM CYTOCHEM, V43, P1053, DOI 10.1177/43.10.7560883
   MYATT L, 1993, PLACENTA, V14, P487, DOI 10.1016/S0143-4004(05)80202-4
   Myatt L, 1997, PLACENTA, V18, P261, DOI 10.1016/S0143-4004(97)80060-4
   MYATT L, 1992, AM J OBSTET GYNECOL, V166, P224, DOI 10.1016/0002-9378(92)91863-6
   MYATT L, 1993, PLACENTA, V14, P373, DOI 10.1016/S0143-4004(05)80459-X
   NANAEV A, 1995, CELL TISSUE RES, V282, P407, DOI 10.1007/s004410050492
   Novaro V, 1997, REPROD FERT DEVELOP, V9, P557, DOI 10.1071/R97005
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   Purcell TL, 1997, MOL HUM REPROD, V3, P485, DOI 10.1093/molehr/3.6.485
   Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467
   RADOMSKI MW, 1995, ANN MED, V27, P321, DOI 10.3109/07853899509002585
   REES DD, 1990, BRIT J PHARMACOL, V101, P146
   ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4
   Schilesinger M, 1975, FERTIL STERIL, V18, P95
   SELIGMAN SP, 1994, AM J OBSTET GYNECOL, V171, P944, DOI 10.1016/S0002-9378(94)70064-8
   SUBURO AM, 1995, BIOL REPROD, V52, P631, DOI 10.1095/biolreprod52.3.631
   Thanda M, 1996, J Obstet Gynaecol Res, V22, P267
   WELSH AO, 1991, AM J ANAT, V192, P347, DOI 10.1002/aja.1001920404
   WELSH AO, 1987, ANAT REC, V217, P213
   YALLAMPALLI C, 1993, AM J OBSTET GYNECOL, V169, P1316, DOI 10.1016/0002-9378(93)90299-X
   Zarlingo TJ, 1997, PLACENTA, V18, P511, DOI 10.1016/0143-4004(77)90004-2
NR 58
TC 66
Z9 70
U1 0
U2 1
PU SOC STUDY REPRODUCTION
PI MADISON
PA 1603 MONROE ST, MADISON, WI 53711-2021 USA
SN 0006-3363
J9 BIOL REPROD
JI Biol. Reprod.
PD FEB
PY 2000
VL 62
IS 2
BP 260
EP 268
DI 10.1095/biolreprod62.2.260
PG 9
WC Reproductive Biology
SC Reproductive Biology
GA 278JV
UT WOS:000084987400006
PM 10642561
OA Bronze
DA 2020-12-01
ER

PT J
AU Ferro, EAV
   Bevilacqua, E
   Favoreto, S
   Silva, DAO
   Mortara, RA
   Mineo, JR
AF Ferro, EAV
   Bevilacqua, E
   Favoreto, S
   Silva, DAO
   Mortara, RA
   Mineo, JR
TI Calomys callosus (Rodentia : Cricetidae) trophoblast cells as host cells
   to Toxoplasma gondii in early pregnancy
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID CONGENITAL TOXOPLASMOSIS; SURFACE PROTEIN; INVASION; MICE;
   REDISTRIBUTION; ENCEPHALITIS; ANTIBODIES; ATTACHMENT
AB The potential of the RH strain of Toxoplasma gondii to invade trophoblast. cells of the cricetid rodent Calomys callosus in a congenital infection in the initial third of pregnancy was investigated in this study using morphological and immunocytochemical approaches. The animals were intraperitoneally inoculated on the Ist day of pregnancy and the infection was observed on day 7. Various numbers of parasites could be observed inside the parasitophorous vacuoles in trophoblastic cells under light and electron microscopy. The trophoblast cells showed characteristics of healthy cells, and no alteration other than parasite vacuoles in their cytoplasm could be detected. Polyclonal or monoclonal anti-T. gondii antibodies (respectively, anti-T. gondii components and the major surface parasite antigen p30) labeled both the parasite surface and parasitophorous vacuole membranes, regardless of the number of parasites inside the compartment. In addition, p30-containing trails were detected in the extracellular matrix surrounding trophoblastic cells similar to those found with other parasites during locomotion and the invasion process. Our results show the ability of T. gondii to infect trophoblast cells during the early blastocyst-endometrial relationship and open new possibilities for more accurate study of the invasion process of this parasite and the role of the trophoblast as an embryo defense barrier.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
   Univ Fed Uberlandia, Dept Morfol, BR-38400902 Uberlandia, MG, Brazil.
   Univ Fed Uberlandia, Dept Patol, BR-38400902 Uberlandia, MG, Brazil.
   Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, BR-04023900 Sao Paulo, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
RI Mortara, Renato A./C-1864-2012; Bevilacqua, Estela/H-3354-2011; Ferro,
   Eloisa/B-2185-2008; Ferro, Eloisa/K-5533-2016; Mineo, Jose
   Roberto/M-6573-2019; Mineo, Jose R/B-4151-2009
OI Mortara, Renato A./0000-0002-2311-8349; Bevilacqua,
   Estela/0000-0003-4178-4625; Ferro, Eloisa/0000-0002-7447-2583; Ferro,
   Eloisa/0000-0002-7447-2583; Mineo, Jose Roberto/0000-0002-9010-7228;
   Mineo, Jose R/0000-0002-9010-7228
CR BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BUXTON D, 1986, J COMP PATHOL, V96, P319, DOI 10.1016/0021-9975(86)90052-6
   CAMARGO ME, 1978, INFECT IMMUN, V21, P35
   COWEN D, 1950, J EXP MED, V92, P393, DOI 10.1084/jem.92.5.393
   DUBEY JP, 1990, VET PATHOL, V27, P411, DOI 10.1177/030098589902700605
   DUBREMETZ JF, 1985, EXP PARASITOL, V59, P24, DOI 10.1016/0014-4894(85)90053-0
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   FADUL CE, 1995, INFECT IMMUN, V63, P4290, DOI 10.1128/IAI.63.11.4290-4294.1995
   FERRO EAV, 1994, J MORPHOL, V221, P139, DOI 10.1002/jmor.1052210204
   GRAHAM DI, 1984, J PATHOL, V142, P265, DOI 10.1002/path.1711420405
   GRIMWOOD J, 1995, PARASITOL RES, V81, P657, DOI 10.1007/BF00931842
   Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996
   HUNTER CA, 1994, J INFECT DIS, V170, P1057, DOI 10.1093/infdis/170.5.1057
   HUTCHISON WM, 1982, ANN TROP MED PARASIT, V76, P53, DOI 10.1080/00034983.1982.11687504
   JOINER KA, 1993, INFECT IMMUN, V61, P1169, DOI 10.1128/IAI.61.4.1169-1172.1993
   Kasper L. H., 1993, Immunology and molecular biology of parasitic infections., P269
   KIMATA I, 1987, J CELL SCI, V88, P231
   MINEO JR, 1980, INFECT IMMUN, V27, P283, DOI 10.1128/IAI.27.2.283-287.1980
   MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054
   Mossmann H. W., 1987, VERTEBRATE FETAL MEM
   ROBERTS CW, 1992, PARASITOLOGY, V104, P19, DOI 10.1017/S0031182000060753
   SIMS TA, 1988, J PATHOL, V156, P255, DOI 10.1002/path.1711560311
   STEWART MJ, 1992, J PROTOZOOL, V39, P663, DOI 10.1111/j.1550-7408.1992.tb04446.x
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
NR 25
TC 24
Z9 26
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0044-3255
J9 PARASITOL RES
JI Parasitol. Res.
PD AUG
PY 1999
VL 85
IS 8-9
BP 647
EP 654
DI 10.1007/s004360050609
PG 8
WC Parasitology
SC Parasitology
GA 213ZH
UT WOS:000081302800005
PM 10431727
DA 2020-12-01
ER

PT J
AU Rossi-Ferragut, LM
   Bevilacqua, EMAF
AF Rossi-Ferragut, LM
   Bevilacqua, EMAF
TI Trophoblastic invasion: is it a chemotactic process?
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Dept Tecidual & Cell Biol, BR-13202550 Sao Paulo, Brazil.
   Coll Med, Dept Histol & Embryol, Jundiai, Brazil.
RI Rossi, Lia M/G-9145-2012; Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
J9 HUM REPROD
JI Hum. Reprod.
PD JUN
PY 1999
VL 14
SU 1
MA O034
BP 19
EP 19
DI 10.1093/humrep/14.Suppl_3.19
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 223EN
UT WOS:000081828000035
OA Bronze
DA 2020-12-01
ER

PT J
AU Albieri, A
   Kipnis, T
   Bevilacqua, E
AF Albieri, A
   Kipnis, T
   Bevilacqua, E
TI A possible role for activated complement component 3 in phagocytic
   activity exhibited by the mouse trophoblast
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE C3b-receptor; erythrophagocytosis; implanting trophoblast
ID HUMAN-MONOCYTES; CELLS; MACROPHAGES; RECEPTOR; RAT; EXPRESSION;
   INDUCTION; PREGNANCY; PLACENTA; INVASION
AB PROBLEM: To determine whether any blood plasma factor may play a regulatory role in trophoblast phagocytosis in rodent early pregnancy.
   METHOD OF STUDY: The effects of alloplasma on the phagocytosis of cultured mouse trophoblast cells (TCs) were evaluated using erythrocytes as target cells, in the presence of 10% fresh, normal plasma, 10% heat-inactivated plasma; 10% component 3 (C3)-depleted plasma; or medium alone. The possible activation of C3 complement, the phagocytosis of zymosan bound or unbound to C3b, and immunoreactivity to C3b receptor were also estimated. Phagocytic activity was expressed as the percentage of phagocytic TCs, and as the number of phagosomes/TCs. RESULTS: The use of complement sufficient plasma significantly enhanced the phagocytosis of the TCs while the use of heat-inactivated plasma eliminated the erythrophagocytosis. Very low levels of phagocytic activity were seen when the plasma was C3-complement deficient. Phagocytosis of C3b-bound zymosan was remarkable in comparison to zymosan alone, and immunoreactivity to C3b-receptors was seen on the TCs.
   CONCLUSION: These results indicate the participation of thermosensitive molecules mediating the phagocytosis of TCs and suggest, as in macrophages, a role for C3-C3b in this process.
C1 Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, BR-05508900 Sao Paulo, Brazil.
   Univ Norte Fluminense, Dept Immunol, Rio De Janeiro, Brazil.
RP Bevilacqua, E (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Histol & Embriol, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BEVILACQUA E, 1988, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BISCHOF P, 1994, HUM REPROD, V9, P1652, DOI 10.1093/oxfordjournals.humrep.a138768
   DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   FOLDES JJ, 1975, INT J FERTIL, V20, P228
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   Gagioti S, 1996, J BRAZ ASS ADV, V48, P37
   GARDNER RL, 1975, IMMUNOBIOLOGY TROPHO, P43
   GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5
   HOLMES CH, 1992, EUR J IMMUNOL, V22, P1579, DOI 10.1002/eji.1830220635
   HOLMES CH, 1992, BAILLIERE CLIN OB GY, V6, P439, DOI 10.1016/S0950-3552(05)80005-7
   JANEWAY CA, 1996, IMMUNOBIOLOGY IMMUNE, P31
   LAW SK, 1988, COMPLEMENT
   LEWIS CE, 1992, MACROPHAGE, P3
   LIMA AO, 1970, IMUNOLOGIA IMUNOPATO, P113
   MANTOVANI B, 1981, J IMMUNOL, V126, P127
   MANTOVANI B, 1987, EXP CELL RES, V173, P282, DOI 10.1016/0014-4827(87)90354-5
   MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6
   NISHIKORI K, 1993, CLIN IMMUNOL IMMUNOP, V69, P167, DOI 10.1006/clin.1993.1166
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   SAPINO AP, 1989, J CELL BIOL, V109, P2471
   SCHLESINGER M, 1975, FERTIL STERIL, V18, P95
   SEAL US, 1972, AM J ANAT, V134, P263, DOI 10.1002/aja.1001340209
   STRICKLAND S, 1992, CELL, V71, P355, DOI 10.1016/0092-8674(92)90503-5
   STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9
   SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   WELSH AO, 1991, AM J ANAT, V192, P215, DOI 10.1002/aja.1001920302
   Whaley K, 1985, METHODS COMPLEMENT C, P77
   WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699
   WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149
NR 38
TC 25
Z9 27
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 8755-8920
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD MAY
PY 1999
VL 41
IS 5
BP 343
EP 352
PG 10
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA 201YH
UT WOS:000080624500007
PM 10378030
DA 2020-12-01
ER

PT J
AU Peters, TJ
   Albieri, A
   Bevilacqua, E
   Chapman, BM
   Crane, LH
   Hamlin, GP
   Seiki, M
   Soares, MJ
AF Peters, TJ
   Albieri, A
   Bevilacqua, E
   Chapman, BM
   Crane, LH
   Hamlin, GP
   Seiki, M
   Soares, MJ
TI Differentiation-dependent expression of gelatinase B/matrix
   metalloproteinase-9 in trophoblast cells
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE trophoblast giant cell; placenta; gelatinase; B/MMP-9/92-kDa gelatinase;
   ectoplacental cone outgrowths; invasion, trophoblast; rat (Sprague
   Dawley)
ID PLACENTAL-LACTOGEN-I; MOUSE EMBRYO IMPLANTATION; PROLACTIN-RELATED
   PROTEIN; EPIDERMAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES;
   TRANSCRIPTIONAL ACTIVATION; COLLAGENASE GENE; RAT PLACENTA; FACTOR-BETA;
   INVASION
AB The purpose of this study was to evaluate the Rcho-1 trophoblast culture system as a model for studying trophoblast invasion and to examine stage-specific expression of enzyme(s) potentially participating in rat trophoblast giant cell invasive behavior. The invasive behavior of the differentiating Rcho-1 trophoblast cells was demonstrated using Matrigel invasion chambers. Gelatin zymography and Western blot analysis of conditioned medium from differentiating Rcho-1 trophoblast cell cultures and rat ectoplacental cone outgrowths revealed a differentiation-dependent increase in gelatinase B/matrix metalloproteinase (MMP-9). Nothern blot and reverse transcriptase polymerase chain reaction (RT-PCR) analyses of Rcho-1 trophoblast or ectoplacental cone cells also showed increasing expression of MMP-9 accompanying cell differentiation. Rcho-1 trophoblast cells stably transfected with MMP-9 promoter/luciferase reporter constructs exhibited a differentiation-dependent increase in MMP-9 promoter activation. In conclusion, trophoblast giant cell differentiation is characterized by transcriptional activation of the MMP-9 gene and appearance of the invasive phenotype.
C1 Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
   Univ Sao Paulo, ICB, Dept Histol & Embryol, Sao Paulo, Brazil.
   Univ Tokyo, Inst Med Sci, Dept Canc Res, Minato Ku, Tokyo 108, Japan.
RP Soares, MJ (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
EM msoares@kumc.edu
RI Seiki, Motoharu/K-9443-2015; Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [HD 33994, HD
   20676] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676, R01HD020676, R01HD020676, R01HD020676] Funding Source: NIH
   RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH
   &HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R01HD020676, R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676, R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676, R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676, R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676, R01HD020676, R01HD020676, R01HD020676, R01HD020676,
   R01HD020676] Funding Source: NIH RePORTER
CR Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8
   Alexander CM, 1996, DEVELOPMENT, V122, P1723
   APLIN JD, 1991, J CELL SCI, V99, P681
   BABIARZ BS, 1992, IN VITRO CELL DEV-AN, V28A, P500, DOI 10.1007/BF02634133
   BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401
   Bischof P, 1997, Early Pregnancy, V3, P81
   CANETESOLER R, 1995, DEV DYNAM, V204, P30, DOI 10.1002/aja.1002040105
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020
   Dai GL, 1996, ENDOCRINOLOGY, V137, P5020, DOI 10.1210/en.137.11.5020
   DAMSKY C, 1993, FASEB J, V7, P1320
   DAMSKY CH, 1994, DEVELOPMENT, V120, P3657
   Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8
   ENDERS AC, 1993, J EXP ZOOL, V266, P578, DOI 10.1002/jez.1402660608
   FARIA TN, 1990, DEV BIOL, V141, P279, DOI 10.1016/0012-1606(90)90384-U
   FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895
   FARIA TN, 1990, ENDOCRINOLOGY, V127, P3131, DOI 10.1210/endo-127-6-3131
   GARDNER RL, 1988, J CELL SCI, P11
   GRAHAM CH, 1994, EXP CELL RES, V214, P93, DOI 10.1006/excr.1994.1237
   Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672
   HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390
   HAMLIN GP, 1995, ENDOCRINOLOGY, V136, P322, DOI 10.1210/en.136.1.322
   HARVEY MB, 1995, DEVELOPMENT, V121, P1005
   HIBBS MS, 1985, J BIOL CHEM, V260, P2493
   Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012
   Hulboy DL, 1997, MOL HUM REPROD, V3, P27, DOI 10.1093/molehr/3.1.27
   KEPPEL G, 1973, DESIGN ANAL
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lala PK, 1996, PLACENTA, V17, P545, DOI 10.1016/S0143-4004(96)80071-3
   Leco KJ, 1996, MOL REPROD DEV, V45, P458, DOI 10.1002/(SICI)1098-2795(199612)45:4&lt;458::AID-MRD8&gt;3.0.CO;2-Q
   LEI HQ, 1995, BIOL REPROD, V53, P339, DOI 10.1095/biolreprod53.2.339
   LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437
   LYONS JG, 1991, BIOCHEMISTRY-US, V30, P1449, DOI 10.1021/bi00220a001
   Nagase H, 1992, Matrix Suppl, V1, P421
   NG YK, 1994, DEVELOPMENT, V120, P3257
   OKADA A, 1995, GENE, V164, P317, DOI 10.1016/0378-1119(95)00447-E
   OKADA Y, 1992, J BIOL CHEM, V267, P21712
   Orwig KE, 1997, ENDOCRINOLOGY, V138, P2491, DOI 10.1210/en.138.6.2491
   PETERS TJ, 1998, TROPHOBLAST DIFFEREN
   PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2
   Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647
   REPONEN P, 1995, DEV DYNAM, V202, P388, DOI 10.1002/aja.1002020408
   RINGLER GE, 1990, ENDOCR REV, V11, P105, DOI 10.1210/edrv-11-1-105
   Rinkenberger JL, 1997, DEV GENET, V21, P6, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;6::AID-DVG2&gt;3.0.CO;2-B
   SALAMONSEN LA, 1994, CELL BIOL INT, V18, P1139, DOI 10.1006/cbir.1994.1040
   SATO H, 1993, J BIOL CHEM, V268, P23460
   SATO H, 1993, ONCOGENE, V8, P395
   Sharkey ME, 1996, AM J REPROD IMMUNOL, V36, P72, DOI 10.1111/j.1600-0897.1996.tb00142.x
   Shi FL, 1997, EXP CELL RES, V234, P147, DOI 10.1006/excr.1997.3603
   SHIDA MM, 1993, MOL ENDOCRINOL, V7, P181, DOI 10.1210/me.7.2.181
   Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X
   SOARES MJ, 1995, DEV GROWTH DIFFER, V37, P355, DOI 10.1046/j.1440-169X.1995.t01-3-00001.x
   SOARES MJ, 1987, DEV BIOL, V124, P134, DOI 10.1016/0012-1606(87)90466-0
   Suenaga A, 1996, PLACENTA, V17, P583, DOI 10.1016/S0143-4004(96)80075-0
   SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331
   SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175
   Tanaka SS, 1998, PLACENTA, V19, P41, DOI 10.1016/S0143-4004(98)90097-2
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VALENZUELA R, 1981, HUM PATHOL, V12, P355, DOI 10.1016/S0046-8177(81)80145-1
   VERSTUYF A, 1992, AM J REPROD IMMUNOL, V28, P6, DOI 10.1111/j.1600-0897.1992.tb00749.x
   YAMAMOTO T, 1994, J BIOL CHEM, V269, P6517
   YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923
NR 64
TC 31
Z9 34
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD FEB
PY 1999
VL 295
IS 2
BP 287
EP 296
DI 10.1007/s004410051235
PG 10
WC Cell Biology
SC Cell Biology
GA 161DJ
UT WOS:000078272900012
PM 9931375
DA 2020-12-01
ER

PT J
AU Lima, GMAC
   Vallochi, AL
   Silva, UR
   Bevilacqua, EMAF
   Kiffer, MMF
   Abrahamsohn, IA
AF Lima, GMAC
   Vallochi, AL
   Silva, UR
   Bevilacqua, EMAF
   Kiffer, MMF
   Abrahamsohn, IA
TI The role of polymorphonuclear leukocytes in the resistance to cutaneous
   Leishmaniasis
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE granulocyte depletion; Leishmania major; mAb RB6-8C5; neutrophils;
   resistance
ID SUSCEPTIBLE MICE; INFECTION; IMMUNITY; CELLS; PHAGOCYTOSIS; NEUTROPHILS;
   LISTERIOSIS; MACROPHAGES; MECHANISM; RECEPTOR
AB The massive infiltration by polymorphonuclear leukocytes (PMN) soon after skin infection with Leishmania major suggests that PMN could participate in reducing parasite load and controlling the spreading of leishmanial infection. Yet, direct evidence for the participation of PMN in host defense against L. major was lacking. We investigated L. major infection in susceptible and resistant mice treated with the monoclonal (mAb) antibody RB6-8C5 that depletes the population of mature neutrophils and eosinophils. Both BALB/c and C57BL/6 mice depleted of PMN show accelerated parasite spreading and more severe footpad swelling than similarly infected untreated mice. In addition, significant higher parasite numbers were found in the lesion draining lymph nodes from PMN-depleted C57BL/6 mice. Histopathological analysis of the paw confirmed neutrophils containing ingested parasites as the dominant cell type in the infiltrate of the first days after infection and the nearly absolute neutrophil depletion in mAb-treated mice. Our data show the importance of PMN in early control of parasite load and parasitism spreading in cutaneous leishmaniasis. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Histol, BR-05508900 Sao Paulo, Brazil.
RP Lima, GMAC (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Av Prof Lineu Prestes 1730, BR-05508900 Sao Paulo, Brazil.
RI Vallochi, Adriana/W-6405-2018; Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR APPELBERG R, 1994, IMMUNOLOGY, V83, P302
   BEIL WJ, 1992, J LEUKOCYTE BIOL, V52, P135
   BELOSEVIC M, 1989, J IMMUNOL, V143, P266
   BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090
   CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322
   DEANE L, 1938, MEM I O CRUZ, V33, P263
   FORTIER AH, 1982, INFECT IMMUN, V38, P1304, DOI 10.1128/IAI.38.3.1304-1308.1982
   GRIMALDI G, 1984, PARASITE IMMUNOL, V6, P397, DOI 10.1111/j.1365-3024.1984.tb00811.x
   GRIMALDI G, 1980, EXP PARASITOL, V50, P45, DOI 10.1016/0014-4894(80)90006-5
   HESTDAL K, 1991, J IMMUNOL, V147, P22
   HILL JO, 1983, INFECT IMMUN, V39, P1087, DOI 10.1128/IAI.39.3.1087-1094.1983
   HOOVER DL, 1984, J IMMUNOL, V132, P1487
   LASKAY T, 1995, EUR J IMMUNOL, V25, P2220, DOI 10.1002/eji.1830250816
   Leal IS, 1996, IMMUNOLOGY, V89, P442, DOI 10.1046/j.1365-2567.1996.d01-758.x
   LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0
   Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2
   MAGALHAES A V D, 1986, Revista do Instituto de Medicina Tropical de Sao Paulo, V28, P253, DOI 10.1590/S0036-46651986000400008
   MOSSER DM, 1985, J IMMUNOL, V135, P2785
   MURRAY HW, 1994, PARASITOL TODAY, V10, P220, DOI 10.1016/0169-4758(94)90117-1
   MURRAY HW, 1987, J IMMUNOL, V138, P2290
   PEARSON RD, 1981, J IMMUNOL, V127, P1438
   POMPEU ML, 1991, ACTA TROP, V48, P185, DOI 10.1016/0001-706X(91)90046-M
   REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055
   RIDLEY MJ, 1986, AM J PATHOL, V123, P79
   Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345
   Taswell C., 1986, CELL SEPARATION METH, P109
   TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093
   THEODOS CM, 1994, PARASITE IMMUNOL, V16, P571, DOI 10.1111/j.1365-3024.1994.tb00312.x
   WARBURG A, 1986, AM J TROP MED HYG, V35, P926, DOI 10.4269/ajtmh.1986.35.926
NR 29
TC 61
Z9 63
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD DEC
PY 1998
VL 64
IS 2-3
BP 145
EP 151
DI 10.1016/S0165-2478(98)00099-6
PG 7
WC Immunology
SC Immunology
GA 148XV
UT WOS:000077560400012
PM 9870666
DA 2020-12-01
ER

PT J
AU Ferreira, HHA
   Bevilacqua, E
   Gagioti, SM
   De Luca, IMS
   Zanardo, RCO
   Teixeira, CE
   Sannomiya, P
   Antunes, E
   De Nucci, G
AF Ferreira, HHA
   Bevilacqua, E
   Gagioti, SM
   De Luca, IMS
   Zanardo, RCO
   Teixeira, CE
   Sannomiya, P
   Antunes, E
   De Nucci, G
TI Nitric oxide modulates eosinophil infiltration in antigen-induced airway
   inflammation in rats
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE eosinophil; nitric oxide (NO); allergic inflammation; lung
ID GUINEA-PIG; ASTHMATIC-PATIENTS; PLASMA EXUDATION; T-LYMPHOCYTES; EXHALED
   AIR; SYNTHASE; LUNG; INDUCTION; CLONING; GLUCOCORTICOIDS
AB The influence of nitric oxide (NO) on eosinophil infiltration into the airways was investigated in rats actively sensitized with ovalbumin. The animals were treated chronically with the NO synthase inhibitor, N-omega-Nitro-L-arginine methyl ester (L-NAME; 75 mu mol rat(-1) day(-1)), for 4 weeks. Bronchoalveolar lavage was performed at 6, 24, 48 and 72 h after intratracheal injection of ovalbumin. Intratracheal challenge of the sensitized rats with ovalbumin caused a significant increase in total leucocyte infiltration in bronchoalveolar lavage fluid both 24 and 48 h post-ovalbumin injection. Neutrophils and eosinophils peaked, respectively, at 24 h (29%) and 48 h (30%) in bronchoalveolar lavage fluid whereas the mononuclear cell did not differ significantly from the counts in non-sensitized rats at any time. At both 6 and 24 h post-ovalbumin injection, the chronic treatment of the animals with L-NAME affected neither the total nor the differential leucocyte content. However, at 48 h post-ovalbumin challenge, the total cell count was reduced by approximately 48% in the L-NAME-treated animals and this was associated with a marked inhibition (81%) of the eosinophil influx. Histological examination of the lungs from these animals (48 h post-ovalbumin challenge) also showed a prominent reduction (69.5%; P < 0.05) of the eosinophil infiltration in the respiratory segments. Our results demonstrate that NO plays a pivotal role in the eosinophil infiltration in airways of actively sensitized rats. (C) 1998 Elsevier Science B.V. All rights reserved.
C1 UNICAMP, Fac Med Sci, Dept Histol & Embryol & Pharmacol, BR-13018197 Campinas, SP, Brazil.
   Univ Sao Francisco, Sch Med, Clin Pharmacol Unit, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Histol & Embryol, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.
RP Antunes, E (corresponding author), UNICAMP, Fac Med Sci, Dept Histol & Embryol & Pharmacol, POB 6111, BR-13018197 Campinas, SP, Brazil.
EM eantunes@bestway.com.br
RI Sannomiya, Paulina/G-1814-2012; Bevilacqua, Estela/H-3354-2011; De
   Nucci, Gilberto/J-5990-2012; ANTUNES, EDSON/F-6731-2012
OI Bevilacqua, Estela/0000-0003-4178-4625; De Nucci,
   Gilberto/0000-0002-4346-7941; ANTUNES, EDSON/0000-0003-2201-8247
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   ALVING K, 1992, ACTA PHYSIOL SCAND, V146, P407, DOI 10.1111/j.1748-1716.1992.tb09439.x
   ALVING K, 1993, EUR RESPIR J, V6, P1368
   BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307
   BARNES PJ, 1995, IMMUNOL TODAY, V16, P128, DOI 10.1016/0167-5699(95)80128-6
   BARNES PJ, 1993, THORAX, V48, P1034, DOI 10.1136/thx.48.10.1034
   BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0
   ERJEFALT JS, 1994, AM J RESP CRIT CARE, V150, P227, DOI 10.1164/ajrccm.150.1.8025753
   Feder LS, 1997, AM J RESP CELL MOL, V17, P436, DOI 10.1165/ajrcmb.17.4.2845
   Ferreira HHA, 1996, EUR J PHARMACOL, V310, P201, DOI 10.1016/0014-2999(96)00379-2
   FORNHEM C, 1995, EUR RESPIR J, V8, P1100, DOI 10.1183/09031936.95.08071100
   GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337
   HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2
   HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474
   JANSSENS SP, 1992, J BIOL CHEM, V267, P14519
   KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8
   KHARITONOV SA, 1995, LAB ANIM SCI, V40, P198
   KNOWLES RG, 1990, BIOCHEM BIOPH RES CO, V172, P1042, DOI 10.1016/0006-291X(90)91551-3
   KROEGEL C, 1994, EUR RESPIR J, V7, P519, DOI 10.1183/09031936.94.07030519
   KUO HP, 1992, EUR J PHARMACOL, V221, P385
   LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348
   Lundberg JON, 1996, ARCH DIS CHILD, V75, P323, DOI 10.1136/adc.75.4.323
   MATSUMOTO T, 1994, J PHARMACOL EXP THER, V269, P1236
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   PERSSON MG, 1994, LANCET, V343, P146, DOI 10.1016/S0140-6736(94)90935-0
   RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298
   ROBBINS RA, 1994, BIOCHEM BIOPH RES CO, V198, P1027
   SANJAR S, 1990, BRIT J PHARMACOL, V99, P679, DOI 10.1111/j.1476-5381.1990.tb12989.x
   TAYLORROBINSON AW, 1994, EUR J IMMUNOL, V24, P980, DOI 10.1002/eji.1830240430
   TEIXEIRA MM, 1993, BRIT J PHARMACOL, V110, P1515, DOI 10.1111/j.1476-5381.1993.tb13994.x
   VANE JR, 1964, BRIT J PHARM CHEMOTH, V23, P360, DOI 10.1111/j.1476-5381.1964.tb01592.x
   VIANNA EO, 1995, AM J RESP CRIT CARE, V151, P809
   XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522
   YEADON M, 1995, BRIT J PHARMACOL, V116, P2545, DOI 10.1111/j.1476-5381.1995.tb17204.x
   Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111
NR 35
TC 48
Z9 49
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-2999
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD OCT 9
PY 1998
VL 358
IS 3
BP 253
EP 259
DI 10.1016/S0014-2999(98)00575-5
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 131ZA
UT WOS:000076604100010
PM 9822892
DA 2020-12-01
ER

PT J
AU Albieri, A
   Bevilacqua, E
AF Albieri, A
   Bevilacqua, E
TI Induction of erythrophagocytic activity in cultured mouse trophoblast
   cells by phorbol myristate acetate and all-trans-retinal
SO PLACENTA
LA English
DT Article
ID RESPIRATORY BURST; HUMAN-NEUTROPHILS; SUPEROXIDE; INVITRO;
   DIFFERENTIATION; IMPLANTATION; CYTOKINES; PLACENTA; ACID; RAT
AB Phorbol myristate acetate (PMA) and all-trans-retinal (retinal) were evaluated as possible phagocytic stimulators of cultured, post implantation, trophoblast cells. Ectoplacental cones dissected from 7.5 day-old mouse embryos provided the source of trophoblastic cells. Co-cultures were performed using stimulated and non-stimulated trophoblast cells and erythrocytes under standard conditions. Phagocytic activity was expressed as the total number of phagocytic cells per ectoplacental cone, and as phagosomic vacuoles per trophoblast giant cell, either in the presence or absence of the stimulators. Both chemical agents had similar effects; less than 12 h after stimulation, statistically significant numbers of erythrophagosomes appear in the trophoblast giant cells (TGC). These findings demonstrate that TGC, like neutrophils and macrophages, can be activated to phagocytosis by exogenous factors. This enhanced activity may result from the generation and release of reactive oxygen species. In conclusion, our data suggest that, because stimulation was provided, the remarkable in vivo phagocytic activity of the trophoblast can be maintained under in vitro conditions, allowing study of the pathways and regulatory steps involved in this process. (C) 1996 W. B. Saunders Company Ltd
C1 UNIV SAO PAULO, INST CIENCIAS BIOMED, DEPT HISTOL & EMBRYOL, BR-05508900 SAO PAULO, SP, BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR AMOROSO EC, 1952, MARSHALLS PHYSIOLOGY, V2, P127
   APLIN JD, 1991, J CELL SCI, V99, P681
   BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553
   BADWEY JA, 1986, J CELL PHYSIOL, V127, P223, DOI 10.1002/jcp.1041270206
   BADWEY JA, 1983, J CELL PHYSIOL, V115, P208, DOI 10.1002/jcp.1041150216
   BELLAVITE P, 1990, NATO ADV SCI I A-LIF, V189, P23
   BENRAFAEL Z, 1992, FERTIL STERIL, V58, P1093
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BOYD JD, 1952, MARSHALLS PHYSL REPR, P1
   CHOU JY, 1983, IN VITRO CELL DEV B, V19, P571
   CHOU JY, 1982, J CLIN ENDOCR METAB, V54, P1174, DOI 10.1210/jcem-54-6-1174
   CURNUTTE JT, 1979, J CLIN INVEST, V63, P637, DOI 10.1172/JCI109346
   DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102
   Gagioti S, 1995, REPROD FERT DEVELOP, V7, P1111, DOI 10.1071/RD9951111
   GAGIOTI S, 1995, J BRAZILIAN ASS ADV, V48, P37
   GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5
   HAIMOVICI F, 1993, MICROSC RES TECHNIQ, V25, P201, DOI 10.1002/jemt.1070250303
   HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842
   KATO Y, 1991, ENDOCRINOLOGY, V128, P401, DOI 10.1210/endo-128-1-401
   LEWIS CE, 1992, MACROPHAGE, P3
   MITCHELL MD, 1993, PLACENTA, V14, P249, DOI 10.1016/S0143-4004(05)80426-6
   Mossman HW, 1937, CONTRIB EMBRYOL, V26, P133
   MUNTENER M, 1977, ACTA ANAT, V98, P241
   PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006
   PEEL S, 1977, J ANAT, V124, P675
   ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4
   RUTANEN EM, 1993, ANN MED, V25, P343, DOI 10.3109/07853899309147295
   SEAL US, 1972, AM J ANAT, V134, P263, DOI 10.1002/aja.1001340209
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   TAKAHASHI R, 1991, ARCH BIOCHEM BIOPHYS, V285, P325, DOI 10.1016/0003-9861(91)90367-R
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
NR 34
TC 21
Z9 21
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
J9 PLACENTA
JI Placenta
PD SEP
PY 1996
VL 17
IS 7
BP 507
EP 512
DI 10.1016/S0143-4004(96)90033-8
PG 6
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA VL495
UT WOS:A1996VL49500015
PM 8899880
DA 2020-12-01
ER

PT J
AU FARIA, M
   BEVILACQUA, E
AF FARIA, M
   BEVILACQUA, E
TI CYTOLOGICAL ASPECTS OF VASCULAR INVASION BY THE TROPHOBLAST OF CALOMYS
   CALLOSUS IN HEPATIC TISSUES
SO JOURNAL OF MORPHOLOGY
LA English
DT Article
ID MATERNAL BLOOD-CIRCULATION; BLASTOCYST ATTACHMENT; IMPLANTATION; MOUSE;
   RAT; CELLS; INVITRO; EXPRESSION; OUTGROWTH; PLACENTA
AB Ectoplacental cones isolated from embryos on the seventh day of pregnancy were transplanted beneath the hepatic capsule of recipient adult animals to document the morphological patterns of vascular invasion by the trophoblast in the absence of the maternal environment and the influence of its peculiar vasculature. Females, and females and males of Calomys callosus, a cricetid rodent, were used, respectively, as embryo donors and recipient animals. Three to 5 days later, the grafted regions were excised and processed for light and electron microscopy. Invasion of the liver parenchyma by the trophoblast progressed along the vascular beds, associated with gradual phagocytosis of hepatic cells, greatly favoring the morphological characterization of invasive steps exhibited by the trophoblast to access the different kinds of vessels, to trespass the various vascular components and the different levels of the surrounding hepatic parenchyma. It is possible that either in utero during the establishment of embryomaternal circulation in early pregnancy or ex utero under experimental conditions, the trophoblast exhibits similar vascular invasion behavior. In view of this, our findings may contribute to a belter understanding of trophoblast cell migration to the maternal blood supply as well as the role of the trophoblast in the establishment of the placental circulation during pregnancy. (C) 1995 Wiley-Liss, Inc.
C1 UNIV SAO PAULO,INST CIENCIAS BIOMED,DEPT HISTOL & EMBRIOL,BR-05508900 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR APLIN JD, 1991, J CELL SCI, V99, P681
   ARMANT DR, 1986, DEV BIOL, V116, P519, DOI 10.1016/0012-1606(86)90152-1
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BEVILACQUA EMAF, 1991, AM J ANAT, V192, P382, DOI 10.1002/aja.1001920406
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPRODUCTIVE PHY, P27
   BILLINGTON WD, 1964, J REPROD FERTIL, V13, P593
   BISHOF P, 1992, PLACENTA, V13, P17
   Boyd JD, 1970, HUMAN PLACENTA
   BURROWS TD, 1994, PLACENTA, V15, P21, DOI 10.1016/S0143-4004(05)80233-4
   CARR DH, 1979, OBSTET GYNECOL, V54, P461
   COCCHIARA R, 1988, J REPROD IMMUNOL, V14, P191, DOI 10.1016/0165-0378(88)90069-1
   DAMSKY CH, 1990, MORPHOREGULATORY MOL, P547
   EHRMANN RL, 1964, NATURE, V202, P404, DOI 10.1038/202404b0
   ENDERS AC, 1991, AM J ANAT, V192, P329, DOI 10.1002/aja.1001920403
   ENDERS AC, 1979, CIBA F S, V64, P3
   FERRO EAV, 1994, J MORPHOL, V220, P1
   GAGIOTI S, 1995, IN PRESS REPROD FERT, V7
   HALLIWELL B, 1991, FREE RADICAL BIO MED, P527
   HOFFMAN LH, 1990, ANAT REC, V227, P47, DOI 10.1002/ar.1092270107
   HUSTIN J, 1992, 1ST 12 WEEKS GESTATI, P97
   JOLLIE WP, 1960, AM J ANAT, V106, P109, DOI 10.1002/aja.1001060204
   KING A, 1988, PLACENTA, V9, P513, DOI 10.1016/0143-4004(88)90024-0
   KIRBY DRS, 1963, J REPROD FERTIL, V5, P1
   KIRBY DRS, 1963, J ANAT, V97, P119
   KIRBY DRS, 1968, EPITHELIAL MESENCHYM, P64
   LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525
   LARSEN JF, 1967, AM J OBSTET GYNECOL, V99, P1109, DOI 10.1016/0002-9378(67)90352-3
   MACPHERSON AM, 1989, CELL TISSUE RES, V258, P417
   PARR EL, 1989, BLASTOCYST IMPLANTAT, P105
   ROGERS PAW, 1988, CELL TISSUE RES, V254, P217
   SAPPINO AP, 1989, J CELL BIOL, V109, P2471, DOI 10.1083/jcb.109.5.2471
   STRICKLAND S, 1976, CELL, V9, P321
   SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   WELSH AO, 1991, AM J ANAT, V192, P347, DOI 10.1002/aja.1001920404
   YAGEL S, 1988, J CELL PHYSIOL, V136, P455, DOI 10.1002/jcp.1041360309
   YAMADA AT, 1990, THESIS I CIENCIEAS B
NR 40
TC 2
Z9 2
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0362-2525
J9 J MORPHOL
JI J. Morphol.
PD NOV
PY 1995
VL 226
IS 2
BP 159
EP 171
DI 10.1002/jmor.1052260205
PG 13
WC Anatomy & Morphology
SC Anatomy & Morphology
GA TC501
UT WOS:A1995TC50100004
PM 7473766
DA 2020-12-01
ER

PT J
AU Gagioti, S
   Colepicolo, P
   Bevilacqua, E
AF Gagioti, S
   Colepicolo, P
   Bevilacqua, E
TI Post-implantation mouse embryos have the capability to generate and
   release reactive oxygen species
SO REPRODUCTION FERTILITY AND DEVELOPMENT
LA English
DT Article
DE embryo implantation; trophoblast; luminol chemiluminescence;
   NADH-oxidase
ID POLYMORPHONUCLEAR LEUKOCYTES; DEPENDENT CHEMILUMINESCENCE;
   CHEMI-LUMINESCENCE; SUPEROXIDE ANION; MACROPHAGES; NEUTROPHILS; LUMINOL;
   TROPHOBLAST; CELLS; RAT
AB The capability of the mouse embryo to generate reactive oxygen species (ROS) was examined. Post-implantation embryos were carefully harvested on Day 8 of pregnancy and the production of ROS was quantified using luminol-sensitized chemiluminescence. The embryos were stimulated with either phorbol myristate acetate (PMA) or all-trans-retinal (retinal) and the reaction kinetics were followed over 10 min. ROS secretion was directly proportional to the number of embryos and was suppressed 56% by superoxide dismutase (SOD), 25% by mannitol and as little as 16% by catalase. Embryos deprived of trophoblast showed no light emission suggesting that the source of ROS generation is the trophoblast. Dihydronicotinamide adenine dinucleotide (NADH)-dependent oxidase activity in the plasma membrane of the trophoblast surface was demonstrated by cytochemical methods. The release of ROS into the extracellular medium during the phagocytic process has been related to the cytolytic effect exhibited by these molecules and, perhaps by this means, the trophoblast can play an active role in the phagocytosis of maternal cells during the process of embryo implantation.
C1 UNIV SAO PAULO, INST CIENCIAS BIOMED, DEPT HISTOL & EMBRIOL, BR-05508900 SAO PAULO, BRAZIL.
   UNIV SAO PAULO, INST QUIM, DEPT BIOQUIM, BR-05508900 SAO PAULO, BRAZIL.
RI Bevilacqua, Estela/H-3354-2011; Colepicolo, Pio/C-1349-2013
OI Bevilacqua, Estela/0000-0003-4178-4625; 
CR AITKEN RJ, 1989, J ANDROL, V10, P214
   AITKEN RJ, 1992, J CELL PHYSIOL, V151, P466, DOI 10.1002/jcp.1041510305
   AITKEN RJ, 1991, AM J OBSTET GYNECOL, V164, P542, DOI 10.1016/S0002-9378(11)80017-7
   ALLEN RC, 1976, BIOCHEM BIOPH RES CO, V69, P245, DOI 10.1016/S0006-291X(76)80299-9
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   BADWEY JA, 1986, J CELL PHYSIOL, V127, P223, DOI 10.1002/jcp.1041270206
   BADWEY JA, 1983, J CELL PHYSIOL, V115, P208, DOI 10.1002/jcp.1041150216
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BELLAVITE P, 1990, NATO ADV SCI I A-LIF, V189, P23
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BISCHOF P, 1992, PLACENTA, V13, P17, DOI 10.1016/0143-4004(92)90003-C
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566
   CADENAS E, 1981, FEBS LETT, V123, P225, DOI 10.1016/0014-5793(81)80293-1
   COLEPICOLO P, 1990, ANAL BIOCHEM, V184, P369, DOI 10.1016/0003-2697(90)90695-6
   DAMSKY C, 1993, FASEB J, V7, P1320
   HALLETT MB, 1983, BIOCHEM J, V216, P459, DOI 10.1042/bj2160459
   Halliwell B., 1991, FREE RADICALS BIOL M
   HAMMOND B, 1985, CAN J PHYSIOL PHARM, V63, P173, DOI 10.1139/y85-034
   HEYWORTH PG, 1990, J BIOENERG BIOMEMBR, V22, P1, DOI 10.1007/BF00762842
   Jenner D E, 1987, J Biolumin Chemilumin, V1, P165, DOI 10.1002/bio.1170010304
   MISRA HP, 1982, ARCH BIOCHEM BIOPHYS, V215, P59, DOI 10.1016/0003-9861(82)90278-8
   PARR MB, 1989, BLASTOCYST IMPLANTAT, P105
   SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581
   STRICKLAND S, 1976, CELL, V9, P231, DOI 10.1016/0092-8674(76)90114-8
   SUNDQVIST T, 1991, J CELL PHYSIOL, V148, P152, DOI 10.1002/jcp.1041480118
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   TAKAHASHI R, 1991, ARCH BIOCHEM BIOPHYS, V285, P325, DOI 10.1016/0003-9861(91)90367-R
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   WELSH AO, 1991, AM J ANAT, V192, P347, DOI 10.1002/aja.1001920404
NR 31
TC 19
Z9 20
U1 0
U2 0
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1031-3613
EI 1448-5990
J9 REPROD FERT DEVELOP
JI Reprod. Fertil. Dev.
PY 1995
VL 7
IS 5
BP 1111
EP 1116
DI 10.1071/RD9951111
PG 6
WC Developmental Biology; Reproductive Biology; Zoology
SC Developmental Biology; Reproductive Biology; Zoology
GA TX587
UT WOS:A1995TX58700018
PM 8848578
DA 2020-12-01
ER

PT J
AU FERRO, EAV
   BEVILACQUA, E
AF FERRO, EAV
   BEVILACQUA, E
TI TROPHOBLASTIC INVASION OF THE UTERINE EPITHELIUM IN CALOMYS CALLOSUS
   (RODENTIA, CRICETIDAE)
SO JOURNAL OF MORPHOLOGY
LA English
DT Article
ID CELL-DEATH; IMPLANTATION; MOUSE; HAMSTER; RAT; EMBRYOS;
   METALLOPROTEINASES; ULTRASTRUCTURE
AB Implantation sites in the uterus of the cricetid rodent Calomys callosus were examined by light and electron microscopy at several points during day 4 of pregnancy to determine the changes occurring in the trophoblast and epithelial cells during the early blastocyst-endometrial relationship, particularly the epithelial removal phase. By morning, the blastocysts had already lodged in the antimesometrial region of the uterine crypts and the embryo-maternal interaction was limited to sparse contacts between the epithelial microvilli and the trophoblast surface. A few dense and altered epithelial cells were present. Three zones could be distinguished in the stromal region. In the subepithelial area, the stromal cells showed features similar to those found in other rodents during the early decidualization process. Effective epithelial invasion by the trophoblast occurred only in the evening, although at noon, apposition and attachment phases were identifiable. During invasion, the trophoblast processes were first seen insinuating between the epithelial cells, projecting towards the basal lamina, and finally replacing these cells. The epithelial cells in contact with the invading trophoblast exhibited severe disorganization similar to that found during the process of cell death by apoptosis. The removal of such cells occurred by trophoblast phagocytosis. Once in contact with the basal lamina, the trophoblast rapidly spread out both mesometrially and antimesometrially, phagocytosing the remaining epithelial cells. Trophoblast processes were also seen penetrating the basal lamina. Given that the epithelium breached and phagocytosed by the trophoblast habitually displays degenerative characteristics, we consider the mechanisms that might be involved in epithelial cell death and in the removal of the uterine epithelium, and the participation of the trophoblast in both these events. (C) 1994 Wiley-Liss, Inc.
C1 UNIV SAO PAULO, INST BIOMED SCI, DEPT HISTOL & EMBRYOL, BR-05508900 SAO PAULO, BRAZIL.
RP FERRO, EAV (corresponding author), UNIV FED UBERLANDIA, DEPT MORPHOL, BR-03840090 UBERLANDIA, MG, BRAZIL.
RI Ferro, Eloisa/B-2185-2008; Ferro, Eloisa/K-5533-2016; Bevilacqua,
   Estela/H-3354-2011
OI Ferro, Eloisa/0000-0002-7447-2583; Ferro, Eloisa/0000-0002-7447-2583;
   Bevilacqua, Estela/0000-0003-4178-4625
CR ABRAHAMSOHN PA, 1983, ANAT EMBRYOL, V166, P848
   BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BEVILACQUA EMAF, 1988, J MORPHOL, V198, P341, DOI 10.1002/jmor.1051980308
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BLAKENSHIP TN, 1990, AM J ANAT, V187, P147
   BLAKENSHIP TN, 1992, ANAT REC, V233, P196
   BOVING BG, 1959, ANN NY ACAD SCI, V80, P1
   BRENNER CA, 1989, GENE DEV, V3, P848, DOI 10.1101/gad.3.6.848
   DICKMANN Z, 1976, VITAM HORM, V34, P215, DOI 10.1016/S0083-6729(08)60077-1
   ELSHERSHABY AM, 1975, J EMBRYOL EXP MORPH, V33, P1067
   ENDERS A. C., 1971, The biology of the blastayst., P71
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   ENDERS AC, 1965, AM J ANAT, V116, P29, DOI 10.1002/aja.1001160103
   ENDERS AC, 1979, CIBA F S, V64, P3
   FINN CA, 1967, J ULTRA MOL STRUCT R, V20, P321, DOI 10.1016/S0022-5320(67)80102-3
   FINN CA, 1967, J REPROD FERTIL, V13, P259
   FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891
   GERSCHENSON LE, 1992, FASEB J, V6, P2450
   HINCHLIFFE JR, 1975, J REPROD FERTIL, V45, P463
   LUNDKVIST O, 1982, CELL TISSUE RES, V225, P355, DOI 10.1007/BF00214688
   NILSSON BO, 1980, GAMETE RES, V3, P369, DOI 10.1002/mrd.1120030408
   NILSSON BO, 1974, J REPROD FERTIL, V39, P187
   PARKENING TA, 1985, GAMETE RES, V12, P373, DOI 10.1002/mrd.1120120405
   PARKENING TA, 1976, J ANAT, V122, P211
   PARKENING TA, 1976, J ANAT, V121, P161
   PARKENING TA, 1976, J ANAT, V122, P486
   PARR EL, 1987, BIOL REPROD, V36, P211, DOI 10.1095/biolreprod36.1.211
   POELMANN RE, 1975, J ANAT, V119, P421
   POTTS DM, 1968, J ANAT, V103, P77
   PSYCHOYOS A, 1961, CR HEBD ACAD SCI, V252, P1515
   QUEENAN JT, 1987, J BIOL CHEM, V262, P10903
   REINIUS S, 1967, Z ZELLFORSCH MIK ANA, V77, P257, DOI 10.1007/BF00340792
   SAPINO AP, 1989, J CELL BIOL, V109, P2471
   SCHLAFKE S, 1975, BIOL REPROD, V12, P41, DOI 10.1095/biolreprod12.1.41
   SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107
   SMITH AF, 1974, CELL TISSUE RES, V152, P525
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   Weitlauf H.M., 1988, P231
   WELSH AO, 1991, AM J ANAT, V192, P215, DOI 10.1002/aja.1001920302
   WELSH AO, 1993, MICROSC RES TECHNIQ, V25, P233
   WU JT, 1985, J EXP ZOOL, V233, P243, DOI 10.1002/jez.1402330211
   WYLLIE AH, 1981, CELL DEATH BIOL PATH, P9
   YOUNG MP, 1968, J EMBRYOL EXP MORPH, V19, P341
NR 44
TC 10
Z9 10
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0362-2525
EI 1097-4687
J9 J MORPHOL
JI J. Morphol.
PD AUG
PY 1994
VL 221
IS 2
BP 139
EP 152
DI 10.1002/jmor.1052210204
PG 14
WC Anatomy & Morphology
SC Anatomy & Morphology
GA PC500
UT WOS:A1994PC50000003
PM 7932767
DA 2020-12-01
ER

PT J
AU BEVILACQUA, E
   ABRAHAMSOHN, PA
AF BEVILACQUA, E
   ABRAHAMSOHN, PA
TI INVASIVENESS OF MOUSE TROPHOBLASTIC CELLS IN CONNECTIVE-TISSUE
SO ACTA ANATOMICA
LA English
DT Article
DE TROPHOBLAST INVASIVENESS; ECTOPLACENTAL CONE; CONNECTIVE TISSUE
   MICROFIBRILS; EMBRYO IMPLANTATION; ULTRASTRUCTURE; MOUSE
ID BASEMENT-MEMBRANE; INVITRO; ATTACHMENT; OUTGROWTH; COLLAGEN;
   DECIDUALIZATION; IMPLANTATION; MICROFIBRILS; FIBRONECTIN; BLASTOCYSTS
AB Ectoplacental cones from 8-day-old mouse embryos were grafted into the dorsal subcutaneous tissue of host mice. The grafts were collected between the 3rd and 8th days after transfer and processed for morphological analysis by light and electron microscopy. Approximately 60% of the grafts formed hemorrhagic nodules in which only invasive, giant trophoblastic cells developed. These cells shared many morphological features with the trophoblastic cells involved in normal implantation. At the periphery of the nodules, trophoblastic giant cells were frequently seen growing toward the host connective tissue. The association between the trophoblast and fibrilar components of the extracellular matrix was examined. No direct association with collagen fibrils was noted; however, many areas of the surface of invasive cells were in close proximity with microfibrils of the extracellular matrix. Since only the invasive trophoblast cells exhibited such an association, a direct comparison was made with the process of trophoblast migration within the connective tissue.
RP BEVILACQUA, E (corresponding author), UNIV SAO PAULO,INST CIENCIAS BIOMED,DEPT HISTOL & EMBRYOL,AV LINEU PRESTES 1524,BR-05508 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR ABRAHAMSOHN PA, 1989, BLASTOCYST IMPLANTAT, P127
   ALBERTORINCON MC, 1989, AM J ANAT, V186, P417, DOI 10.1002/aja.1001860411
   ARMANT DR, 1986, DEV BIOL, V116, P519, DOI 10.1016/0012-1606(86)90152-1
   ARMANT DR, 1986, P NATL ACAD SCI USA, V83, P6751, DOI 10.1073/pnas.83.18.6751
   BEVILACQUA EMA, 1991, J EXP ZOOL, V259, P386
   BEVILACQUA EMAF, 1991, AM J ANAT, V192, P382, DOI 10.1002/aja.1001920406
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393
   CARR DH, 1979, OBSTET GYNECOL, V54, P461
   CARSON DD, 1987, DEV BIOL, V120, P228, DOI 10.1016/0012-1606(87)90120-5
   CLEARY EG, 1983, INT REV CONNECT TISS, V10, P197
   DAMSKY CH, 1990, MORPHOREGULATORY MOL, P547
   DAVIES EC, 1988, 4TH P INT C CELL BIO, P176
   DICKSON AD, 1963, J REPROD FERTIL, V6, P465, DOI 10.1530/jrf.0.0060465
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   FAINSTAT T, 1963, AM J ANAT, V112, P337, DOI 10.1002/aja.1001120305
   FAIRA MR, 1994, UNPUB CYTOLOGICAL AS
   FARMER DR, 1992, PLACENTA, V13, P163, DOI 10.1016/0143-4004(92)90031-N
   Finn C.A., 1977, BIOL UTERUS, P245
   FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891
   HAUST MD, 1965, AM J PATHOL, V47, P1113
   HERMO L, 1977, AM J ANAT, V148, P433, DOI 10.1002/aja.1001480402
   INOUE S, 1986, AM J ANAT, V176, P121, DOI 10.1002/aja.1001760203
   INOUE S, 1989, AM J ANAT, V186, P43, DOI 10.1002/aja.1001860104
   KATZ S, 1987, ANAT EMBRYOL, V176, P251, DOI 10.1007/BF00310059
   KIRBY DRS, 1963, J ANAT, V97, P119
   KIRBY DRS, 1968, EPITHELIAL MESENCHYM, P64
   KIRBY DRS, 1993, J REPROD FERTIL, V5, P1
   KIRBY DRS, 1960, NATURE, V20, P707
   KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057
   LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525
   LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.bi.55.070186.005133
   LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205
   MACPHERSON AM, 1989, CELL TISSUE RES, V258, P417
   MEHROTRA P K, 1988, Biological Structures and Morphogenesis, V1, P63
   OLIVEIRA SF, 1991, CELL MOL BIOL, V37, P315
   ROGERS PAW, 1988, CELL TISSUE RES, V254, P217
   ROSS E, 1984, BIOCHIM BIOPHYS ACTA, V738, P263
   SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331
   WEITLAUF HM, 1988, PHYSL REPRODUCTION, V1, P231
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   WEWER UM, 1986, DIFFERENTIATION, V32, P49, DOI 10.1111/j.1432-0436.1986.tb00555.x
   WILSON IB, 1974, J REPROD FERTIL, V39, P243, DOI 10.1530/jrf.0.0390243
   YAGEL S, 1988, J CELL PHYSIOL, V136, P455, DOI 10.1002/jcp.1041360309
   YAMADA AT, 1990, THESIS U SAO PAULO, P115
   ZORN TMT, 1986, CELL TISSUE RES, V244, P443
NR 47
TC 12
Z9 12
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5180
J9 ACTA ANAT
JI Acta Anat.
PY 1994
VL 150
IS 4
BP 246
EP 252
PG 7
WC Anatomy & Morphology
SC Anatomy & Morphology
GA PP219
UT WOS:A1994PP21900002
PM 7839792
DA 2020-12-01
ER

PT J
AU BEVILACQUA, EMAF
   FARIA, MR
   ABRAHAMSOHN, PA
AF BEVILACQUA, EMAF
   FARIA, MR
   ABRAHAMSOHN, PA
TI GROWTH OF MOUSE ECTOPLACENTAL CONE CELLS IN SUBCUTANEOUS TISSUES -
   DEVELOPMENT OF PLACENTAL-LIKE CELLS
SO AMERICAN JOURNAL OF ANATOMY
LA English
DT Article
ID ALKALINE-PHOSPHATASE; TROPHOBLAST; RAT; DIFFERENTIATION; INVITRO;
   ORIGIN; ESTABLISHMENT; LACTOGEN; CULTURE; LINES
AB Ectoplacental cones of mouse embryos collected on day 8 of pregnancy were grafted into the dorsal subcutaneous tissue of host mice. The grafts were collected between days 3 and 8 after transfer and processed for light and electron microscope morphological analysis as well as for cytochemistry of nonspecific alkaline phosphatase. Fragments of normal mouse placentas collected between days 12 and 18 of pregnancy were processed similarly. About 37% of the grafts were nonhemorrhagic nodules formed by different kinds of trophoblastic cells. These cells had many morphological and cytochemical features of cells present in normal mouse placentas. Non-phagocytic giant cells, glycogen cells, as well as cells with a well-developed granular endoplasmic reticulum were similar to cells found in the placenta and were always present in the grafts. Cells showing features intermediate between the above-mentioned cells and those whose cytoplasm was poor in organelles also were found in the grafts. The latter resembled cells of layer 1 of the labyrinth of the placenta. These results suggest that trophoblastic cells of the ectoplacental cones had differentiated into placental cells following their transfer to the subcutaneous tissue.
RP BEVILACQUA, EMAF (corresponding author), UNIV SAO PAULO,INST BIOMED SCI,DEPT HISTOL & EMBRYOL,BR-05508 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR AMOROSO EC, 1952, MARSHALLS PHYSIOLOGY, V2, P127
   ANSELL JD, 1975, J EMBRYOL EXP MORPH, V33, P177
   BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447
   BELL SC, 1983, J REPROD IMMUNOL, V5, P185, DOI 10.1016/0165-0378(83)90234-6
   BERNFIELD MR, 1981, MORPHOGENESIS PATTER, P139
   BEVILACQUA EMA, 1991, J EXP ZOOL, V259, P386
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1965, J REPROD FERTIL, V10, P343
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   CARR DH, 1979, OBSTET GYNECOL, V54, P461
   CHRISTIE GA, 1967, HISTOCHEMISTRY, V9, P93, DOI 10.1007/BF00305853
   COPP AJ, 1979, J EMBRYOL EXP MORPH, V51, P109
   DAVIES J, 1968, ACTA ANAT, V69, P542
   FAWCETT DW, 1947, AM J ANAT, V81, P413, DOI 10.1002/aja.1000810305
   FAWCETT DW, 1950, ANAT REC, V108, P71, DOI 10.1002/ar.1091080107
   Gardner R. L., 1975, EARLY DEV MAMMALS, P107
   GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63
   GARDNER RL, 1973, J EMBRYOL EXP MORPH, V30, P561
   GROBSTEIN C, 1950, J EXP ZOOL, V1114, P359
   HAY ED, 1981, CELL BIOL EXTRACELLU
   HERNANDE.D, 1974, CELL TISSUE RES, V148, P381
   HUNT JS, 1988, PLACENTA, V9, P159, DOI 10.1016/0143-4004(88)90014-8
   HUNT JS, 1989, PLACENTA, V10, P161, DOI 10.1016/0143-4004(89)90038-6
   ILGREN EB, 1983, PLACENTA, V4, P307, DOI 10.1016/S0143-4004(83)80010-1
   JOHNSON MH, 1981, J EMBRYOL EXP MORPH, V61, P103
   JOLLIE WP, 1961, ANAT REC, V141, P159, DOI 10.1002/ar.1091410209
   JOLLIE WP, 1960, AM J ANAT, V106, P109, DOI 10.1002/aja.1001060204
   JOLLIE WP, 1965, J ULTRA MOL STRUCT R, V12, P420, DOI 10.1016/S0022-5320(65)80109-5
   JONES CJP, 1976, J PATHOL, V118, P143, DOI 10.1002/path.1711180303
   KIRBY DRS, 1960, NATURE, V187, P707, DOI 10.1038/187707a0
   KIRBY DRS, 1963, J REPROD FERTIL, V5, P1
   KIRBY DRS, 1963, J ANAT, V97, P119
   KIRBY DRS, 1968, EPITHELIAL MESENCHYM, P64
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Kliman HJ, 1987, TROPHOBLAST RES, V2, P407
   MEHROTRA P K, 1988, Biological Structures and Morphogenesis, V1, P63
   MUNTENER M, 1977, ACTA ANAT, V98, P241
   Nicholas JS, 1942, J EXP ZOOL, V90, P41, DOI 10.1002/jez.1400900104
   PADYKULA HA, 1958, J ANAT, V92, P118
   Pearse A. G. E., 1972, HISTOCHEMISTRY THEOR, V2
   PEEL S, 1977, J ANAT, V124, P675
   ROBINSON JM, 1983, J HISTOCHEM CYTOCHEM, V31, P1198
   ROSSANT J, 1985, J EMBRYOL EXP MORPH, V86, P177
   ROSSANT J, 1981, J EMBRYOL EXP MORPH, V62, P217
   ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183
   RUNNER MN, 1947, ANAT RECORD, V98, P1, DOI 10.1002/ar.1090980102
   SNELL GEORGE D., 1966, P205
   SOARES MJ, 1987, J REPROD FERTIL, V79, P93
   SOARES MJ, 1987, J REPROD FERTIL, V79, P335, DOI 10.1530/jrf.0.0790335
   SOARES MJ, 1987, DEV BIOL, V124, P134, DOI 10.1016/0012-1606(87)90466-0
   SOARES MJ, 1988, PLACENTA, V9, P313, DOI 10.1016/0143-4004(88)90039-2
   ZUCKERMANN FA, 1986, PLACENTA, V7, P349, DOI 10.1016/S0143-4004(86)80153-9
NR 52
TC 11
Z9 11
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0002-9106
J9 AM J ANAT
PD DEC
PY 1991
VL 192
IS 4
BP 382
EP 399
DI 10.1002/aja.1001920406
PG 18
WC Anatomy & Morphology
SC Anatomy & Morphology
GA GU697
UT WOS:A1991GU69700004
PM 1781448
DA 2020-12-01
ER

PT J
AU BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI GROWTH OF MOUSE EMBRYOS IMPLANTED IN THE SUBCUTANEOUS TISSUE OF
   RECIPIENT MICE
SO JOURNAL OF EXPERIMENTAL ZOOLOGY
LA English
DT Article
ID ANTIMESOMETRIAL DECIDUA; RAT; ENDOMETRIUM; PREGNANCY; COLLAGEN;
   DECIDUALIZATION; INVASION; CELLS
AB Eight-days-old mouse embryos were transferred to the subcutaneous tissue of the dorsal skin of host mice.  A high rate of embryos developed into hemorrhagic (HN) or nonhemorrhagic nodules (NHN).  The latter had trophoblastic cells as well as embryoblastic derivatives whereas HN contained almost only trophoblastic cells.
   At least two kinds of trophoblastic cells were present in NHN:  small cells and large cells similar to trophoblastic giant cells.  In HN most trophoblastic cells arranged themselves into a network whose meshes contained host blood.  Although embryoblastic derivatives such as endoderm and Reichert's membrane were apposed to host connective tissue cells, trophoblastic cells were always surrounded by collagen fibrils or by a layer of an amorphous material.
RP BEVILACQUA, EMAF (corresponding author), UNIV SAO PAULO,INST CIENCIAS BIOMED,DEPT HISTOL & EMBRIOL,CAIXA POSTAL 4365,BR-05508 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR ALBERTORINCON MC, 1989, AM J ANAT, V186, P417, DOI 10.1002/aja.1001860411
   BEVILACQUA EMAF, 1989, ARCH BIOL MED EXP, V22, P107
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BLAND KP, 1965, J REPROD FERTIL, V10, P189
   CARR DH, 1979, OBSTET GYNECOL, V54, P461
   CARR DH, 1977, OBSTET GYNECOL, V50, P189
   CARSON DD, 1987, DEV BIOL, V120, P228, DOI 10.1016/0012-1606(87)90120-5
   CHRISTOFFERSON RH, 1988, THESIS U UPPSALA
   FAINSTAT T, 1963, AM J ANAT, V112, P337, DOI 10.1002/aja.1001120305
   FAWCETT DW, 1947, AM J ANAT, V81, P413, DOI 10.1002/aja.1000810305
   GARDNER RL, 1985, IMPLANTATION HUMAN E, P155
   GLASS RH, 1983, J CELL BIOL, V96, P1108, DOI 10.1083/jcb.96.4.1108
   GRINNELL F, 1982, J CELL BIOL, V94, P597, DOI 10.1083/jcb.94.3.597
   JOLLIE WP, 1960, AM J ANAT, V106, P109, DOI 10.1002/aja.1001060204
   KATZ S, 1987, ANAT EMBRYOL, V176, P251, DOI 10.1007/BF00310059
   KIRBY DRS, 1967, J REPROD FERTIL, V14, P515
   KIRBY DRS, 1960, NATURE, V187, P707, DOI 10.1038/187707a0
   KIRBY DRS, 1963, J REPROD FERTIL, V5, P1
   KIRBY DRS, 1963, J ANAT, V97, P119
   KIRBY DRS, 1968, EPITHELIAL MESENCHYM, P64
   Nicholas JS, 1942, J EXP ZOOL, V90, P41, DOI 10.1002/jez.1400900104
   PIJNENBORG R, 1980, PLACENTA, V1, P3, DOI 10.1016/S0143-4004(80)80012-9
   ROGERS PAW, 1982, J REPROD FERTIL, V65, P211, DOI 10.1530/jrf.0.0650211
   ROGERS PAW, 1982, MICRON, V13, P373, DOI 10.1016/0047-7206(82)90065-6
   SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107
   Watermnn AJ, 1934, ANAT REC, V59, P27, DOI 10.1002/ar.1090590105
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   WELSH AO, 1989, BLASTOCYST IMPLANTAT, P55
   ZORN TMT, 1986, CELL TISSUE RES, V244, P443
   ZORN TMT, 1989, ANAT REC, V225, P96, DOI 10.1002/ar.1092250203
NR 31
TC 7
Z9 7
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0022-104X
J9 J EXP ZOOL
JI J. Exp. Zool.
PD MAR
PY 1991
VL 257
IS 3
BP 386
EP 400
DI 10.1002/jez.1402570312
PG 15
WC Zoology
SC Zoology
GA FC254
UT WOS:A1991FC25400011
PM 2005426
DA 2020-12-01
ER

PT J
AU BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI ASSOCIATION OF EXTRACELLULAR-MATRIX FIBRILS WITH INVASIVE TROPHOBLASTIC
   CELLS OF THE MOUSE
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Proceedings Paper
CT 1ST BRAZILIAN SYMP ON EXTRACELLULAR MATRIX ( SIMEC 90 )
CY SEP 13-16, 1990
CL PARQUE NACL ITALIANA, RIO DE JANEIRO, BRAZIL
HO PARQUE NACL ITALIANA
C1 UNIV SAO PAULO,INST CIENCIAS BIOMED,DEPT HISTOL & EMBRIOL,BR-05508 SAO PAULO,BRAZIL.
RI BEVILACQUA, ESTELA/H-3354-2011
OI BEVILACQUA, ESTELA/0000-0003-4178-4625
CR ABRAHAMSOHN PA, 1989, BLASTOCYST IMPLANTAT, P127
   Finn C.A., 1977, BIOL UTERUS, P245
   INOUE S, 1986, AM J ANAT, V176, P121, DOI 10.1002/aja.1001760203
   WEITLAUF HM, 1988, PHYSL REPRODUCTION
NR 4
TC 0
Z9 0
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 1991
VL 86
SU 3
BP 103
EP 105
DI 10.1590/S0074-02761991000700016
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HU829
UT WOS:A1991HU82900016
PM 1845233
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU ZORN, TMT
   BIJOVSKY, AT
   BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF ZORN, TMT
   BIJOVSKY, AT
   BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI PHAGOCYTOSIS OF COLLAGEN BY MOUSE DECIDUAL CELLS
SO ANATOMICAL RECORD
LA English
DT Article
RP ZORN, TMT (corresponding author), UNIV SAO PAULO,INST BIOMED SCI,DEPT HISTOL & EMBRYOL,AIXA POSTAL 4365,BR-01051 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011; Bijovsky, Tania/I-2442-2012; Zorn, Telma
   MT TT TMT/C-4065-2008
OI Bevilacqua, Estela/0000-0003-4178-4625; 
CR ABRAHAMSOHN PA, 1983, ANAT EMBRYOL, V166, P263, DOI 10.1007/BF00305087
   AGGELER J, 1984, J CELL BIOL, V98, P1662, DOI 10.1083/jcb.98.5.1662
   BROKELMANN J, 1979, ARCH GYNECOL, V227, P103, DOI 10.1007/BF02103284
   DEPORTER DA, 1973, J ANAT, V114, P457
   DYER RF, 1977, ANAT REC, V187, P241, DOI 10.1002/ar.1091870209
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   FAINSTAT T, 1963, AM J ANAT, V112, P337, DOI 10.1002/aja.1001120305
   Finn C.A., 1977, BIOL UTERUS, P245
   FINN CA, 1967, J ULTRA MOL STRUCT R, V20, P321, DOI 10.1016/S0022-5320(67)80102-3
   HENELL F, 1983, VIRCHOWS ARCH CELL P, V36, P319
   KISALUS LL, 1987, ANAT RECORD, V218, P402, DOI 10.1002/ar.1092180408
   KLEINFELD RG, 1976, BIOL REPROD, V15, P593, DOI 10.1095/biolreprod15.5.593
   KREHBIEL ROBERT H[ENRY], 1937, PHYSIOL ZOOL, V10, P212
   LAURENT G, 1987, AM J PHYSIOL, V21, pC1
   LOBEL BL, 1965, ACTA ENDOCRINOL-COP, V50, P469, DOI 10.1530/acta.0.0500469
   LUNDKVIST O, 1977, CELL TISSUE RES, V184, P435
   LUSE S, 1964, ANAT REC, V148, P308
   MARTELLO EMVG, 1986, ACTA ANAT, V127, P146
   MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0
   OKAMURA H, 1976, Acta Obstetrica et Gynaecologica Japonica (English Edition), V23, P179
   OLIVEIRA SF, 1985, THESIS USP BRASIL
   PADYKULA HA, 1976, ANAT REC, V184, P49, DOI 10.1002/ar.1091840105
   PADYKULA HA, 1976, ANAT REC, V184, P27, DOI 10.1002/ar.1091840104
   PARAKKAL PF, 1969, J ULTRA MOL STRUCT R, V29, P210, DOI 10.1016/S0022-5320(69)90101-4
   PARAKKAL PF, 1969, J CELL BIOL, V41, P345, DOI 10.1083/jcb.41.1.345
   PARKENING TA, 1976, J ANAT, V122, P485
   PARR MB, 1986, AM J ANAT, V176, P423, DOI 10.1002/aja.1001760405
   PEREZTAMAYO R, 1970, LAB INVEST, V22, P142
   ROBINSON JM, 1983, J HISTOCHEM CYTOCHEM, V31, P1198
   SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107
   SCHWARZ W, 1967, Z ZELLFORSCH MIK ANA, V83, P416, DOI 10.1007/BF00336868
   SVOBODA ELA, 1979, J ANAT, V128, P301
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   TENCATE AR, 1975, ANAT RECORD, V182, P1
   TENCATE AR, 1974, ANAT REC, V179, P543
   TENCATE AR, 1972, J ANAT, V112, P401
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   ZORN TMT, 1986, CELL TISSUE RES, V244, P443
NR 38
TC 28
Z9 28
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0003-276X
J9 ANAT REC
JI Anat. Rec.
PD OCT
PY 1989
VL 225
IS 2
BP 96
EP 100
DI 10.1002/ar.1092250203
PG 5
WC Anatomy & Morphology
SC Anatomy & Morphology
GA AV781
UT WOS:A1989AV78100002
PM 2817434
DA 2020-12-01
ER

PT J
AU BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI TROPHOBLAST INVASION DURING IMPLANTATION OF THE MOUSE EMBRYO
SO ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES
LA English
DT Article
RP BEVILACQUA, EMAF (corresponding author), UNIV SAO PAULO,INST BIOMED SCI,DEPT HISTOL & EMBRYOL,CAIXA POSTAL 4365,BR-01051 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR ABRAHAMSOHN PA, 1983, ANAT EMBRYOL, V166, P263, DOI 10.1007/BF00305087
   Amoroso E.C., 1952, MARSHALLS PHYSIOLOGY, P127
   BEER AE, 1976, SCI AM, V230, P36
   Bevilacqua E M, 1985, Microsc Electron Biol Celular, V9, P45
   BEVILACQUA EMA, 1984, THESIS U SAO PAULO B
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BOYD JD, 1952, MARSHALLS PHYSL REPR, P1
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   FINN CA, 1967, J ULTRA MOL STRUCT R, V20, P321, DOI 10.1016/S0022-5320(67)80102-3
   FINN CA, 1967, J REPROD FERTIL, V13, P259
   GLASS RH, 1983, J CELL BIOL, V96, P1108, DOI 10.1083/jcb.96.4.1108
   GRINNELL F, 1982, J CELL BIOL, V94, P586
   JOLLIE WP, 1965, AM J ANAT, V116, P217, DOI 10.1002/aja.1001160111
   KATZ S, 1981, ACTA ANAT, V111, P72
   KATZ S, 1987, ANAT EMBRYOL, V176, P251, DOI 10.1007/BF00310059
   Kaufmann MH, 1983, BIOL TROPHOBLAST, P23
   KIRBY DRS, 1968, EPITHELIAL MESENCHYM, P64
   KLEINFELD RG, 1976, BIOL REPROD, V15, P593, DOI 10.1095/biolreprod15.5.593
   KREHBIEL ROBERT H[ENRY], 1937, PHYSIOL ZOOL, V10, P212
   Mossman HW, 1937, CONTRIB EMBRYOL, V26, P133
   PADYKULA HA, 1979, ANAT RECORD, V193, P329, DOI 10.1002/ar.1091930302
   PARKENING TA, 1976, J ANAT, V122, P485
   PSYCHOYOS A, 1961, CR HEBD ACAD SCI, V252, P1515
   PSYCHOYOS A, 1960, CR SOC BIOL, V154, P1384
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   WELSH AO, 1985, AM J ANAT, V172, P1, DOI 10.1002/aja.1001720102
   ZORN TMT, 1986, CELL TISSUE RES, V244, P443
NR 27
TC 45
Z9 45
U1 0
U2 0
PU SOC BIOL CHILE
PI SANTIAGO
PA CASILLA 14164 CORREO, SANTIAGO 9, CHILE
SN 0004-0533
J9 ARCH BIOL MED EXP
PD JUL
PY 1989
VL 22
IS 2
BP 107
EP 118
PG 12
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA AN719
UT WOS:A1989AN71900005
PM 2619314
DA 2020-12-01
ER

PT J
AU BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI ULTRASTRUCTURE OF TROPHOBLAST GIANT-CELL TRANSFORMATION DURING THE
   INVASIVE STAGE OF IMPLANTATION OF THE MOUSE EMBRYO
SO JOURNAL OF MORPHOLOGY
LA English
DT Article
RP BEVILACQUA, EMAF (corresponding author), UNIV SAO PAULO,INST BIOMED SCI,DEPT HISTOL & EMBRYOL,CP 4365,BR-01051 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011
OI Bevilacqua, Estela/0000-0003-4178-4625
CR ALDEN RH, 1948, AM J ANATOMY, V82, P143
   Amoroso E.C., 1952, MARSHALLS PHYSIOLOGY, P127
   ATLAS M, 1960, J HISTOCHEM CYTOCHEM, V8, P171, DOI 10.1177/8.3.171
   BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447
   BARLOW PW, 1971, J EMBRYOL EXP MORPHO, V27, P431
   BEVILACQUA EMA, 1984, THESIS U DAO PAULO B
   BILLINGTON WD, 1971, ADV REPROD PHYSIOL, V5, P27
   BOVING BG, 1959, ANN NY ACAD SCI, V80, P1
   COPP AJ, 1978, J EMBRYOL EXP MORPH, V48, P109
   DICKSON AD, 1963, J REPROD FERTIL, V6, P465, DOI 10.1530/jrf.0.0060465
   DICKSON AD, 1969, J ANAT, V105, P371
   DICKSON AD, 1966, J ANAT, V100, P335
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   ENDERS AC, 1965, AM J ANAT, V116, P29, DOI 10.1002/aja.1001160103
   FINN CA, 1967, J REPROD FERTIL, V13, P259
   GARDNER RL, 1973, J EMBRYOL EXP MORPHO, V30, P501
   ILGREN EB, 1981, J EMBRYOL EXP MORPH, V62, P183
   JOHNSON MH, 1977, DEV MAMMALS, P67
   KATZ S, 1987, ANAT EMBRYOL, V176, P251, DOI 10.1007/BF00310059
   Kaufmann MH, 1983, BIOL TROPHOBLAST, P23
   KIRBY DRS, 1965, ANAT REC, V152, P279, DOI 10.1002/ar.1091520307
   KIRBY DRS, 1965, EARLY CONCEPTUS NORM, P393
   LUNDKVIST O, 1977, CELL TISSUE RES, V184, P453
   MADEN BEH, 1973, CELLULAR BIOL MED, P325
   PARR MB, 1986, BIOL REPROD, V34, P393, DOI 10.1095/biolreprod34.2.393
   PEEL S, 1977, J ANAT, V124, P675
   POTTS DM, 1968, J ANAT, V103, P77
   POTTS M, 1969, ADV REPROD PHYSIOL, V4, P241
   PSYCHOYOS A, 1961, CR HEBD ACAD SCI, V252, P1515
   REINIUS S, 1967, Z ZELLFORSCH MIK ANA, V77, P257, DOI 10.1007/BF00340792
   ROSSANT J, 1977, DEVELOPMENT MAMMALS, V2, P119
   SACCOMAN EM, 1967, ANAT REC, V158, P197
   SHERMAN MI, 1972, NATURE-NEW BIOL, V238, P175
   SMITH AF, 1974, CELL TISSUE RES, V152, P525
   Snell GD, 1941, BIOL LABORATORY MOUS, P1
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   WELSH AO, 1987, ANAT REC, V217, P203, DOI 10.1002/ar.1092170213
NR 37
TC 57
Z9 59
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0362-2525
J9 J MORPHOL
JI J. Morphol.
PD DEC
PY 1988
VL 198
IS 3
BP 341
EP 351
PG 11
WC Anatomy & Morphology
SC Anatomy & Morphology
GA R3111
UT WOS:A1988R311100007
PM 3221406
DA 2020-12-01
ER

PT J
AU ZORN, TMT
   BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
AF ZORN, TMT
   BEVILACQUA, EMAF
   ABRAHAMSOHN, PA
TI COLLAGEN REMODELING DURING DECIDUALIZATION IN THE MOUSE
SO CELL AND TISSUE RESEARCH
LA English
DT Article
C1 UNIV SAO PAULO,INST BIOMED SCI,DEPT HISTOL & EMBRYOL,CAIXA POSTAL 4365,BR-01051 SAO PAULO,BRAZIL.
RI Bevilacqua, Estela/H-3354-2011; Zorn, Telma MT TT TMT/C-4065-2008
OI Bevilacqua, Estela/0000-0003-4178-4625; 
CR ABRAHAMSOHN PA, 1983, ANAT EMBRYOL, V166, P263, DOI 10.1007/BF00305087
   BIENKOWSKI RS, 1978, NATURE, V276, P413, DOI 10.1038/276413a0
   ENDERS AC, 1967, AM J ANAT, V120, P185, DOI 10.1002/aja.1001200202
   FAINSTAT T, 1963, AM J ANAT, V112, P337, DOI 10.1002/aja.1001120305
   FARQUHAR MG, 1977, COMP ENDOCRINOLOGY P, P37
   Finn C.A., 1977, BIOL UTERUS, P245
   FINN CA, 1967, J ULTRA MOL STRUCT R, V20, P321, DOI 10.1016/S0022-5320(67)80102-3
   FISCHER N, 1982, ACTA ANAT, V144, P125
   GARANT PR, 1976, J PERIODONTOL, V47, P380, DOI 10.1902/jop.1976.47.7.380
   HENELL F, 1983, VIRCHOWS ARCH CELL P, V36, P319
   JEFFREY JJ, 1981, COLLAGEN REL RES, V1, P257
   JOLLIE WP, 1965, AM J ANAT, V116, P217, DOI 10.1002/aja.1001160111
   KLEINFELD RG, 1976, BIOL REPROD, V15, P593, DOI 10.1095/biolreprod15.5.593
   KREHBIEL ROBERT H[ENRY], 1937, PHYSIOL ZOOL, V10, P212
   LOBEL BL, 1967, ACTA ENDOCRINOL-COP, VS 56, P7
   LUSE S, 1964, ANAT REC, V148, P308
   MANCINI AM, 1982, BASIC APPL HISTOCHEM, V26, P241
   MARCHI F, 1983, AM J ANAT, V168, P167, DOI 10.1002/aja.1001680206
   MARTELLO EMV, ACTA ANAT
   MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0
   OKAMURA H, 1976, Acta Obstetrica et Gynaecologica Japonica (English Edition), V23, P179
   OLIVEIRA SF, 1985, THESIS U SAO PAULO B
   OSHEA JD, 1983, AM J ANAT, V166, P271, DOI 10.1002/aja.1001660304
   PADYKULA HA, 1979, ANAT RECORD, V193, P329, DOI 10.1002/ar.1091930302
   PSYCHOYOS A, 1961, CR HEBD ACAD SCI, V252, P1515
   PSYCHOYOS A, 1960, CR SOC BIOL, V154, P1384
   REVEL JP, 1967, J CELL BIOL, V33, pC7, DOI 10.1083/jcb.33.3.C7
   ROSS R, 1968, BIOL REV, V43, P51, DOI 10.1111/j.1469-185X.1968.tb01109.x
   SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319
   STAUBESAND J, 1977, BEITR PATHOL, V161, P187
   STAUBESAND J, 1980, CONNECT TISSUE RES, V7, P213, DOI 10.3109/03008208009152356
   TACHI S, 1970, J REPROD FERTIL, V21, P37, DOI 10.1530/jrf.0.0210037
   TENCATE AR, 1975, ANAT RECORD, V182, P1
   TENCATE AR, 1972, J ANAT, V112, P401
NR 34
TC 52
Z9 52
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PY 1986
VL 244
IS 2
BP 443
EP 448
PG 6
WC Cell Biology
SC Cell Biology
GA C0334
UT WOS:A1986C033400022
PM 3719669
DA 2020-12-01
ER

PT J
AU FAVADEMORAES, F
   FRIEDMAN, H
   EGAMI, MI
   BEVILACQUA, EMAF
   COSSERMELLI, W
AF FAVADEMORAES, F
   FRIEDMAN, H
   EGAMI, MI
   BEVILACQUA, EMAF
   COSSERMELLI, W
TI HISTOCHEMICAL STUDY OF LABIAL SALIVARY-GLANDS IN SJOGREN SYNDROME
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
C1 UNIV SAO PAULO, DEPT PATHOL, SAO PAULO, BRAZIL.
   UNIV SAO PAULO, FAC MED, DEPT RHEUMATOL, SAO PAULO, BRAZIL.
   HOSP SERVIDOR PUBL ESTADUAL, DEPT PATHOL, SAO PAULO, BRAZIL.
RP FAVADEMORAES, F (corresponding author), INST BIOMED SCI, DEPT HISTOL, SAO PAULO 4365, BRAZIL.
RI BEVILACQUA, ESTELA/H-3354-2011
OI BEVILACQUA, ESTELA/0000-0003-4178-4625
CR ALARCONS.D, 1974, AM J MED, V57, P78, DOI 10.1016/0002-9343(74)90771-2
   BLOCH KJ, 1965, MEDICINE, V44, P187, DOI 10.1097/00005792-196505000-00001
   COHEN A S, 1971, Bulletin on the Rheumatic Diseases, V21, P643
   DAVIES JD, 1973, J PATHOL, V109, P307, DOI 10.1002/path.1711090405
   EVERSOLE LR, 1972, ARCH ORAL BIOL, V17, P1225, DOI 10.1016/0003-9969(72)90093-3
   FIESSINGER JN, 1975, NOUV PRESSE MED, V4, P3177
   GALLETTA VP, 1975, THESIS U SAO PAULO
   GALLETTA VP, 1972, THESIS U SAO PAULO
   GREENSPAN JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4
   HARRISON JD, 1976, J PATHOL, V118, P245, DOI 10.1002/path.1711180407
   KATZ WA, 1972, ANN RHEUM DIS, V31, P384, DOI 10.1136/ard.31.5.384
   LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309
   LISON L, 1960, HISTOCHEMIE CYTOCHEM
   MCMANUS JFA, 1946, NATURE, V158, P202, DOI 10.1038/158202a0
   MCMANUS JFA, 1950, J EXP MED, V91, P651, DOI 10.1084/jem.91.6.651
   MEDSGER TA, 1971, ANN INTERN MED, V74, P714, DOI 10.7326/0003-4819-74-5-714
   QUINTARELLI G, 1961, J HISTOCHEM CYTOCHEM, V9, P176, DOI 10.1177/9.2.176
   QUINTARELLI G, 1961, ACTA HISTOCHEM, V12, P1
   ROPES M W, 1958, Bull Rheum Dis, V9, P175
   SCOTT J, 1976, J ORAL PATHOL MED, V5, P334, DOI 10.1111/j.1600-0714.1976.tb01785.x
   SCOTT JE, 1965, HISTOCHEMISTRY, V5, P221, DOI 10.1007/BF00306130
   SHACKLEFORD JM, 1962, AM J ANAT, V111, P25, DOI 10.1002/aja.1001110104
   SPICER SS, 1964, ANAT REC, V149, P333, DOI 10.1002/ar.1091490304
   TANDLER B, 1969, J MORPHOL, V127, P383, DOI 10.1002/jmor.1051270402
   TARPLEY TM, 1974, ORAL SURG ORAL MED O, V37, P64, DOI 10.1016/0030-4220(74)90160-1
   TERNER JY, 1963, J HISTOCHEM CYTOCHEM, V11, P804, DOI 10.1177/11.6.804
NR 26
TC 2
Z9 2
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PY 1978
VL 7
IS 3
BP 135
EP 142
DI 10.1111/j.1600-0714.1978.tb01589.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA FH194
UT WOS:A1978FH19400003
PM 98631
DA 2020-12-01
ER

EF